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Abstract 
This thesis reports the synthesis of novel, air-stable, fluorescent phosphorus-containing 
compounds, based on a Bodipy backbone, and their applications in cell imaging and catalysis. The 
syntheses of all the novel target compounds reported in this thesis are via a primary phosphine, an 
under-utilised class of compound due to a hazardous reputation. Chapter 1 explores the stability of 
primary phosphines, how they can be made user-friendly and the ability to create a library of novel 
phosphorus compounds via the phosphorus-hydrogen bonds. The LJH group synthesised the first, 
air-stable, fluorescent primary phosphine and Chapter 2 explores a second generation of this type 
of ligand with an increased fluorescent quantum yield due to the addition of alkyne groups on the 
boron atom. Chapter 3 details the coordination chemistry of primary phosphines to group 6 and 8 
transition metals. Interestingly, the addition of the metals had different effects on the photophysical 
properties, group 6 metal complexes retained high quantum yields, whereas group 8 metals 
quenched the fluorescence, possibly due to the heavy atom effect. 
 
 
Chapter 4 discusses the synthesis of fluorescent phosphonium salts which have the potential to be 
used as trifunctional imaging agents. The three functions within the compounds include i) a 
fluorophore, to provide in vitro fluorescence imaging, ii) a positive charge on the phosphorus atom 
to introduce organelle specificity – in this case, to the mitochondria and iii) the inclusion of an 18F 
radioisotope enables in vivo imaging techniques such as PET imaging. Chapter 5 shows further 
versatility of fluorescent primary phosphines where we report the synthesis of a novel, chiral, 
fluorescent phosphonite ligand that has been tested for its applications as a catalyst in asymmetric 
hydrogenation reactions of a benchmark substrate. The results showed full conversion and an 
enantiomeric excess (ee) of >99%. The final chapter discusses the importance of the aryl linker 
between the Bodipy core and the phosphorus atom. The compounds synthesised in this chapter 
show decreased fluorescence when the phosphorus atom is directly bound to the fluorophore and 
have potential applications as a switch. 
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 Background and Introduction 
1.1 Organophosphorus Compounds 
Organophosphorus compounds are phosphorus-containing organic molecules that have a range of 
applications in catalysis,1 medicine,2, 3 agriculture4 and the plastics industry, where phosphorus is 
commonly used as a flame retardant.5 Phosphorus is also found in natural products, such as a 
phosphate group – found in DNA, or as a C-P bond in compounds such as 2-aminoethylphosphonic 
acid and Fosfomycin, an effective antibiotic produced by certain Streptomyces species, both shown 
in Figure 1.1.6, 7 
 
Figure 1.1 Natural products containing a C-P bond. 
1.2 Phosphines 
Of particular interest to this thesis are the phosphine compounds R3P, and their derivatives, the 
phosphonium salts [R4P][X], their general structures are shown in Figure 1.2. The chemistry of 
phosphines is usually centred on the donation of the lone pair on the phosphorus atom to 
electrophilic centres.8 Often, phosphines adopt a pyramidal structure, and if one assumes that the 
lone pair points out from the top of the pyramid, it is easy to understand that as the size of the 
substituents on the phosphorus atom increase, it is more difficult for the lone pair to bond with 
reagents. 
In 1977, Tolman wrote a review which described the effects that steric hindrance has on phosphorus 
ligands in organometallic chemistry and homogeneous catalysis. He noted that prior to 1970 almost 
everything was rationalised in terms of electronic effects.9 
 Steric Parameters of Phosphorus Ligands 
The Tolman cone angle T is commonly used to describe the steric effects of phosphorus ligands. 
The steric parameter, when all three substituents are the same, was defined as the apex angle of a 
cylindrical cone, centred 2.28 Å away from the phosphorus atom and the edges of the cone just 
touching the Van der Waals radii of the outermost atoms, shown in Figure 1.2.  
3 
 
 
Figure 1.2 General structures of a phosphine and a phosphonium salt, and a schematic of the Tolman cone 
angle. 
 Electronic Parameters of Phosphorus Ligands 
Tolman also used IR spectroscopy to determine the electronic parameter, , of phosphorus ligands, 
by determining the symmetric frequency of [Ni(CO)3L] complexes. The stretching frequency of 
the carbonyl vibration is dependent on the other ligands and the magnitude depends on the 
electronic nature of the complex. The phosphine ligand acts as a -donor which increases the 
electron density on the metal, the electron density is transferred through -backbonding into the π* 
anti-bonding orbitals of the carbonyl group, which reduces the bond order of CO, as shown in 
Figure 1.3. Therefore, good net donor ligands are indicated by a shift of the CO stretching 
frequencies to lower wavenumbers, as they are lower in energy.10 
 
 
Figure 1.3 Back-bonding into the anti-bonding orbital of the carbonyl group. 
In 2009 Gusev published a paper comparing the donor properties of a range of two-electron ligands. 
Where Tolman only used [Ni(CO)3L] complexes to identify CO stretching frequencies, Gusev also 
used [IrCl(CO)2L] and [IrCp(CO)L] complexes, as well as DFT calculations to find a relationship 
between the structural and experimental findings. After deducing that there were still complications 
when using the [IrCl(CO)2L] complex, due to two CO groups, he concluded that the [IrCp(CO)L] 
complex was the most advantageous due to the following factors: 1) low coordination number, 
therefore minimising any ligand repulsion, 2) only one CO ligand as opposed to two or three CO 
ligands reduced complications when analysing the IR spectra, 3) the CO ligand is at 90 angle to 
4 
 
the ligand L avoiding any interference due to the trans influence, as illustrated in Figure 1.4. There 
was found to be a high correlation between the observed IR stretching frequencies of the CO 
ligands and the DFT calculations for the [Ni(CO)3L] and [IrCp(CO)L] complexes.
11 
 
 
Figure 1.4 Structures of the [IrCp(CO)L] complexes, L = pta (1,3,5-triaza-7- phosphaadamantane) and biy 
(1,3-dibutylimidazolin-2-ylidene).11 
 Phosphine Ligands of Relevance 
This introductory chapter started with organophosphorus compounds of biological interest and one 
of the research aims of the LJH research group is the development of phosphorus compounds with 
biological applications. 
Phosphines are extremely versatile and can be used in several applications such as medicine; 
previous work within the Higham research group resulted in the synthesis of fluorescent rhenium 
complexes 2 and 3 from tridentate phosphorus compound 1a, based on the fluorophore Bodipy, 
shown in Figure 1.5.12 Tridentate phosphine 1a was reacted with [Re(CO)5][OTf] to produce 
tricarbonyl species 2 and [ReCl(CO)3(PPh3)2] to form complex 3. Rhenium and technetium are 
both in group 7 of the periodic table; however, technetium is radioactive. The two elements have 
similar chemistries; therefore, synthesising rhenium complexes as a cold standard for the 
radioactive technetium analogues would allow for comparisons between the two compounds to be 
made. 
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Figure 1.5 Synthesis of rhenium complexes 2 and 3 from tridentate phosphorus compound 1a to produce a 
cold standard for a SPECT imaging agent. 
Both Bodipy-rhenium complexes 2 and 3 underwent a preliminary screening for cell testing in 
prostate carcinoma (PC-3) cells, shown in Figure 1.6. The two complexes displayed notable 
differences in the cell screening; compound 3 (top row) allowed for high resolution imaging and 
enabled visualisation of organelles without any apparent cytotoxic effects, whereas compound 2 
(bottom row) caused some morphological changes to the cells. This enables the tricarbonyl 
complex to act in a therapeutic mode by promoting cell death. Complexes 2 and 3 both possessed 
negligible cytotoxicity at the concentrations required for SPECT (Single Photon Emission 
Computed Tomography) (Section 1.71) scanning and therefore both have the potential as imaging 
agents. 
 
Figure 1.6 Imaging of PC-3 living cells with: top: cis-[ReCl(CO)2(1a)], bottom: fac-[Re(CO)3(1a)] (A) 
brightfield image, (B) green channel λex = 460-500 nm, long pass filtered at 510 nm, C) overlay of A and B. 
The rhenium complexes constituted a cold standard for a corresponding technetium complex for 
use in SPECT imaging. Tridentate Bodipy compound 1a was reacted with 
fac-[99mTc(CO)3(OH2)3]
+ to form complex 4. The crude reaction was monitored by HPLC which 
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displayed a single peak and matched well with triphos derivative 5 and the cold standard rhenium 
complex 2 as shown in Figure 1.7. 
 
    
Figure 1.7, 99mTc Bodipy complex 4, Triphos control 5, and the HPLC chromatogram used for comparing the 
crude reactions of rhenium and technetium complexes showing analogous physical properties. 
Technetium complex 4 was the first example of a phosphine-based, multi-functional imaging agent 
comprised of (i) a tridentate phosphine for kinetic stability, (ii) a fluorophore for in vitro imaging 
and (iii) a radioactive metal centre for in vivo imaging via SPECT. 
 Multifunctional Imaging Agents 
The development of multimodal imaging agents, as opposed to single-modality imaging agents, is 
becoming increasingly popular due to the ability to overcome the current limitations of individual 
imaging techniques. One such limitation is the inability of radiopharmaceuticals to image the fate 
of the agents at a cellular level, which would increase the understanding of biological mechanisms 
and the localisation within a cell.13 In vitro techniques such as fluorescence microscopy produce a 
higher spatial resolution than PET or SPECT radioimaging, (nm scale rather than mm), which 
would make it possible to follow mechanisms and processes at a subcellular level. Combination of 
the two imaging techniques would produce dual imaging agents that could provide a more detailed 
explanation of the events occurring within a cell. 
Valliant synthesised a rhenium/technetium complex in 2004, based on a tridentate nitrogen ligand 
which is shown in Figure 1.8. It was synthesised as a multifunctional imaging agent consisting of 
(i) a radionuclide - 99mTc - for in vivo SPECT imaging, (ii) a quinoline fluorophore for fluorescence 
microscopy, an in vitro imaging technique, (iii) a tridentate nitrogen ligand to provide chelation 
stability of the metal and (iv) a peptide which can be used to guide radionuclides to a specific target 
receptor.14 
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Figure 1.8 Valliant’s multifunctional imaging agent. 
Valliant used quinoline as a fluorophore in his complex; in the research that the Higham group are 
interested in, Bodipy is the fluorophore of choice, which will be discussed in detail in Section 1.5. 
There are other reports published in the literature showing the versatility of the Bodipy dye as a 
dual imaging agent. Li et.al. reported that the Bodipy structures shown in Figure 1.9 were used 
successfully as PET/fluorescent imaging probes after an efficient [19F/18F] exchange at the boron 
atom.15, 16 Li commented that [18F]-BAP-1 holds great potential for the diagnosis of Alzheimer’s 
disease (AD), the cold analogue which contains 19F has been developed for AD imaging by 
targeting cerebral β-amyloid plaques. By incorporating an 18F radiolabel into the molecule, it makes 
it possible to correlate the images from the fluorescence imaging with images from SPECT scans 
to visualise the mode of action and the fate of radiopharmaceuticals within the body. [18F]-V is an 
example of a trifunctional imaging agent, as well as the fluorescent core and the radiolabel for both 
in vitro and in vivo imaging techniques respectively, the positively charged ammonium group 
would guide the molecule to the myocardium, due to the attraction to the negatively charged 
mitochondrial matrix. [18F]-V was tested as a heart imaging agent in mice models and successfully 
showed accumulation in the myocardium.16 This multi-modal imaging agent is a foresight into the 
target compounds synthesised within this project. 
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Figure 1.9 Bodipy compounds for potential use in AD diagnosis and cardiac imaging.  
In 2016, Min et. al. published a review on radiolabelled tetraphenylphosphonium cation derivatives 
as myocardial imaging agents for PET, two examples of which are shown in Figure 1.10.17 
Triphenylphosphonium cations can penetrate cell and organelle membranes and accumulate in the 
mitochondria and heart cells due to the increased membrane potential as the positive charge is 
attracted to the negatively charged mitochondrial matrix. The authors noted that the alkyl-chain-
conjugated triphenylphosphonium cations had improved characteristics through lipophilicity 
control. 
 
Figure 1.10 Radiolabelled phosphonium cations with applications in myocardial imaging.  
The previous examples were of organophosphorus compounds used in imaging, this next section 
introduces phosphorus-containing therapeutics such as RAPTA-C, a ruthenium-based, anti-cancer 
drug, shown in Figure 1.11. Ruthenium complexes have shown great potential in treating cancers 
that have platinum drug resistance, as well as exhibiting fewer side effects and lower toxicity.18  
Dyson and co-workers have researched the anticancer properties of ruthenium half sandwich 
compounds coordinated to various arene ligands.19 The pta ligand (1,3,5-triaza-7-
phosphatricyclo[3.3.1.1]decane), is hydrophilic and promotes good aquatic solubility, which is 
important in therapeutic applications. The labile chloride ligands undergo aquation, (substitution 
for water), in a similar way to Cisplatin, which may be an important step for anticancer drug 
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activity. At physiological pH, the major species carries no charge and can diffuse through lipid 
membranes and move freely through cells. In some unhealthy cells, the pH is lower due to 
associated changes in metabolism, which can protonate the pta ligand, trapping the complex in the 
cell. Dyson et.al have completed studies that show protonated species induce DNA damage in cells 
more readily than un-protonated species.20  
 
 
Figure 1.11 The synthesis of RAPTA-C from a ruthenium dimer [RuCl2(p-cymene)] and pta (1,3,5-triaza-7-
phosphatricyclo[3.3.1.1]decane). 
Bodio and co-workers synthesised a Bodipy phosphine and the corresponding ruthenium 
(compound 6, Fig. 1.12), gold and osmium complexes. All of the metal complexes were tested in 
human ovarian cancer cell lines A2780S and A2780cisR which were sensitive and are now resistant 
to Cisplatin. Bodio’s complexes showed moderate cytotoxicity and a preference for accumulation 
in the cell membrane. The fluorescence properties of the complexes associated with the Bodipy 
ligand showed good emission and water solubility, which allowed for the monitoring of the 
compounds in cancer cells in vitro.21 
 
Figure 1.12 Bodio and co-workers synthesised ruthenium complex 6 as an imaging organometallic complex. 
The examples described above have outlined various imaging techniques including fluorescence 
microscopy, SPECT and PET imaging, and the targeting of specific organelles within a cell. The 
primary target for this thesis is to develop a multi-modal compound that facilitates all of these 
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imaging techniques. The four functions that will be relevant to this project will now be discussed 
in detail: (i) primary phosphine synthesis, as a precursor to tridentate ligands that confer kinetic 
stability on resulting complexes, (ii) the fluorescent Bodipy core for in vitro imaging, (iii) 
incorporation of a radionuclide such as 18F or 99mTc for PET and SPECT imaging, and (iv) a moiety 
that would allow for the direct targeting of an organelle, such as a phosphonium salt. 
 
 Primary Phosphines 
An important class of compound for this thesis is the primary phosphine, which consists of two 
phosphorus-hydrogen bonds connected to an aryl or alkyl backbone. Working with primary 
phosphines is often assumed to be problematic due to their toxic and pyrophoric nature; however, 
the P–H bonds are highly reactive making them an excellent starting material for synthesising a 
range of functionalised phosphorus compounds.22, 23 Figure 1.13 shows several types of reactions 
that can occur by starting with a primary phosphine. 
 
Figure 1.13 A range of reactions that can occur through a primary phosphine; R/Rʹ = alkyl or aryl group, 
X = halogen, Z = PR2, NR2. 
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The decomposition of primary phosphines occurs by an oxidation reaction with the formation of a 
strong P=O bond (544 kJ/mol) acting as the driving force.24 Scheme 1.1 shows how primary 
phosphines are initially oxidised to phosphine oxides, before further oxidation which can result in 
phosphinic and phosphonic acid formation.8 
 
Scheme 1.1 A series of oxidation steps which are possible starting from a primary phosphine. 
Despite this oxidation, it is possible to prepare certain primary phosphines which are “user-
friendly”, and within the past decade the number of air-stable examples in the literature has steadily 
increased, although there still remains fewer than twenty examples.23 The stability of these 
compounds can be attributed to two main phenomena: steric effects and electronic effects. 
 
It is essential to define the interpretation of “air-stable phosphines” within this research, and for 
the purpose of this thesis it is regarded as the measure of resistance of a primary phosphine to 
undergo oxidation by aerobic oxygen, and here we regard air-stable primary phosphines as those 
that display inertness to oxidation over several weeks. It is also worth noting that different authors 
have different definitions for “air-stable”, making it difficult to directly compare examples within 
the literature.  
1.2.5.1 Steric Protection 
There are a number of primary phosphines in the literature that owe their stability, with respect to 
air-oxidation, to the steric bulk which surrounds the phosphorus, inhibiting the reaction with 
dioxygen. Three examples can be seen in Figure 1.14, phenylphosphine 7, is a highly air-sensitive 
and pyrophoric liquid which undergoes oxidation rapidly. However, as you add substituents around 
the phosphorus atom such as the methyl groups in mesitylphosphine 8, an increase in stability to 
air-oxidation is observed.25 A further increase in stability is seen for 9, supermesitylphosphine, 
which is described as odourless and air-stable.26 
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Figure 1.14 Steric properties can help to protect primary phosphines from oxidation.  
1.2.5.2 Unexplained Stability 
There are several examples in the literature where steric hindrance cannot explain the stability 
towards air-oxidation. Figure 1.15 shows four examples; compounds 10 and 11 have been 
identified as air stable, the origin of which has been suggested as being due to negative 
hyperconjugation arising from the presence of the heteroatoms - however this is only a theory and 
has not been proven experimentally.27 Henderson and co-workers postulated that the alkyl spacer 
between the ferrocene moiety and the phosphine was responsible for the air stability of compounds 
13a and 13b, as compound 12 was found to be unstable in air, but no further explanation was 
provided.28 A DFT-based model has been developed within the Higham group which may be able 
to offer an alternative explanation for the stability of these compounds, and is described next, in 
Section 1.2.5.3. 
 
Figure 1.15 Examples of primary phosphines where steric effects are not responsible for their air-stability. 
1.2.5.3 Electronic Effects 
The aforementioned examples shown in Figure 1.15 demonstrate that an alternative explanation 
must be in operation here, rather than steric encumbrance. The Higham group has also synthesised 
several primary phosphines that are stable in air, and do not contain any steric encumbrance; 
therefore, it was necessary to consider the electronic nature of these compounds in some detail. 
Figure 1.16 shows two such examples, in this instance of chiral primary phosphines synthesised 
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within the research group for use as precursors to ligands with applications in transition metal 
catalysed asymmetric transformations, namely (S)-H-MOPH2 14 and (R)-MOPH2 15.
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Figure 1.16 Chiral primary phosphines 14 and 15 have significant π-conjugation and were found to be air-
stable. 
The LJH research group developed a computational model based on Density Functional Theory 
(DFT) calculations using the B3LYP function with a 6-31G* basis set in order to understand the 
relationship between phosphines and their stability in air.30 The energies of the neutral primary 
phosphines and their radical cations were both calculated, as it is thought that the route to oxidation 
may occur via the radical cation; in 2005, Majima et al. described how the photoreaction of 
triarylphosphines resulted in their oxidation to the corresponding phosphine oxide. Laser flash 
photolysis and further analysis suggested that the radical cation of the triarylphosphine was initially 
formed, which eventually led to the formation of the oxide, see Figure 1.17.31  
 
 
 
Figure 1.17 Proposed steps in the photolytic oxidation of a tertiary phosphine. 
Initial findings showed one particular trend for the Highest Occupied Molecular Orbital (HOMO) 
in the neutral phosphines. It was found that the HOMO of the air-stable phosphines was situated 
on the backbone of the compound and away from the phosphorus atom as represented by 
compounds 11, 13a and 14 in Figure 1.18. The air-sensitive phosphines, such as phenylphosphine 
7, demonstrated that the phosphorus was incorporated into the HOMO.   
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Figure 1.18 DFT calculations showing that the HOMO is delocalised away from the phosphorus atom on 
compounds which are experimentally found to be air-stable; note how compound 7 demonstrates phosphorus 
participation in the HOMO – this is a very air-sensitive compound. 
           
However, the model showed that the HOMO for the tertiary phosphine, triphenylphosphine 16, 
does contain the phosphorus atom – shown in Figure 1.19. As triphenylphosphine is an air-stable 
compound, the localisation of the phosphorus in the HOMO or not is unlikely to be able to explain 
the air-sensitivity of phosphines. 
                                                       
 
Figure 1.19 DFT calculations for triphenylphosphine showed that the phosphorus was incorporated into the 
HOMO. As PPh3 is air-stable, this appears to rule out P atom participation in the HOMO (or not) as a 
rationale for air-stability. 
 
Next, the corresponding radical cations of the aforementioned phosphines were studied and it was 
found that the phosphorus atom was incorporated into the Singly Occupied Molecular Orbital 
(SOMO) in all cases. More importantly, there also appeared to be a threshold SOMO energy value 
which correlated with resistance towards air-oxidation. When the energies of these SOMOs were 
plotted against their experimental air-stability, all of the primary phosphines with a SOMO energy 
below −10 eV were found to be experimentally air-stable, whereas those above this value are found 
to be air-sensitive. A graph showing these SOMO energies for a range of primary phosphines is 
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shown in Figure 1.20. Compounds 10, 11, 13a and 14 all have SOMO energies below –10 eV and 
are predicted to be stable to air-oxidation - which was found experimentally to be true. Compounds 
7, 12, 17, 18 and 19 have SOMO energies above –10 eV and therefore are predicted to be unstable, 
which was also confirmed in laboratory testing. 
   
 
 
 
 
 
 
 
One explanation for this phenomenon is that whilst increased π-conjugation in a molecule leads to 
higher energy orbitals, less or no conjugation will afford more stable ones. As such, a radical cation 
generated by the removal of an electron from a stable orbital will be more reactive, and enter into 
an irreversible oxidative chain reaction. The aforementioned work by Majima and Neta support 
this theory.32, 33Efforts to understand this proposed mechanism in better detail are underway. 
Fluorophores also tend to be highly conjugated, and we were interested to ascertain if a primary 
phosphine with a Bodipy function, (highlighted in blue in Figure 1.21), would be air-stable. The 
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Figure 1.20 Plot showing the SOMO energies for a range of air-stable and air-sensitive primary phosphine radical 
cations, separated by an apparent threshold value of -10 eV. 
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DFT-based computational model gave SOMO values of –8.82 eV for 20a and –8.94 eV for 20b 
and they are indeed air-stable. Compounds 20a/20b are the first examples of air-stable, fluorescent 
primary phosphines and were synthesised within the Higham group in 2012.34 In addition, primary 
phosphines 20a/20b readily undergo hydrophosphination reactions to form tridentate compounds 
such as 1a/1b (BodP3), also shown in Figure 1.21, which remain highly fluorescent. The 
hydrophosphination of primary phosphines has been used as a means of generating tridentate 
phosphine ligands for coordinating a range of transition metals.12  
The significance of the addition of a phosphorus atom on the photophysical properties of these 
compounds will be discussed in detail in the following section, because if the incorporation of the 
phosphorus atom causes fluorescence quenching, this will render them inapplicable as potential 
imaging agents.  
 
Figure 1.21  The first examples of an air-stable, fluorescent primary phosphine 20a/20b that can undergo a 
hydrophosphination reaction to give tridentate phosphines 1a/1b. 
1.3 Luminescence 
Luminescence is the emission of photons from an electronically excited species. There are many 
types of luminescence, including chemiluminescence (the emission of light due to chemical 
reactions), and photoluminescence (the emission of light due to the absorption of photons).35 
 Photoluminescence 
Fluorescence is a type of photoluminescence and occurs when a photon relaxes from the singlet 
excited state to the singlet ground state (S1-S0), detailed in the Jablonski diagram shown in Figure 
1.22.36 There are also other pathways for de-excitation such as internal conversion and intersystem 
crossing, which may result in emission by phosphorescence, a spin-forbidden transition, where a 
photon relaxes from the triplet excited state to the singlet ground state (T1-S0). 
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Figure 1.22 Schematic of a Jablonski Diagram outlining the important pathways of luminescence. 
1.4 Fluorescent Dyes and Stains 
Dyes and stains can be used to detect and visualise structures and processes within biology. Many 
of them contain a fluorescent component because they can be detected with incredible sensitivity, 
in principle to ‘single molecule detection’ levels of sensitivity.35, 37 A fluorophore can repeatedly 
undergo the process of fluorescence, which means that a single fluorophore can generate a signal 
multiple times, making it a very sensitive technique for visualising biological samples. Fluorescent 
molecules are often used to visualise cells or tag part of a cell, there are many dyes and stains that 
can be purchased for these applications. Figure 1.23 shows three well known fluorophores, which 
can all be used for cell detection and live-cell imaging: Ethidium Bromide, Fluorescein and 
Bodipy.38  
 
Figure 1.23 Three well known fluorophores used for detection and imaging within cells: Ethidium Bromide, 
Fluorescein and Bodipy. 
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1.5 Bodipy 
Bodipy (4,4-difluoro-4-borata-3a-azonia-4a-aza-s-indacene), shown in Figure 1.24, is one of the 
most versatile fluorophores available, due to it possessing many desirable properties, including (i) 
high quantum yields, (ii) a strong UV absorption profile and sharp fluorescence emission peak, (iii) 
high thermal and photochemical stability, (iv) negligible triplet state formation and (v) chemical 
robustness.39, 40  
 
Figure 1.24 Bodipy (4,4-difluoro-4-borata-3a-azonia-4a-aza-s-indacene) core structure. 
Figure 1.25 shows a typical Bodipy spectrum, where the absorption and emission maxima are 
characteristically around 500-530 nm; the Stokes shift is the energy gap between the maximum of 
the absorption and maximum of the fluorescence spectra. The Stokes shift is observed due to the 
loss of energy through non-radiative vibrational relaxations. For many fluorophores, a symmetrical 
absorption and emission spectra is observed, like a mirror image. This is due to the same transitions 
between S0 and S1 being the most favourable for both absorption and emission; however, there are 
exceptions to this rule that can alter a spectrum, such as S0-S2 transitions. These S0-S2 transitions 
have been noted for some Bodipy compounds and usually appear as a broad peak around 375 nm.  
 
The fluorescence quantum yield (Φ) is an important tool for identifying the efficiency of a 
fluorophore to emit light. It is measured as the ratio between the number of photons emitted through 
fluorescence to the total number of absorbed photons - usually out of 1. Fluorophores with a 
quantum yield close to 1 are the best emitters, although several factors can influence the quantum 
yield of a fluorophore, including both temperature and solvent polarity.39 
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Figure 1.25 A typical Bodipy absorption and emission spectrum recorded in THF at room temperature. 
The symmetrical Bodipy core is synthesised by a pyrrole condensation reaction. Two pyrrole units 
are bridged together by a highly electrophilic carbonyl, followed by an oxidation and finally the 
addition of boron trifluoride diethyl etherate to close the structure, as shown in Figure 1.26.40  
 
 
Figure 1.26 General synthesis of a symmetrical Bodipy system. 
 Modifications to the Bodipy Core 
It is also possible to make unsymmetrical Bodipy compounds, such as 21 and 22. The authors 
observed relatively small differences in terms of the absorption and emission maxima, and the 
quantum yields of these compounds compared well to symmetrical Bodipy systems (Fig. 1.27).41 
Comparison of compounds 21-24 generally showed a trend in red-shifted absorption and emission 
maxima as more substituents were introduced to the Bodipy core.  
Stokes shift 
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Figure 1.27 Unsymmetrical and symmetrical Bodipy compounds 21-24 (measurements recorded in ethanol). 
A common position for the addition of further groups on to the Bodipy backbone is the meso-
position at carbon 8 (Figure 1.24). It has been noted that the addition of alkyl and aryl groups at 
the 8-position have little effect on the absorption or emission wavelengths. However, further 
addition of substituents on the 1 and 7 positions has large effects on the quantum yield. The 
quantum yield of 25 is far less than the quantum yield of 26 (0.19 and 0.65 respectively). This has 
been attributed to the 1,7-substituents inhibiting free rotation about the phenyl group decreasing 
the loss of energy from the excited states by way of non-irradiative molecular motions.39, 42 
Similarly, the more substituted the aryl group on the meso-position, the higher the quantum yield - 
compare compounds 27 and 28 shown in Figure 1.28. 
 
Figure 1.28 Substituted Bodipy cores have higher quantum yields which is attributed to the inhibition of free 
rotation about the phenyl group. 
An F-Bodipy core with methyl groups on the 3 and 5 positions, such as compound 29 in Scheme 
1.2, has been shown to be capable of undergoing chemical modifications due to the strong 
nucleophilic character of the methyl carbon atoms. The ability to extend the degree of 
π-conjugation at these 3 and 5 positions results in a bathochromic shift of the absorption and 
emission maxima.40, 43 Both the mono- and di-substituted products can be obtained by varying the 
reaction times. The excitation wavelength of a fluorophore is important when they are being 
considered for imaging agents because fluorophores with a short wavelength (~500 nm, the 
blue/green region) have poor tissue penetration, and can be used for imaging cells and organelles 
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in vitro. The optimal excitation wavelengths are in the deep-red or near-infrared range (650-900 
nm) as they have good tissue penetration and there is low autofluorescence, which limits the 
interference of background light with the images that are being produced.44 Autofluorescence is 
the natural emission of light by biological structures, such as the mitochondria and can be 
problematic in fluorescence microscopy due to interference with the detection of a specific 
fluorescent signal.45  
 
Scheme 1.2 Mono and di-substituted styryl-Bodipy derivatives achieved by condensation of 3,5-dimethyl 
Bodipys and aromatic aldehydes. 
Mono- and di-substitution at these methyl groups can have an effect on the photophysical properties 
of a compound. An example, shown in Figure 1.29, compares the spectral data for the mono-
substituted compound 30 and the di-substituted compound 31. The study showed that the presence 
of the extra styryl group (compound 31) gives a bathochromic shift in the UV absorbance of almost 
100 nm and >50 nm in the emission spectrum. It was also noted that the quantum yields increased 
when the amine was protonated, due to Intramolecular Charge Transfer (ICT) in the excited state 
being disfavoured.46 
 
Figure 1.29 The spectral data of mono-substituted compound 30 and di-substituted compound 31, compared 
in methanol. 
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 Preparation of C-Bodipys from F-Bodipys 
The fluorines of the BF2 group can be substituted for an alkyl or aryl group using lithium or 
Grignard reagents to form C-Bodipys. The addition of two equivalents of the reagent to precursor 
32 produces the di-substituted product 33. However, it is possible to control the substitution by 
using only one equivalent at low temperatures, in order to achieve mono-substituted Bodipy 
compounds such as compound 34 (Scheme 1.3). 
 
 
Scheme 1.3 Synthesis of C-Bodipys using Grignard reagents. 
Synthesis of ethynyl (E-Bodipy) systems are also possible by the addition of ethynyl groups on to 
the boron atom. Compounds 35 and 36, shown in Figure 1.30, were synthesised from 
4-lithioethynyltoluene and 1-lithioethynylpyrene, respectively. Compound 36 was successfully 
conjugated to proteins, including bovine serum albumin and maintained a high fluorescence 
quantum yield.47, 48  
The addition of ethynyl groups to the boron atom does not however bring them into conjugation 
with the Bodipy core, therefore similar absorption and emission maxima were observed as for the 
C-Bodipy systems.47 The synthesis of ethynyl Bodipy structures will be discussed further in 
Chapter 2.  
  
Figure 1.30 Synthesis of E-Bodipy systems by the incorporation of ethynyl groups onto the boron atom. 
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 Photoinduced electron Transfer (PeT) 
Photoinduced electron Transfer (PeT) is an excited state electron transfer process, and can 
sometimes lead to fluorescence quenching. There are various examples of Bodipy dyes being used 
as sensors to detect changes within a process, for example, a change in pH or the presence of metal 
ions, which can be indicated by an increase or decrease in fluorescence.49, 50 
PeT occurs in a system containing an electron donor (D) and an acceptor (A), which when they are 
combined, form a D+A- species, which can then return to the ground state without photon emission. 
Both oxidative and reductive PeT processes are possible, shown schematically in Figure 1.31. The 
flow of electron donation is determined by the redox potentials of the fluorophore and the quencher. 
 
Figure 1.31 Adapted schematic of reductive PeT (left), where an electron is transferred from the HOMO of 
the quencher donor to the HOMO of the excited fluorophore acceptor and (right) oxidative PeT, where an 
electron is transferred from the LUMO excited fluorophore donor to the LUMO of the quencher acceptor.35  
 Fluorescence Quenchers 
Fluorescence quenching refers to any process which diminishes the fluorescence intensity of a 
compound. There are several processes responsible for this, including excited state reactions, such 
as excimer formation, energy transfer and collisional quenching. 
The formation of excimers (excited dimers formed by the collision of an excited molecule with an 
identical unexcited molecule) and exciplexes (excited complexes formed by the collision of an 
excited molecule with a non-identical unexcited molecule) also decrease the fluorescence. The 
formation of excimers and exciplexes is a diffusion-controlled process and occurs more frequently 
in more highly concentrated solutions.51 
Another form of quenching can be due to the presence of heavy atoms which promotes intersystem 
crossing, a non-radiative transition between two electronic states with different spin multiplicity 
e.g. S1-T1. This process is formally spin forbidden, although if the coupling between the orbital 
magnetic moment and the spin magnetic moment i.e spin-orbit coupling, is large enough, it can 
make this process possible. Heavy atoms often increase spin-orbit coupling, which in turn promotes 
intersystem crossing.51 Another spin-forbidden process is phosphorescence, the emission of a 
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photon from an excited triplet state to the ground singlet state (T1-S0), shown in the Jablonski 
diagram in Figure 1.22. 
This section has touched upon one important compound, 2 a tridentate phosphine-containing 
rhenium complex that was successfully used to image cancer cells, and subsequently led to the 
preparation of the technetium analogue 4.12 In the next section, examples of other fluorescent 
phosphorus-containing compounds are briefly discussed. 
1.6 Phosphorus-containing Fluorescent Compounds 
Fluorescent compounds containing nitrogen are common in applications such as near-infrared 
sensors and switches,52, 53intra-molecular charge transfer,54 as OFF-ON fluorescent chemosensors 
and chemodosimeters for Cu2+ and Pb2+ complexes,55 as pH indicators56 and in the production of 
fluorescent carbon nanotubes.57 
However, fluorescent molecules containing phosphorus are much less common, perhaps due to an 
assumption that a heavy atom could cause fluorescence quenching. Examples that are known in the 
literature usually refer to phosphonates, phosphine oxides and phosphonic acids.4, 58  
Phosphonic acids and bisphosphonates have shown potential applications in bone imaging, due to 
their high affinity for calcium (II), which leads to accumulation of these compounds in areas with 
increased bone metabolism.59, 60   
 
In 2013, Ishow and co-workers published their findings on fluorescent phosphonic and carboxylic 
acid nanoparticles. In particular the phosphonic acid derivatives, such as compounds 37a/37b have 
been shown to chelate to metal oxide surfaces and form magnetofluorescent core-shell 
nanomaterials.61 Yetimoğlu et.al. described how a fluorescent vinyl phosphonic acid had been 
synthesised as a sensor for Hg(II) detection in aqueous solution62 and fluorescent phosphine oxides 
such as 38 act as efficient blue Thermally Activated Delayed Fluorescent (TADF) diodes, described 
by Huang et al.63  
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Figure 1.32 Ishow’s fluorescent phosphonic acid 37a, phosphonate 37b and Huang’s phosphine oxide 38. 
In 2015 Xiao and co-workers reported the synthesis of novel compounds PODIPY (phosphorus-
dipyrromethene) 39 and aza-PODIPY (phosphorus-azadipyrromethene) 40. They are related to the 
well-known Bodipy dyes, and have shown suitability for labelling living Hep-2 cells for imaging 
assays in the near-infrared region.64 The photophysical data for the two compounds 
is shown in Figure 1.33, and although the absorption and emission maxima are in relative 
accordance with Bodipy dyes, the extinction coefficients are considerably lower (compare 34000 
M-1cm-1 with 77000 M-1 cm-1 (the extinction coefficient for compound 2)).  
 
Figure 1.33 Novel PODIPY and aza-PODIPY compounds synthesised by Xiao. 
 
An example of a fluorescent phosphine was described by Protasiewicz who synthesised a class of 
compound known as R2-NBOPs (2,7-R2-naphthobis(oxaphosphole)s) via the primary phosphine 
41, which are air and water stable and exhibit interesting blue fluorescence (Figure 1.34).65  
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Figure 1.34 Protasiewicz et al. synthesised the di-primary phosphine 41 which was then converted into the 
fluorescent phospha-acene 42. 
 
So far the versatility of primary phosphines and the role that fluorescence can play in imaging 
agents has been discussed. Another important feature in our multimodality imaging probe is the 
incorporation of a radiolabel, for example the addition of 99mTc to facilitate SPECT imaging, which 
was shown by the synthesis of complex 4, illustrated in Figure 1.35. 
 
 
Figure 1.35 Re and Tc complexes of BodP3 provide a cold and a hot fluorescent analogue of multimodal 
imaging agents. 
1.7 Radioimaging 
Radiopharmaceuticals are a type of compound that contain a radioactive label which can be used 
as a diagnostic or therapeutic agent. The two most commonly used techniques are Single Photon 
Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). The main 
difference between the two techniques is the type of radiotracer that is used, which is explained 
further in the following sections. SPECT and PET are often combined with other techniques such 
as Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) to gain a better 
visualisation of in vitro processes.13  
 Single Photon Emission Computed Tomography (SPECT) 
SPECT is a radio-imaging technique that is used to observe metabolic processes within the body. 
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The radionuclides that are introduced into the body emit a single γ-ray during decay, which is 
measured directly by a collimator.66 The nuclides used in SPECT generally have a longer half-life 
than PET radionuclides, which together with the low cost of gamma cameras, makes a SPECT scan 
far cheaper and more easily available. However, the use of a collimator in SPECT results in low 
detection compared to PET, therefore between the two techniques, PET is more sensitive which 
means higher resolution.13 The most commonly used SPECT radionuclides are shown in Table 
1.1.13 
Table 1.1 Commonly used SPECT radionuclides. 
Nuclide Half-life/h Emission Type Photon Emission Energies/MeV 
123I 13.2 Electron capture 0.16 
99mTc 6 Isomeric transition 0.14 
111In 67.9 Electron capture 0.17/0.25 
67Ga 78.3 Electron capture 0.09/0.19/0.30 
201Tl 73.1 Electron capture 0.17 
 
The most commonly used radionuclide in SPECT is 99mTc. It has ideal properties, which include a 
convenient half-life of 6 hours, and a relatively low cost of generation through the decay of the 
parent 99Mo (half-life = 66 hours) using commercially available generator systems.13 The 
99Mo/99mTc generators produce 99mTc in the form of [99mTc]-pertechnetate, in its highest oxidation 
state of +7. A popular technetium-based drug, 99mTc-Tetrofosmin (also known as Myoview), is 
synthesised from pertechnetate in a commercially available kit.67 Myoview is a heart imaging agent 
based on the bidentate phosphorus ligand 1,2-bis[di(2-ethoxyethyl)phosphino]ethane, and has the 
structure shown in Figure 1.36. 99mTc is used in radiopharmaceuticals for imaging organs and 
metabolic processes in the body, including the lungs, liver, brain and kidneys.68 
             
Figure 1.36 Schematic of 99Mo decaying to 99mTc via β decay (left); 99mTc-Tetrafosmin which is commercially 
known as Myoview (right). 
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 Positron Emission Tomography (PET) 
In PET imaging, a positron-emitting radionuclide is introduced into the body, the positron is 
emitted from the nucleus and travels a short distance in the surrounding tissue before eventually 
colliding with an electron, causing a pair of γ-rays to be emitted at approximately 180° to one 
another. These γ-rays are detected by surrounding detectors, which records information about the 
positron annihilation. Once a large number of annihilation events have been recorded, the data can 
be reconstructed into an image, detailing information on the spatial distribution of radioactivity as 
a function of time, shown schematically in Figure 1.37.13 
 
Figure 1.37 Adapted schematic of the principle behind PET imaging.69 
There are a large number of radionuclides available for PET imaging - the most common are shown 
in Table 1.2.13  
Table 1.2 Commonly used PET radionuclides. 
Nuclide Half-life / min Emission type Max. energy / MeV 
11C 20.3 β+ 0.97 
18F 110 β+ 0.64 
64Cu 762 β+ / electron capture 0.66 
68Ga 68.1 β+ / electron capture 1.90 
76Br 972 β+ / electron capture 4.00 
124I 60192 β+ / electron capture 2.14 
 
One advantage of PET imaging over SPECT imaging is that the radiolabelled imaging agent is 
almost identical to its nonradioactive analogue. The most common radiolabel is 18F due to its 
favourable half-life (110 mins), and although fluorine atoms are not common in biomolecules, it is 
relatively easy (in principle) to substitute a hydrogen or hydroxyl group with a fluorine atom and 
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retain the molecules original biological function, because fluorine and hydrogen are similar sized 
atoms so replacement between the two has limited effects, other than the difference in 
electronegativity. This may change the electronic properties of the compound, although there are 
examples where this change has proven advantageous.70 The choice of radionuclide is very 
important - the half-life must be considered; some biological processes take longer than others and 
selecting a radionuclide with a half-life that is too short will result in no useful data being obtained. 
Secondly, as is evident in Table 1.2 above, radionuclides emit positrons at different energies, which 
effects the resolution of the PET image; ideally, the annihilation event will occur close to the origin 
of the positron, however, high energy positrons will travel further, resulting in annihilation events 
occurring remotely, thus increasing the uncertainty in its location and resulting in a lower resolution 
PET image. 
 Mitochondria Specific Compounds 
The fourth and final aspect of the proposed multi-modal imaging agent studied in this thesis is the 
addition of a phosphonium cation to introduce mitochondria specific targeting. 
Targeting the mitochondria has become a popular option for therapeutics due to the increasing 
knowledge of the link between mitochondrial dysfunction and several diseases such as a range of 
cancers,71-73 Alzheimer’s74 and Parkinson’s Disease.75  
It is known that positively charged molecules are attracted to the negative charge within the 
mitochondrial matrix, therefore a phosphonium cation has been identified as a promising 
compound for specific targeting of the mitochondria (previously discussed in Section 1.2.4 and in 
more detail in Chapter 4). 
So far, the four major functions of the target multi-modal imaging agent have been discussed – 
(i) primary phosphine synthesis, as a precursor to tridentate ligands that confer kinetic stability on 
resulting complexes, (ii) the fluorescent Bodipy core for in vitro imaging, (iii) incorporation of a 
radionuclide such as 18F or 99mTc for PET/SPECT imaging, and (iv) a phosphonium salt, that would 
allow for the direct targeting of an organelle. The work presented in this thesis will exploit these 
advances and broaden the research into new territories.  
 
The final sections of the introduction will briefly introduce the applications of phosphines in 
catalysis, in preparation for the penultimate chapter of this thesis where a novel, Bodipy-based, 
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fluorescent, chiral phosphonite has been synthesised for the first time and has been used 
successfully in an asymmetric hydrogenation reaction. 
1.8 Phosphines in Catalysis 
 Asymmetric Catalysis 
Asymmetric catalysis is an important method of synthesising chiral compounds with high 
enantioselectivity. An asymmetric catalyst favours the formation of one enantiomer over the other 
by lowering the transition state energy for the favoured enantiomer, making it kinetically more 
favourable to synthesise the lower energy route enantiomer.  
Many of the building blocks in biological systems, such as sugars or amino acids, are produced 
exclusively as one single enantiomer.76 There can be noticeable differences between two 
enantiomers, such as flavour. For example l-aspartame has a sweet taste and d-aspartame is 
tasteless;77 another variance can be in the odour - for example carvone, a molecule found naturally 
in many essential oils; the (R)-(-) enantiomer has a distinctive spearmint smell but the (S)-(+) 
enantiomer smells like caraway seeds (Fig. 1.38).78 
 
Figure 1.38 Different enantiomers can have varied tastes and odours, such as aspartame and carvone. 
Chirality is also crucial in many pharmaceuticals, and there are several examples in the literature 
where only one enantiomer is effective. Citalopram for instance, is an anti-depressant drug which 
is sold as a racemic mixture, however, studies have shown that only the (S)-(+) enantiomer is 
responsible for the effectiveness of the drug.79 Chirality is also essential for drug safety; d-
penicillamine is used in chelation therapy and for the treatment of rheumatoid arthritis, whereas l-
penicillamine is toxic and inhibits the action of pyridoxine, an essential B vitamin.80 This reiterates 
the importance of catalysts that are able to selectively form one enantiomer over the other, and are 
therefore in high demand. 
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 Asymmetric Hydrogenation 
Asymmetric hydrogenation is the addition of two hydrogen atoms preferentially to one of two faces 
of an unsaturated substrate molecule, such as an alkene or ketone. The asymmetric hydrogenation 
of prochiral olefins is one of the most widely studied transformations in asymmetric catalysis. 
Figure 1.39 shows an example of asymmetric hydrogenation reported by Noyori and co-workers 
using a BINAP-Rh complex, which showed conversions up to 99% and with very high 
enantiomeric excesses, sometimes up to 99%.81  
 
 
Figure 1.39 Asymmetric hydrogenation of α-(acylamino)acrylic acids with Rh-BINAP catalyst. 
A chiral compound is one that is non-superimposable on its mirror image. The most common 
generator of asymmetry found in organic molecules is a chiral stereocentre, where a carbon atom 
has four different groups bonded to it. Another form is axial chirality, which is observed in 
atropisomeric biaryls, such as biphenyl or binaphthyl compounds, where rotation about the 
aryl-aryl bond is restricted, shown in Figure 1.40. 
 
Figure 1.40 Viewing of the axis of chirality of a substituted biaryl - its configuration is assigned following the 
Cahn-Ingold-Prelog priority rules. 
 
A major application of phosphines in catalysis was introduced in 1965 by Wilkinson and co-
workers, who used [RhCl(PPh3)] to catalyse the hydrogenation of alkenes.
82  
Monodentate phosphines dominated the catalysis industry for many years until the 1970s where 
the development of bidentate phosphines began, including major examples all shown in Figure 
1.41, such as DIOP (2,3-o-isopropylidene-2,3-dihydroxy-1,4-bis-(diphenylphosphino)butane), 
BINAP (2,2’bis(diphenylphosphino)-1,1’-binaphthyl) and DuPhos (from the company name 
DuPont and the class of compound, phospholanes) which are all used in asymmetric reductions. 
BINAP in particular has had a significant impact on the industrial synthesis of compounds such as 
menthol which saw Noyori jointly win the 2001 Nobel Prize for his role in the development of the 
ligand.81, 83, 84   
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Figure 1.41 DIOP, BINAP, DuPhos and phosphonite ligands are all highly proven ligands in asymmetric 
catalysis. 
The phosphonite ligand will be investigated in Chapter 5 of this thesis, where a novel fluorescent 
phosphonite has been synthesised and used in an asymmetric hydrogenation reaction with a 
benchmark substrate.  
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1.9 Aims of the project 
Following this introductory section, this thesis describes the synthesis of the primary phosphines, 
as well as their coordination chemistry to transition metals. Chapters 4 and 5 concentrate on using 
these primary phosphines as important precursors to fluorescent phosphonium salts and fluorescent 
phosphonites for use in multi-modal imaging and catalysis. Finally, Chapter 6 explores the 
relationship between the aryl linker, separating the phosphorus moiety from the Bodipy core, and 
the photophysical properties of these derivatives. 
 
Chapter 2 discusses the synthesis of first and second generation primary phosphines, where the 
substituents attached to the boron atom were varied in order to synthesise highly fluorescent 
analogues. 
Chapter 3 investigates the coordination chemistry of primary phosphines to group 6 and 8 transition 
metals. Primary phosphines are weaker donor ligands that their secondary and tertiary counterparts 
and therefore it is important to establish their ability to bind transition metals. Phosphine complexes 
of molybdenum carbonyls are often synthesised to elucidate the stereoelectronic nature of the 
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phosphines, due to a weakening of the CO triple bond. By varying the substituents on the 
phosphorus atom, the IR absorptions in the carbonyl region will be modified; better electron donors 
and/or poorer acceptors exhibit lower carbonyl stretching frequencies.  
The coordination of four primary phosphines to a range of halo-bridged ruthenium(II) dimers was 
conducted and their photophysical properties were recorded to identify the effects that the 
coordination of transition metals has on the fluorescence of the phosphorus ligands. In order to 
make more direct comparisons to the ruthenium-phosphine pharmaceutical RAPTA-C, the 
coordination of ruthenium to tertiary phosphines was also briefly investigated. 
Chapter 4 will investigate how primary phosphines can be used to prepare phosphonium salts of 
relevance to medical imaging. A major target is the synthesis of a multifunctional imaging probe, 
consisting of three functions: a phosphonium cation to allow for mitochondria-specific targeting 
within the cell, a Bodipy fluorophore for cell imaging via fluorescence microscopy, and the 
incorporation of an 18F radionuclide for in vivo nuclear imaging.  
The thesis will conclude with two short, ambitious accounts of new research avenues – Chapter 5 
features a novel, fluorescent phosphonite which can afford an enantioselectivity of >99% for the 
asymmetric hydrogenation of benchmark substrate methyl (Z)-β-acetamidocinnamate (MAC), and 
Chapter 6, which will show the photophysical effects of the aryl linker in separating the phosphorus 
moiety from the Bodipy core, the photophysical properties will be examined to establish what 
effects the phosphorus group – when bound directly to the core – has on the photophysical 
properties of the derivatives. 
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Chapter 2: Synthesis of Air-stable, 
Fluorescent Primary Phosphines 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L. H. Davies, J. F. Wallis, M. R. Probert and L. J. Higham, Efficient multigram synthesis of air-
stable, fluorescent primary phosphines via palladium-catalyzed phosphonylation of aryl bromides, 
Synthesis, 2014, 46, 2622-2628.  
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 Air-stable, Fluorescent Primary Phosphines 
Primary phosphines constitute a class of ligand which have been under-utilised due to their 
notorious reputation as highly air and moisture sensitive compounds.22, 23, 85 As previously 
discussed in Section 1.2.2.3 it is possible for these compounds to be stabilised to air oxidation by 
the use of electronic effects, rather than steric protection.30 This is achieved by incorporating a high 
level of π-conjugation within the compound. The Density Functional Theory (DFT) model 
developed by the Higham group concluded that primary phosphines that showed resistance to air 
oxidation contained either sufficient π-conjugation, steric bulk or heteroatoms.30  
As previously discussed in the introduction, it is essential to define the meaning of “air-stable 
phosphines” in this thesis. And for the purposes of this research an “air-stable” phosphine is one 
which displays inertness towards oxidation over several weeks. 
 
In 2006, Higham and co-workers synthesised the first air-stable, chiral primary phosphine (R)-
MOPH2, 15, shown in Figure 2.1.
86 The discovery of this primary phosphine led to the development 
of the DFT model previously described. 
 
Figure 2.1 The first air-stable, chiral primary phosphine. 
In order to test the model’s limitations, other highly conjugated backbones were sought. 
Fluorophores also tend to be highly conjugated systems therefore a primary phosphine containing 
a backbone based on the Bodipy core was modelled – and predicted to be air-stable.34 This chapter 
will discuss the synthesis of a series of fluorescent primary phosphines based on the Bodipy 
fluorophore alongside their air stability studies and photophysical properties.   
2.1 Synthesis of the First Generation of Fluorescent Primary Phosphines 
The Higham group reported the original and improved syntheses of Bodipy primary phosphines 
20a and 20b between 2012 and 2014.34, 87  Both routes are shown in Figure 2.2 and will be briefly 
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discussed. The improved synthesis removed the problematic lowest-yielding step of the four-step 
synthesis, where an unwanted side product was formed.  
 
Figure 2.2 Original synthesis via the red route and the improved synthesis shown in the blue. i) 2 RLi, THF, RT 
ii) Pd(OAc)2, DPPB, iPr2NEt, HP(O)(OEt)2, DMSO, 90°C, iii) 2 RMgBr, THF, RT, iv) LiAlH4/TMSCl, THF, 
–78°C to RT; R = Me or Ph. 
The first step in both syntheses was a one-pot pyrrole condensation reaction between 3-ethyl-2,4-
dimethyl-1-pyrrole and 4-bromobenzaldehyde to give 43 in a moderate yield of 55%, as illustrated 
in Scheme 2.1. The reaction was analysed by NMR spectroscopy, which confirmed the presence 
of the desired product. The 11B{1H} NMR spectrum showed a triplet at  –0.2 ppm 
(JBF = 31.8 Hz) and the 
19F{1H} NMR spectrum showed a quartet at  –145.6 ppm (equal intensity) 
with a coupling constant JFB = 31.8 Hz. Since boron possesses two isotopes – 11B (80%) and 10B 
(20%), it is possible to detect coupling of both isotopes, in which case a quartet and a septet would 
be observed in the 19F NMR spectrum. The dominant peaks would be the 1:1:1:1 quartet with the 
underlying seven line multiplet in between. In our case, the fluorine line widths are significantly 
broadened by the boron so that 10B is not visible. The four lines of the quartet are not symmetrical 
because the 10B peaks are actually shifted slightly to one side because of the isotope shift effect. 
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Scheme 2.1 Synthesis of the F-Bodipy aryl bromide 43. 
 
Route A 
In order to successfully synthesise primary phosphines 20a/20b, the fluorine atoms had to be 
substituted for carbon-containing substituents. This is because previous work has shown that 
reducing the phosphonate 45, where the fluorine atoms are still bound to the boron does not result 
in the desired primary phosphine but instead, the lithium aluminium hydride reducing agent attacks 
the BF2 moiety and breaks open the Bodipy ring.
34  
The substitution of the fluorine atoms to form the methyl and phenyl derivatives was performed by 
stirring two equivalents of an organolithium reagent with Bodipy arylbromide 43 in anhydrous 
THF at room temperature for one hour. However, this step was low yielding (~30%) due to the 
formation of a side product, 47a or 47b, shown in Figure 2.3. The presence of polar side products 
was also noted when Ziessel and co-workers converted F-Bodipys into C-Bodipys – however they 
were not successfully isolated.88  
              
Figure 2.3 Side product and X-ray crystal structure of compound 47b. Crystals grown via slow diffusion using 
petrol:toluene. Selected bond distances [Å] and angles [˚]: C10-C11 1.5610(4), Br1-C38 1.9022(3), Br2-C44 
1.8964(3), all B-C bonds have an average distance of 1.62(4); C9-C10-C11 115.928(34), C47-B1-N1 107.663(22), 
N1-B1-N2 105.301(35), C47-B1-C53 117.366(2), C65-B2-C59 116.737(23), N3-B2-N4 105.058(30). 
The side products were isolated in ~10% yield during the purification of the C-Bodipy compounds 
44a and 44b by column chromatography and showed a connection of two units through the 3 and 
5 carbon atoms. These methyl groups have previously been identified as acidic, and as described 
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in Section 1.51, the addition of substituents in these position has been reported.43 The mechanism 
for the production of these side products is not known, although it is possible that it is a radical 
reaction. 
The phosphonate was introduced via a palladium-catalysed cross-coupling reaction with diethyl 
phosphite in dimethyl sulfoxide at 90°C for three days. Introduction of the phosphonate group 
works efficiently with either the fluorine atoms or the methyl/phenyl groups on the boron atom; 
there was a marginally higher yield for the phosphonate coupling reaction with the fluorine atoms 
still present – therefore improving the yield of the reactions during the conversion of the F-Bodipys 
to the C-Bodipys was the important step. 
 
Route B 
Route B introduced the use of Grignard reagents rather than the organolithium reagents in attempts 
to minimise the formation of side products. Phosphonate 45 was reacted with two equivalents of 
methyl or phenylmagnesium bromide to form phosphonates 46a and 46b in higher yields (83-87% 
compared to 30-40%) and with no side products. 
A common route to synthesising a primary phosphine is via a phosphonate, which are easily 
reduced using lithium aluminium hydride. In this case, a dual reducing agent was used – lithium 
aluminium hydride and chlorotrimethylsilane because Rajanbabu found that this mixture worked 
particularly well.85, 89 
 
Scheme 2.2 Synthesis of aryl and alkyl phosphonates 46a/46b and reduction to primary phosphines 20a/20b. 
2.2 Second Generation Air-stable, Highly Fluorescent Primary Phosphines 
A second target for this project was to synthesise analogues of primary phosphines 20a and 20b 
that exhibited an increased fluorescence quantum yield. Within the literature, the addition of 
ethynyl groups to the boron atom has been shown to achieve this – two examples are compounds 
35 and 36, shown in Figure 2.4, they display high quantum yields of 0.95 and 0.94, respectively. 
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The compounds were synthesised by Ziessel et. al. in 2005 to determine the importance of the size 
of the Stokes’ shift in an attempt to minimise fluorescence quenching during bioconjugation.47  
 
Figure 2.4 Two examples of highly fluorescent ethynyl Bodipy dyes. 
 Synthesis of Novel Primary Phosphine 50 
In order to introduce ethynyl groups on to the boron atom, Bodipy arylbromide 43 was reacted with 
two equivalents of ethynylmagnesium bromide at 75 °C in anhydrous THF under a nitrogen 
atmosphere for 16 hours (Scheme 2.3). The reaction was monitored by 11B{1H} NMR spectroscopy 
which showed a change from a triplet to a broad singlet, indicating the formation of a B-C bond. 
Analysis by 19F{1H} NMR spectroscopy also confirmed that there was no fluorine present. The 
presence of the ethynyl groups could also be observed in the 1H NMR spectrum due to the new 
singlet peak at  ~2.15 ppm, corresponding to the two terminal protons of the ethynyl groups. The 
product was purified by column chromatography on silica gel to give the novel Bodipy 48 in a 
good yield of 84%.  
 
Scheme 2.3 Synthesis of the alkyne-Bodipy aryl bromide 48. 
A crystal of 48 suitable for X-ray diffraction was obtained by slow diffusion of pentane into a 
deuterated chloroform solution of 48; the molecular structure can be seen in Figure 2.5. This is the 
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first example of a Bodipy dye with an ethynyl group attached to the boron atom where no further 
substituents are present on the terminal end of the alkyne. 
 
Figure 2.5 Molecular structure of 48. Selected bond distances [Å] and angles [°]: C25-B4 1.581(4), C27-B4 
1.603(4), C22-Br 1.901(2), C25-C26 1.189(4), C27-C28 1.179(4); C25-B4-C27 111.5(2), N1-B4-N2 106.3(2), N1-
B4-C25 108.5(2). 
 
The B-C bond lengths of 1.581(4) and 1.603(4) Å and the alkyne C-C bond lengths of 1.179(4) and 
1.189(4) Å respectively are all in agreement with literature references of similar structures.47,90  
 
A palladium-catalysed cross-coupling reaction of ethynyl Bodipy 48 with diethyl phosphite in 
anhydrous dimethyl sulfoxide yielded novel phosphonate 49 after heating at 90C for three days. 
It was important that the solvent was dry, as when the reaction was attempted with standard grade 
dimethyl sulfoxide, the desired product was not formed and starting material was still present. The 
reaction was monitored by 31P{1H} NMR spectroscopy and the formation of the phosphonate peak 
at δ 17.8 ppm was observed. The product was purified by column chromatography on silica gel to 
give phosphonate 49 as an orange solid in 55% yield. 
 
Scheme 2.4 Palladium-catalysed cross-coupling reaction to afford novel phosphonate 49. 
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A crystal of compound 49 suitable for X-ray diffraction was obtained by slow diffusion of pentane 
into a deuterated chloroform solution of 49, and is shown in Figure 2.7. The reduction of 
phosphonate 49 to primary phosphine 50 was a quantitative reaction which was achieved using a 
dual reducing agent consisting of lithium aluminium hydride and chlorotrimethylsilane, as shown 
in Scheme 2.5. 
 
Scheme 2.5 Reduction of phosphonate 49 to novel primary phosphine 50. 
The reaction was monitored by 31P{1H} NMR spectroscopy and showed a resonance at δ –121.6 
ppm and no peak at δ 17.8, confirming that the phosphonate had been successfully reduced to the 
primary phosphine 50. Analysis by 31P–1H NMR spectroscopy showed a triplet of triplets at δ –
121.6 ppm, shown in Figure 2.6, due to the splitting of the signal by the two equivalent P–H protons 
and the two ortho-aryl protons on the phenyl ring attached to the Bodipy core. The coupling 
constants observed were typical for primary phosphines, (1JPH = 203.1 Hz, 
3JPH = 6.4 Hz).
8 
Purification was performed using column chromatography on silica gel to afford primary 
phosphine 50 as a bright orange solid. 
 
Figure 2.6 31P-1H NMR spectrum of primary phosphine 50 showing a distinctive triplet of triplets. 
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After purification, a sample of primary phosphine 50 suitable for X-ray crystallographic analysis 
was obtained by slow diffusion of deuterated chloroform and pentane, as shown in Figure 2.7. The 
photophysical properties of all of these novel compounds will be discussed in Section 2.5. 
 
Figure 2.7: (Left) Molecular structure of novel phosphonate 49 obtained via slow diffusion of CDCl3/pentane. 
Selected bond distances [Å] and angles [°]: P1-O1 1.4637(1), P1-O2 1.5732(1), P1-C22 1.7793(1), B4-C29 
1.5729(1), C29-C30 1.1820(1); C22-P1-O1 111.745(3), P1-O3-C27 117.952(5), C32-C31-B4 179.357(5), C29-B4-
C31 110.896(3). (Right) Molecular structure of novel primary phosphine 50. Selected bond distances [Å] and 
angles [°]: C25-B4 1.601(5), C27-B4 1.605(5), C22-P1 1.853(3); C25-B4-C27 111.7(3), N1-B4-N2 106.5(2), N1-
B4-C27 109.7(3). 
 Extending the Ethynyl Chain 
Within the literature there are examples of long-chained ethynyl groups bonded to the boron atom 
of a Bodipy core, rather than a simple alkyne group described above. This may be due to the 
accessibility of the required starting materials or may be due to the increased fluorescence quantum 
yields with longer chained substituents. Bard and co-workers synthesised 51 in 2011 and described 
the electrogenerated chemiluminescence (ECL) properties of three Bodipy derivatives, by varying 
the R groups on the 3 and 5 position of the Bodipy core.91 Ziessel et al. synthesised compounds 52 
and 53 between 2006 and 2008 (Figure 2.8), 52 exhibited a high quantum yield (0.89) and showed 
potential as a precursor for labelling biological materials. Whereas compound 53, displayed a slight 
bathochromic shift with a quantum yield of 0.99 and is subsequently part of a library of novel 
compounds being used to investigate dendritic Bodipy scaffoldings for photon concentrators.92, 93  
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Figure 2.8 Addition of alkyne-aryl groups on to the boron atom increase the fluorescence quantum yield. 
 Synthesis of Phenylethynyl Bodipy Derivatives 
The next target was an extension of novel primary phosphine 50. Compounds with extended 
ethynyl groups were attached to the boron atom and the photophysical properties were examined 
and compared to see if an increased fluorescence was observed. 
Bodipy 54 can be synthesised via two routes, shown in Scheme 2.6. The first method involved the 
addition of two equivalents of phenylethynylmagnesium bromide to arylbromide 43, stirred in THF 
at 75 C for five days. The reaction was monitored by 11B{1H} NMR spectroscopy which showed 
the triplet, corresponding to the starting material, transform into a broad singlet at approximately  
12.0 ppm. When all of the starting material had been converted to the desired product, the reaction 
was quenched with methanol and the solvent was removed in vacuo. The purple solid was purified 
using column chromatography on silica gel to give the desired product in 23% yield. The second 
route utilised the addition of n-butyllithium to phenylacetylene in THF at 78 C, which gave the 
desired product overnight after the addition to compound 43, and gave significantly higher yields 
(88%) after purification by column chromatography. Therefore, the second route is the more 
favourable method for synthesising compound 54. 
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Scheme 2.6 Addition of phenylethynyl groups to the boron atom to yield compound 54. 
The phosphonate group was added via a palladium-catalysed cross-coupling reaction using diethyl 
phosphite in anhydrous dimethyl sulfoxide at 90 C for three days, illustrated in Scheme 2.7. The 
product was extracted with dichloromethane and washed with a large volume of water to remove 
the DMSO, and purified by column chromatography to give a red solid in a good yield of 73%. 
Analysis by 31P{1H} NMR spectroscopy showed a peak at δ 17.9 ppm which falls in the correct 
region for a phosphonate group. 
 
 
Scheme 2.7 A palladium-catalysed cross coupling reaction of 54 to the novel phosphonate 55, followed by a 
reduction to the novel primary phosphine 56. 
Phosphonate 55 was reduced to novel primary phosphine 56 using the lithium aluminium hydride 
and chlorotrimethylsilane dual reducing agent (Scheme 2.7). The product was purified by column 
chromatography on silica gel to give the desired product as a red solid. Analysis by 31P-1H NMR 
spectroscopy showed a triplet of triplets at δ –122.3 ppm, with coupling constants of 1JPH = 202.9 
Hz, 3JPH = 7.3 Hz, which again are typical values of a primary phosphine.
8  
2.3 Air Stability Studies of Primary Phosphines 50 and 56 
The air-stability of the novel primary phosphines 50 and 56 has been examined both theoretically 
and experimentally. The synthesis of both compounds included purification by column 
46 
 
chromatography in air which is remarkable for this type of compound without the formation of a 
phosphine oxide. Air-stability studies that were performed on compounds 50 and 56 included 
31P{1H} NMR spectroscopy studies and DFT calculations. 
 31P-1H NMR Spectroscopy Studies 
The air stability of novel primary phosphines 50 and 56 were measured using 31P-1H NMR 
spectroscopy. A neat sample of the phosphines and a sample dissolved in deuterated chloroform 
were exposed to the air, in a dark cupboard. Both samples showed no oxidation in neat form or in 
solution after three weeks, as shown in Figure 2.9. 
 
Figure 2.9 The 31P{1H} NMR spectrum of primary phosphine 50 after three weeks in air, in CDCl3 showed no 
oxidation. 
 Spartan DFT Models 
Identifying the reasons for the air-stability of primary phosphines was discussed previously in 
Section 1.2.2. One common contributor to air-stability is steric hindrance, however, in the cases of 
primary phosphines 20a, 20b, 50 and 56, the PH2 group is not subjected to this, and therefore, 
electronic factors must be considered as the controlling factor. 
DFT calculations using a B3LYP functional with a 6-31G* basis set were employed to look at the 
electronic nature of the novel primary phosphines. The calculations identified where the HOMO 
was situated on the neutral compounds and it was determined that the localisation of the HOMO 
on the phosphorus atom resulted in air sensitivity. This theory is only applicable to primary 
phosphines, because tertiary arylphosphines, such as triphenylphosphine, which are well-known to 
be air-stable, exhibited a phosphorus-containing HOMO, implying incorrectly its instability in air.  
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The mechanism of phosphine oxidation has been postulated as being a radical reaction (Scheme 
1.1, Section 1.2.8). Therefore, the radical cation SOMO energies of the primary phosphines were 
also calculated.  The model suggested an air-stability threshold was observed at 10 eV, where air-
stable phosphines had SOMO energies below this value. All four of the primary phosphines 
displayed SOMO energies of −8.94 eV, –8.82 eV, –8.96 eV and −8.17 eV, implying that they 
would be stable if they were synthesised experimentally. When all four of the primary phosphines 
are compared using the computational studies, it predicts that the phenylethynyl primary phosphine 
56 will be most resistant to oxidation.  
 
Figure 2.10 Calculated SOMO energies in eV for radical cations of primary phosphines 20a, 20b, 50 and 56. 
2.4 Photophysical Studies 
 
Previous calculations were performed for first generation primary phosphines 20a/20b, which both 
displayed no phosphorus-containing frontier orbitals for the neutral molecules until HOMO (-3) 
for 20a and HOMO (-7) for 20b. In both cases the energy difference between the HOMO and the 
orbital incorporating the phosphorus atom was 1.7 eV. This indicates that the reductive-PeT from 
the potential phosphorus donor may not be occurring, and the excited state is not quenched. This 
may be attributed to the phenyl spacer group between the Bodipy core and the phosphorus atom, 
which minimises the conjugation between the phosphorus lone pair and the Bodipy backbone.  
It was important to understand the effects that the substituents had on the photophysical properties 
of the compounds described, and whether the addition of a phosphino group would quench the 
fluorescence of the Bodipy compounds via PeT. 
 
The same calculations were conducted for novel primary phosphines 50 and 56, which showed 
localisation of the HOMO on the Bodipy core until HOMO (-4) for 50, illustrated in Figure 2.11 
and HOMO (-8) for 56, shown in Figure 2.12. The energy separation between the HOMO and these 
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orbitals were 1.4 and 1.6 eV respectively. As was the case for primary phosphines 20a and 20b, 
the model also predicts compounds 50 and 56 to be air-stable. 
 
Figure 2.11 Calculated molecular orbital surfaces from LUMO to HOMO (-8) for primary phosphine 50. 
 
 
 
Figure 2.12 Calculated molecular orbital surfaces from LUMO to HOMO (-8) for primary phosphine 56. 
 
Reference compounds 58-61 were synthesised in order to identify the effects that substituents, such 
as phosphorus, have on the photophysical effects when added to the 8-position. Photophysical data 
including absorption and emission maxima were collected for all of the compounds in anhydrous, 
degassed tetrahydrofuran and their quantum yields were measured with respect to compound 57. 
LUMO = -2.2 eV HOMO = -5.1 eV HOMO-1 = -6.1 eV HOMO-2 = -6.1 eV HOMO-3 = -6.5 eV 
HOMO-4 = -6.5 eV HOMO-5 = -6.7 eV HOMO-6 = -6.8 eV HOMO-7 = -6.9 eV HOMO-8 = -7.2 eV 
LUMO = -2.2 eV HOMO = -5.2 eV HOMO-1 = -5.6 eV HOMO-2 = -5.7 eV HOMO-3 = -6.7 eV 
HOMO-4 = -6.4 
eV 
HOMO-5 = -6.4 
eV 
HOMO-6 = -6.7 eV HOMO-7 = -6.7 eV HOMO-8 = -6.8 eV 
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Figure 2.13 Reference compounds were synthesised with a proton where the bromo substituent would be. 
Table 1.1 Photophysical data of first and second generation primary phosphines synthesised and described in 
this chapter. 
 
a Measured in dry, degassed tetrahydrofuran at room temperature, dyes were excited at 485 nm; b Fluorescence quantum yields were 
measured with respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 57. ε are quoted to 2 s.f. 
 
 
λ abs (nm)a λ em (nm)a Φa,b ε (M-1cm-1)a 
20a 512 526 0.33 79,000 
20b 518 532 0.042 79,000 
43 526 540 0.65 78,000 
44a 514 524 0.36 87,000 
44b 519 531 0.079 80,000 
45 526 540 0.56 56,000 
46a 513 527 0.29 91,000 
46b 518 534 0.039 83,000 
48 521 534 0.81 77,000 
49 521 535 0.72 82,000 
50 520 534 0.79 78,000 
54 
55 
56 
523 
523 
521 
535 
535 
535 
0.65 
0.63 
0.78 
78,000 
84,000 
81,000 
57 524 537 0.76 86,000 
58 
59 
60 
61 
511 
516 
519 
518 
524 
530 
533 
533 
0.35 
0.042 
0.74 
0.84 
88,000 
82,000 
83,000 
86,000 
50 
 
 Absorption and Emission Spectra 
 
 
Figure 2.14 Absorption spectra for the primary phosphines 20a, 20b, 50 and 56, measured in dry, degassed 
tetrahydrofuran at room temperature. 
 
 
Figure 2.15 Emission spectra for the primary phosphines 20a, 20b, 50 and 56, measured in dry, degassed 
tetrahydrofuran at room temperature. 
The absorption maxima for all of the Bodipy compounds described in this chapter are situated 
between 511 and 526 nm, corresponding to the S0-S1 (π-π*) electronic transition associated with 
the Bodipy core. A broader less intense band seen at approximately 375 nm corresponds to the 
S0-S2 (π-π*) transition of the boradiazaindacene unit. The emission maxima of the compounds are 
between 524 and 540 nm and the extinction coefficients range from 56,000 to 91,000 M-1cm-1, all 
of which are typical for Bodipy compounds published in the literature.39 
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As the four primary phosphines vary the substituent on the aryl group in the 8-position from a 
bromine atom to a phosphonate and finally a primary phosphine, the photophysical properties do 
not significantly change. The absorption and emission maxima are similar and the quantum yields 
are all comparable. 
There is a slight hypsochromic shift in the absorption and emission spectra upon incorporation of 
the ethynyl substituents compared to the bromo difluoro precursor (3-5 nm), but the methyl and 
phenyl derivatives show a greater separation (7-16 nm). This may be observed due to the increased 
electron density around the boron atom – this is seen more for the methyl derivative due to the 
inductive effect being increased. When the substituents are varied on the boron atom, a change in 
the fluorescence quantum yield is observed; the addition of phenyl groups tends to produce low 
quantum yields, but as these groups are changed for methyl groups, the quantum yield is 
significantly increased. The new ethynyl derivatives have all shown to increase the quantum yield 
even further.  
The incorporation of the –PH2 moiety had little effect on the photophysical properties of novel 
primary phosphines 50 and 56 compared to their parent compounds 60 and 61 respectively, when 
a proton is in place of the phosphino group, indicating phosphorus groups can be added to these 
compounds without any significant change in their photophysical properties. 
 
2.5 Summary 
This chapter introduced the synthesis of the primary phosphines 20a and 20b and also describes an 
improved synthetic route. After this, the synthesis of the novel second generation primary 
phosphines 50 and 56 was described in a four-step synthetic procedure, which have shown 
remarkable air-stability – no oxidation of the primary phosphines was observed. This air-stability 
is in agreement with our DFT calculations, as both of the primary phosphines displayed SOMO 
values below the apparent threshold of –10 eV. The photophysical measurements concluded that 
the addition of the ethynyl groups to the boron atom significantly increased the fluorescence 
quantum yield compared to the alkyl and – especially – the aryl derivatives. The primary 
phosphines are an excellent starting point for synthesising a range of metal complexes which will 
be discussed in detail in Chapter 3.  
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2.6 Experimental 
 General Procedure 
All air- and/or water-sensitive reactions were performed under a nitrogen atmosphere using 
standard Schlenk line techniques. Tetrahydrofuran was dried over sodium/benzophenone and 
deuterated chloroform was dried over phosphorus pentoxide; these solvents were distilled prior to 
use. Dimethyl sulfoxide was purchased from Fisher in an anhydrous state and was used as received. 
Most starting materials were purchased from Sigma Aldrich, Alfa Aesar or Fisher and were used 
as received. Column chromatography was performed on silica gel (40-63 μm, 60 Å) from Merck, 
thin-layer chromatography was carried out using Merck aluminium-based plates with silica gel and 
fluorescent indicator (254 nm). 1H, 13C{1H}, 19F{1H}, 31P{1H} and 11B{1H} NMR spectra were 
recorded on a JEOL ECS-400 (1H 399.78 MHz) or Bruker Avance III 300 (1H 300.13 Hz) 
spectrometer at room temperature; 1H and 13C shifts are reported relative to tetramethylsilane, 31P 
relative to 80% H3PO4, 
11B relative to BF3.Et2O and 
19F relative to CFCl3. Infrared spectra were 
recorded on a Varian 800 FT-IR spectrometer and mass spectrometry was carried out by the 
EPSRC NMSF, Swansea. DFT calculations were carried out on Spartan 14 using the B3LYP 
functional with a 6-31G* basis set, details of the xyz coordinates and SCF energies can be found 
in the appendix. 
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 8-(4-Bromophenyl)-4,4-difluoro-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-
diaza-s-indacene (43) 
 
4-Bromobenzaldehyde (15.0 g, 81 mmol) was dissolved in anhydrous DCM (1500 mL) and 3-
ethyl-2,4-dimethyl-1H-pyrrole (21.9 mL, 162 mmol) and TFA (0.025 mL) were added. The 
reaction mixture was stirred overnight under a nitrogen atmosphere at room temperature in a 
darkened flask. DDQ (20.2 g, 81 mmol) was added and the mixture was stirred for four hours. 
i-Pr2NEt (84.7 mL, 486 mmol) and BF3.OEt2 (80.0 mL, 648 mmol) were added dropwise and the 
mixture was stirred at room temperature overnight. The volume was reduced by half and the 
mixture was washed with H2O (3 x 150 mL) and brine (2 x 150 mL), then the organics were 
combined and dried with MgSO4, filtered and the solvent removed in vacuo to yield a dark purple 
solid with a green tint. Purification using column chromatography on silica gel (toluene) afforded 
the dark purple product in a moderate yield (20.85 g, 56%).  
1H NMR (400 MHz, CDCl3) δ 7.61 (d, 3JHH = 8.2 Hz, 2H), 7.16 (d, 3JHH = 8.2 Hz, 2H), 
2.52 (s, 6H), 2.29 (q, 3JHH = 7.8 Hz, 4H), 1.30 (s, 6H), 0.96 (t, 
3JHH = 7.8 Hz, 6H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 154.2, 138.6, 138.2, 134.9, 133.1, 132.4, 130.6, 130.2, 123.1, 17.2, 
14.7, 12.6, 12.0 ppm; 19F{1H} NMR (376 MHz, CDCl3) δ –145.6 [q (equal intensity),1JFB = 31.8 
Hz, 2F] ppm; 11B{1H} NMR (128 MHz, CDCl3) δ – 0.2 (t, 1JFB = 31.8 Hz, 1B) ppm; IR (neat) 𝜈: 
2969, 2903 (C-H), 1532, 1475, 1403, 1318, 1255, 1185, 1066, 973, 754, 623 cm-1; HRMS (ESI+) 
calcd. for C26H26
11BBrF2N2 [M]+ requires m/z 457.1368; found m/z 457.1368. 
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 8-[(4-Diethylphosphonato)phenyl]-4,4-difluoro-1,3,5,7-tetramethyl-2,6-diethyl-
4-bora-3a,4a-diaza-s-indacene (45) 
 
[Pd(OAc)2] (1.02 g, 4.5 mmol), DPPB (1.94 g, 4.5 mmol) and arylbromide 43 (20.85 g, 45 mmol) 
were dissolved in anhydrous DMSO (800 mL) under a nitrogen atmosphere. i-Pr2NEt (23.7 mL, 
136.2 mmol)  and diethyl phosphite (6.4 mL, 49.9 mmol) were added and the mixture was heated 
to 90 °C for 72 h. H2O (500 mL) was added to the reaction mixture and the suspension was 
extracted with dichloromethane (600 mL). The organic layer was washed with H2O (200 mL) and 
brine (200 mL), dried over MgSO4, filtered and the solvent removed in vacuo to yield a dark pink 
/ purple solid. Purification by column chromatography on silica gel (EtOAc:petrol, 3:2) gave the 
product in a moderate yield (15.0 g, 64%).  
1H NMR (400 MHz, CDCl3) δ 7.91 (dd, 3JHH = 7.9 Hz, 3JHP = 12.9 Hz, 2H), 7.44 (dd, 3JHH = 8.0 
Hz, 4JHP = 4.1 Hz, 2H), 4.28 (m, 4H), 2.44 (s, 6H), 2.28 (q, 
3JHH = 8.3 Hz, 4H), 1.31 (t, 
3JHH = 6.4 
Hz, 6H), 1.21 (s, 6H), 0.97 (t, 3JHH = 7.6 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 154.3, 140.1, 138.4, 138.0, 133.1, 132.3 (d, JCP = 10.5 Hz), 130.2, 129.7 (d, 1JCP = 121.7 Hz), 
128.6 (d, JCP = 15.3 Hz), 62.3 (d, 
2JCP = 5.8 Hz), 17.0, 16.3 (d, 
3JCP = 5.8 Hz), 14.6, 12.5, 11.7 ppm; 
31P{1H} NMR (162 MHz, CDCl3) δ 18.3 ppm; 19F{1H} NMR (376 MHz, CDCl3) δ –145.6 (q 
(equal intensity), 1JFB = 32.0 Hz, 2F) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ – 0.2 (t, 1JFB = 32.0 
Hz, 1B) ppm; IR (neat) 𝜈: 2971, 2901, 1534, 1406, 1315, 1250, 1183, 1056, 975 cm-1; HRMS 
(ESI+) calcd. for C27H37B1F2N2P1O3 [M+H]
+ requires m/z 516.2634; found m/z 516.2626. 
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 8-(4-Diethylphosphonato)phenyl]-4,4-dimethyl-1,3,5,7-tetramethyl-2,6-diethyl-
4-bora-3a,4a-diaza-s-indacene (46a) 
 
Phosphonate 45 (12.0 g, 23.2 mmol) was dissolved in anhydrous THF (300 mL). To this solution 
was added methylmagnesium bromide (15.5 mL, 46.5 mmol, 3.0 M solution in Et2O) dropwise at 
room temperature. The mixture was left to stir until complete consumption of starting material was 
observed by TLC (~3 h). The reaction was quenched with MeOH (40 mL) and the solvent was 
evaporated to give a red solid, which was purified by column chromatography  
(EtOAc:petrol, 3:1) to give the product as a dark orange solid (9.81 g, 83%). 
1H NMR (400 MHz, CDCl3) δ 7.89 (dd, 3JHH = 7.8 Hz, 3JHP = 13.1 Hz, 2H), 7.40 (dd, 3JHH = 7.8 
Hz, 4JHP = 3.8 Hz, 2H), 4.09 (m, 4H), 2.44 (s, 6H), 2.27 (q, 
3JHH = 7.3 Hz, 4H), 1.31 (t, 
3JHH = 7.0 
Hz, 6H), 1.19 (s, 6H), 0.93 (t, 3JHH = 7.4 Hz, 6H), 0.24 (s, 6H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 150.8, 141.1(d, JCP = 2.9 Hz), 138.5, 133.6, 132.4, 131.9 (d, JCP = 10.5 Hz), 129.3 (d, JCP 
= 10.5 Hz), 128.6 (d, 1JCP = 186.6 Hz), 128.4, 62.3 (d, 
2JCP = 5.6 Hz), 17.5, 16.3 (d, 
3JCP = 5.6 Hz), 
14.4, 14.0, 11.7, 10.5 (br) ppm; 31P{1H} NMR (162 MHz, CDCl3) δ 18.7 ppm; 11B{1H} NMR (128 
MHz, CDCl3) δ –1.9 (s, 1B) ppm; IR (neat) 𝜈: 2960, 2931, 1556, 1453, 1360, 1322, 1244, 1172, 
1047, 1014, 945 cm-1; HRMS (NSI+) calcd. for C29H43BN2O3P [M+H]
+ requires m/z 508.3135, 
found m/z 508.3129. 
 8-[(4-Diethylphosphonato)phenyl]-4,4-diphenyl-1,3,5,7-tetramethyl-2,6-diethyl-
4-bora-3a,4a-diaza-s-indacene (46b) 
 
Phosphonate 45 (1.5 g, 2.9 mmol) was dissolved in anhydrous THF (50 mL). To this solution was 
added phenylmagnesium bromide (2.0 mL, 6.0 mmol, 3.0 M solution in Et2O) dropwise at room 
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temperature. The mixture was left to stir until complete consumption of starting material was 
observed by TLC (1.5 h). The reaction was quenched with MeOH (40 mL) and the solvent was 
evaporated to give a dark red solid, which was purified by column chromatography (EtOAc : petrol, 
2:1) to give the product as a dark red solid. (1.42 g, 87%). 
1H NMR (400 MHz, CDCl3) δ 7.98 (dd, 3JHH = 7.8 Hz, 3JHP = 13.2 Hz, 2H), 7.53 (dd, 3JHH = 7.8 
Hz, 4JHP = 4.0 Hz, 2H), 7.41 (m, 4H), 7.26-7.15 (m, 6H), 4.18 (m, 4H), 2.21 (q, 
3JHH = 7.4 Hz, 4H), 
1.79 (s, 6H), 1.35 (t, 3JHH = 7.2 Hz, 6H), 1.30 (s, 6H), 0.86 (t, 
3JHH = 7.4 Hz, 6H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 153.4, 150.1 (br), 141.3, 139.0, 134.8, 133.8, 133.1, 132.1 (d, JCP = 
10.4 Hz), 130.2, 129.1 (d, JCP = 15.2 Hz), 128.8 (d, 
1JCP = 187.9 Hz), 127.2, 125.5, 62.2 (d, 
2JCP = 
5.7 Hz), 17.3, 16.3 (d, 3JCP = 5.8 Hz), 14.7, 14.6, 12.1 ppm; 31P{1H} NMR (162 MHz, CDCl3) δ 
18.7 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ –1.1 (s, 1B) ppm; IR (neat) 𝜈: 2960, 1547, 1474, 
1386, 1254, 1168, 1141, 1032, 970, 773 cm-1; HRMS (NSI+) calcd. for C39H47BN2O3P [M+H]
+ 
requires m/z 632.3448, found m/z 632.3447. 
 8-[(4-Phosphino)phenyl]-4,4-dimethyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-
3a,4a-diaza-s-indacene (20a) 
 
LiAlH4 (57.8 mL, 57.8 mmol, 1.0 M solution in THF) was cooled to – 78 °C. TMSCl (7.35 mL, 
57.8 mmol) was added and the mixture was warmed to room temperature over 45 minutes. The 
solution was cooled to –78 °C and phosphonate 46a (9.81 g, 19.3 mmol) dissolved in anhydrous 
THF (900 mL) was added slowly. The solution was allowed to warm up to room temperature and 
stirred overnight. The mixture was concentrated in vacuo and slowly quenched with degassed H2O 
(50 mL). The product was extracted with Et2O (3 x 150 mL), dried over MgSO4, filtered and the 
solvent was evaporated. The orange solid was purified by column chromatography on silica gel 
(chloroform:petrol, 1:4)  to give the intended product (6.1 g, 79%). 
1H NMR (400 MHz, CDCl3) δ 7.58 (m, 2H), 7.25 (m, 2H), 4.08 (d, 1JHP = 202.5 Hz, 2H), 2.43 (s, 
6H), 2.33 (q, 3JHH = 7.6 Hz, 4H), 1.25 (s, 6H), 0.97 (t, 
3JHH = 7.6 Hz, 6H), 0.26 (s, 6H) ppm; 
13C{1H} NMR (CDCl3, 100 MHz) δ 150.7, 139.7, 137.2 134.9 (d, JCP = 15.3 Hz), 133.7, 132.4, 
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128.9, 128.8 (d, JCP = 5.7 Hz), 128.7, 17.4, 14.7, 14.3, 11.9, 10.4 (br) ppm; 31P-1H NMR (400 
MHz, CDCl3) δ –121.6 (tt, 1JPH = 202.5 Hz, 3JPH = 7.4 Hz) ppm; 11B{1H} NMR (CDCl3, 128 MHz) 
δ –2.1 (s, 1B) ppm; IR (neat) 𝜈: 2958, 2925, 2361, 2341, 1551, 1470, 1531, 1167, 1143, 1110, 
1060, 942 cm-1; HRMS (NSI+) calcd. for C25H35BN2P [M+H]
+ requires m/z 404.2662, found m/z 
404.2665. 
 
 8-[(4-Phosphino)phenyl]-4,4-diphenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-
3a,4a-diaza-s-indacene (20b) 
 
 
LiAlH4 (6.73 mL, 6.73 mmol, 1.0 M solution in THF) was cooled to – 78 °C. TMSCl (0.85 mL, 
6.73 mmol) was added and the mixture was warmed to room temperature over 45 minutes. The 
solution was cooled to –78 °C and phosphonate 46b (1.42 g, 2.24 mmol) dissolved in anhydrous 
THF (150 mL) was added slowly. The solution was allowed to warm up to room temperature and 
stirred for 4 hours. The mixture was concentrated in vacuo and slowly quenched with degassed 
H2O (20 mL). The product was extracted with Et2O (3 x 50 mL), dried over MgSO4, filtered and 
the solvent was evaporated. The orange solid was purified by column chromatography on silica 
gel, (dichloromethane:petrol, 1:2) to give the intended product. (0.90 g, 76%). 
1H NMR (400 MHz, CDCl3) δ 7.63-7.58 (m, 2H), 7.40-7.37 (m, 4H), 7.28-7.16 (m, 8H), 4.11 (d, 
1JHP = 202.5 Hz, 2H), 2.21 (q, 
3JHH = 7.3 Hz, 4H), 1.76 (s, 6H), 1.31 (s, 6H), 0.90 (t, 
3JHH = 7.3 Hz, 
6H) ppm; 13C{1H} NMR (CDCl3, 100 MHz) δ 153.0, 150.3 (br), 139.9, 136.8, 135.1, 134.9 (d, JCP 
= 15.3 Hz), 133.8, 132.8, 130.6, 129.0, 128.8 (d, JCP = 5.6 Hz), 127.1, 125.4, 17.3, 14.7, 14.5, 12.1 
ppm; 31P-1H NMR (400 MHz, CDCl3) δ –121.5 (tt, 1JPH = 202.5 Hz, 3JPH = 7.6 Hz) ppm; 11B{1H} 
NMR (CDCl3, 128 MHz) δ –1.1 (s, 1B) ppm; IR (neat) 𝜈: 2963, 2928, 2869, 2285, 1545, 1469, 
1393, 1303, 1169, 1143, 962, 774 cm-1; HRMS (APCI+) calcd. for C35H39BN2P [M+H]
+ requires 
m/z 528.2975, found m/z 528.2970. 
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 8-(4-Bromophenyl)-4,4-diethynyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-
diaza-s-indacene (48) 
 
Arylbromide 43 (2.93 g, 6.38 mmol) was dissolved in anhydrous THF (60 mL) and 
ethynylmagnesium bromide (26.78 mL, 0.5M in THF, 13.89 mmol) was added dropwise. The 
reaction was heated to 76 °C overnight. The reaction was quenched with MeOH (10 mL) and the 
solvent was removed. The product was purified by column chromatography (toluene) to afford the 
desired product as a purple solid. (2.53 g, 84%).  
1H NMR (400 MHz, CDCl3) δ 7.54 (d, 3JHH = 8.3 Hz, 2H), 7.12 (d, 3JHH = 8.3 Hz, 2H), 2.68 (s, 
6H), 2.25 (q, 3JHH = 7.5 Hz, 4H), 2.15 (s, 2H), 1.23, (s, 6H), 0.92 (t, 
3JHH = 7.5 Hz, 6H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 153.6, 140.2, 136.6, 136.3, 132.9, 129.0, 128.9, 128.6, 128.5, 
128.3, 82.9 (br), 17.4, 14.8, 14.0, 11.8 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ –13.9 ppm; IR 
(neat) 𝜈: 3281, 2963, 2927, 2869, 2361, 2337, 2065, 1609, 1538, 1473, 1401, 1369, 1318, 1068, 
977, 750 cm-1; HRMS (APCI+ SOLID) calcd. for C27H28BBrN2H [M+H]
+ requires m/z 470.1638, 
found m/z 470.1634. 
 
 
 8-[(4-Diethylphosphonate)phenyl]-4,4-diethynyl-1,3,5,7-tetramethyl-2,6-
diethyl-4-bora-3a,4a-diaza-s-indacene (49) 
 
Arylbromide 48 (1.02 g, 2.16 mmol), [Pd(OAc)2] (0.048 g, 0.216 mmol) and DPPB (0.092 g, 0.216 
mmol) were combined and dissolved in anhydrous DMSO (50 mL). i-Pr2NEt (1.13 mL, 6.49 mmol) 
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and diethyl phosphite (0.31 mL, 2.38 mmol) were added and the reaction was heated to 90 °C for 
72 h. The reaction mixture was cooled to room temperature and H2O (40 mL) was added and the 
mixture was extracted with DCM (50 mL). The organics were washed with H2O (30 mL), dried 
over MgSO4, filtered and the solvent was removed. The dark red solid was purified by column 
chromatography on silica gel (ethyl acetate:petrol 3:1) to yield the desired product as a red solid 
(0.62 g, 55%).  
1H NMR (400 MHz, CDCl3) δ 7.86 (dd, 3JHH = 8.1 Hz, 3JHP = 13.1 Hz, 2H), 7.38 (dd, 3JHH = 8.1 
Hz, 4JHP = 3.9 Hz, 2H), 4.07 (m, 4H), 2.67 (s, 6H), 2.25 (q, 
3JHH = 7.8 Hz, 4H), 2.15 (s, 2H), 1.26 
(t, JHH = 7.0 Hz, 6H), 1.17 (s, 6H), 0.91 (t, J = 7.5 Hz, 6H) ppm; 13C{1H} NMR: δ 154.2, 140.6 (d, 
J = 3.3 Hz), 138.4, 136.2, 133.3, 132.2 (d, J = 10.0 Hz), 129.1, (d, J = 188.7 Hz), 128.8 (d, J = 15.0 
Hz), 128.5, 83.0, 68.0, 62.4 (d, J = 5.6 Hz), 17.4, 16.4 (d, J = 6.1 Hz), 14.7, 14.0, 11.9 ppm; 31P{1H} 
NMR (162 MHz, CDCl3) δ 17.8 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ –14.9 ppm; HRMS 
(APCI+ SOLID) calcd. for C31H38B1N2O3P1H [M+H]
+ requires m/z 528.2822, found m/z 528.2821. 
 8-[(4-Phosphino)phenyl]-4,4-diethynyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-
3a,4a-diaza-s-indacene (50) 
 
LiAlH4 (2.55 mL, 1.0 M in THF, 2.55 mmol) was cooled to –78 °C. TMSCl  (0.32 mL, 2.55 mmol) 
was added and the mixture was warmed to room temperature over 45 minutes. The solution was 
cooled to – 78 °C and phosphonate 49 (0.45 g, 0.88 mmol) in anhydrous THF (50 mL) was added 
slowly. The solution was allowed to warm to room temperature and stirred for four hours. The 
mixture was concentrated in vacuo and was slowly quenched with degassed water. The product 
was extracted with DCM (3 x 15 mL), dried over MgSO4, filtered and the solvent was removed, 
producing an orange solid which was purified by column chromatography (chloroform:hexane 1:4) 
to yield an orange solid (0.280 g, 78%).  
1H NMR (400 MHz, CDCl3) δ 7.59 (m, 2H), 7.23 (m, 2H), 4.08 (d, 1JHP = 202.9 Hz, 2H), 2.74 (s, 
6H), 2.33 (q, 3JHH = 7.6 Hz, 4H), 2.23 (s, 2H), 1.27 (s, 6H), 0.98 (t, 
3JHH = 7.6 Hz, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 153.9, 139.5, 136.6, 136.2, 135.2 (d, JCP = 9.1 Hz), 133.1, 129.4, 
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129.2, 128.9, 128.6 (d, JCP = 5.8 Hz), 82.9, 17.4, 14.8, 14.1, 12.1 ppm; 31P NMR (162 MHz, CDCl3) 
δ –121.6 (tt, 1 JPH = 202.9 Hz, 3JPH = 6.7 Hz) ppm; 11B NMR (128 MHz, CDCl3) δ –14.9 ppm; IR 
(neat) 𝜈: 3292, 2960, 2926, 2870, 2360, 2341, 2301, 2060, 1540, 1473, 1261, 1172, 1109, 1067, 
964 cm-1; HRMS (APCI+ SOLID) calcd. for C27H31B1N2P1 [M+H]
+ requires m/z 424.2349, found 
m/z 424.2345. 
 
 Preparation of 8-(4-Bromophenyl)-4,4-diethynylphenyl-1,3,5,7-tetramethyl-2,6-
diethyl-4-bora-3a,4a-diaza-s-indacene (54) 
 
Phenylacetylene (0.24 mL, 2.18 mmol) was dissolved in anhydrous THF (6 mL) and cooled 
to –78°C, to this flask was added n-Butyllithium (1.5 mL, 2.4 mmol, 1.6M in hexane) and the 
solution was stirred for 15 minutes. In a separate flask arylbromide 43 (0.50 g, 1.09 mmol) was 
dissolved in anhydrous THF (15 mL), the phenylacetylene mixture was added dropwise to the 
Bodipy solution at – 78°C and the reaction mixture was stirred overnight at room temperature. The 
compound was purified by column chromatography on silica gel (dichloromethane:petrol, 2:1) to 
yield the desired product as an orange solid (0.60, 88%). 
1H NMR (700 MHz, CDCl3) δ 7.53-7.04 (m, 14H), 2.78 (s, 6H), 2.26 (q, 3JHH = 7.6 Hz, 4H), 1.23 
(s, 6H), 0.92 (t, 3JHH = 7.6 Hz, 6H) ppm; 13C{1H} NMR (176 MHz, CDCl3) δ 154.2, 136.1, 135.5, 
133.1, 132.5, 132.3, 131.6, 130.5, 129.0, 128.5, 128.0, 127.1, 125.5, 95.3, 81.7, 17.5, 14.9, 14.1, 
12.1 ppm; 11B{1H} NMR (96 MHz, CDCl3) δ –12.6 ppm; HRMS (ASAP+ SOLID) calcd. for 
C39H37BBrN2 [M+H]
+ requires m/z 622.2269, found m/z 622.2233. 
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 Preparation of 8-[(4-Diethylphosphonate)phenyl]-4,4-diethynylphenyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (55) 
 
 
Arylbromide 54 (0.29 g, 0.47 mmol), [Pd(OAc)2] (0.011 g, 0.047 mmol) and DPPB (0.020 g, 0.047 
mmol) were combined and dissolved in anhydrous DMSO (12 mL). After five minutes of stirring, 
i-Pr2NEt (0.07 mL, 0.52 mmol) was added, followed by diethyl phosphite (0.25 mL, 1.41 mmol). 
The reaction mixture was heated to 90 °C for 48 hours under nitrogen. The mixture was extracted 
with DCM (3 x 25 mL) and washed with water (3 x 25 mL), dried over MgSO4, filtered and the 
solvent was removed in vacuo. The resultant purple solid was purified by column chromatography 
on silica gel (ethyl acetate:petrol, 3:1) to give the product as a purple solid (0.235 g, 73%). 
1H NMR (300 MHz, CDCl3) δ 7.85 (dd, 3JHH = 8.3 Hz, 3JHP = 13.1 Hz, 2H), 7.39 (dd, 3JHH = 8.3 
Hz, 4JHP = 3.9 Hz, 2H), 7.33-7.30 (m, 4H), 7.16-7.08 (m, 6H),  4.07 (m, 4H), 2.78 (s, 6H), 2.26 (q, 
3JHH = 7.5 Hz, 4H), 1.24 (t, JHH = 7.1 Hz, 6H), 1.18 (s, 6H), 0.93 (t, J = 7.5 Hz, 6H) ppm; 13C{1H} 
NMR (75 MHz, CDCl3) δ 154.3, 140.8 (d, J = 3.3 Hz), 138.4, 135.9, 133.2, 132.2 (d, J = 10.2 Hz), 
131.5, 129.0 (d, J = 188.8 Hz), 128.9 (d, J = 15.0 Hz), 128.6, 128.0, 127.0, 125.4, 119.4, 95.3, 62.3 
(d, J = 5.5 Hz), 17.4, 16.3 (d, J = 6.0 Hz), 14.7, 14.0, 11.9 ppm; 31P{1H} NMR (121 MHz, CDCl3) 
δ 17.9 ppm; 11B{1H} NMR (96 MHz, CDCl3) δ –12.7 ppm. 
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 Preparation of 8-[(4-Phosphino)phenyl]-4,4-diethynylphenyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (56) 
 
 
LiAlH4 (1.01 mL, 1.0 M in THF, 1.01 mmol) was cooled to –78 °C, and TMSCl (0.13 mL, 2.55 
mmol) was added; the mixture was warmed to room temperature over 45 minutes. The solution 
was cooled to –78 °C and phosphonate 55 (0.23 g, 0.34 mmol) in anhydrous THF (30 mL) was 
added dropwise. The solution was warmed to room temperature and stirred for four hours. The 
mixture was concentrated in vacuo and slowly quenched with degassed H2O (10 mL). The product 
was extracted with DCM (3 x 15 mL), dried over MgSO4, filtered and the solvent was removed, 
producing an orange solid which was purified by column chromatography on silica gel 
(chloroform:hexane 1:2) to yield a red solid (0.05 g, 78%).  
1H NMR (300 MHz, CDCl3) δ 7.53 (m, 2H), 7.35-7.32 (m, 2H), 7.21-7.12 (m, 10H), 4.02 (d, 1JHP 
= 202.8 Hz, 2H), 2.79 (s, 6H), 2.30 (q, 3JHH = 7.6 Hz, 4H), 1.24 (s, 6H), 0.95 (t, 
3JHH = 7.5 Hz, 6H) 
ppm; 13C{1H} NMR (75 MHz, CDCl3) δ 154.0, 139.5, 136.5, 136.3, 135.2, (d, JCP = 16.3 Hz), 
133.0, 131.7, 129.1, 128.8 (d, JCP = 5.7 Hz), 128.1, 127.1, 125.7, 60.5, 41.5, 22.8, 17.6, 14.9, 14.1, 
12.2 ppm; 31P NMR (121 MHz, CDCl3) δ –122.3 (tt, 1 JPH = 202.9 Hz, 3JPH = 7.0 Hz) ppm; 11B{1H} 
NMR (96 MHz, CDCl3) δ –12.5 ppm; IR (neat) 𝜈: 3292, 2960, 2925, 2360, 1541, 1473, 1314, 
1171, 963, 691 cm-1; HRMS (ASAP+ SOLID) calcd. for C39H39B1N2P1 [M+H]
+ requires m/z 
576.2980, found m/z 576.2919. 
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 Preparation of 8-Phenyl-4,4-diethynyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-
3a,4a-diaza-s-indacene (60) 
 
Compound 57 (0.25 g, 0.65 mmol) was dissolved in anhydrous THF (5 mL), 
and ethynylmagnesium bromide (2.76 mL, 05 M in THF, 1.38 mmol) was added dropwise. The 
mixture was heated to 76 C overnight before being quenched with methanol (5 mL) and the solvent 
removed. The compound was purified by column chromatography on silica gel (petrol:toluene 1:4) 
to yield the desired product as a red solid (0.21 g, 82%). 
1H NMR (700 MHz, CDCl3) δ 7.41-7.39 (m, 3H), 7.26-7.24 (m, 2H), 2.71 (s, 6H), 2.29 (q, 3JHH = 
7.6 Hz, 4H), 2.19 (s, 2H), 1.22 (s, 6H), 0.95 (t, 3JHH = 7.6 Hz, 6H) ppm; 13C{1H} NMR (176 MHz, 
CDCl3) δ 153.6, 140.2, 136.6, 136.3, 132.9, 129.0, 128.9, 128.6, 128.5, 96.0, 82.9, 17.4, 14.8, 14.0, 
11.8 ppm; 11B{1H} NMR (96 MHz, CDCl3) δ –14.8 ppm; IR (neat) 𝜈: 3273, 2965, 2929, 2871, 
2057, 1540, 1474, 1315, 1173, 973, 718 cm-1; HRMS (ASAP+ SOLID) calcd. for C27H30B1N2 
[M+H]+ requires m/z 392.2533, found m/z 392.2530. 
 8-Phenyl-4,4-diethynylphenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-
diaza-s-indacene (61) 
 
Compound 57 (0.50 g, 1.32 mmol) was dissolved in anhydrous THF (15 mL), 
and phenylethynylmagnesium bromide (2.76 mL, 1.0 M in THF, 2.76 mmol) was added dropwise. 
The mixture was heated to 76 C for five days before being quenched with methanol (5 mL) and 
the solvent removed. The compound was purified by column chromatography on silica gel 
(dichloromethane:petrol, 2:1) to yield the desired product as a red solid (0.23, 33%). 
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1H NMR (700 MHz, CDCl3) δ 7.45-7.10 (m, 15H), 2.79 (s, 6H), 2.28 (q, 3JHH = 7.6 Hz, 4H), 1.21 
(s, 6H), 0.94 (t, 3JHH = 7.6 Hz, 6H) ppm; 13C{1H} NMR (176 MHz, CDCl3) δ 153.8, 140.2, 136.6, 
136.4, 132.8, 132.6, 131.7, 129.2, 129.0, 128.7, 128.1, 127.1, 125.7, 95.2, 81.7, 17.5, 14.9, 14.1, 
11.9 ppm; 11B{1H} NMR (96 MHz, CDCl3) δ –12.5 ppm; IR (neat) 𝜈: 3059, 2961, 2927, 2869, 
2178, 1611, 1538, 1474, 1315, 1171, 963, 715, 689 cm-1; HRMS (ASAP+ SOLID) calcd. for 
C39H38BN2 [M+H]
+ requires m/z 544.3164, found m/z 544.3129. 
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 Coordination Chemistry of Primary Phosphines 
This chapter describes the synthesis of a library of fluorescent transition metal phosphine 
complexes. The primary phosphines 20a, 20b, 50 and 56 whose synthesis was described in Chapter 
2, were coordinated to group 6 and 8 transition metals and their photophysical properties were 
examined. 
3.1 Introduction 
There have been extensive coordination studies of tertiary and secondary phosphines to transition 
metals, however, the equivalent studies of primary phosphines is relatively limited.22, 23 This may 
be due to the anticipated difficulty of working with primary phosphines, due to their reputation as 
spontaneously flammable compounds. In addition, the electronic and steric properties of primary 
phosphines are different to secondary and tertiary phosphines - due to the presence of the two 
hydrogen atoms on the phosphorus, the lone-pair orbital has more s-character associated with it, 
resulting in a weaker donor ligand with regard to transition metal binding ability. 
3.2 Fluorescent Transition Metal Phosphine Complexes 
Metals are typically thought of as fluorescence quenchers, due to the heavy atom effect, which 
promotes intersystem crossing to the triplet state and leads to non-radiative decay to the ground 
state. The presence of the phenyl spacer group in the ligands described in Chapter 2, appears to 
segregate the phosphino group from the Bodipy, and quenching of the fluorescence is not observed. 
In this section, the effect of the photophysical behaviour of these compounds when coordinated to 
transition metals was of interest, as to whether quenching would be observed. 
 Synthesis of Group 6 [M(CO)5L] complexes (M=Mo, W) 
Molybdenum carbonyl complexes of phosphines are usually synthesised in order to gain insight 
into the electronic nature of a given phosphine, due to the change in the IR absorptions in the 
carbonyl region. This is dependent on the substituents attached to the phosphorus; better electron 
donors/poorer acceptors give rise to lower carbonyl stretching frequencies.28, 94  
Hey-Hawkins et al. reported the synthesis and X-ray crystal structure of a primary 
ferrocenylphosphine tungsten(II) complex in 2002 that showed a distorted capped octahedral 
structure. Hey-Hawkins has since published other molybdenum and tungsten primary 
ferrocenylphosphine complexes.95-97 Figure 3.1 shows a ferrocenylphosphine tungsten complex 
which was used in the hydrophosphination of a range of alkenes. It was found that the alkenes 
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bearing a strong electron withdrawing group, such as acrylonitrile had faster reaction times than 
alkenes containing weaker electron withdrawing groups, such as methyl acrylate.95 
 
Figure 3.1 A ferrocenylphosphine tungsten complex synthesised by Hey-Hawkins and used in 
hydrophosphination reactions of alkenes. 
The synthesis of the first and second generation primary phosphines (20a, 20b, 50 and 56) was 
described in Chapter 2 – this section describes the synthesis of the group 6 complexes formed from 
those primary phosphines and a comparison of their photophysical properties will then be 
discussed. 
The molybdenum and tungsten primary phosphine complexes were synthesised starting from the 
metal hexacarbonyl in a photochemical reaction using UV irradiation. The appropriate metal 
hexacarbonyl, [Mo(CO)6] and [W(CO)6], was dissolved in anhydrous tetrahydrofuran and 
irradiated with UV light in a quartz vessel under a stream of nitrogen for one hour. The primary 
phosphine was dissolved in anhydrous tetrahydrofuran and added to the quartz vessel, and the 
reaction mixture was stirred for a further thirty minutes which led to the mono-substituted 
complexes [M(CO)5(20a)], [M(CO)5(20b)], [M(CO)5(50)] and [M(CO)5(56)] (M = Mo and W), 
illustrated in Scheme 3.1.  
 
Scheme 3.1 Primary phosphines 20a, 20b, 50 and 56 were reacted with [Mo(CO)6] and [W(CO)6] to produce 
the primary phosphine metal complexes shown. 
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Analysis of the four mono-substituted molybdenum complexes by 31P{1H} NMR spectroscopy 
gave downfield peaks of approximately δ –64 ppm relative to the primary phosphine peak 
(~  −122 ppm) and coupling constants of 1JPH = 326 Hz. The chemical shift compares well to 
examples in the literature, such as [Mo(CO)5(FcCH2PH2)] (Fc = ferrocene) which was reported by 
Henderson and gives a signal in the 31P{1H} NMR spectrum at δ –63.2 ppm and shows a 
phosphorus–hydrogen coupling constant of 1JPH = 315 Hz.28 Hey-Hawkins et al. published a 
[Mo(CO)5(FcPH2)] derivative which showed a comparable 
1JPH coupling constant of 328.0 Hz and 
a chemical shift of  −81.5 ppm on the 31P{1H} NMR spectrum .95  
The tungsten complexes also showed downfield shifts close to δ –85 ppm and coupling constants 
of 1JPH = 340 Hz. 
183W satellite peaks were also visible on the 31P{1H} NMR spectra that showed 
1JPW coupling constants of approximately 223 Hz. These data are comparable to that measured for 
[W(CO)5(PhPH2)] published by McFarlane in 1976, who gave values of δ –90.2 ppm, 1JPH = 343.5 
Hz and 1JPW = 220 Hz.
98 The characteristic NMR and IR data for all of the molybdenum and 
tungsten complexes have been compiled into Table 3.1. 
A crystalline sample of 63 was analysed by X-ray crystallography and the solid state structure was 
determined as shown in Figure 3.2. The W1–P1 of 2.4957(0) Å is in agreement with published 
examples.99  
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Figure 3.2 Molecular structure of 63. Crystals grown via slow diffusion of chloroform:pentane. Selected bond 
lengths [Å] and angles [°]: W1-P1 2.4957(0), P1-C22 1.8194(0), W1-C27 2.010(4), W1-C28 2.048(4), W1-C29 
2.019(5), W1-C30 2.035(5), W1-C31 2.041(5), C-O average 1.14(0); C22-P1-W1 125.21(1), C22-P1-H1A 99.12(1), 
W1-C28-O2 179.09(0), H1B-P1-H1a 95.50(1). 
A side-product formed in these reactions was the di-substituted complex where two primary 
phosphine units had coordinated to the metal centre. Previously within the Higham research group, 
these di-substituted group 6 complexes were intentionally synthesised via the route shown in 
Scheme 3.2. The metal hexacarbonyl is reacted with two equivalents of piperidine which replaces 
two carbonyl groups, and when [M(CO)4(piperidine)2] is reacted with two equivalents of a primary 
phosphine in refluxing dichloromethane, two ligands are coordinated to the metal centre to form 
complexes cis–[M(CO)4(RPH2)2]. The di-substituted molybdenum complex 70 gave a triplet of 
multiplets in the 31P-1H NMR spectrum at  –51.6 ppm and a 1JPH coupling constant of 316.5 Hz. 
The di-substituted tungsten complex 71 also showed a triplet of multiplets in the 31P-1H NMR 
spectrum at  –76.9 ppm and a 1JPH coupling constant of 388.9 Hz, a tungsten satellite peak was 
also observed with a coupling constant of 1JPW = 217.4 Hz. Details of the synthesis can be found 
in the experimental section.100 
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Scheme 3.2 Synthesis of group 6 di-substituted complexes [M(CO)4(20a)2]. 
 IR and NMR Spectroscopic Characterisation 
The carbonyl groups bound to the metal show distinctive peaks in the IR spectrum. In the case of 
the pentacarbonyl complexes synthesised within this series, three carbonyl stretching frequencies 
can be observed; bonds corresponding to the A1 (cis/equatorial), A1 (trans/axial) and E 
absorbance’s are in accordance with the C4v point group - to which they have been assigned.99, 101, 
102 Table 3.1 shows the IR and NMR data for compounds 62-69, alongside  two literature examples 
which have been added for comparison. Hey-Hawkins et. al. researched transition metal 
ferrocenylphosphine complexes that could subsequently be used in hydrophosphination 
reactions.95 Goerlich and co-workers synthesised a range of 1-adamantylphosphine complexes by 
reacting 1-adamantylphosphine with molybdenum and tungsten carbonyl compounds.102  
 
Table 3.1 Selected IR and NMR data for monodentate group 6 transition metal-phosphine complexes. 
Compound ν(CO)A1 
Eq cm-1 
ν(CO)A1
Ax cm-1 
ν(CO), 
E cm-1 
31P δ, 
ppm 
1JP-H, 
Hz 
1JP-W, 
Hz 
δ (2JP-C) 
CO trans 
δ (2JP-C) 
CO cis 
62 2076 1992 1929 −63.5 326.7 - 208.8 (24.2) 204.7 (9.8) 
63 2077 1973 1902 −85.7 340.6 222.9 198.3 (23.1) 195.5 (7.2) 
64 2077 1945 1917 −64.2 330.5 - 208.4 (24.2) 203.5 (8.9) 
65 2076 1969 1921 −85.7 342.5 223.3 198.2 (22.8) 194.3 (7.1) 
66 2076 1994 1928 −64.0 328.3 - 207.7 (24.1) 203.5 (9.2) 
67 2075 1972 1914 −85.6 342.1 223.7 198.0 (22.6) 195.3 (7.0) 
68 2077 1989 1924 −64.7 327.9 - 208.2 (24.3) 204.4 (9.2) 
69 
Mo(CO)5FcPH2a 
W(CO)5FcPH2a
 
Mo(CO)5(1-AdPH2)b
 
W(CO)5(1-AdPH2)b 
2075 
2074 
2073 
2074 
2075 
1974 
1950 
1935 
1987 
1980 
1915 
1933 
1906 
1952 
1945 
−85.7 
81.5 
101.8 
28.5 
47.6 
342.2 
328.0 
341.5 
308.2 
321.0 
222.4 
- 
221.0 
- 
212.5 
198.3 (22.9) 
208.8 (23.7) 
198.1 (22.2) 
208.3 (21.9) 
196.9 (21.8) 
194.3 (6.9) 
205.0 (9.2) 
195.9 (7.1) 
205.4 (8.9) 
196.9 (6.9) 
IR recorded neat; NMR in d-chloroform, Fc = ferrocene, 1-Ad = 1-adamantyl. a IR in nujol. b IR in hexane. 
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 Photophysical Studies 
After successfully synthesising a range of group 6 metal phosphine complexes, it was important to 
determine and understand their photophysical properties. It was imperative to know how the 
coordination of metals affected the quantum yield in the resultant complex and whether the 
presence of the heavy atoms quenched the fluorescence of the free ligand. The photophysical data 
were collected for the primary phosphines and their transition metal complexes in anhydrous, 
degassed tetrahydrofuran at room temperature, and are shown in Table 3.2. 
Table 3.2 Photophysical properties of primary phosphines 20a, 20b, 50 and 56 and their novel group 6 metal 
complexes 62-69. 
 λ abs (nm)a λ em (nm)a Φa,b ε (M-1cm-1)a 
20a 512 526 0.33 79,000 
[Mo(CO)5(20a)] (62) 512 527 0.25 72,000 
[W(CO)5(20a)] (63) 512 527 0.20 73,000 
20b 518 532 0.042 79,000 
[Mo(CO)5(20b)] (64) 519 534 0.055 75,000 
[W(CO)5(20b)] (65) 519 535 0.059 75,000 
50 520 534 0.79 78,000 
[Mo(CO)5(50)] (66) 521 534 0.53 77,000 
[W(CO)5(50)] (67) 520 534 0.45 75,000 
56 521 535 0.78 81,000 
[Mo(CO)5(56)] (68) 521 535 0.59 77,000 
[W(CO)5(56)] (69) 522 536 0.60 78,000 
a Measured in dry, degassed tetrahydrofuran at room temperature, dyes were excited at 485 nm; b Fluorescence quantum yields 
were measured with respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 57. ε given to 
2 s.f. 
 
The absorption maxima for the parent primary phosphines ranged from 512 nm for 20a to 521 nm 
for 56, and upon complexation to the molybdenum and tungsten carbonyl complexes varied by 
1-2 nm. As the substituents on the boron atom are changed from methyl to phenyl to ethynyl and 
phenylethynyl, a small bathochromic shift is observed.  
In general, a decrease in the fluorescence quantum yield is observed, (except for primary phosphine 
20b) but the complexes remain highly fluorescent. Figures 3.3 and 3.4 show the absorption and 
emission spectra for the four tungsten complexes 63, 65, 67 and 69. The spectra for the 
molybdenum complexes can be found in the appendix. 
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Figure 3.3 Absorption spectra for tungsten complexes 63, 65, 67 and 69, measured in dry, degassed 
tetrahydrofuran at room temperature. 
 
 
Figure 3.4 Emission spectra for tungsten complexes 63, 65, 67 and 69, measured in dry, degassed 
tetrahydrofuran at room temperature. 
This research has identified that the coordination of primary phosphines 20a, 20b, 50 and 56 to 
group 6 metals, molybdenum and tungsten pentacarbonyl complexes, does not appear to 
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significantly quench the fluorescence quantum yield of these novel complexes. This means that 
these complexes may have potential applications as imaging agents. 
3.3 Synthesis of [RuX2(arene)(RPH2)] Complexes 
Having established that the coordination of primary phosphines 20a, 20b, 50 and 56 to group 6 
metals does not appear to cause quenching, the next target was bio-relevant group 8 metal 
ruthenium. The introductory section discussed the importance of RAPTA-C as a ruthenium anti-
cancer drug, it would therefore be interesting to synthesise a fluorescent ruthenium complex in 
order to monitor the mode of action within cells in vitro. Therefore, primary phosphines 20a, 20b, 
50 and 56 were reacted with four ruthenium dimers, [RuCl2(C6H6)]2, [RuCl2(p-cymene)]2, 
[RuI2(C6H6)]2 and [RuI2(p-cymene)]2 to form a library of novel ruthenium phosphine complexes. 
Their photophysical properties were analysed and a number of X-ray crystal structures were 
obtained. 
 Ruthenium Complexes in Medicine 
Ruthenium has shown promise in pharmacological applications due to its ability to access many 
different oxidation states. There has been much interest in ruthenium complexes as anticancer 
agents, due to their effective behaviour towards cancerous cells, without toxic side effects, unlike 
their platinum analogues. Cisplatin was the first platinum-containing anti-cancer drug to be 
synthesised and since its success, several more platinum containing drugs have been produced, 
shown in Figure 3.5.103  
 
 
Figure 3.5 Platinum containing pharmaceuticals Cisplatin, Carboplatin and Oxaliplatin. 
Carboplatin and Oxaliplatin are direct analogues of Cisplatin, and their modes of action are all 
known; the chloride or dicarboxylate ligands generate a bis-aqua species when undergoing 
hydrolysis within a cell, which binds irreversibly to DNA through two guanine bases, forming a 
“kink” which stops the cell from replicating and leads to apoptosis.104 Platinum compounds have 
shown great promise in chemotherapeutics, however, they also come with several side effects, such 
as nerve damage, nausea and hair loss. Ruthenium compounds have been found to show fewer and 
less severe side effects. Two examples are NAMI-A and KP1019, shown in Figure 3.6. These drugs 
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are both structurally similar to each other, although they exhibit different anticancer activities. 
Whilst KP1019 is active against primary cancers – the main tumour, NAMI-A is effective against 
secondary tumour cells - cells from the main tumour that may have migrated around the body via 
the bloodstream and into a different organ.18  
 
 
Figure 3.6 NAMI-A and KP1019 are two ruthenium based anti-cancer drugs that have been entered into 
clinical trials. 
 Ruthenium Phosphine Complexes 
There have been several ruthenium phosphine complexes published with potential therapeutic 
properties.105-109 In Sections 1.2.4 and 3.3.1, the importance of ruthenium in medicine was 
discussed, and RAPTA-C was highlighted as an anti-cancer drug currently in clinical trials (Fig 
3.7). The next section will discuss the coordination chemistry of fluorescent primary phosphines 
to several ruthenium dimers. The photophysical properties of these novel complexes will also be 
measured in order to identify what effects are observed. 
 
Figure 3.7 Synthesis of RAPTA-C, an anti-cancer drug in clinical trials. 
 Synthesis of Novel Fluorescent Ruthenium Complexes 
Primary phosphines 20a, 20b, 50 and 56 were reacted with benzene and p-cymene ruthenium(II) 
dimer complexes, containing an iodo or chloro bridge, to form novel complexes 72-87 as shown in 
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Scheme 3.3. The weak bridge of the ruthenium dimer can be broken by a stronger donor such as a 
phosphine, to generate an 18-electron species. 
  
 
Scheme 3.3 Primary phosphines can be reacted with ruthenium (II) dimers to give the novel complexes shown. 
Two equivalents of primary phosphine 20a, 20b, 50 and 56 were reacted with one equivalent of a 
ruthenium dimer in deuterated chloroform at room temperature for one hour. The solution was 
analysed by 31P{1H} NMR spectroscopy which showed a single product peak and no starting 
material peak (δ −121 ppm), in the 31P-1H NMR spectra a triplet of triplets was observed, with 
coupling constants consistent with the presence of a primary phosphine (1JPH = 398.1 Hz, 
3JPH = 
11.0 Hz).8 Table 3.3 shows the phosphorus chemical shifts observed for each complex alongside 
the phosphorus-hydrogen coupling constants. The iodo-bridged ruthenium dimers tended to give a 
downfield shift of approximately δ −50 ppm, whereas the chloro-bridged dimers appeared further 
downfield at between δ −30 and −32 ppm. 
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Table 3.3 Phosphorus chemical shifts and phosphorus-hydrogen couplings for the ruthenium complexes 72-87 
in deuterated chloroform. 
Compound 31P δ, ppm 1JPH, Hz 3JPH, Hz 
[RuCl2(C6H6)(20a)] 72 −31.3 397.2 10.7 
[RuCl2(p-cymene)(20a)] 73 −29.5 390.8 11.5 
[RuI2(C6H6)(20a)] 74 −49.8 398.3 11.5 
[RuI2(p-cymene)(20a)] 75 −43.7 392.2 10.9 
[RuCl2(C6H6)(20b)] 76 −31.4 395.8 10.9 
[RuCl2(p-cymene)(20b)] 77 −30.2 390.0 11.1 
 [RuI2(C6H6)(20b)] 78 −50.2 398.5 11.2 
[RuI2(p-cymene)(20b)] 79 −43.9 391.8 11.2 
 [RuCl2(C6H6)(50)] 80 −32.4 398.3 11.9 
[RuCl2(p-cymene)(50)] 81 −30.3 390.4 11.4 
[RuI2(C6H6)(50)] 82 −50.1 398.1 11.6 
[RuI2(p-cymene)(50)] 83 −43.9 390.8 11.4 
[RuCl2(C6H6)(56)] 84 −32.2 398.0 11.9 
[RuCl2(p-cymene)(56)] 85 −30.5 391.2 11.6 
[RuI2(C6H6)(56)] 86 −49.6 398.4 11.2 
 [RuI2(p-cymene)(56)] 87 −44.6 391.4 11.5 
 
Complexes 72, 74 and 75 were crystallised by adding a layer of pentane over a deuterated 
chloroform solution of the relevant complex, which formed crystals suitable for analysis by X-ray 
diffraction, as shown in Figures 3.8, 3.9 and 3.10. 
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Figure 3.8 X-Ray crystal structure of 72. Crystals grown via slow diffusion of CDCl3:pentane. Selected bond 
distances [Å] and angles [˚]: P-C23 1.8218(1), Ru-P 2.2944(1), Ru-Cl1 2.3879(1), Ru-Cl2 2.4226(1), P-H1 1.25(5), 
P-H2 1.26(5), aromatic carbon atoms show an average distance of 2.19(6); Cl1-Ru-Cl2 87.820(4), Ru-P-C23 
121.189(4), Cl1-Ru-P 83.369(3), Cl2-Ru-P 78.61(5).  
 
The Ru−P bond length of 2.2944(1) Å and the Ru−Cl bond lengths of 2.3879(1) and 2.4226(1) Å 
respectively, are in agreement with other similar reported examples.110  
 
 
Figure 3.9 X-Ray crystal structures of 74. Crystals grown in CDCl3. Selected bond distances [Å] and angles [˚]: 
P1-C22 1.8203(0), P1-H1 1.275(0), P1-Ru1 2.2912(0), Ru-I1 2.7021(0), Ru1-I2 2.7054(0), Ru-aromatic C average 
distance 2.20(0); C22-P1-Ru1 118.182(1), P1-Ru1-I1 81.902(1), H1A-P1-H1B 100.695(1). 
The Ru−P bond length of 2.2912(0) Å and Ru−I bond lengths of 2.7021(0) and 2.7054(0) Å are 
also in agreement with reported examples.111 
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Figure 3.10 Molecular structure of 75. Crystals grown in CDCl3. Selected bond distances [Å] and angles [˚]: 
C22-P1 1.8103(1), P1-Ru1 2.2918(1), Ru1-I1 2.7220(1), Ru1-I2 2.7138(1), Ru1-aromatic C average distance 
2.24(1); C22-P1-Ru1 115.206(2), I1-Ru1-I2 89.788(2), I1-Ru1-P1 81.642(2), I2-Ru-P1 84.0253(2). 
The Ru−P bond length of 2.2918(1) Å and Ru−I bond lengths of 2.7220(1) and 2.7138(1) Å are 
also in agreement with other published examples.110, 111  
 
When primary phosphine 20b was reacted with the [RuCl2(p-cymene)]2 dimer, along with the 
intended product 77, a side product was also formed where a phenyl group on the boron atom had 
been replaced by an OH group (compound 77a, Figure 3.11).  
                            
Figure 3.11 ChemDraw structure and X-ray crystal structure of 77a. Crystals grown in CDCl3. Selected bond 
distances [Å] and angles [˚]: P1-C28 1.818(2), Ru1-P1 2.3066(6), B4-O1 1.430(3), B4-C15 1.617(4), Ru-Cl 
2.41(6); O1-B4-C15 110.27(19), C28-P1-Ru1 122.48(7), Cl1-Ru1-Cl2 86.44(2). 
It was not immediately obvious how this substitution had occurred, as the carbon-boron bond is 
quite robust in our hands. However, it is possible to use the OH as a good leaving group and 
substitute it for a different group. The addition of a radiolabel such as 18F would enable the 
compound to be used in PET imaging; there are examples in the literature where this substitution 
has in fact been exploited, as shown in Figure 3.12.112 In this way, it is possible to create a multi-
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modal imaging agent – the Bodipy function facilitates in vitro cell imaging and the 18F PET label 
allows for in vivo clinical imaging of a patient. 
 
Figure 3.12 An example from the literature where an OH group has been replaced by an 18F radiolabel. 
 Photophysical Properties of [RuX2(arene)(RPH2)] Complexes 
The photophysical properties of the novel ruthenium phosphine complexes were recorded in 
anhydrous tetrahydrofuran at room temperature. The absorption and emission maxima, quantum 
yield and extinction coefficients were identified and can be found in Table 3.4. 
 
Table 3.4 Photophysical properties of [RuX2(arene)(RPH2)] complexes (X = I, Cl) 
 λ abs (nm)a λ em (nm)a Φa,b ε (M-1cm-1)a 
20a 512 526 0.33 79,000 
[RuCl2(C6H6)(20a)] (72) 512 527 0.09 74,000 
[RuCl2(p-cymene)(20a)] (73) 512 527 0.09 77,000 
[RuI2(C6H6)(20a)] (74) 512 528 0.06 74,000 
[RuI2(p-cymene)(20a)] (75) 512 527 0.02 72,000 
20b 518 532 0.042 79,000 
[RuCl2(C6H6)(20b)] (76) 518 534 0.017 73,000 
[RuCl2(p-cymene)(20b)] (77) 518 534 0.011 73,000 
[RuI2(C6H6)(20b)] (78) 519 534 0.007 72,000 
[RuI2(p-cymene)(20b)] (79) 519 534 0.005 75,000 
50 520 534 0.79 78,000 
[RuCl2(C6H6)(50)] (80) 520 534 0.36 79,000 
[RuCl2(p-cymene)(50)] (81) 521 534 0.14 78,000 
[RuI2(C6H6)(50)] (82) 521 534 0.27 77,000 
[RuI2(p-cymene)(50)] (83) 521 534 0.31 74,000 
56 521 535 0.78 81,000 
[RuCl2(C6H6)(56)] (84) 521 535 0.40 79,000 
[RuCl2(p-cymene)(56)] (85) 521 535 0.38 79,000 
[RuI2(C6H6)(56)] (86) 521 535 0.32 77,000 
[RuI2(p-cymene)(56)] (87) 521 535 0.29 78,000 
a Measured in dry, degassed tetrahydrofuran at room temperature, dyes were excited at 485 nm; b Fluorescence quantum yields 
were measured with respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 57. ε quoted to 
2 s.f. 
 
 
Table 3.4 shows the photophysical properties of the free primary phosphines compared to their 
ruthenium complexes. Primary phosphine 20a – which has methyl groups attached to the boron 
atom, has shown a dramatic decrease in the fluorescent quantum yield upon coordination to the 
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ruthenium dimers. The absorption and emission maxima and the extinction coefficients have all 
remained similar to the free primary phosphine. The same relationship can be seen between primary 
phosphine 20b and its ruthenium complexes – the phenyl substituents on the boron atom have 
already significantly lowered the quantum yield, and upon complexation, the quantum yield is 
decreased further. Primary phosphines 50 and 56 contain ethynyl-type substituents on the boron 
atom and the free primary phosphines have a much higher quantum yield; however, the same 
relationship is observed and the quantum yields are also decreased upon complexation to the 
ruthenium dimers. 
3.4 DFT Calculations on the [M(CO)5(RPH2)] and [RuX2(arene)(RPH2)] 
complexes (M = Mo, W) 
It was important to investigate why the ruthenium complexes exhibited a reduced quantum yield, 
whereas the group 6 metals did not. DFT computational studies were performed on the synthesised 
ruthenium, molybdenum and tungsten complexes. All of the modelled group 6 and 8 complexes 
showed a Bodipy-based HOMO, however, the ruthenium complexes contained a metal-based 
LUMO whereas the group 6 complexes had a Bodipy-based LUMO. Figures 3.13, 3.14 and 3.15 
show complexes 62, 63 and 72 illustrating the different nature of the HOMO and LUMO orbital 
distributions. Other ruthenium complexes including complexes 73-79 were also modelled and can 
be seen in the appendix where the same orbital distribution is observed. 
            
                                        
                  HOMO -5.2 eV LUMO -2.2 eV 
Figure 3.13 Molybdenum complex [Mo(CO)5(20a)] (62) showing the HOMO and LUMO distribution for 
complex 62. 
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Figure 3.13 shows the molybdenum complex 62 where the HOMO and LUMO are both visible on 
the Bodipy core, the phosphorus atom is not incorporated into the HOMO until HOMO (-3). The 
same is observed for the tungsten complex 63, the phosphorus is not incorporated into the HOMO 
until HOMO (-3). 
                                      
 HOMO -5.3 eV LUMO -2.2 eV 
       
Figure 3.14 Tungsten complex [W(CO)5(20a)] (63) with the HOMO and LUMO orbitals shown. 
The ruthenium complexes however, exhibit a metal-based LUMO rather than a Bodipy-based 
LUMO and show more quenched fluorescence than the group 6 complexes. This may suggest that 
the ruthenium metal orbitals are involved in the fluorescence process, possibly in a LMCT process, 
which may identify why a bigger increase in fluorescence quenching is observed for them. 
  
                       
 HOMO -5.2 eV LUMO -2.8 eV  
Figure 3.15 Ruthenium complex [RuCl2(C6H6)(20a)] (72) with the HOMO and LUMO orbitals depicted. 
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3.5 Tertiary Phosphine-Ruthenium Complexes 
Despite the large degree of fluorescent quenching observed on binding to ruthenium, some of the 
resultant complexes did remain fluorescent. This led us to investigate the possibility of synthesising 
a fluorescent ruthenium-phosphine complex – similar to RAPTA-C but with a different tertiary 
phosphine. 
RAPTA-C, shown in Scheme 3.4, was formed by the reaction of dichloro(p-cymene) ruthenium(II) 
dimer and pta (1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane) in refluxing methanol (see Section 
1.2.4). RAPTA-C has shown promising properties as an anti-cancer drug, and it would be 
interesting to synthesise a fluorescent analogue to facilitate in vitro imaging and help elucidate the 
mode of action.19 
 
Scheme 3.4 Synthesis of the ruthenium-phosphine complex RAPTA-C. 
The RAPTA-C structure includes a tertiary phosphine bound to a ruthenium metal centre; therefore, 
it was proposed to synthesise a fluorescent version of RAPTA-C by coordinating the Bodipy-based 
tertiary phosphines 89a and 89b to the [RuI2(p-cymene)]2 and [RuCl2(C6H6)]2 dimers. This 
approach is similar to that published by Bodio and co-workers, who developed a phosphine that 
had an extended linker between the Bodipy core and the diphenylphosphino moiety, which was 
then coordinated to ruthenium (Figure 3.16).21 Therefore, it would be interesting to synthesise an 
alternative compound where the diphenylphosphino group was attached to the Bodipy core with a 
shorter linker, and see how this affects the fluorescence of the compound. 
 
Figure 3.16 Bodio and co-workers developed a Bodipy-based phosphine and coordinated it to ruthenium. 
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 Synthesis of Fluorescent Tertiary Phosphines 89a and 89b. 
The synthesis of the tertiary phosphines 89a and 89b will be discussed in detail in Chapter 4; 
Scheme 3.5 shows the reaction conditions that were used. Phosphorus pentachloride was dissolved 
in anhydrous toluene and primary phosphine 20a was added, the reaction was stirred at room 
temperature for one hour. The solution was analysed by 31P{1H} NMR spectroscopy, which 
identified the presence of dichlorophosphine 88 ( 159.7 ppm). The orange solid was dissolved in 
anhydrous THF and two equivalents of dicyclohexylmagnesium chloride/ phenylmagnesium 
bromide were added, which formed tertiary phosphines 89a and 89b. 
 
 
Scheme 3.5 Synthesis of the tertiary phosphines 89a and 89b from primary phosphine 20a. 
Tertiary phosphines 89a and 89b were then reacted with the ruthenium(II) dimer precursors in the 
same manner as primary phosphine 20a was, analysis by 31P{1H} NMR spectroscopy identified 
that the product peak had shifted downfield – implying complexation with ruthenium. 
 
 
Scheme 3.6 Tertiary phosphines were reacted with ruthenium dimers to give novel complexes 90-92. 
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In general, the coordination of ruthenium to tertiary phosphines 89a and 89b causes a decrease in 
the fluorescence quantum yield, however, the complexes do still remain moderately fluorescent 
and could be useful for in vitro imaging. The Stokes’ shift appears to increase in the complexes 
(19-23 nm) compared to the free tertiary phosphines (14 nm). 
The future work for these compounds will include sending the complexes with the most interesting 
photophysical properties, such as 92, to Dyson and co-workers in Zurich to see how they compare 
to RAPTA-C complexes when tested in vitro. It would also be interesting to explore further the 
relationship between primary and tertiary phosphine complexes and the resulting photophysical 
complexes.  
Table 3.5 Photophysical properties for tertiary phosphines 89a and 89b and their ruthenium phosphine 
complexes 90, 91 and 92. 
 
 
 
 
  
 λabs (nm) λem (nm) ΦF 
Bod-PCy2 89a 512 526 0.44 
Bod-PPh2 89b 513 527 0.29 
[RuI2(89a)(p-cymene)] 90 511 531 0.16 
[RuCl2(89a)(C6H6)] 91 513 531 0.19 
[RuI2(89b)(p-cymene)] 92 510 533 0.04 
Measured in dry, degassed tetrahydrofuran at room temperature, dyes were excited at 485 nm; Fluorescence quantum yields were measured with 
respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 57. 
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3.6 Summary 
This chapter has explored the coordination of novel Bodipy primary phosphines with group 6 and 
8 transition metals, for both a fundamental insight into their reactivity and coordination chemistry, 
but also to probe their photophysical properties and establish whether they can be used as in vitro 
imaging agents. The four primary phosphines were reacted with molybdenum and tungsten 
hexacarbonyl to form [M(CO)5(RPH2)] complexes. We have demonstrated that the air-stability of 
these primary phosphines does not hinder their reactivity in transition metal coordination 
chemistry. All of the novel complexes were characterised by IR and NMR spectroscopy and one 
tungsten complex (63) was also successfully analysed by X-ray crystallography. The group 6 
complexes retained high quantum yields with respect to the free primary phosphine ligands, with 
only a relatively slight decrease observed. The extinction coefficients were only slightly decreased 
by the metal coordination and the absorption and emission maxima were only marginally altered 
by 1-2 nm. 
Primary phosphines 20a, 20b, 50 and 56 were also reacted with four ruthenium(II) dimers, 
[RuCl2(C6H6)]2, [RuCl2(p-cymene)]2, [RuI2(C6H6)]2 and [RuI2(p-cymene)]2 to form a library of 
novel ruthenium phosphine complexes. The compounds were analysed by NMR spectroscopy and 
several complexes were characterised by X-ray crystallography. In these cases, the complexation 
caused a significant decrease in the fluorescence quantum yields compared to the uncomplexed 
primary phosphines. The absorption and emission maxima remained similar to the free primary 
phosphine whereas the extinction coefficients gave slightly lower values than the free phosphine.  
DFT calculations were performed in order to try and understand why the ruthenium complexes 
quench the fluorescence more than the molybdenum and tungsten complexes. The molybdenum 
and tungsten complexes displayed a Bodipy-based HOMO and LUMO whereas the ruthenium 
complexes exhibited a Bodipy-based HOMO and a metal-based LUMO. This would suggest that 
the ruthenium metal orbitals are involved in the fluorescence process, possibly in a MLCT process, 
which may identify why a bigger increase in fluorescence quenching is observed for them. 
Tertiary phosphines 89a and 89b were also coordinated to ruthenium dimers [RuI2(p-cymene)]2 
and [RuCl2(C6H6)]2 to form fluorescent ruthenium-phosphine complexes, which could be tested in 
cells for anti-cancer properties and be compared to RAPTA-C. These tertiary phosphines are of 
key importance in Chapter 4 where the synthesis of a range of phosphonium salts is discussed, for 
applications in mitochondrial imaging. 
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3.7 Experimental 
 General procedure 
All air- and/or water-sensitive reactions were performed under a nitrogen atmosphere using 
standard Schlenk line techniques. Tetrahydrofuran and toluene were dried over 
sodium/benzophenone and sodium, respectively, and dichloromethane was dried over calcium 
hydride – these solvents were distilled prior to use. Solvents used for column chromatography were 
not anhydrous. All starting materials were purchased from Aldrich, Acros Organics, Alfa Aesar, 
or Strem and used as received. The ruthenium complexes and [Mo(CO)6] and [W(CO)6] were used 
as received, other than [RuI2(C6H6)]2 which was synthesised following the published literature 
procedure.113 Flash chromatography was performed on silica gel from Fluorochem (silica gel, 40–
63 u, 60 A). Thin-layer chromatography was carried out on Fisher aluminium-based plates with 
silica gel and fluorescent indicator (254 nm). 1H, 13C{1H}, 31P{1H}, 31P-1H, and 11B{1H} NMR 
spectra were recorded on a JEOL Lambda 500 (1H 500.16 MHz), JEOL ECS-400 (1H 399.78 
MHz), or Bruker Avance III 300 (1H 300.13 Hz) spectrometer at room temperature (21 °C); 1H and 
13C shifts are reported relative to tetramethylsilane, 31P relative to 80% H3PO4, 
11B relative to 
BF3.Et2O and 
19F relative to CFCl3. Infrared spectra were recorded on a Varian 800 FT-IR 
spectrometer and mass spectrometry was carried out by the EPSRC NMSF, Swansea. DFT 
calculations were carried out on Spartan 14 using the B3LYP functional with a 6-31G* basis set, 
details of the xyz coordinates and SCF energies can be found in the appendix. 
 [Mo(CO)5(20a)] (62) 
A solution of [Mo(CO)6] (0.066 g, 0.25 mmol) in anhydrous THF (15 mL) was irradiated with UV 
light in a quartz vessel under a stream of nitrogen at room temperature for one hour. Primary 
phosphine 20a (0.100 g, 0.25 mmol) in anhydrous THF (15 mL) was added and the mixture was 
stirred for a further thirty minutes. The solvent was removed and the red product was purified by 
column chromatography (hexane:chloroform, 4:1), to yield the intended product as an orange solid 
(0.041 g, 26%).  
1H NMR (300 MHz, CDCl3) δ 7.66 (m, 2H), 7.42 (m, 2H), 5.56 (d, 1JHP = 326.7 Hz, 2H), 2.45 (s, 
6H), 2.31 (q, J = 7.5 Hz, 4H), 1.25 (s, 6H), 0.99 (t, J = 7.5 Hz, 6H), 0.28 (s, 6H) ppm; 13C{1H} 
NMR (75 MHz, CDCl3) δ 208.8 (d, 2JCP = 24.2 Hz), 204.7 (d, 2JCP = 9.8 Hz), 151.2, 139.9, 138.7, 
133.6, 132.9, 132.7 (d, JCP = 11.7 Hz), 130.0 (d, JCP = 10.6 Hz), 128.8, 126.8 (d, 
1JCP = 42.3 Hz), 
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17.6, 14.8, 14.5, 12.1, 10.4 (br) ppm; 31P-1H NMR (121 MHz, CDCl3) δ −63.5 (tt, 1JPH = 326.7 
Hz, 3JPH = 11.8 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ −2.2 ppm; IR (neat) 𝜈: 2962, 2929, 
2868, 2076, 1992, 1929 cm−1; HRMS (APCI+) calcd. for C30H35B1N2P1O5Mo1 [M + H]
+ requires 
m/z 636.1476, found 636.1493. 
 [W(CO)5(20a)] (63) 
A solution of [W(CO)6] (0.050 g, 0.14 mmol) in anhydrous THF (15 mL) was irradiated with UV 
light in a quartz vessel under a stream of nitrogen at room temperature for one hour. Primary 
phosphine 20a (0.057 g, 0.14 mmol) in anhydrous THF (15 mL) was added and the mixture was 
stirred for a further thirty minutes. The solvent was evaporated and purified by column 
chromatography (hexane:chloroform, 4:1) which yielded a red solid (0.018 g, 18%).  
1H NMR (300 MHz, CDCl3) δ 7.67 (m, 2H), 7.46 (m, 2H), 5.91 (d, 1JHP = 340.3 Hz, 2H), 2.46 (s, 
6H), 2.32 (q, J = 7.6 Hz, 4H), 1.25 (s, 6H), 0.99 (t, J = 7.6 Hz, 6H), 0.29 (s, 6H) ppm; 13C{1H} 
NMR (75 MHz, CDCl3) δ 198.3 (d, 2JCP = 23.1 Hz), 195.5 (d, 2JCP = 7.2 Hz), 151.3, 140.2, 138.5, 
133.6, 132.9, 132.8 (d, JCP = 11.3 Hz), 130.1 (d, JCP = 10.5 Hz), 128.8, 126.1 (d, 
1JCP = 47.3 Hz), 
17.6, 14.8, 14.5, 12.2, 10.5 (br) ppm; 31P-1H NMR (121 MHz, CDCl3) δ −85.7 (tt, 1JPH = 340.6 
Hz, 3JPH = 12.1 Hz, 
1JPW = 222.9 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ −1.6 ppm; IR (neat) 
𝜈: 2958, 2926, 2869, 2077, 1973, 1902 cm−1; HRMS (APCI+) calcd. for C30H35N2O5P110B1182W1 
(M + H)+ requires m/z 726.1890, found 726.1902. 
 [Mo(CO)5(20b)] (64) 
A solution of [Mo(CO)6] (0.015 g, 0.056 mmol) in anhydrous THF (8 mL) was irradiated with UV 
light in a quartz vessel under a stream of nitrogen at room temperature for 45 minutes. A solution 
of 20b (0.030 g, 0.056 mmol) in THF (8 mL) was added and the reaction was stirred for a further 
30 minutes. The solvent was removed and the orange solid was purified by column chromatography 
(petrol:chloroform, 4:1) to yield the product as an orange solid (8 mg, 19%). 
1H NMR (300 MHz, CDCl3) δ 7.63-7.58 (m, 2H), 7.40-7.37 (m, 4H), 7.28-7.16 (m, 8H), 4.11 (d, 
1JHP = 202.5 Hz, 2H), 2.21 (q, 
3JHH = 7.3 Hz, 4H), 1.76 (s, 6H), 1.31 (s, 6H), 0.90 (t, 
3JHH = 7.3 Hz, 
6H) ppm; 13C{1H} NMR (75 MHz, CDCl3) δ 208.4 (d, 2JCP = 24.2 Hz), 203.5 (d, 2JCP = 8.9 Hz), 
153.0, 150.3, 139.9, 136.8, 135.1, 134.9 (d, JCP = 15.3 Hz), 133.8, 132.8, 130.6, 129.0, 128.8 (d, 
JCP = 5.6 Hz), 127.1, 125.4, 17.3, 14.7, 14.5, 12.1 ppm; 31P-1H NMR (121 MHz, CDCl3) δ –64.2 
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(tt, 1JPH = 330.5 Hz, 
3JPH = 11.7 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ 1.7 ppm; IR (neat) 
𝜈: 2961, 2923, 2858, 2077, 1945, 1917 cm-1. 
 [W(CO)5(20b)] (65) 
A solution of [W(CO)6] (0.020 g, 0.056 mmol) in anhydrous THF (8 mL) was irradiated with UV 
light in a quartz vessel under a stream of nitrogen at room temperature for 30 minutes. A solution 
of 20b (0.030 g, 0.056 mmol) in THF (8 mL) was added and the reaction was stirred for a further 
30 minutes. The solvent was removed and the orange solid was purified by column chromatography 
(petrol:chloroform, 4:1) to yield the product as an orange solid (18 mg, 38 %). 
1H NMR (300 MHz, CDCl3) δ 7.63-7.58 (m, 2H), 7.40-7.37 (m, 4H), 7.28-7.16 (m, 8H), 4.11 (d, 
1JHP = 202.5 Hz, 2H), 2.21 (q, 
3JHH = 7.3 Hz, 4H), 1.76 (s, 6H), 1.31 (s, 6H), 0.90 (t, 
3JHH = 7.3 Hz, 
6H) ppm; 13C{1H} NMR (75 MHz, CDCl3) δ 198.2 (d, 2JCP = 22.8 Hz), 194.3 (d, 2JCP =7.1 Hz), 
153.0, 150.3, 139.9, 136.8, 135.1, 134.9 (d, JCP = 15.3 Hz), 133.8, 132.8, 130.6, 129.0, 128.8 (d, 
JCP = 5.6 Hz), 127.1, 125.4, 17.3, 14.7, 14.5, 12.1 ppm; 31P-1H NMR (121 MHz, CDCl3) 
δ –85.7 (tt, 1JPH = 342.5 Hz, 3JPH = 12.3 Hz, 1JPW = 223.3 Hz) ppm; 11B{1H} NMR (96 MHz, 
CDCl3) δ 1.7 ppm; IR (neat) 𝜈: 2962, 2910, 2360, 2076, 1969, 1921 cm-1. 
 
 [Mo(CO)5(50)] (66) 
A solution of [Mo(CO)6] (0.025 g, 0.094 mmol) in anhydrous THF (10 mL) was irradiated with 
UV light in a quartz vessel under a stream of nitrogen at room temperature for 45 minutes. A 
solution of 50 (0.040 g, 0.094 mmol) in THF (10 mL) was added and the reaction was stirred for a 
further 30 minutes. The solvent was removed and the orange solid was purified by column 
chromatography (petrol:chloroform, 4:1) to yield the product as an orange solid (11 mg, 16%). 
1H NMR (300 MHz, CDCl3) δ 7.66 (m, 2H), 7.40 (m, 2H), 5.54 (d, 1JHP = 327.3 Hz, 2H), 2.74 (s, 
6H), 2.33 (q, J = 7.5 Hz, 4H), 2.23 (s, 2H), 1.25 (s, 6H), 0.97 (t, J = 7.5 Hz, 6H) ppm; 13C{1H} 
NMR (75 MHz, CDCl3) δ 207.7 (d, 2JCP = 24.1 Hz), 203.5 (d, 2JCP = 8.9 Hz), 154.3, 139.6, 136.3, 
136.2, 133.4, 133.3, 132.8 (d, JCP = 11.8 Hz), 129.7 (d, JCP = 10.5 Hz), 128.7, 
103.9, 98.4, 17.4, 14.8, 14.1, 12.0 ppm; 31P-1H NMR (121 MHz, CDCl3) δ −64.0 
(tt, 1JPH = 327.1 Hz, 
3JPH = 12.4 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ −13.9 ppm; IR (neat) 
𝜈: 3295, 2962, 2925, 2854, 2360, 2076, 1994, 1928, 699 cm-1. 
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  [W(CO)5(50)] (67) 
A solution of [W(CO)6] (0.042 g, 0.118 mmol) in anhydrous THF (15 mL) was irradiated with UV 
light in a quartz vessel under a stream of nitrogen at room temperature for 45 minutes. A solution 
of 50 (0.050 g, 0.118 mmol) in THF (15 mL) was added and the reaction was stirred for a further 
30 minutes. The solvent was removed and the orange solid was purified by column chromatography 
(petrol:chloroform, 4:1) to yield the product as an orange solid (15 mg, 20%). 
1H NMR (300 MHz, CDCl3) δ 7.65 (m, 2H), 7.44 (m, 2H), 5.89 (d, 1JHP = 339.4 Hz, 2H), 2.75(s, 
6H), 2.32 (q, J = 7.8 Hz, 4H), 2.23 (s, 2H), 1.25 (s, 6H), 0.99 (t, J = 7.5 Hz, 6H) ppm; 13C{1H} 
NMR (75 MHz, CDCl3) δ 198.0 (d, 2JCP = 22.6 Hz), 195.3 (d, 2JCP = 7.0 Hz), 154.4, 139.1, 138.1, 
136.3, 133.5, 132.8 (d, JCP = 11.4 Hz), 129.8 (d, JCP = 10.3 Hz), 128.8, 126.5, 100.1, 83.1, 17.4, 
14.8, 14.1, 12.1 ppm; 31P-1H NMR (121 MHz, CDCl3) δ −85.6 (tt, 1JPH = 342.1 Hz, 3JPH = 12.7 
Hz, 1JPW = 223.10 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ −13.9 ppm; IR (neat) 𝜈: 3295, 
2958, 2854, 2924, 2360, 2075, 1972, 1914, 698 cm-1. 
 [Mo(CO)5(56)] (68) 
A solution of [Mo(CO)6] (0.027 g, 0.047 mmol) in anhydrous THF (10 mL) was irradiated with 
UV light in a quartz vessel under a stream of nitrogen at room temperature for 45 minutes. A 
solution of 56 (0.013 g, 0.047 mmol) in THF (10 mL) was added and the reaction was stirred for a 
further 30 minutes. The solvent was removed and the orange solid was purified by column 
chromatography (petrol:chloroform, 4:1) to yield the product as an orange solid (12 mg, 31%). 
1H NMR (300 MHz, CDCl3) δ 7.53 (m, 2H), 7.35-7.32 (m, 2H), 7.21-7.12 (m, 10H), 4.08 (d, 1JHP 
= 202.8 Hz, 2H), 2.79 (s, 6H), 2.30 (q, 3JHH = 7.6 Hz, 4H), 1.24 (s, 6H), 0.95 (t, 
3JHH = 7.5 Hz, 6H) 
ppm; 13C{1H} NMR (75 MHz, CDCl3) δ 208.2 (d, JCP = 24.2 Hz), 204.4 (d, JCP = 9.2 Hz), 154.0, 
139.5, 136.5, 136.3, 135.2, (d, JCP = 16.3 Hz), 133.0, 131.7, 129.1, 128.8 (d, JCP = 5.7 Hz), 128.1, 
127.1, 125.7, 60.5, 41.5, 22.8, 17.6, 14.9, 14.1, 12.2 ppm; 31P-1H NMR (121 MHz, CDCl3) δ –
64.7 (tt, 1JPH = 327.9 Hz, 
3JPH = 11.8 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) 
δ –12.5 ppm; IR (neat) 𝜈: 3574, 2962, 2930, 2845, 2358, 2077, 1989, 1924 cm-1. 
 [W(CO)5(56)] (69) 
A solution of [W(CO)6] (0.018 g, 0.052 mmol) in anhydrous THF (8 mL) was irradiated with UV 
light in a quartz vessel under a stream of nitrogen at room temperature for 30 minutes. A solution 
of 56 (0.030 g, 0.052 mmol) in THF (8 mL) was added and the reaction was stirred for a further 30 
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minutes. The solvent was removed and the orange solid was purified by column chromatography 
(petrol:chloroform, 4:1) to yield the product as an orange solid (13 mg, 28%). 
1H NMR (300 MHz, CDCl3) δ 7.53 (m, 2H), 7.35-7.32 (m, 2H), 7.21-7.12 (m, 10H), 4.12 (d, 1JHP 
= 342.3 Hz, 2H), 2.79 (s, 6H), 2.30 (q, 3JHH = 7.6 Hz, 4H), 1.24 (s, 6H), 0.95 (t, 
3JHH = 7.5 Hz, 6H) 
ppm; 13C{1H} NMR (75 MHz, CDCl3) δ 198.3 (d, 2JCP = 22.9 Hz), 194.3 (d, 2JCP = 6.9 Hz), 154.5, 
139.3, 138.9, 136.0, 133.2, 132.8 (d, JCP = 11.6 Hz), 131.6, 129.8 (d, JCP = 10.8 Hz), 128.9, 128.1, 
127.1, 125.5, 104.0, 103.2, 100.1, 17.5, 14.9, 14.1, 12.1 ppm; 31P-1H NMR (121 MHz, CDCl3) δ 
–85.7 (tt, 1JPH = 342.3 Hz, 3JPH = 12.4 Hz, 1JPW = 222.8 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) 
δ –12.6 ppm; IR (neat) 𝜈: 3648, 2960, 2922, 2852, 2360, 2075, 1974, 
1915 cm-1. 
 [Mo(CO)4(20a)2] (70) 
cis-[Mo(CO)4(pip)2] (0.070 g, 0.19 mmol) and 8-((4-phosphino)phenyl)-4,4-dimethyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (0.150 g, 0.37 mmol) were dissolved in 
anhydrous dichloromethane (6 mL) under nitrogen. The reaction was refluxed for two hours and 
analysed by 31P{1H} NMR spectroscopy. The complex was purified by column chromatography 
on silica gel (petroleum ether/dichloromethane 3:1, Rf = 0.4) to yield an orange solid (0.120 g, 
63%). A sample suitable for X-ray crystallographic analysis was obtained from 
chloroform/pentane. 1H NMR (400 MHz, CDCl3) δ 7.64 (dd, 3JHH = 7.8 Hz, 3JHP = 11.5 Hz, 4H), 
7.26 (dd, 3JHH = 7.8 Hz, 
4JHP = 1.4 Hz, 4H), 5.50 (dd, 
1JHP = 318.9 Hz, 
3JHP = 8.7 Hz, 4H), 2.44 (s, 
12H), 2.29 (q, 3JHH = 7.8 Hz, 8H), 1.22 (s, 12H), 0.96 (t, 
3JHH = 7.8 Hz, 12H), 0.26 (s, 12H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 213.2 (m, CO), 207.8 (pseudo t, 2JCP = 9.6 Hz, CO), 151.1, 
139.5, 138.8, 133.5, 132.9 (pseudo t, JCP = 4.8 Hz), 132.8, 129.8 (pseudo t, JCP = 4.8 Hz), 128.8, 
127.2 (m), 17.5, 14.7, 14.4, 12.1, 10.4 (br) ppm; 31P-1H NMR (202 MHz, CDCl3) δ −56.1 (m) 
ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.8 ppm; IR (neat): 𝜈 = 2360 (w, PH), 2332 (w, PH), 
2029 (s, CO), 1947 (s, CO), 1919 (s, CO), 1896 (s) (CO) cm−1; HRMS (ESI+) calcd for 
C54H69B2N4P2O4Mo1 [M+H]
+ requires m/z 1012.4084, found m/z 1012.4078 (0.6 ppm). 
 
 [W(CO)4(20a)2] (71) 
cis-[W(CO)4(pip)2] (0.057 g, 0.126 mmol) and 8-((4-phosphino)phenyl)-4,4-dimethyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (0.100 g, 0.247 mmol) were dissolved in 
anhydrous toluene (5 mL) under nitrogen. The reaction was heated to 75°C for 20 hours and the 
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solvent was evaporated. The complex was purified by column chromatography on silica gel 
(petroleum ether/dichloromethane 5:1, Rf = 0.2) to yield an orange solid (0.092 g, 67%). 1H NMR 
(400 MHz, CDCl3) δ 7.64 (dd, 3JHH = 7.9 Hz, 3JHP = 11.8 Hz, 4H), 7.42 (dd, 3JHH = 7.9 Hz, 4JHP = 
1.6 Hz, 4H), 5.79 (d, 1JHP = 388.9 Hz, 4H), 2.44 (s, 12H), 2.29 (q, 
3JHH = 7.6 Hz, 8H), 1.24 (s, 
12H), 0.96 (t, 3JHH = 7.6 Hz, 12H), 0.26 (s, 12H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 203.5 
(m, CO), 199.3 (pseudo t, 2JCP = 7.3 Hz, CO), 151.2, 139.7, 138.6, 133.4, 132.9 (pseudo t, JCP = 
5.7 Hz), 132.7, 129.8 (pseudo t, JCP = 4.3 Hz), 128.7, 126.9, 17.4, 14.7, 14.3, 12.0, 10.4 (br) ppm; 
31P-1H NMR (202 MHz, CDCl3) δ −76.9 (m) ppm; 31P{1H} NMR (202 MHz, CDCl3) δ −76.9 
(1JPW = 217.4 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −2.0 ppm; IR (neat): 𝜈 = 2961 (w), 
2926 (w), 2870 (w), 2359 (w, PH), 2341 (w, PH), 2026 (s, CO), 1940 (s, CO), 1912 (s, CO), 1888 
(s, CO), 1549 (s), 1454 (m), 1404 (m), 1360 (m), 1319 (s), 1262 (m), 1171 (s), 1145 (s), 1112 (m), 
1020 (m), 981 (m), 944 (s), 884 (s), 795 (s) cm−1; HRMS (ESI+) calcd for C54H68B2N4P2O4W1 
[M]+ requires m/z 1102.4507, found m/z 1102.4486 (1.9 ppm). 
 
  [RuCl2(η6-C6H6)(20a)] (72) 
20a (0.050 g, 0.12 mmol) and dichloro(benzene)ruthenium(II) dimer (0.030 g, 0.06 mmol) were 
dissolved in CDCl3 (3 mL) and stirred under nitrogen for one hour to yield an orange solid 
(0.078 g, 99%). A sample suitable for X-ray crystallographic analysis was obtained from 
chloroform/hexane. 1H NMR (500 MHz, CDCl3) δ 7.98 (dd, 3JHH = 7.8 Hz, 3JHP = 11.8 Hz, 2H), 
7.48 (dd, 3JHH = 7.8 Hz, 
4JHP = 1.4 Hz, 2H), 5.87 (d, 
1JHP = 397.2 Hz, 2H), 5.58 (s, 6H), 2.45 (s, 
6H), 2.30 (q, 3JHH =7.7 Hz, 4H), 1.28 (s, 6H), 0.97 (t, 
3JHH = 7.7 Hz, 6H), 0.27 (s, 6H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 151.4, 141.1, 138.3, 133.0 (d, JCP = 5.8 Hz), 132.8 (d, JCP = 8.4 Hz), 
130.1 (d, JCP = 11.4 Hz), 128.6, 128.1, 127.1, 88.0 (d, JCP = 3.8 Hz), 17.5, 14.8, 14.5, 12.1, 10.4 
(br) ppm; 31P-1H NMR (162 MHz, CDCl3) δ −31.3 (tt, 1JPH = 397.2 Hz, 3JPH = 10.7 Hz) ppm; 
11B{1H} NMR (128 MHz, CDCl3) δ −1.8 (s) ppm; IR (neat) 𝜈: 2963, 2928, 2870, 2359 (w, PH), 
2343 (w, PH), 1549, 1435, 1360, 1317, 1262, 1172, 1145, 1111, 1021, 981, 944, 877, 795 cm−1; 
HRMS (ESI+) calcd. for C31H40B1N2P1Cl2RuNa [M+Na]
+ requires m/z 677.1348, found m/z 
677.1381. 
 [RuCl2(p-cymene)(20a)] (73) 
20a (0.060 g, 0.15 mmol) and dichloro(p-cymene)ruthenium(II) dimer (0.046 g, 0.075 mmol) were 
dissolved in CDCl3 (3 mL) and stirred at room temperature under nitrogen for one hour. The solvent 
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was removed to give an orange solid (0.098 g, 93%). 1H NMR (500 MHz, CDCl3) δ 7.95 (m, 2H), 
7.48 (m, 2H), 5.76 (d, 1JHP = 390.1 Hz, 2H), 5.38 (
3JHH = 5.9 Hz, 2H), 5.21 (
3JHH = 5.9 Hz, 2H), 
2.78 (m, 1H), 2.46 (s, 6H), 2.30 (q, 3JHH = 7.4 Hz, 4H), 2.14 (s, 3H), 1.29 (s, 6H), 1.25 (d, 
3JHH = 
6.9 Hz, 6H), 0.99 (t, J = 7.4 Hz, 6H), 0.28 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 151.4, 
140.9, 138.4, 133.1 (d, JCP = 8.5 Hz), 132.9 (d, JCP = 8.5 Hz), 130.0 (d, JCP = 10.1 Hz), 128.7, 
127.8, 127.4, 106.4, 100.9, 87.1 (d, 2JCP = 4.9 Hz), 86.4 (d, 
2JCP = 4.2 Hz), 31.1, 22.3, 18.7, 17.5, 
14.8, 14.5, 12.2, 10.5 (br) ppm; 31P-1H NMR (162 MHz, CDCl3) δ −29.5 (tt, 1JPH = 390.8 Hz, 3JPH 
= 11.5 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.5 (s) ppm. 
 [RuI2(η6-C6H6)(20a)] (74) 
20a (0.050 g, 0.12 mmol) and diiodo(benzene)ruthenium(II) dimer (0.053 g, 0.062 mmol) were 
dissolved in anhydrous DCM (3 mL) and stirred at 60°C under nitrogen for two hours. The solvent 
was removed to give an orange solid (0.088 g, 93%). 1H NMR (300 MHz, CDCl3) δ 8.01 (m, 2H), 
7.48 (m, 2H), 7.07 (d, 1JHP = 398.3 Hz, 2H), 5.66 (s, 6H), 2.46 (s, 6H), 2.32 (q, J = 7.6 Hz, 4H), 
1.30 (s, 6H), 0.99 (t, J = 7.6 Hz, 6H), 0.29 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 151.4, 
141.0, 138.4, 133.1 (d, JCP = 2.4 Hz), 132.7 (d, JCP = 8.6 Hz), 131.3, 130.7, 130.1 (d, JCP = 10.0 
Hz), 128.7, 88.9 (d, 2JCP = 4.0 Hz), 17.6, 14.8, 14.5, 12.2, 10.6 (br) ppm; 31P-1H NMR (121 MHz, 
CDCl3) δ −49.8 (tt, 1JPH = 398.3 Hz, 3JPH = 11.4 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ 0.6 
(s) ppm; HRMS (NSI+) calcd. for C32H43B1I2N2P1Ru1O1 [M + OCH3]
+ requires m/z 862.0402, 
found m/z 862.0402. 
 [RuI2(p-cymene)(20a)] (75) 
20a (0.050 g, 0.12 mmol) and diiodo(p-cymene)ruthenium(II) dimer (0.060 g, 0.062 mmol) were 
dissolved in CDCl3 (3 mL) and stirred under nitrogen for one hour, the solvent was removed to 
give an orange solid (0.12 g, 95%). A sample suitable for X-ray crystallographic analysis was 
obtained via slow diffusion of pentane/chloroform. 1H NMR (500 MHz, CDCl3) δ 7.99 (m, 2H), 
7.45 (m, 2H), 6.54 (d, 1JHP = 392.2 Hz, 2H), 5.40 (d, 
3JHH = 5.9 Hz, 2H), 5.23 (d, 
3JHH = 5.9 Hz, 
2H), 2.99 (m, 1H), 2.46 (s, 6H), 2.36 (s, 3H), 2.30 (q, 3JHH =7.6 Hz, 4H), 1.28 (s, 6H), 1.25 (d, 
3JHH 
=7.6 Hz, 6H), 0.98 (t, J = 7.6 Hz, 6H), 0.27 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
151.3, 140.8, 138.5, 133.3 (d, JCP = 8.1 Hz), 131.1 (d, JCP = 11.5 Hz), 131.0, 130.7, 129.8 (d, JCP = 
9.7 Hz), 128.7, 109.6 (d, JCP = 3.3 Hz), 101.6 (d, JCP = 3.3 Hz), 87.8 (d, JCP = 3.6 Hz), 86.9 (d, JCP 
= 3.6 Hz), 32.0, 22.8, 20.2, 17.5, 14.8, 14.4, 12.2, 10.4 (br) ppm; 31P-1H NMR (162 MHz, CDCl3) 
δ −43.7 (tt, 1JPH = 392.2 Hz, 3JPH = 10.9) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.8 (s) ppm; 
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IR (neat) 𝜈: 2962, 2930, 2867, 2359, 2341, 1550, 1453, 1364, 1320, 1262, 1171, 1144, 1111, 1024, 
981, 944, 887, 796 cm-1; HRMS (ESI+) calcd. for C35H48B1N2P1I2Ru1 [M]
+ requires m/z 889.0898, 
found m/z 889.0930. 
 [RuCl2(η6-C6H6)(20b)] (76) 
20b (0.050 g, 0.095 mmol) and dichloro(benzene)ruthenium(II) dimer (0.030 g, 0.060 mmol) were 
dissolved in CDCl3 (3 mL) and stirred under nitrogen for one hour. The solvent was removed which 
gave an orange solid (0.070 g, 95%). 1H NMR (500 MHz, CDCl3) δ 8.04 (m, 2H), 7.52 (m, 2H), 
7.38 (m, 4H), 7.16-7.26 (m, 6H), 5.95 (d, 1JHP = 395.8 Hz, 2H), 5.63 (s, 6H), 2.20 (q, 
3JHH = 7.4 
Hz, 4H), 1.77 (s, 6H), 1.35 (s, 6H), 0.89 (t, 3JHH = 7.4 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 153.8, 150.1 (br), 140.7, 138.7, 134.6, 133.9, 133.4, 133.0 (d, JCP = 8.6 Hz), 130.4, 130.2 
(d, JCP = 10.0 Hz), 127.9, 127.4, 125.7, 88.1, 17.5, 14.9, 14.4, 12.4 ppm; 31P-1H NMR (162 MHz, 
CDCl3) δ −31.4 (tt, 1JPH = 395.8 Hz, 3JPH = 10.9 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ 
−0.9 (s) ppm; IR (neat) 𝜈: 2962, 2926, 2870, 2358 (w, PH), 2340 (w, PH), 1546, 1472, 1433, 1396,  
1360, 1304, 1263, 1172, 1143, 1111, 1061, 1016, 973, 881, 772 cm−1; HRMS (ESI+) calcd. for 
C41H44B1N2P1Cl2Ru1Na [M+Na]
+ requires m/z 802.1743, found m/z 802.1758. 
 [RuCl2(η6-p-cymene)(20b)] (77) 
20b (0.050 g, 0.095 mmol) and dichloro(p-cymene)ruthenium(II) dimer (0.028 g, 0.047 mmol) 
were dissolved in CDCl3 (3 mL) and stirred at room temperature under nitrogen for one hour. The 
solvent was removed to give an orange solid (0.098 g, 93%). 1H NMR (300 MHz, CDCl3) δ 7.99 
(m, 2H), 7.61 (m, 1H), 7.49 (m, 1H), 7.25-7.06 (m, 6H), 5.77 (d, 1JHP = 390.0 Hz, 2H), 5.39 (
3JHH 
= 5.5 Hz, 2H), 5.23 (3JHH = 6.2 Hz, 2H), 2.79 (m, 1H), 2.27 (q, 
3JHH = 7.8 Hz, 4H), 2.22 (s, 6H), 
2.16 (s, 3H), 1.37 (s, 6H), 1.27 (d, 3JHH = 6.6 Hz, 6H), 0.92 (t, J = 7.4 Hz, 6H) ppm; 13C{1H} NMR 
(75 MHz, CDCl3) δ 154.7, 152.5, 140.2, 138.8, 134.1, 133.3, 133.1, 132.5, 130.0 (d, JCP = 10.0 
Hz), 129.7 (d, JCP = 10.0 Hz), 129.2, 127.3, 125.5, 106.4, 101.1, 87.1 (d, 
2JCP = 4.9 Hz), 86.4 (d, 
2JCP = 4.1 Hz), 31.1, 22.4, 17.4, 14.8, 15.0, 13.0, 12.1 ppm; 31P-1H NMR (121 MHz, CDCl3) 
δ−30.2 (tt, 1JPH = 390.0 Hz, 3JPH = 11.1 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) 
δ −1.8 (s) ppm. 
 [RuI2(η6-C6H6)(20b)] (78) 
20b (0.050 g, 0.095 mmol) and diiodo(benzene)ruthenium(II) dimer (0.040 g, 0.047 mmol) were 
dissolved in anhydrous DCM (3 mL) and stirred at 60°C under nitrogen for two hours. The solvent 
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was removed to give an orange solid (0.098 g, 93%). 1H NMR (300 MHz, CDCl3) δ 8.06 (m, 2H), 
7.57 (m, 4H), 7.44 (m, 2H), 7.24-7.10 (m, 6H), 7.06 (d, 1JHP = 398.5 Hz, 2H), 5.68 (s, 6H), 2.23 (s, 
6H), 2.20 (q, 3JHH = 7.4 Hz, 4H), 1.35 (s, 6H), 0.90 (t, 
3JHH = 7.4 Hz, 6H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 153.8, 150.1 (br), 140.7, 138.7, 134.6, 133.9, 133.4, 133.0 (d, JCP = 8.6 Hz), 130.4, 
130.2 (d, JCP = 10.0 Hz), 127.9, 127.4, 125.7, 88.1, 17.5, 14.9, 14.4, 12.4 ppm; 31P-1H NMR (121 
MHz, CDCl3) δ −50.2 (tt, 1JPH = 398.5 Hz, 3JPH = 11.2 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) 
δ 0.6 (s) ppm. 
 [RuI2(p-cymene)(20b)] (79) 
20b (0.050 g, 0.12 mmol) and diiodo(p-cymene)ruthenium(II) dimer (0.060 g, 0.062 mmol) were 
dissolved in CDCl3 (3 mL) and stirred under nitrogen for one hour. The solvent was removed to 
give an orange solid (0.118 g, 97%). 1H NMR (500 MHz, CDCl3) δ 8.01 (dd, 3JHH = 7.8 Hz, 3JHP 
= 11.3 Hz, 2H), 7.47 (dd, 3JHH = 7.8 Hz, 
4JHP = 1.4 Hz, 2H), 7.37 (m, 4H), 7.26-7.16 (m, 6H), 6.94 
(d, 1JHP = 391.8 Hz, 2H), 5.40 (d, 
3JHH = 5.7 Hz, 2H), 5.23 (d,
 3JHH = 5.7 Hz, 2H), 2.99 (m, 1H), 
2.37 (s, 3H), 2.22 (q, J =7.8 Hz, 4H), 1.76 (s, 6H), 1.33 (s, 6H), 1.26 (d, 3JHH = 6.9 Hz, 6H), 0.90 
(t, J = 7.02 Hz, 6H) ppm;13C{1H} NMR (100 MHz, CDCl3) δ 158.3, 140.5, 138.7, 134.6, 133.9, 
133.4 (d, JCP = 5.7 Hz), 131.4, 130.9, 130.4, 129.9 (d, JCP = 9.6 Hz), 127.3, 125.7, 109.6 (d, 
2JCP = 
3.0 Hz), 101.7 (d, JCP = 3.0 Hz), 87.8 (d, JCP = 3.0 Hz), 86.9 (d, JCP = 3.0 Hz), 32.0, 22.8, 20.2, 
17.5, 14.8, 14.7, 12.4 ppm;  31P-1H NMR (162 MHz, CDCl3) δ −43.9 (tt, 1JPH = 391.8 Hz, 3JPH = 
11.2 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.0 (s) ppm; IR (neat) 𝜈: 2964, 2927, 2870, 
2356 (w, PH), 2342 (w, PH), 1545, 1472, 1433, 1386, 1360, 1304, 1263, 1172, 1143, 1112, 1061, 
1016, 973, 888, 859, 772 cm−1; HRMS (ESI+) calcd. for C45H52B1N2P1I2Ru1 [M]
+ requires m/z 
1013.1213, found m/z 1013.1194. 
 [RuCl2(η6-C6H6)(50)] (80) 
50 (0.050 g, 0.12 mmol) and dichloro(benzene)ruthenium(II) dimer (0.029 g, 0.059 mmol) were 
dissolved in CDCl3 (3 mL) and stirred at room temperature under nitrogen for 45 minutes. The 
solvent was removed to give the desired product as an orange solid (0.070 g, 95%). 1H NMR (300 
MHz, CDCl3) δ 7.99 (m, 2H), 7.49 (m, 2H), 5.87 (d, 1JHP = 397.9 Hz, 2H), 5.59 (s, 6H), 2.77 (s, 
6H), 2.31 (q, J = 7.8 Hz, 4H), 2.26 (s, 2H), 1.25 (s, 6H), 0.99 (t, JHH = 7.5 Hz, 6H) ppm; 13C{1H} 
NMR (75 MHz, CDCl3) δ 154.5, 135.7, 135.5, 132.9, 129.8, 129.6, 128.5, 128.3, 127.4, 124.9, 
98.2, 88.0 (d, JCP = 3.8 Hz), 29.7, 17.5, 14.9, 14.2, 12.2 ppm; 31P-1H NMR (121 MHz, CDCl3) δ 
−32.4 (tt, 1JPH = 398.3 Hz, 3JPH = 11.9 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ −13.9 (s) ppm; 
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 [RuCl2(p-cymene)(50)] (81) 
50 (0.033 g, 0.078 mmol) and dichloro(p-cymene)ruthenium(II) dimer (0.024 g, 0.039 mmol) were 
combined in anhydrous DCM (4 mL) and stirred for one hour. The solvent was removed to give a 
red solid (0.074, 97%). 1H NMR (300 MHz, CDCl3) δ 7.96 (m, 2H), 7.45 (m, 2H), 5.74 (d, 1JHP = 
390.7 Hz, 2H), 5.39 (d, 3JHH = 5.9 Hz, 2H), 5.22 (d, 
3JHH = 5.9 Hz, 2H), 2.91 (m, 1H), 2.76 (s, 6H), 
2.33 (q, 3JHH = 7.6 Hz, 4H), 2.24 (s, 2H), 2.13 (s, 3H), 1.30 (s, 6H), 1.24 (d, 
3JHH = 7.0 Hz, 6H), 
0.99 (t, J = 7.6 Hz, 6H) ppm; 13C{1H} NMR (75 MHz, CDCl3) δ 154.5, 139.8, 138.1, 135.9, 133.5, 
133.2 (d, JCP = 8.3 Hz), 129.7 (d, JCP = 9.7 Hz), 128.6, 127.7, 106.6, 87.1(d, J = 5.1 Hz), 86.5 (d, 
J = 4.4 Hz), 81.4, 80.6, 31.1, 22.4, 18.7, 17.5, 14.8, 14.4, 12.2 ppm; 31P-1H NMR (121 MHz, 
CDCl3) δ −30.3 (tt, 1JPH = 390.4 Hz, 3JPH = 11.4 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ 
−13.8 (s) ppm. 
 [RuI2(η6-C6H6)(50)] (82) 
50 (0.025 g, 0.24 mmol) and diiodo(η6-C6H6)ruthenium(II) dimer (0.025 g, 0.012 mmol) were 
dissolved in CDCl3 (3 mL) and stirred at room temperature under nitrogen for 45 minutes. The 
solvent was removed to give the desired product as an orange solid (0.070 g, 95%). 1H NMR (300 
MHz, CDCl3) δ 7.99 (m, 2H), 7.49 (m, 2H), 5.87 (d, 1JHP = 397.9 Hz, 2H), 5.59 (s, 6H), 2.77 (s, 
6H), 2.31 (q, J = 7.8 Hz, 4H), 2.26 (s, 2H), 1.25 (s, 6H), 0.99 (t, JHH = 7.5 Hz, 6H) ppm; 13C{1H} 
NMR (75 MHz, CDCl3) δ 154.5, 135.7, 135.5, 132.9, 129.8, 129.6, 128.5, 128.3, 127.4, 124.9, 
98.2, 88.2 (d, JCP = 3.8 Hz), 29.7, 17.5, 14.9, 14.2, 12.2 ppm; 31P-1H NMR (121 MHz, CDCl3) 
δ −50.1 (tt, 1JPH = 398.1 Hz, 3JPH = 11.6 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ −13.9 (s) 
ppm; 
 [RuI2(p-cymene)(50)] (83) 
50 (0.040 g, 0.094 mmol) and diiodo(p-cymene)ruthenium(II) dimer (0.046 g, 0.047 mmol) were 
dissolved in CDCl3 (3 mL) and stirred under nitrogen for one hour. The solvent was removed to 
give an orange solid (0.118 g, 97%). 1H NMR (CDCl3, 500 MHz) δ 8.01 (m, 2H), 7.47 (m, 2H), 
7.37 (m, 4H), 7.26-7.16 (m, 6H), 6.94 (d, 1JHP = 391.8 Hz, 2H), 5.40 (d, 
3JHH = 5.7 Hz, 2H), 5.23 
(d, 3JHH = 5.7 Hz, 2H), 2.99 (m, 1H), 2.37 (s, 3H), 2.22 (q, J =7.8 Hz, 4H), 1.76 (s, 6H), 1.33 (s, 
6H), 1.26 (d, 3JHH = 6.9 Hz, 6H), 0.90 (t, J = 7.02 Hz, 6H) ppm;13C{1H} NMR (CDCl3, 100 MHz) 
δ 158.3, 140.5, 138.7, 134.6, 133.9, 133.4 (d, JCP = 5.7 Hz), 131.4, 130.9, 130.4, 129.9 (d, JCP = 
9.6 Hz), 127.3, 125.7, 109.6 (d, 2JCP = 3.0 Hz), 101.7 (d, 
2JCP = 3.0 Hz), 87.8, 86.9, 32.2, 22.8, 
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20.2, 17.6, 14.9, 14.7, 12.2 ppm;  31P-1H NMR (162 MHz, CDCl3) δ −43.9 (tt, 1JPH = 390.8 Hz, 
3JPH = 11.4 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −13.7 (s) ppm. 
 
 [RuCl2(η6-C6H6)(56)] (84) 
56 (0.025 g, 0.043 mmol) and dichloro(benzene)ruthenium(II) dimer (0.011 g, 0.022 mmol) were 
dissolved in CDCl3 (2 mL) and stirred at room temperature under nitrogen for 45 minutes. The 
solvent was removed to give the desired product. 1H NMR (300 MHz, CDCl3) δ 7.99 (m, 2H), 7.52 
(m, 2H), 7.43-7.39 (m, 4H), 7.25-7.20 (m, 6H), 5.87 (d, 1JHP = 397.6 Hz, 2H), 5.59 (s, 6H), 2.88 
(s, 6H), 2.37 (q, 3JHH = 7.5 Hz, 4H), 1.34 (s, 6H), 1.03 (t, 
3JHH = 7.5 Hz, 6H) ppm; 13C{1H} NMR 
(75 MHz, CDCl3) δ 154.6, 140.3, 135.4, 133.4, 132.9, 132.1, 131.5, 129.8 (d, JCP = 11.6 Hz), 128.6, 
128.3, 128.0, 127.1, 125.5, 125.4, 87.9, 83.7, 17.4, 14.8, 14.1, 12.1 ppm; 31P-1H NMR (162 MHz, 
CDCl3) δ −32.2 (tt, 1JPH = 398.0 Hz, 3JPH = 11.9 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ 
−12.6 (s) ppm. 
 [RuCl2(η6-p-cymene)(56)] (85) 
56 (0.025 g, 0.043 mmol) and dichloro(benzene)ruthenium(II) dimer (0.013 g, 0.022 mmol) were 
dissolved in CDCl3 (2 mL) and stirred at room temperature under nitrogen for 45 minutes. The 
solvent was removed to give the desired product. 1H NMR (300 MHz, CDCl3) δ 7.96 (m, 2H), 7.50 
(m, 2H), 7.43-7.40 (m, 4H), 7.28-7.22 (m, 6H), 5.75 (d, 1JHP = 389.9 Hz, 2H), 5.38 (d, JHH = 6.0 
Hz, 2H), 5.21 (d, JHH = 6.0 Hz, 2H), 2.88 (s, 6H), 2.80 (m, 1H), 2.39 (q, 
3JHH = 7.8 Hz, 4H), 2.15 
(s, 3H), 1.34 (s, 6H), 1.27 (s, 3H), 1.24 (s, 3H), 1.03 (t, J = 7.5 Hz, 6H) ppm; 13C{1H} NMR δ 
154.7, 140.1, 138.1, 135.6, 133.4, 132.2 (d, JCP = 8.2 Hz), 131.6, 129.9 (d, JCP = 10.4 Hz), 128.8, 
128.1, 127.7, 127.2, 125.5, 106.5, 101.0, 87.1, 86.5, 81.4, 80.7, 31.1, 22.4, 18.7, 17.6, 14.9, 14.2, 
12.3 ppm; 31P-1H NMR (121 MHz, CDCl3) δ −30.5 (tt, 1JPH = 391.2 Hz, 3JPH = 11.6 Hz) ppm; 
11B{1H} NMR (96 MHz, CDCl3) δ −12.7 (s) ppm; 
 
 [RuI2(η6-C6H6)(56)] (86) 
56 (0.025 g, 0.043 mmol) and dichloro(benzene)ruthenium(II) dimer (0.019 g, 0.022 mmol) were 
dissolved in CDCl3 (3 mL) and stirred at room temperature under nitrogen for 45 minutes. The 
solvent was removed to give the desired product. 1H NMR (300 MHz, CDCl3) δ 7.99 (m, 2H), 7.52 
(m, 2H), 7.43-7.39 (m, 4H), 7.25-7.20 (m, 6H), 5.87 (d, 1JHP = 397.6 Hz, 2H), 5.59 (s, 6H), 2.88 
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(s, 6H), 2.37 (q, 3JHH = 7.5 Hz, 4H), 1.34 (s, 6H), 1.03 (t, 
3JHH = 7.5 Hz, 6H) ppm; 13C{1H} NMR 
(75 MHz, CDCl3) δ 154.6, 140.3, 135.4, 133.4, 132.9, 132.1, 131.5, 129.8 (d, JCP = 11.6 Hz), 128.6, 
128.3, 128.0, 127.1, 125.5, 125.4, 87.9, 83.7, 17.4, 14.8, 14.1, 12.1 ppm; 31P-1H NMR (162 MHz, 
CDCl3) δ −49.6 (tt, 1JPH = 398.4 Hz, 3JPH = 11.2 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ 
−12.6 (s) ppm. 
 [RuI2(η6-p-cymene)(56)] (87) 
56 (0.025 g, 0.043 mmol) and dichloro(benzene)ruthenium(II) dimer (0.022 g, 0.022 mmol) were 
dissolved in CDCl3 (2 mL) and stirred at room temperature under nitrogen for 45 minutes. The 
solvent was removed to give the desired product. 1H NMR (300 MHz, CDCl3) δ 8.00 (m, 2H), 7.49 
(m, 2H), 7.43-7.39 (m, 4H), 7.34-7.22 (m, 6H), 6.94 (d, 1JHP = 392.1 Hz, 2H), 5.42 (d, JHH = 5.9 
Hz, 2H), 5.23 (d, JHH = 5.9 Hz, 2H), 3.00 (m, 1H), 2.88 (s, 6H), 2.38 (q, 
3JHH = 7.6 Hz, 4H), 2.37 
(s, 3H), 1.34 (s, 6H), 1.29 (s, 3H), 1.27 (s, 3H), 1.03 (t, 3JHH = 7.4 Hz, 6H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 154.7, 140.0, 138.1, 136.0, 135.6, 133.6, 133.5, 133.4, 132.3, 131.7, 129.6 
(d, JCP =10.3 Hz), 128.8 (d, JCP =7.7 Hz), 128.4, 128.1, 127.2, 125.5, 87.7, 86.9, 82.2, 32.1, 22.9, 
20.2, 17.6, 14.9, 14.2, 12.3 ppm; 31P-1H NMR (121 MHz, CDCl3) δ −44.6 (tt, 1JPH = 391.4 Hz, 
3JPH = 11.5 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ −12.6 (s) ppm; 
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 Towards a Trifunctional Mitochondrial Imaging Agent 
This chapter describes the synthesis of fluorescent phosphonium salts which have the potential to 
be used as trifunctional imaging agents consisting of three features: i) a positive charge on the 
phosphorus atom to introduce organelle specificity, in this case to the mitochondria, ii) a 
fluorophore, to provide in vitro imaging and iii) the inclusion of an 18F radionuclide to enable in 
vivo imaging techniques such as PET imaging. The work in this chapter was jointly performed 
between the Higham research group at Newcastle University and the Archibald research group at 
Hull University.114  
4.1 Targeting the Mitochondria 
Mitochondria are essential for most eukaryotic cells to function as they provide energy for the 
necessary activities in the form of ATP (adenosine triphosphate) via the oxidative phosphorylation 
pathway. This pathway releases free radicals as a side product and therefore the mitochondria are 
subjected to oxidative damage at a faster rate than the rest of the cell.115 Mitochondrial dysfunction 
has been extensively studied and has found to be associated with several conditions including 
ischemia-reperfusion injury116, Alzheimer’s disease74, a range of cancers71-73 and Parkinson’s 
disease.75  
The mitochondrial membrane potential (MMP) is a key factor in conditions such as ischemic heart 
failure and cancer.117 Loss of MMP is an early characteristic of apoptosis caused by myocardial 
ischemia and due to this change, the accumulation of MMP dependent compounds can increase by 
almost tenfold in cancerous and ischaemic heart cells. 17,118 
Lipophilic cations such as phosphonium salts are able to penetrate and accumulate within the 
mitochondrial matrix, and by attaching a bioactive molecule to the cation, it is possible for 
accumulation of the active molecule within the matrix, which could potentially open up a range of 
therapeutic options.119, 120 
 Phosphonium Cations 
Neamati and co-workers synthesised compounds containing a triphenylphosphine moiety  
(Fig 4.1) which showed remarkable activity in a range of cancer cell lines, as well as in a mouse 
model of human breast cancer. The authors suggested that the mode of action was due to 
mitochondrial localisation causing decreased oxygen consumption, increased superoxide 
production and attenuated growth factor signalling.121 
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Figure 4.1 TP compounds synthesised by Neamati that show promising results for a range of cancer cell lines. 
Figure 4.2 shows a series of mitochondria-targeting antioxidants synthesised by Murphy et. al. 
which are comprised of a triphenylphosphonium cation attached to the antioxidant chroman moiety 
of vitamin E via an alkyl linker. When the length of the linker was varied, the hydrophobicity of 
the compound was altered, the authors reported that a 10-carbon alkyl chain length gave the 
maximum antioxidant efficacy for this series of compounds.115 The enhanced hydrophobicity that 
comes with a longer chain length, favours the accumulation of these compounds in mitochondria 
and preliminary biological data has demonstrated that they show greater efficacy in preventing 
mitochondrial oxidative damage than non-targeted compounds. This series of compounds describes 
an example of mitochondria-targeting phosphonium cations that protect the mitochondrial DNA 
from oxidative damage and therefore decrease the risk of diseases such as cancer and 
Alzheimer’s.115 
 
Figure 4.2 Triphenylphosphine salt synthesised by Murphy to target mitochondria, and protect mitochondrial 
DNA from oxidative damage. 
Another example shown in Figure 4.3 identifies a series of triphenylphosphonium cations of a 
diterpenoid which were synthesised and tested in an in vivo phenyotypic sea urchin embryo. The 
results suggested that the cations induced mitotic spindle defects and mitotic arrest, presumably 
due to interactions with the mitochondrial DNA.122 This research details an example of a 
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triphenylphosphonium cation being used to attack diseased cells and by inducing mitotic arrest, 
will stop cell division, which is suggested as a promising starting point for possible anticancer 
agents. Antimitotic drugs within the treatment of cancer are highly validated chemotherapy 
agents.123 They work by inhibiting the polymerisation dynamics of microtubules (microtubules are 
formed during interphase and are essential for correct chromosome segregation and cell division 
undergoing mitosis).124 
 
Figure 4.3 Phosphonium cations based on isosteviol derivatives were tested for antimitotic activity in a sea 
urchin embryo model. 
4.2 Multifunctional Imaging Agents 
The advantage of combining two or three imaging techniques within one probe permits a better 
understanding of what happens within a cell and the fate of a radiopharmaceutical inside the body. 
The use of Bodipy dyes as multifunctional imaging agents has increased in recent years. The 
addition of the positron emitting radioisotope, fluorine-18, to these compounds would result in a 
PET/optical imaging agent. 18F-Positron emission tomography (PET) is a powerful technique 
which provides in vivo information on radiolabelled biomolecules. However, there are two major 
limitations to this technique 1) 18F radionuclide has a half-life of 110 minutes, and therefore needs 
to be incorporated into the molecules as quickly as possible and 2) PET imaging has relatively low 
spatial resolution (1-2 mm). 
The incorporation of an 18F radiolabel into a triphenylphosphonium cation has been reported 
several times.125-129 This enables mitochondria specific targeting combined with PET imaging 
within one probe. Figure 4.4 shows examples of compounds that have been effectively used in 
myocardial PET imaging. However, these compounds are not fluorescent, therefore they cannot be 
used in optical imaging which contrasts with the compounds prepared in this thesis. 
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Figure 4.4 Examples of 18F-radiolabelled triphenylphosphonium cations used in myocardial imaging. 
4.3 Synthesis of Tertiary Phosphines 89a and 89b. 
An important aim of this thesis is to combine a number of imaging techniques that have been 
discussed above: (i) in vitro imaging, (ii) in vivo imaging and (iii) mitochondria specific targeting 
all in a single molecular probe. As described above, there are several published examples of 
triphenylphosphonium salts currently being used in selective mitochondrial imaging. Our initial 
approach was to synthesise a fluorescent version of triphenylphosphine based on a Bodipy 
fluorophore, capable of dual imaging. The phosphonium salt would allow for selective 
mitochondrial imaging, and the Bodipy fluorophore for fluorescence microscopy.  
 Route 1 
The tertiary phosphines 89a and 89b can be synthesised in two ways; the first route is from the 
primary phosphine, shown in Scheme 4.1. Phosphorus pentachloride was dissolved in anhydrous 
toluene and primary phosphine 20a was added. After one hour at room temperature, the solvent 
was removed and the orange solid was analysed by 31P{1H} NMR spectroscopy, where no starting 
material was apparent and only a peak at  159.7 ppm was observed, corresponding to the 
dichlorophosphine 88. The solid was dissolved in anhydrous THF and phenylmagnesium bromide 
or dicyclohexylmagnesium chloride were added. The reaction was stirred at room temperature for 
16h. After purification by column chromatography, analysis by 31P{1H} NMR spectroscopy 
determined that the desired product had been synthesised (δ 2.9 ppm for 89a and δ –5.5 ppm for 
89b). The advantage of using this route is the large number of organolithium and Grignard reagents 
available compared to the chloro-phosphine starting material required in route 2. 
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Scheme 4.1 First method for the synthesis of tertiary phosphines 89a and 89b. 
 Route 2 
The second route for the synthesis of tertiary phosphines 89a and 89b is shown in Scheme 4.2. 
Arylbromide 44a was reacted with n-butyllithium at –78°C in anhydrous diethyl ether followed by 
the addition of chlorodicyclohexyl- or chlorodiphenylphosphine. The reaction was monitored by 
31P{1H} NMR spectroscopy and the product peaks were observed at δ 2.9 ppm for 89a and δ –5.5 
ppm for 89b. Both compounds were purified by column chromatography on silica gel to give the 
desired products as orange solids. 
 
Scheme 4.2 Synthesis of tertiary phosphines 89a and 89b. 
A crystal of 89b was obtained via slow diffusion of DCM/pentane and analysed by X-ray 
diffraction, the molecular structure is shown in Figure 4.5. The three C–P bond lengths of 
1.8312(19), 1.836(2) and 1.833(2) Å and the C–P–C bond angles of 100.95(9), 102.14(8) and 
103.58(9)° are typical for tertiary phosphines and are a good comparison to triphenylphosphine.130  
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Figure 4.5 Molecular structure of 89b obtained by slow diffusion with dichloromethane/pentane. Hydrogen 
atoms have been omitted for clarity. Selected bond distances [Å] and angles [°]: C22-P1 1.8312(19), P1-C25 
1.836(2), P1-C31 1.833(2), C37-B4 1.626(3), C38-B4 1.623(3) ; C22-P1-C25 100.95(9), C22-P1-C31 102.14(8), 
N1-B4-N2 105.14(14). 
4.4 Phosphonium Salt Synthesis 
In order to form a mitochondria-specific imaging agent, the phosphines needed to be transformed 
into the corresponding phosphonium cations. Phosphonium salts 93a and 93b were synthesised by 
reacting compounds 89a and 89b with methyl trifluoromethanesulfonate in DCM for two hours at 
room temperature, 93a precipitated out of the solution as an orange solid whereas 93b required 
purification by column chromatography (chloroform:methanol, 10:0.3) to give the desired product 
(Fig 4.6).114 
 
Figure 4.6 Structures of phosphonium derivatives 93a and 93b. 
Compounds 93a and 93b were sent to Hull University, to the research group of Professor Steve 
Archibald who performed mitochondrial uptake studies. Compounds 93a and 93b were tested 
using confocal microscopy in human breast cancer cells (MCF-7) and rat cardiomyocytes (H9c2) 
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shown in Figure 4.7. Mitotracker deep red was used as a reference due to its sufficiently different 
photophysical properties to allow independent detection, (MDR emission wavelength is at 665 nm 
and Bodipy compounds at 532 nm). 
 
 
Figure 4.7  Confocal microscopy of 93a (top two rows) and 93b (bottom two rowa) in MCF-7 and H9c2 cell 
lines (left), mitotracker deep red (MDR) (centre) amd overlaid mitochondrial localisation (right). 
Figure 4.7 confirms mitochondrial localisation of both of the Bodipy phosphonium salts 93a and 
93b in H9c2 and MCF-7 cells; the overlay shows the green Bodipy compounds localise in the same 
area as the red MDR reference dye. Both compounds 93a and 93b showed a good localisation in 
the rat cardiomyocyte (H9c2) cells, however, in the human breast cancer cell line (MCF-7), 
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compound 93a showed an increased uptake of 37% over the diphenyl derivative 93b, indicating 
that it has a significantly greater potential as an imaging agent. 
Since the MMP plays a key role in cardiac failure and cancer, the development of imaging agents 
that show MMP-dependant uptake provide an ideal tool to probe mitochondrial function, there are 
several derivatives based on rhodamine that are commonly used.131 The MMP specific uptake of 
compounds 93a and 93b was measured using flow cytometry in the presence of carbonyl cyanide 
m-chlorophenylhydrazone (CCCP), a protonophore which eliminates the MMP (Fig 4.8).132, 133 
Both tracers showed a decrease in mean fluorescent intensity (MFI) upon CCCP induced MMP 
depolarisation in both cell lines. The dicyclohexyl derivative showed a 70% decrease in both the 
MCF-7 and H9c2 cells, and the diphenyl derivative showed a 38% and 58% decrease respectively. 
 
Figure 4.8 Flow cytometry studies of 93a (top) and 93b (bottom) in MCF-7 (l) and H9c2 (r) cells without 
(green) and with(pink) CCCP present to assess MMP uptake. 
It was apparent that the dicyclohexyl derivative 93a showed an increase in MMP-dependent, 
mitochondrial specific uptake. This was investigated further using DFT calculations to determine 
the distribution of the electron density of the phosphonium salt (Fig 4.9), which concluded that the 
charge is located on the phosphorus atom for the dicyclohexyl compound but for the diphenyl 
analogue it is delocalised on the aromatic rings. The lipophilicity (logP) of the two compounds was 
measured (93a (3.19) and 93b (2.80)) and a significant variance was observed, which is possibly 
responsible for the difference in activity between the two compounds. 
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Figure 4.9 The electron density distribution for 93a and 93b was computed which illustrated that the charge is 
located on the phosphorus atom for 93a and on the aromatic rings for 93b. 
4.5 Transforming the Fluorescent Phosphonium Salt into a PET Probe 
Our approach to synthesising a multifunctional imaging agent containing a radionuclide was 
achieved by substituting the methyl trifluoromethanesulfonate reagent for a range of dihaloalkanes, 
such as 1-bromo-4-fluorobutane. These compounds would constitute a cold standard for a potential 
radiolabelled compound in the future. 
18F would be the most popular radionuclide of choice as it has an ideal half-life (110 minutes), 
however, 131I is also currently being used in the treatment of thyroid cancer as the thyroid cells 
absorb iodine, and works by shrinking or destroying all or part of the thyroid.134  
 
The addition of the dihaloalkane reagents has only been attempted with the dicyclohexylphosphine 
derivative so far, as this compound displayed more promising results as an imaging agent. 
The novel phosphonium salts were initially synthesised by combining BodPCy2 89a and the 
relevant dihaloalkane in anhydrous DCM. The reaction was stirred until complete consumption of 
the starting materials was confirmed by 31P{1H} NMR spectroscopy, which varied between 16-72 
hours. Although these reaction conditions showed successful synthesis of the product when 
analysed by 31P{1H} NMR spectroscopy (~ 34.0 ppm), there was always a second peak present 
corresponding to the phosphine oxide (~ 42 ppm). The reactions were subsequently conducted in 
anhydrous toluene at 110 C, which resulted in faster reaction times and cleaner products. In all 
cases, there was no starting material remaining after 16 hours and only small quantities of oxide 
remained (Figure 4.10, structure 89ab). 
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Figure 4.10 General synthesis of novel phosphonium salts 94-97 and phosphine oxide side product 89ab. 
Crystals of compounds 94 and 95 suitable for X-ray analysis were obtained by slow diffusion of 
CDCl3/pentane (94) and DCM/pentane (95) as shown in Figures 4.11 and 4.12. The F-C bond 
length of 1.316(19) Å and Br-C bond length of 2.00(2) Å are in agreement with examples reported 
in the literature.87, 135 
 
        
Figure 4.11 Molecular structures of 94 was obtained by slow diffusion with CDCl3/pentane. Hydrogen atoms 
have been omitted for clarity. Selected bond distances [Å] and angles [°]: C22-P1 1.7952, P1-C31A 1.7998, P1-
C31B 1.8051, P1-C25 1.8210, C39A-F1A 1.316(19); C22-P1-C31B 109.2(3), C31B-P1-C31A 110.5(3), C31B-P1-
C25 109.7(3), F1A-C39A-C38A 119.0(2). 
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Figure 4.12 Molecular structures of 95 was obtained by slow diffusion with DCM/pentane Selected bond 
distances [Å] and angles [°]: C22-P1 1.795(5), P1-C25 1.806(5), P1-C34 1.826(6), C33-Br1 2.00(2); C22-P1-C25 
109.87(18), C25-P1-C25 110.6(3), C25-P1-C34 109.0(2), Br1-C33-C32 105.0(14). 
Compound 94 was also extensively analysed by NMR spectroscopy; Figure 4.13 shows the 1H, 
1H{31P} and 1H{19F} NMR spectra, which made it possible to deduce which peaks corresponded 
to the protons adjacent to the fluorine atom, due to the splitting patterns observed. The proton NMR 
spectrum at the top showed the aromatic protons around 7.7-8.0 ppm, the peaks highlighted in the 
box corresponded to protons on the alkyl chain attached to the phosphorus atom, but it was not 
immediately obvious which protons were adjacent to the fluorine or the phosphorus atom. 
Therefore the 1H{31P} and 1H{19F} NMR spectra were recorded which helped to identify which 
nucleus was splitting the protons into a doublet of triplets. It can be observed in the 1H{31P} 
spectrum, the doublet of triplets is still visible, whereas in the 1H{19F} spectrum it is a single triplet. 
This indicates that the fluorine atom is responsible for the splitting of the protons in this instance. 
The remainder of the spectra correlated well, signifying that the fluorine and phosphorus atoms are 
not visibly splitting any other protons. 
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Figure 4.13 NMR studies to deduce the protons within the alkylhalide chain attached to the phosphorus atom. 
 Photophysical Results 
In order to gain an understanding of how the photophysical properties were affected by the addition 
of the alkyl halide chain, the absorption and emission maxima were recorded, along with the 
quantum yield to see if any fluorescence quenching was observed. 
The photophysical properties of all of the novel phosphonium salts were compared to the parent 
ligands, shown in Table 4.1.   
Table 4.1 Photophysical properties for novel phosphonium salts. 
 labs (nm) lem (nm) F 
 89a 
89b 
93a 
93b 
94 
512 
513 
516 
516 
515 
526 
527 
532 
532 
534 
0.44 
0.29 
0.24 
0.14 
0.29 
95 514 533 0.28 
96 515 535 0.23 
97 512 527 0.36 
98 514 532 0.24 
Measured in dry, degassed tetrahydrofuran at room temperature, dyes were excited at 485 nm; Fluorescence quantum yields were 
measured with respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 57. 
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The majority of the phosphonium salts displayed a slight bathochromic shift (3-4 nm) compared to 
the phosphine ligands 89a and 89b. A decrease in quantum yield of the novel phosphonium salts -
94-97 can be observed compared to the parent compound 89a. However, they all remain high, 
concluding that quaternisation of the phosphorus atom does not diminish the fluorescence to an 
extent that the compounds are no longer fluorescent. As the halogen attached to the alkyl chain 
gets larger F<Br<I, the quantum yield is marginally decreased, which can possibly be attributed to 
the heavy atom effect.35 
Figures 4.14 and 4.15 show the absorption and emission spectra for the novel phosphonium salts – 
they show similar profiles to the parent compounds, with the absorption maxima observed between 
512-516 nm and the fluorescence maxima between 527-535 nm.  
 
Figure 4.14 Absorption spectra for phosphonium cations 94-98, measured in dry, degassed tetrahydrofuran at 
room temperature. 
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Figure 4.15 Emission spectra for phosphonium cations 94-98, measured in dry, degassed tetrahydrofuran at 
room temperature. 
The photophysical properties have provided us with information to acknowledge that we have 
successfully made a range of phosphonium salts that are both mitochondria specific and possess 
important fluorescent properties required for optical imaging. 
 Flow Cytometry Studies 
Flow cytometry studies were carried out for fluoride-substituted compound 94, which showed 
improved results relative to the earlier phosphonium salts, 93a and 93b. The replacement of the 
methyl group bound to the phosphorus atom, for the fluorobutyl group, led to an increase in MMP 
dependent uptake. The addition of CCCP was responsible for a decrease in uptake of 84% for 
MCF-7 cells and 83% for H9c2 cells, thus validating this approach for the design of MMP-
dependent multimodal optical/PET imaging agents.  
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Figure 4.16  Flow cytometry in MCF-7 (left) and H9c2 (right) cells, without (green) and with (pink) CCCP 
present for compound 94. 
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 Propargyl Derivative for Click Chemistry 
A final reaction was attempted where propargyl bromide was reacted with BodPCy2 89a in 
anhydrous toluene and stirred at reflux (110 °C) overnight, which successfully formed novel 
compound 98. Analysis by 31P{1H} NMR spectroscopy showed a product peak at δ 29.9 ppm, in 
comparison to the starting material peak at δ 2.8 ppm. The 1H NMR spectrum also illustrated the 
additional proton relating to the alkyne group at δ 4.47 ppm. This derivative could theoretically be 
used in click chemistry where the alkyne is reacted with another compound containing an azide to 
introduce a bioactive species such as a protein or oligonucleotide (Fig 4.18). This route would 
present another method to a cell-specific imaging agent and will be looked at in more detail in the 
future. 
 
Figure 4.17 A reaction with propargyl bromide introduces an alkyne group which would allow bioconjugation 
via click chemistry. 
An example of click chemistry is shown in Figure 4.18, where copper-catalysed azide-alkyne click 
chemistry was used for bioconjugation.136 THPTA (Tris(3-hydroxypropyltriazolyl-methyl)amine] 
is added to accelerate the reaction by protecting the biomolecule from hydrolysis by Cu(II) by-
products and also sacrificially intercepting any radicals or peroxides that are formed. Compound 
(2) is aminoguanidine and can be added to suppress any unwanted side reactions. 
 
Figure 4.18 A general copper catalysed reaction, and structures of THPTA (1) and aminoguanidine additive 2. 
114 
 
4.6 Applications of Novel Phosphonium Salts in Cell Imaging 
Three of the phosphonium salts (94, 96 and 98) were also sent to Dr Amy Reeve, a research fellow 
at Newcastle University’s Wellcome Trust for Mitochondrial Research. The salts were tested in a 
mouse embryonic stem cell line and compared against Mitotracker Deep Red (MDR) in order to 
see if they successfully localised within the mitochondria of the cells.  
 
Figure 4.19 Three salts tested in mouse embryonic stem cells at Newcastle University. 
The stem cells can be differentiated into neurons and were created to model the effect of a 
mitochondrial defect on neurons. WT are wild type cells, which are normal cells with no adverse 
phenotype. Figure 4.20 shows an illustration of the electron transport chain where Complex I and 
IV play key roles.137 Complex I and IV deficient cells contain a defect in the mitochondrial complex 
I or IV. Complex I is a large enzyme which catalyses the first step of the electron transport chain 
and is responsible for driving ATP production.138 Complex IV is the last enzyme in the respiratory 
electron transport chain located in the mitochondrial membrane. It receives an electron from four 
cytochrome c molecules which are transferred to an oxygen molecule, which helps convert 
molecular oxygen into two molecules of water.139 
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Figure 4.20 Representative diagram of the electron transport chain from the Journal of Clinical Investigation.137 
The images below in Figure 4.21 show compounds 94, 96 and 98 in the three cell types described 
above. The top right image of each group of images, shows the fluorescent detection at 488 nm 
excitation, bottom right shows a light microscopy image, the red image is MDR, used as a 
reference, and top left shows an overlay of all three images.  
        
Figure 4.21 Compound 94 in WT cells (left), Complex I-deficient cells (middle) and Complex IV-deficient cells 
(right). 
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Figure 4.22 Compound 96 in WT cells (left), Complex I-deficient cells (middle) and Complex IV-deficient cells 
(right). 
      
Figure 4.23 Compound 98 in WT cells (left), Complex I-deficient cells (middle) and Complex IV-deficient cells 
(right). 
All three of the phosphonium salts were found to localise in the mitochondria, as confirmed by the 
overlay picture which shows the orange image of the green Bodipy compounds overlapping with 
the red MDR dye, indicating that they locate in the mitochondria as predicted. 
 
 
4.7 Summary 
The synthesis of several novel fluorescent phosphonium salts has been described in this chapter, 
via the addition of an alkylhalide reagent to a tertiary phosphine. Compounds 93a and 93b were 
formed by the addition of methyl trifluoromethanesulfonate to tertiary phosphines 89a and 89b 
which created fluorescent phosphonium cations that were successfully imaged in human breast 
cancer cells (MCF-7) and rat cardiomyocytes (H9c2). The second part of this chapter discussed the 
synthesis of five novel phosphonium salts (94-98) that, in the future, have the potential to be multi-
modal imaging probes containing (i) a phosphonium cation to introduce organelle specificity, in 
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this case targeting the mitochondria; (ii) a fluorescent Bodipy core for fluorescent microscopy and 
(iii) a radiolabel such as 18F to allow for PET scanning. 
The synthesis and characterisation of five novel phosphonium salts is described, and compounds 
94 and 95 have also been successfully analysed by X-ray crystallography.  
The photophysical properties of the novel compounds was recorded which identified that the 
quaternisation of the phosphorus atom did not have a detrimental effect on the fluorescence. All of 
the phosphonium salts retain high quantum yields and exhibit strong absorption and emission 
graphs similar to their parent compounds. 
Three of the novel phosphonium salts were tested in a mouse embryonic stem cell line, specifically 
in wild type cells, and complex I and IV deficient cells, all of which showed uptake of the 
phosphonium salts into the mitochondria, as highlighted by and compared to MDR. 
The final compound, propargyl 98, can potentially open a route to a new range of compounds to 
be synthesised via click chemistry, which will allow bioactive species, such as proteins, to bind to 
the Bodipy phosphonium salts. 
This next step is currently underway with the research group of Professor Steve Archibald at Hull 
University, who are attempting to substitute the halogen for an 18F radiolabel and so generate a 
multifunctional PET imaging probe. 
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4.8 Experimental 
 General Experimental Procedure 
All air- and/or water-sensitive reactions were performed under a nitrogen atmosphere using 
standard Schlenk line techniques. Tetrahydrofuran was dried over sodium/benzophenone and 
deuterated chloroform was dried over phosphorus pentoxide; these solvents were distilled prior to 
use. Dimethyl sulfoxide was purchased from Fisher in an anhydrous state and was used as received. 
All starting materials were purchased from Sigma Aldrich, Alfa Aesar or Fisher and were used as 
received. Flash chromatography was performed on silica gel (40-63 μm, 60 Å) from Merck, thin-
layer chromatography was carried out using Merck aluminium-based plates with silica gel and 
fluorescent indicator (254 nm). 1H, 13C{1H}, 19F{1H}, 31P{1H} and 11B{1H} NMR spectra were 
recorded on a JEOL ECS-400 (1H 399.78 MHz) or Bruker Avance III 300 (1H 300.13 Hz) 
spectrometer at room temperature (21 °C); 1H and 13C shifts were relative to tetramethylsilane, 31P 
shifts were relative to 80% H3PO4, 
11B relative to BF3.Et2O and 
19F relative to CFCl3. Infrared 
spectra were recorded on a Varian 800 FT-IR spectrometer and mass spectrometry was carried out 
by the EPSRC NMSF, Swansea. DFT calculations were carried out on Spartan 14 using the B3LYP 
functional with a 6-31G* basis set, details of the xyz coordinates and SCF energies can be found 
in the appendix. 
 Preparation of of 8-((4-Dicyclohexylphosphino)phenyl)-4,4-dimethyl-1,3,5,7-
tetramethyl-2,6- diethyl-4-bora-3a,4a-diaza-s-indacene (89a) 
Route 1: 
Phosphorus pentachloride (0.283 g, 1.36 mmol) was dissolved in anhydrous toluene (6 mL), 
primary phosphine 20a was added (0.25 g, 0.62 mmol) and the mixture was stirred at room 
temperature for one hour. The orange solution was analysed by 31P{1H} NMR spectroscopy to 
show the formation of the dichlorophosphine species at  159.7 ppm and the solvent was removed 
in vacuo. The orange solid was dissolved in anhydrous THF (6 mL) and triethylamine (0.38 mL, 
1.63 mmol) and dicyclohexylmagnesium chloride (1.24 mL, 1.24 mmol, 1M in THF) were added. 
The reaction mixture was stirred at room temperature overnight. The solvent was removed in vacuo 
and the orange solid was purified by column chromatography (chloroform:petrol, 1:4) to yield the 
desired product as an orange solid (0.14 g, 40%) 
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Route 2: 
44a (0.50 g, 1.11 mmol) was dissolved in anhydrous diethyl ether (40 mL) and cooled to – 78 °C. 
n-Butyllithium (0.49 mL, 1.22 mmol, 2.5M in hexane) was added dropwise and the reaction 
mixture was warmed to room temperature over 45 minutes. The solution was cooled back down to 
– 78 °C and chlorodicyclohexylphosphine (0.27 mL, 1.22 mmol) was added dropwise. The reaction 
mixture was stirred overnight at room temperature under nitrogen. The reaction was quenched with 
water (25 mL) and extracted with diethyl ether (3 x 50 mL). The combined organic phases were 
washed with water, dried over MgSO4 and filtered. The solvent was removed and the dark orange 
solid was purified by column chromatography (petrol:chloroform 4:1) to yield an orange crystalline 
solid (0.39 g, 62 %).  
1H NMR (400 MHz, CDCl3) δ 7.47 (m, 2H), 7.21 (d, 3JHH = 8.2 Hz, 2H), 2.37 (s, 6H), 2.23 (q, 
3JHH = 7.3 Hz, 4H), 1.90 (s, 6H), 1.90-1.56 (m, 12H), 1.30- 0.78 (m, 10H), 0.90 (t, 
3JHH = 7.3 Hz, 
6H), 0.21 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 150.6, 140.2, 137.9, 135.0 (d, JCP = 
19.2 Hz), 134.7 (d, JCP = 19.2 Hz), 133.8, 132.5, 129.1, 128.3 (d, JCP = 7.7 Hz), 32.1 (d, 
1JCP = 12.5 
Hz), 29.9 (d, 2JCP = 16.3 Hz), 28.7 (d, 
2JCP = 6.7 Hz), 27.4 (d, 
3JCP = 12.5 Hz), 27.1 (d, 
3JCP = 6.7 
Hz), 26.7, 17.6, 14.8, 14.4, 11.9, 10.5 (br) ppm; 31P{1H} NMR (162 MHz, CDCl3) δ 2.8 ppm; 
11B{1H} NMR (128 MHz, CDCl3) δ −2.1 ppm; IR (neat) 𝜈: 2927 (w), 2856 (w), 1551 (s), 1448 
(m), 1321 (m), 1171 (s), 1145 (s), 946 (s) cm−1; HRMS (AP+) calcd. for C37H55B1N2P1 [M+H]
+ 
requires m/z 568.4227, found m/z 568.4226. 
 
 Preparation of 8-((4-Diphenylphosphino)phenyl)-4,4-dimethyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (89b) 
Route 1: 
Phosphorus pentachloride (0.112 g, 0.54 mmol) was dissolved in anhydrous toluene (6 mL), 
primary phosphine 20a was added (0.100 g, 0.25 mmol) and the mixture was stirred at room 
temperature for one hour. The orange solution was analysed by 31P{1H} NMR spectroscopy to 
show the formation of the dichlorophosphine species at  159.7 ppm,the solvent was removed in 
vacuo. The orange solid was dissolved in anhydrous THF (6 mL) and triethylamine (0.15 mL, 1.1 
mmol) and phenylmagnesium bromide (0.16 mL, 0.50 mmol, 3.0M in diethyl ether) were added. 
The reaction mixture was stirred at room temperature overnight. The solvent was removed in vacuo 
and the orange solid was purified by column chromatography (chloroform:petrol, 1:4) to yield the 
desired product as an orange solid (0.114, 82%). 
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Route 2: 
44a (0.50 g, 1.11 mmol) was dissolved in anhydrous diethyl ether (40 mL) and cooled to -78 °C. 
n-Butyllithium (0.49 mL, 1.22 mmol, 2.5M in hexane) was added dropwise over five minutes and 
the reaction was warmed to room temperature over 45 minutes. The solution was cooled to -78 °C 
and chlorodiphenylphosphine (0.22 mL, 1.22 mmol) was added dropwise. The reaction was 
warmed to room temperature and stirred overnight. The reaction mixture was washed with water 
and extracted with diethyl ether. The combined fractions were dried over MgSO4 and filtered. The 
solvent was removed in vacuo to yield a red/orange solid which was purified using column 
chromatography on silica gel (chloroform:hexane 1:4) and gave an orange solid (0.34 g, 56%). 1H 
NMR (400 MHz, CDCl3) δ 7.45-7.42 (m, 2H), 7.41-7.35 (m, 10H), 7.34-7.30 (m, 2H), 2.47 (s, 
6H), 2.35 (q, 3JHH = 7.3 Hz, 4H), 1.36 (s, 6H), 1.01 (t, 
3JHH = 7.3 Hz, 6H), 0.30 (s, 6H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 150.6, 139.8, 137.9, 137.8, 136.7 (d, JCP = 11.5 Hz), 133.8, 
133.6, 133.5, 132.4, 132.1, 132.0, 128.8, 128.5 (d, JCP = 6.7 Hz), 17.4, 14.7, 14.5, 11.9, 10.4 (br) 
ppm; 31P{1H} NMR (162 MHz, CDCl3) δ −5.5 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.9 
ppm; IR (neat) 𝜈: 2924 (w), 2863 (w), 1552 (s), 1455 (m), 1372 (w), 1314 (s), 1170 (s), 1144 (s), 
1064 (m), 977 (s) cm−1; HRMS (EI+) exact mass calcd. for C37H43N2B1P1 [M+H]
+ requires m/z 
556.3288, found m/z 556.3294. 
 Preparation of [89a.Me][OTf] (93a)  
89a (0.21 g, 0.36 mmol) was dissolved in DCM (4 mL) and methyl trifluoromethanesulfonate 
(0.08 mL, 0.73 mmol) was added. The reaction was stirred at room temperature for two hours, 
which produced an orange precipitate. The solid was filtered off and washed with petroleum ether 
(3 x 10 mL) to give the desired product as a fine orange solid. (0.18 g, 68 %).  
1H NMR (400 MHz, CD3CN) δ 7.82 (dd, 3JHH = 8.2 Hz, 3JHP = 11.0 Hz, 2H), 7.67 (dd, 3JHH = 8.2 
Hz, 4JHP = 2.6 Hz, 2H), 2.71 (m, 2H), 2.43 (s, 6H), 2.31 (q, 
3JHH = 8.2 Hz, 4H), 2.04 (d, 
2JHP = 12.4 
Hz, 3H), 1.98-1.69 (br, 10H), 1.40 (m, 4H), 1.26-1.07 (br, 6H), 1.20 (s, 6H), 0.93 (t, 3JHH = 8.2 Hz, 
6H), 0.30 (s, 6H) ppm; 31P{1H} NMR (162 MHz, CD3CN) δ 34.5 ppm; 11B{1H} NMR (128 MHz, 
CD3CN) δ −1.6 ppm. Low solubility precluded the collection of a 13C NMR spectrum. HRMS 
(ESI+) exact mass calculated for C38H57N2B1P1 [M]
+ requires m/z 582.4383, found m/z 582.4382 
(0.2 ppm). 
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 Preparation of [89b.Me][OTf] (93b)  
89b (0.13 g, 0.22 mmol) was dissolved in DCM (4 mL) and methyl trifluoromethanesulfonate 
(0.07 mL, 0.45 mmol) was added. The reaction was stirred at room temperature for two hours. 
After removal of the solvent, purification by column chromatography (chloroform:methanol, 
10:0.3, Rf = 0.3) was performed to yield the desired product as an orange solid. (0.35 g, 61 %).  
1H NMR (400 MHz, CDCl3) δ 7.75-7.70 (m, 4H), 7.66-7.59 (m, 10H), 3.01 (d, 2JHP = 13.7 Hz, 
3H), 2.38 (s, 6H), 2.23 (q, 3JHH = 7.8 Hz, 4H), 1.19 (s, 6H), 0.91 (t, 
3JHH = 7.8 Hz, 6H), 0.20 (s, 
6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 151.8, 145.1 (d, JCP = 2.8 Hz), 136.6, 135.3 (d, JCP 
= 2.9 Hz), 133.4 (d, JCP = 11.5 Hz), 133.1 (d, JCP = 11.5 Hz), 133.0 (d, JCP = 39.3 Hz), 131.3 (d, 
JCP = 13.4 Hz), 130.6 (d, JCP = 13.4 Hz), 128.2, 119.8, 119.2, 118.3, 117.7 (q, JCF = 249.2 Hz), 
17.4, 14.6, 14.4, 12.1, 10.4 (br), 9.34 (d, 1JCP = 57.5 Hz) ppm; 31P{1H} NMR (162 MHz, CDCl3) 
δ 22.6 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.9 ppm; HRMS (ESI+) exact mass calculated 
for C38H45N2B1P1 [M]
+ requires m/z 570.3444, found m/z 570.3443. 
4.9 General Procedure for the Synthesis of Phosphonium Salts 
Bod-dicyclohexylphosphine 89a (0.27 mmol) was dissolved in anhydrous toluene (7 mL), the 
appropriate dihalogenated species (0.27 mmol) was added and the mixture was heated at 110 C 
until complete consumption of the starting materials (~16 hours), which was confirmed by 31P{1H} 
NMR spectroscopy. The desired product was crystallised out of solution using a layered mixture 
of deuterated chloroform and pentane. 
 Preparation of 8-((4-Dicyclohexylphosphino)(fluorobutyl)phenyl)-4,4-dimethyl-
1,3,5,7-tetramethyl-2,6- diethyl-4-bora-3a,4a-diaza-s-indacene (94) 
1H NMR (300 MHz, CDCl3) δ 8.09 (m, 2H), 7.70 (m, 2H), 4.65 (t, J = 5.2 Hz, 1H), 4.50 (t, J = 5.2 
Hz, 1H), 3.20 (m 4H), 2.44 (s, 6H), 2.28 (q, J = 7.6 Hz, 4H), 2.22-1.73 (m, 16H), 1.58-1.32 (m, 
10H), 1.17 (s, 6H), 0.96 (t, J = 7.5 Hz, 6H), 0.26 (s, 6H) ppm; 13C{1H} NMR (176 MHz, CDCl3) 
δ 151.8, 144.4, 136.9, 133.4 (d, JCP = 7.5 Hz), 133.4, 132.8, 131.3 (d, JCP = 11.4 Hz), 128.4, 83.7, 
82.8, 31.2, 30.4 (d, JCP = 43.5 Hz), 26.6 (dd, JCP = 13.0 Hz, JCP = 2.9 Hz), 26.3 (m), 25.6, 19.5, 
17.5, 15.9 (d, JCP = 44.4 Hz), 14.8, 14.5, 12.1, 10.4 (br) ppm; 31P{1H} NMR (121 MHz, CDCl3) 
δ 32.6 ppm; 19F{1H} NMR (470 MHz, CDCl3) δ – 221. 3 ppm; 11B{1H} NMR (96 MHz, CDCl3) 
δ –0.4 ppm; HRMS (ESI+) calcd. for C41H62BFN2P [M+H]+ requires m/z 643.4729, found m/z 
643.4719. 
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 Preparation of 8-((4-Dicyclohexylphosphino)(bromobutyl)phenyl)-4,4-
dimethyl-1,3,5,7-tetramethyl-2,6- diethyl-4-bora-3a,4a-diaza-s-indacene (95) 
1H NMR (400 MHz, CDCl3) δ 8.02-7.94 (m, 2H), 7.73-7.63 (m, 2H), 3.57 (t, 3JHH = 5.1 Hz, 1H), 
3.37 (t, 3JHH = 5.1 Hz, 1H), 3.29-3.19 (m, 4H), 2.40 (s, 6H), 2.23 (q, 
3JHH = 7.3 Hz, 4H), 2.18-1.65 
(m, 16H), 1.60-1.32 (m, 10H), 1.12 (s, 6H), 0.91 (t, 3JHH = 7.5 Hz, 6H), 0.21 (s, 6H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 151.7, 144.3, 136.8, 133.4, 133.2, 132.6, 131.2, 128.3, 33.8, 32.5, 30.6, 
30.0,  26.4, 26.2, 25.5, 19.5, 17.4, 15.6, 14.7, 14.4, 11.9, 10.4 (br) ppm; 31P{1H} NMR (162 MHz, 
CDCl3) δ 33.0 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ –1.1 ppm; IR (ATR) 𝜈: 2929, 2857, 1555, 
1448, 1323, 1174, 946, 728, 640 cm-1; HRMS (ESI+) calcd. for C41H63BBrN2P [M-HBr]
+ requires 
m/z 705.3915, found m/z 705.3919. 
 Preparation of 8-((4-Dicyclohexylphosphino)(iodobutyl)phenyl)-4,4-dimethyl-
1,3,5,7-tetramethyl-2,6- diethyl-4-bora-3a,4a-diaza-s-indacene (96) 
1H NMR (400 MHz, CDCl3) δ 8.00-7.93 (m, 2H), 7.69-7.64 (m, 2H), 3.33 (t, 3JHH = 5.6 Hz, 1H), 
3.32 (t, 3JHH = 5.1 Hz, 1H), 3.16-2.90 (m, 4H), 2.39 (s, 6H), 2.23 (q, 
3JHH = 7.6 Hz, 4H), 1.96-1.72 
(m, 16H), 1.58-1.29 (m, 10H), 1.12 (s, 6H), 0.91 (t, 3JHH = 7.5 Hz, 6H), 0.21 (s, 6H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 151.9, 144.6, 135.3, 133.6, 133.5, 132.7, 131.4, 128.3, 33.9, 
33.1, 30.7, 30.3, 26.4, 26.2, 25.6, 17.5, 15.8, 14.8, 14.5, 12.2, 10.4 (br) ppm; 31P{1H} NMR (162 
MHz, CDCl3) δ 33.0 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ –19.3 ppm; IR (ATR) 𝜈: 2930, 
2857, 1552, 1443, 1320, 1171, 945, 801, 731, 674, 601 cm-1. 
 Preparation of 8-((4-Dicyclohexylphosphino)(fluoropropyl)phenyl)-4,4-
dimethyl-1,3,5,7-tetramethyl-2,6- diethyl-4-bora-3a,4a-diaza-s-indacene (97) 
1H NMR (400 MHz, CDCl3) δ 7.78-7.67(m, 4H), 7.32-7.25 (m, 4H), 4.47 (t, 3JHH = 5.4 Hz, 1H), 
4.36 (t, 3JHH = 5.4 Hz, 1H), 3.24-3.14 (m, 4H), 2.40 (s, 9H), 2.24 (q, 
3JHH = 7.6 Hz, 4H), 2.05-1.90 
(m, 16H), 1.55-1.46 (m, 10H), 1.19 (s, 6H), 0.91 (t, 3JHH = 7.6 Hz, 6H), 0.21 (s, 6H) ppm; 31P{1H} 
NMR (162 MHz, CDCl3): δ 32.6 (s) ppm; 19F{1H} NMR (376 MHz, CDCl3): δ –223.1 ppm; 
11B{1H} NMR (128 MHz, CDCl3): δ –1.0 ppm; IR (ATR) 𝜈: 2925, 2851, 1548, 1447, 1359, 1320, 
1189, 1173, 1144, 941, 753, 663 cm-1; HRMS (ESI+) calcd. for C40H60BFN2P [M]
+ requires m/z 
629.4573, found m/z 629.4562. 
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 Preparation of 8-((4-Dicyclohexylphosphino)(propargyl)phenyl)-4,4-dimethyl-
1,3,5,7-tetramethyl-2,6- diethyl-4-bora-3a,4a-diaza-s-indacene (98) 
1H NMR (400 MHz, CDCl3) δ 8.28-8.04 (m, 2H), 7.69-7.53 (m, 2H), 4.59 (t, 3JHH = 5.4 Hz, 1H), 
4.47 (t, 3JHH = 5.4 Hz, 1H), 3.94-3.81 (m, 4H), 2.48-2.35 (m, 11H), 2.20-2.00 (m, 16H), 1.80-1.53 
(m, 10H), 1.13 (s, 6H), 0.92 (t, 3JHH = 7.5 Hz, 6H), 0.21 (s, 6H) ppm; 31P{1H} NMR (162 MHz, 
CDCl3) δ 29.9 ppm; 11B{1H} NMR (128 MHz, CDCl3): δ–1.0 ppm; IR (ATR) 𝜈: 3301 (alkyne CC 
bond), 2969, 2857, 2209, 1549, 1450, 1320, 1172, 944, 802, 720 cm-1. 
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 Chiral Fluorescent Catalysts 
This chapter explores the development of a route to the first chiral, fluorescent phosphonite based 
on Bodipy and containing the Binol function. The novel phosphonites were then coordinated to a 
rhodium centre and were subsequently tested in an asymmetric hydrogenation reaction with the 
benchmark substrate methyl (Z) β-acetamidocinnamate (MAC) which gave excellent conversion 
and enantioselectivity. 
5.1 Fluorescent Catalysts 
There are several advantages for using a fluorescent ligand in catalysis, such as: 1) the ability to 
monitor low concentrations of a catalytically relevant species, 2) to assess catalyst contamination 
and 3) to monitor the catalytic pathway of a catalyst by measuring the photophysical properties at 
different stages of the cycle. 
There are few examples of fluorescent catalysts within the literature; Plenio et al. tagged N-
heterocyclic carbenes with a dansyl fluorophore and synthesised the corresponding palladium 
complexes [(NHC)Pd(allyl)Cl] which were used to follow the course of a Suzuki coupling 
reaction.140 NHC groups are used because they can be tightly bound to a metal centre, therefore 
limiting problems such as the fluorophore dissociating from the transition metal centre. Figure 5.1 
shows the fluorescence time curve for the NHC palladium-catalysed Suzuki coupling reaction 
described. Two notable changes were observed in the fluorescence behaviour of the dansyl group: 
the addition of the base and the addition of the aryl halide. This corresponds to the formation of 
catalytically active species from the pre-catalyst, and also during the cross-coupling reaction.  
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Figure 5.1 Fluorescence time curve for the NHC palladium-catalysed Suzuki coupling. 
5.2 Chiral Bodipy Compounds 
In 2009, Huszthy and co-workers reported two novel, enantiopure Bodipy-linked azacrown ether 
chemosensors, 99 and 100, which are shown in Figure 5.2.141 The two compounds exhibited 
prominent off-on fluorescence changes on coordination to metals such as Ca2+ and Pb2+. In some 
cases, more than a 10-fold increase was observed upon complexation.  
 
Figure 5.2:  Chiral compounds 99 and 100. 
 
In Figure 5.3, compound 101, synthesised by Ziessel and co-workers, is an example of a resolved 
Bodipy compound based around an asymmetric boron atom, where the chirality is embedded in the 
 
addition of base 
addition of aryl bromide 
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core structure of the fluorophore.142 Nabeshima described the efficient synthesis of boron-centred 
chiral Bodipy 102, based on the intramolecularly B-O bonded Bodipy.143 In 2014 Hall et al. 
published a route for the synthesis of axially chiral Bodipy systems, 103 in Figure 5.3 and is 
currently investigating the interactions between these dyes with chiral analytes in solution and their 
potential applications in sensing.144  
 
 
Figure 5.3 Resolved chiral Bodipys containing an asymmetric boron centre (left, 101) and (centre) the 
Nabeshima compound 102, and (right) Hall’s compound 103 an unresolved boron-centred chiral Bodipy. 
The ability to make chiral Bodipys opens up the potential development of chiral Bodipy ligands 
for asymmetric catalysis. The prospect of synthesising a fluorescent catalyst has many positive 
outcomes, such as the potential to detect low concentrations of catalytically important species due 
to the sensitivity of the fluorescence method, and the ability to monitor the purity of a product after 
a catalytic reaction, allowing for verification that there is no contamination i.e. catalyst, remaining 
in the product.  
5.3 Ligand Knowledge Base 
The Ligand Knowledge Base (LKB) was developed by Fey and co-workers145 to collect 
information on ligands in metal complexes and to predict the effects that the ligands may have, 
before being synthesised experimentally. A range of monodentate and chelating phosphorus donor 
ligands, carbon donors and P-N chelating donor ligands have been mapped to create the database 
with more than 1000 ligands.146, 147 An example of the factors that have been calculated within this 
model include Tolman (steric and electronic) parameters, molecular orbital energies and adduct 
binding energies. The LKB can also be used to identify applications for the ligands, where the 
assumption is that ligands grouped close to one another may be efficient at the same type of 
catalytic process. 
128 
 
Principal Component Analysis (PCA) can be used to identify interactions between variables within 
a dataset. It has been used within the LKB to identify chemically similar ligands which will be 
clustered together in a 3D scatter graph, i.e. ligands which are clustered together are likely to have 
similar properties than those ligands further away; an example of a relevant plot is shown in Figure 
5.4.145 
 
Figure 5.4 An example of a plot representing chemically similar ligands by colour. 
Fey modelled a number of MOP ligands reported by the Higham research group, including 
phosphonites and phosphiranes, and this information has been used to predict the direction of the 
research of the novel compounds synthesised within this chapter. 
 Phosphonites 
Phosphonites are a class of compound that contain one P-C bond and two P-O bonds. They can be 
used in homogeneous catalysis and their corresponding transition metal complexes are of interest 
due to the success of the related phosphines, phosphinites and phosphites in a variety of catalytic 
reactions.148 The primary phosphine offers a route to a novel, fluorescent derivative, which will be 
described in the next section. 
PA3, PA2B, A = R
CH2=CH2
SiMe3
Ar
OR/OAr
NR2/NAr2
Hal
PABC
Phosphinine (L1-L6)
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5.4 Synthesis of Fluorescent, Chiral Phosphonites 104 and 105 
The synthesis of novel fluorescent, chiral phosphonites 104 and 105 is a one-pot, two step reaction 
starting from primary phosphine 20a, as shown in Scheme 5.1. 
 
Scheme 5.1 One-pot, two-step synthesis to novel compounds 104 and 105.  
Phosphorus pentachloride and primary phosphine 20a were dissolved in anhydrous toluene and 
stirred under a nitrogen atmosphere at room temperature. The solution was analysed by 31P{1H} 
NMR spectroscopy to show a singlet at δ 159.7 ppm corresponding to the Bodipy 
dichlorophosphine derivative 88. The solvent was removed in vacuo to remove PCl3 and the 
subsequent red solid was dissolved in anhydrous THF. Triethylamine and (R) or (S)-Binol were 
added and the solution was stirred for a further 16 hours. The compounds were purified by column 
chromatography on silica gel to yield the desired products as orange solids. The compounds were 
analysed by 31P{1H} NMR spectroscopy and showed single peaks for (Rb)-104 at 
δ 181.9 ppm and (Sb)-105 at δ 181.5 ppm.  
5.5 Photophysical Properties 
The photophysical properties for (Rb)-104 and (S)-105 were recorded at room temperature in dry, 
degassed tetrahydrofuran, which included its absorption and emission spectra and its quantum 
yield. 
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Table 5.1 Comparison of the photophysical properties of primary phosphine 20a, (Rb)-104 and (Sb)-105. 
 λabs (nm) λem (nm) ΦF 
20a 512 526 0.33 
(Rb)-104 
(Sb)-105 
513 
513 
529 
529 
0.31 
0.31 
[Rh((Sb)-105)] 512 535 0.27 
Measured in dry, degassed tetrahydrofuran at room temperature, dyes were excited at 485 nm; Fluorescence quantum yields were 
measured with respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 57. 
 
Table 5.1 shows that the addition of the Binol group onto the primary phosphine has no significant 
effects on the absorption and emission maxima, and only a minimal decrease in the quantum yield. 
The absorption and emission graph for compound (Rb)-104 is shown in Figure 5.5. The absorption 
maxima at 513 nm is due to the S0-S1 (π-π*) electronic transition associated with the Bodipy core. 
The small Stokes shift of 13 nm is typical of many Bodipy compounds, and shows that there is 
minimal structural change between the ground state and excited state of the fluorophore.39  
 
Figure 5.5 Absorption and emission graph for compound (Rb)-104. 
 Use in Asymmetric Hydrogenation 
One equivalent of the novel Bodipy phosphonites (Rb)-104 and (Sb)-105 was stirred with the 
rhodium complex [Rh(nbd)2][BF4] in anhydrous dichloromethane for thirty minutes and used 
immediately in situ. The Rh coordinated complex [Rh((Rb)-104)] was tested in an asymmetric 
hydrogenation reaction using a benchmark substrate, methyl (Z)-β-acetamidocinnamate (MAC), 
shown in Scheme 5.2. The conditions that were initially employed were published by Pringle and 
co-workers in 2000, when they tested their MOP-based phosphonites in an asymmetric 
hydrogenation reaction of methyl 2-acetamidoacrylate.149   
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Scheme 5.2 First attempt at asymmetric hydrogenation with (Rb)-104. 
The rhodium-catalysed asymmetric hydrogenation reaction studied by Pringle utilised the three 
phosphonite ligands shown in Figure 5.6, all went to full conversion, but gave a wide range of 
enantioselectivities, which can be seen in Table 5.2. 
 
Figure 5.6 Ligands 106, 107 and 108 tested by Pringle and co-workers in an asymmetric hydrogenation 
reaction of methyl 2-acetamidoacrylate. 
Table 5.2 Conversions and enantioselectivities for compounds 106-108 in an asymmetric hydrogenation 
reaction.149 
Ligand Conv. %ee 
106 >99 80 
107 >99 10 
108 >99 63 
   
The Bodipy phosphonite (Rb)-104 was tested under the same hydrogenation conditions as described 
above, in order to investigate how its performance compared to those studied by Pringle – Bodipy 
phosphonite (Rb)-104 was found to give >99% conversion, but only 36(S) % ee.  
In order to try and increase the enantioselectivity of the reaction, a screening regimen was 
undertaken to identify the optimum conditions. The reaction time and the Rh complex remained 
the same, however, the hydrogen pressure was increased from 1.5 bar to 5 bar. This resulted in a 
>99% conversion and also a >99 (S)% ee, as shown in the chromatogram in Figure 5.7. 
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Figure 5.7 HPLC chromatogram showing 99% ee for the S-product using the novel fluorescent catalyst  
(Rb)-104. 
The product from the asymmetric hydrogenation was subsequently tested for any emissive signal, 
which would inform us if there was any catalytic amounts of a fluorescent complex still present. 
The absorption and emission spectra showed no signs of any peaks corresponding to the presence 
of a Bodipy compound,which confirms that there are no Bodipy-based compounds in the final 
product. In order to confirm there is no rhodium metal remaining – whereby the rhodium has 
dissociated from the Bodipy backbone – XPS (X-ray Photoelectron Spectroscopy) could be 
utilised. 
 
The absorption and emission spectra were recorded for the rhodium complex, [Rh-((Sb)-105)] and 
are shown in Figure 5.8. The maxima appeared to be unaltered compared to (Rb)-104, with a λabs = 
512 nm and a λem = 535 nm. The quantum yield was slightly lower than the ligand (0.27 vs 0.31) 
which may allow us to compare the two stages (free ligand and metal coordination) of the catalytic 
cycle by fluorescence.  
R-Product 
S-Product 
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Figure 5.8 Absorption and emission spectra for [Rh-((S)-105)] measured in dry, degassed tetrahydrofuran at 
room temperature. 
The asymmetric hydrogenation reaction of methyl (Z)-β-acetamidocinnamate (MAC) using  
[Rh-((Sb)-105)] was attempted however the conversion and enantioselectivity are still pending. 
Future work for this chapter would involve synthesising the three compounds from Pringles’ paper 
and testing them under the new conditions to see if the enantioselectivities also increase – this will 
allow a fair comparison. 
5.6 Summary 
A novel fluorescent, chiral phosphonite ligand has been prepared and used successfully in an 
asymmetric hydrogenation reaction of MAC to give >99% conversion and >99% selectivity. The 
synthesis of the fluorescent phosphonite was a one-pot two step reaction that was easily monitored 
by 31P{1H} NMR spectroscopy, and formed the products in moderate yields. The ability to purify 
this class of compound via column chromatography is remarkable without seeing any degradation. 
The fluorescent catalyst will allow for monitoring of catalytic pathways, and also the detection of 
any contamination in the final product. Future work will include exploring a range of other 
benchmark substrates to see how efficient the Bodipy phosphonite catalyst can be in other 
reactions. 
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5.7 Experimental 
 General Procedure 
All air- and/or water-sensitive reactions were performed under a nitrogen atmosphere using 
standard Schlenk line techniques. Tetrahydrofuran was dried over sodium/benzophenone, toluene 
was dried over sodium, dichloromethane was dried over calcium hydride, and deuterated 
chloroform was dried over phosphorus pentoxide; all solvents were distilled prior to use. All 
starting materials were purchased from Sigma Aldrich, Alfa Aesar or Fisher and were used as 
received. Column chromatography was performed on silica gel (40-63 μm, 60 Å) from Merck, 
thin-layer chromatography was carried out using Merck aluminium-based plates with silica gel and 
fluorescent indicator (254 nm). 1H, 13C{1H}, 19F{1H}, 31P{1H} and 11B{1H} NMR spectra were 
recorded on a JEOL ECS-400 (1H 399.78 MHz) or Bruker Avance III 300 (1H 300.13 Hz) 
spectrometer at room temperature; 1H and 13C chemical shifts were relative to tetramethylsilane, 
31P chemical shifts were relative to 80% H3PO4, 
11B chemical shifts were relative to BF3.Et2O and 
19F chemical shifts were relative to CFCl3. Infrared spectra were recorded on a Varian 800-FT-IR 
spectrometer and mass spectrometry was carried out by the EPSRC NMSF, Swansea. 
 
 Synthesis of Bodipy Phosphonites (Rb)-104 and (Sb)-105 
 
PCl5 (339 mg, 1.63 mmol) was dissolved in anhydrous toluene (10 mL). 20a (300 mg, 0.74 mmol) 
was added and the reaction mixture was stirred under nitrogen for 45 minutes. The volatiles were 
removed in vacuo to give the corresponding dichlorophosphine (31P NMR spectrum in CDCl3 
showed a peak at δ = 159.7 ppm as a red solid). THF (10 mL), NEt3 (0.45 mL, 3.26 mmol) and 
(R)- or (S)-BINOL (0.74 mmol) were added and the solution was stirred overnight. The volatiles 
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were removed in vacuo and the crude product was purified by column chromatography (anhydrous 
toluene) to give the title compound as a red solid: 0.29 g, 55% for (R)-104 and 0.28 g, 52% for (S)-
105)). 
1H NMR (700 MHz, CDCl3) δ 8.10 (d, J = 8.7 Hz, 1H), 8.01 (d, J = 8.2 Hz, 1H), 7.90 (d, 
J = 8.6 Hz, 1H), 7.69 (m, 2H), 7.63 (t, J = 7.5 Hz, 2H), 7.52-7.43 (m, 4H), 7.34 (m, 4H), 6.72 (d, 
J = 8.7 Hz, 1H), 2.52 (s, 6H), 2.40 (q, J = 7.5 Hz, 4H), 1.34 (s, 6H), 1.07 (t, J = 7.5 Hz, 6H), 0.35 
(s, 6H) ppm; 13C{1H} NMR δ 151.0, 149.8, 148.3 (d, J = 5.4Hz), 141.3, 139.4, 139.0, 138.8, 138.0, 
133.6, 133.1, 132.7, 131.2, 131.0 (d, J = 10.2 Hz), 130.9, 129.4, 129.2, 128.8, 128.7 (d, J = 6.5 
Hz), 128.5 (d, J = 22.8 Hz), 128.3, 127.0, 126.5, 126.3, 125.2, 125.1, 122.4, 121..5, 17.6, 14.9, 
14.5, 12.3, 10.4 (br) ppm; 31P{1H} NMR (121 MHz, CDCl3) δ 181.9 ppm; 11B{1H} NMR (96 MHz, 
CDCl3) δ – 0.5 ppm. 
 
 General Procedure for Rhodium-Catalysed Asymmetric Hydrogenation of 
Prochiral Alkene MAC 
The rhodium source, [Rh(nbd)2][BF4] (0.008 mmol, 1.0 mol%) and the ligand (104/105) (0.009 
mmol, 1.1 mol%) were combined in a 45 mL capacity autoclave and dissolved in 4.5 mL of 
anhydrous DCM, and left to stir for 45 minutes under a nitrogen environment. The substrate 
(MAC), (0.79 mmol, 1.0 eq) was added, the autoclave was loaded with 5 bar pressure of hydrogen 
gas. The misture was stirred at room temperature for 18 hours. Conversions were calculated from 
1H NMR spectroscopy, where samples were taken from the crude reaction mixture and dissolved 
in deuterated chloroform. After sample filtration through a plug of silica gel, and again using 
column chromatography (toluene) in order to remove any traces of colour from the final product, 
the enantioselectivity was determined using chiral HPLC, using a Phenomenex Lux 5u Cellulose-
1 chiral column (250mm x 4.6mm ID).  Retention times for product = 21.1 min (R) and 26.7 min 
(S) (>99%).  
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  Synthesis of a Bodipy ‘Switch’ 
 
This chapter describes the synthesis of Bodipy compounds with a potential application as a 
‘switch’. The Bodipy compounds that have previously been described in this thesis have all had an 
aryl linker separating the Bodipy core and the phosphorus group in the 8-position, illustrated in 
Figure 6.1. The aryl linker appears to insulate the phosphorus and metal from the Bodipy 
photophysical properties as evidenced by the calculated molecular orbitals shown in Section 2.4. 
This chapter details an investigation where the phosphorus is likely to be incorporated in the 
frontier orbitals of the compounds – thus, rather than being insensitive to the Bodipy (which is a 
useful attribute for imaging), the phosphorus donor can now act as a reporter to its environment – 
representing an off/on switch which could be manipulated in sensing applications. 
The photophysical properties will be recorded and compared with their analogues containing the 
aryl linker, to establish the effect that the aryl linker has on the fluorescence quantum yield, 
absorption and emission maxima and the Stokes’ shift. 
 
 
Figure 6.1 Examples of compounds where the Bodipy core and the phosphorus group are separated by an aryl 
linker. 
6.1 Introduction 
There are examples in the literature where metal coordination to fluorescent compounds affects the 
photophysical properties of the resulting complexes, causing a switching of the fluorescence “off” 
or “on” upon coordination. Fluorescent transition metal phosphine complexes are usually 
categorised into either i) LMCT, Ligand-to-Metal Charge Transfer (with phosphines as donors) ii) 
MLCT, Metal-to-Ligand Charge Transfer (with phosphines as acceptors) or iii) MMCT, Metal-to-
Metal Charge Transfer (with phosphines as bridging ligands).150  
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There are examples in the literature of nitrogen donors on a fluorophore that lead to fluorescence 
quenching via electron transfer processes such as intramolecular and Photoinduced electron 
Transfer (PeT).151, 152  
Figure 6.2 shows an example of an acid-responsive fluorescent switch where the presence of a 
proton increases the fluorescence quantum yield from <0.01 to 0.34, which was synthesised in 2012 
by Saito.153 
 
Figure 6.2 Acid-responsive fluorescent compound prepared by Saito and co-workers; the fluorescence was 
switched on when the amine was protonated, and switched off upon deprotonation. 
 
Figure 6.3 shows an example of a purposely quenched phosphine-fluorophore that is activated upon 
Staudinger ligation (a reaction between an azide and a phosphine). Bertozzi has published several 
fluorescent phosphorus-containing compounds which can be used for live-cell imaging.154  
 
Figure 6.3 Schematic of a FRET-based fluorogenic phosphine for live-cell imaging. 
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 Phosphine Oxides and Oxidative Stress 
Oxidative stress refers to the imbalance between Reactive Oxygen Species (ROS) and anti-oxidant 
defence. There are assays available that measure oxidative stress in cell samples that have 
fluorescent indicators in them.155, 156  
Reactive Oxygen Species (ROS) are radicals, ions or molecules that have a single unpaired electron 
which makes them highly reactive; they can be categorised into two types of ROS: free oxygen 
radicals, (such as superoxide and organic radicals), and non-radical ROS (such as hydrogen 
peroxide and singlet oxygen).157  ROS have been associated with cancer - elevated rates have been 
detected in almost all cancers, where they are responsible for the promotion of tumour development 
and progression. High levels of ROS can be found in cancer cells due to several reasons, including 
increased metabolic activity or mitochondrial dysfunction.158, 159 
 
Figure 6.4 Photoinduced electron Transfer mechanism for the oxidation of a phosphine.  
There are several known examples of fluorescent phosphines that have been used as sensors for 
reactive oxygen species (ROS). They can display interesting fluorescence “turn-on” properties due 
to the oxidation of the phosphine, which deactivates the phosphorus-to-fluorophore Photoinduced 
electron Transfer (PeT), and results in a reappearance of the fluorophore’s emission, illustrated in 
Figure 6.4.160  
Figure 6.5 shows four examples of ROS sensors: Akasaka’s diphenyl-1-pyrenylphosphine, 109, 
showed no fluorescence but the corresponding oxide showed blue fluorescence.161 Santa 
synthesised compound 110 as an effective way to detect hydroperoxides, which is important in 
many different fields including certain cancers and Alzheimer’s disease. Compound 111 is weakly 
fluorescent, but upon oxidation, due to the presence of hydroperoxides, becomes thirty-one times 
more fluorescent.162 Imato designed a novel fluorescent probe for monitoring hydrogen peroxide 
in cellular systems; 112 was developed with Photoinduced electron Transfer (PeT) in mind, with 
the diphenylphosphine moiety acting as the donor and the 7-hydroxycoumarin as the acceptor. It 
was rationalised that the formation of the oxide would cancel the PeT process, which in turn would 
switch the fluorescence on – this was found to be the case.163  
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Figure 6.5 Four examples of phosphorus-containing reactive oxygen species sensors. 
6.2 Results and Discussion 
 Novel Phosphine Bodipy Compounds via a Thioether Cleavage Reaction 
This research was part of a collaboration with Dr Keith Pannell from the University of Texas, El 
Paso, whose research group published work showing the rapid reaction between ethylenediamine 
and 8-thiomethyl Bodipy, as illustrated in Figure 6.6.164 This reaction could be applicable to a range 
of diamines, opening up a potentially large range of novel compounds. 
 
Figure 6.6 The reaction with an ethylenediamine and 8-thiomethyl Bodipy. 
This reaction identified a simple way to introduce an amine into the 8-position of the Bodipy core, 
of interest to our research group was whether phosphorus could be introduced into the same 
position. However, the corresponding diphosphine analogue of the diamine that Pannell utilised in 
Figure 6.5 is volatile and can spontaneously ignite in air, therefore the reaction was attempted using 
a range of more user-friendly primary phosphines, such as 20a, as shown in Scheme 6.1.  
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Scheme 6.1 Reaction between 20a and 8-thiomethyl Bodipy to form compound 113. 
Compound 20a and 8-thiomethyl Bodipy were combined in anhydrous THF and stirred for ten 
minutes; the solution was analysed by 31P{1H} NMR spectroscopy, which showed two species to 
be present – a peak at δ –126.2 ppm which corresponded to the primary phosphine starting material 
20a, and a peak at δ –61.0 ppm, which is indicative of a secondary phosphine. Further analysis by 
31P-1H NMR spectroscopy revealed that the peak at δ −61.0 ppm was a doublet of triplets, (1JPH = 
230.7 Hz, 3JPH = 7.4 Hz) which is expected for compound 113, due to the splitting of the P−H 
proton, and also the ortho-aryl protons from the phenyl ring. After a further two hours of stirring, 
no more product had formed, so the reaction was stopped and purified by column chromatography 
to yield 113 in a poor yield of 11%. The reaction was attempted again in anhydrous THF at 76 °C 
overnight which increased the yield to 40%. 
The photophysical properties of di-Bodipy compound 113 were measured which concluded that 
the absorption and emission maxima had been unaltered, (512 nm and 527 nm respectively), 
however, the quantum yield had reduced from 0.33 (compound 20a) to 0.068, indicating that the 
presence of a phosphorus atom bound directly to the Bodipy core is detrimental to the fluorescence. 
Figure 6.7 shows the absorption and emission spectra of the di-Bodipy compound 113. 
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Figure 6.7 Absorption and emission spectra for di-Bodipy 113 measured in dry, degassed tetrahydrofuran at 
room temperature. 
Although the research that has been described above did successfully add a phosphorus atom 
directly on to the Bodipy core, (and several phosphines could be used using this method, in 
principle), a new approach was taken. Bodipy compounds with a halogen situated in the 8-position 
could be substituted with a phosphine, a literature search discovered the following synthesis to 
form compound 116.165, 166  
Compound 116 was synthesised via a three-step synthesis shown in Scheme 6.2. Pyrrole was 
reacted with thiophosgene in anhydrous diethyl ether at 0 °C to give 114 which was purified 
through a silica plug. Compound 114 which was then reacted with hydrogen peroxide and 
potassium hydroxide in aqueous methanol to form 115 which precipitated out as pale yellow 
needles in a good yield of 80%.  
Compound 115 can be converted into the chloro- or bromo-Bodipy structures 116 and 117 
respectively. The synthesis of 116 was achieved by heating 115 at reflux with phosphoryl 
oxychloride in 1,2-dichloroethane for three hours before being cooled and treated with 
triethylamine and boron trifluoride. Purification by column chromatography yielded 116 as a red 
crystalline solid and a sample suitable for X-ray crystallographic analysis was obtained by 
evaporation of deuterated chloroform and is shown in Figure 6.8. Bodipy 117 was synthesised by 
stirring 115 with phosphoryl oxybromide in 1,2-dichloroethane at room temperature for 72 hours. 
After purification by column chromatography, compound 117 was isolated as a red solid in a good 
yield of 80% and was also analysed by X-ray crystallography after evaporation in deuterated 
chloroform, as shown in Figure 6.8. 
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Scheme 6.2 Synthesis of halo-substituted Bodipy compounds 116 and 117. 
    
Figure 6.8 Molecular structures of 116 (l) and 117 (r). Selected bond distances [Å] and angles [°] for 116: Cl1-
C8 1.7187(16), B4-F1 1.383(2), B4-F2 1.381(2); F1-B4-F2 109.13(13), F1-B4-N2 110.20(13). Selected bond 
distances [Å] and angles [°] for 117: Br1-C8 1.8676(19), B4-F1 1.376(3), B4-F2 1.388(3); F1-B4-F2 109.82(18), 
F1-B4-N2 110.81(18).  
The Cl-C bond length of 1.7187(16) Å and the Br-C bond length of 1.8676(19) Å are in agreement 
with similar structures published within the literature.167, 168 
6.3 Substitution to give Diphenylphosphino Derivative 118 
A method to synthesise phosphine 118 was published by Peña-Cabrera and co-workers in 2013 
where they reacted three equivalents of diphenylphosphine with thiomethyl Bodipy, to give 118, 
shown in Figure 6.9, however, after several attempts this reaction was not successful.169  
  
Figure 6.9 A published route for the synthesis of phosphine 118 by Peña-Cabrera. 
An alternative method to attach a phosphorus group to the 8-position directly was reacting 
diphenylphosphine with n-butyllithium in anhydrous THF at 0C, followed by the addition of the 
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Bodipy 116 in anhydrous tetrahydrofuran to form compound 118, as detailed in Scheme 6.3. 
Purification by column chromatography on silica gel gave the desired product and when analysed 
by 11B{1H} and 19F{1H} NMR spectroscopy gave a triplet at  0.9 ppm (1JBF = 28.6 Hz) and a 
quartet (of equal intensity) at  145.4 ppm (1JFB = 28.6 Hz) respectively. A sample of 118 suitable 
for X-ray crystallographic analysis was obtained via slow evaporation of dichloromethane, shown 
in Figure 6.10. The C-P bond lengths of 1.820(2), 1.824(2) and 1.8530(18) Å are all in accordance 
with bond lengths associated with tertiary phosphines and are a good comparison to 
triphenylphosphine.130  
 
Scheme 6.3 Substitution of the chlorine atom for a diphenylphosphine group to give compound 118. 
 
Figure 6.10: Molecular structure of 118. Selected bond distances [Å] and angles [°]: P1-C11 1.820(2), P1-C17 
1.824(2), P1-C8 1.8530(18), B4-F1 1.398(2), B4-F2 1.375(2); C17-P1-C11 103.92(9), C17-P1-C8 100.73(8), 
N1-B4-N2 105.15(15), F1-B4-F2 109.90(16). 
The absorption and emission spectra were recorded for phosphine 118 in anhydrous 
tetrahydrofuran at room temperature which showed a red shift of the maxima and a large decrease 
in the fluorescence quantum yield (labs = 539 nm, lem = 552 nm, F = 0.005). These findings will 
be discussed in more detail later in the chapter in Section 6.5.   
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 Phosphine Oxide Formation 
It may be possible that the oxidation of a phosphine will turn “on” the fluorescence of a compound. 
If the phosphorus lone pair is coordinated to an oxygen, and no longer  engaging in fluorescence 
quenching via Photoinduced electron Transfer, then the quantum yield may increase. 
Compound 118 was converted to phosphine oxide 119 via the addition of hydrogen peroxide in 
chloroform. The reaction occurred instantly and in a quantitative fashion, which was indicated by 
a colour change (dark red to purple) and analysis by 31P{1H} NMR spectroscopy showed a 
downfield shift from δ −7.7 to δ 25.4 ppm.. It was also evident that oxidation of the phosphine 
induced fluorescence and increased the quantum yield from 0.005 to 0.13, which means compound 
118 could be used as an imaging probe for the detection of oxidative stress. The photophysical 
properties of compounds 118 and 119 can be found in Table 6.1. 
 
Scheme 6.4 Phosphine 118 was immediately oxidised to phosphine oxide 119. 
 Gold Coordination 
Following the successful production of the phosphine 118 and phosphine oxide 119, the next step 
was to study the coordination chemistry of 118. The coordination of a transition metal may also 
turn “on” the fluorescence of a compound, in the same way as the oxidation of phosphines has 
shown to do, detailed by the examples of ROS sensors in Figure 6.5. 
The investigation into the use of gold complexes in medicine has been extensively researched, 
including research towards therapeutics for cancer, rheumatoid arthritis, bronchial asthma, AIDS 
and malaria.170, 171 It is known that gold targets the thiol-containing proteins in the body, which 
have been found to cause or contribute to many human diseases if they malfunction.172 Gold has 
many potential therapeutic properties including anticancer and anti-inflammatory effects,170 some 
gold complexes have been compared to the successful chemotherapy drug Cisplatin, since gold(III) 
is isoelectronic with platinum(II) and some tetracoordinate gold (III) complexes can adopt the same 
square planar geometry.173 
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In 1985 Auranofin, shown in Figure 6.11, was discovered by Sutton and was subsequently 
approved to treat rheumatoid arthritis.174 Since then, Auranofin has also demonstrated anticancer 
properties, specifically for ovarian cancer and bactericidal activity towards tuberculosis.175, 176 
 
Figure 6.11 Structure of Auranofin which has shown several applications (see text) in medicine. 
There are examples in the literature where the coordination of a transition metal - such as gold or 
silver, has switched “on” the fluorescence of a compound.177, 178 This is due to the transition metal 
coordinating through the phosphorus lone pair, thus preventing the lone pair from engaging in PeT 
quenching. 
Therefore, phosphine 118 was coordinated to gold to give the metal complex 120, shown in Scheme 
6.5. Compound 118 and [AuCl(tht)] (tht = tetrahydrothiophene) were combined in anhydrous 
dichloromethane and stirred at room temperature for one hour under a nitrogen environment. The 
solvent was evaporated and the solid was washed with hexane to remove excess traces of 
tetrahydrothiophene. The solid was analysed by 31P{1H} NMR spectroscopy which revealed that 
the starting material peak (δ −7.7 ppm) was no longer present and a new peak had appeared at δ 
27.9 ppm. This downfield shift suggests that the gold had successfully coordinated to the 
phosphine. The photophysical properties of this compound will be discussed in Section 6.5. 
  
Scheme 6.5 Phosphine 118 was successfully coordinated to a gold complex to form complex 120. 
 Synthesis of a Switch Containing a Substituted Pyrrole Backbone 
A related synthesis was then attempted using a substituted pyrrole, shown in Scheme 6.6. It would 
be interesting to note the differences in photophysical properties between the two final products 
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and whether the methyl and ethyl groups on the Bodipy core cause any changes in the fluorescence 
quantum yield or absorption/emission maxima. The synthesis of dipyrrylketone was outlined by 
Plater et al.166 The dipyrrylthioketone was synthesised via the addition of thiophosgene and 3-
ethyl-2,4-dimethylpyrrole in anhydrous diethyl ether under a nitrogen atmosphere, in a darkened 
flask. Compound 121 was purified by column chromatography to yield a red solid, in a low yield 
of 13%. Low yields have been attributed to this reaction due to the tendency of the pyrrole units to 
polymerise, which was minimised by darkening the flask with foil. The next step saw compound 
121 reacted with hydrogen peroxide and potassium hydroxide in an aqueous methanol solution to 
form 122 which was purified by sublimation, and gave the product as a yellow solid in a high yield 
of 80%. 
 
Scheme 6.6 Synthesis of substituted chloro Bodipy 123. 
The synthesis of chloro Bodipy 123 was performed following the procedure of Leen and 
coworkers.165 Compound 122 was heated to reflux with phosphorus oxychloride in 1,2-
dichloroethane, the reaction mixture was cooled, triethylamine and boron trifluoride were both 
added dropwise and the mixture was stirred at room temperature for two hours. After purification 
by column chromatography, 123 was produced in a moderate yield of 59%. A sample suitable for 
analysis by X-ray crystallography was obtained by slow evaporation of 
dichloromethane:methanol:n-pentane (1:1:1 ratio), shown in Figure 6.12 and is a novel structure. 
The C-Cl bond length of 1.7252(0) Å was representative of other similar compounds published in 
the literature.167  
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Figure 6.12 Molecular structure of 123. Hydrogens atoms omitted for clarity. Selected bond distances [Å] and 
angles [°]: C8-Cl1 1.7252(0), B4-F1 1.3881(0), B4-F2 1.3929(0), B4-N1 1.546(0), B4-N2 1.540(0); C9-C8-Cl1 
118.168(1), F1-B4-F2 109.042, N1-B4-N2 106.906(2). 
 Synthesis of Substituted Bodipy Switch Phosphine 124 
The final step in the preparation of the novel phosphine compound 124 was the substitution of the 
chlorine group for a dicyclohexylphosphine which was achieved in the same way as described for 
phosphine 118, and is shown in Scheme 6.7. n-Butyllithium and dicyclohexylphosphine were 
combined in anhydrous THF, and added dropwise to a solution of 123 in anhydrous tetrahydrofuran 
at 0°C; there was an instant colour change from bright pink to dark purple. Analysis by 31P{1H} 
NMR spectroscopy at this stage revealed that there was still a large percentage of the 
dicyclohexylphosphine starting material present (δ –27.2 ppm) and a small second peak at δ –2.9 
ppm, which indicated the formation of the desired product. The reaction was stirred for two days, 
and the 31P{1H} NMR spectrum showed that the product peak at 
δ –2.9 ppm had increased by tenfold. Purification by column chromatography yielded the novel 
phosphine as a dark purple solid. The 11B{1H} NMR spectrum showed a triplet ( 0.5 ppm, 1JBF = 
32.8 Hz) and the 19F{1H} NMR spectrum showed a quartet (of equal intensity) at ( 145.6 ppm, 
1JBF = 32.3 Hz) confirming that no reagents had reacted with the BF2 group. 
 
Scheme 6.7 The chloro-substituted Bodipy 123 was reacted with lithium dicyclohexylphosphide to form 
phosphine 124. 
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The absorption and emission spectra were recorded in anhydrous THF at room temperature. 
Interestingly the absorption showed two peaks, one at 528 nm and the other at 567 nm. This may 
indicate the presence of two species, as the standard Bodipy curve would be assumed for compound 
124, just as compound 118 displayed. The emission maxima showed only one peak with a maxima 
at 539 nm. 
 
6.4 Spartan Calculations 
DFT calculations were ran for the ‘switch’ Bodipy phosphine compounds 118 and 124, to establish 
their electronic properties. 
The compounds were performed with both fluorine and methyl groups on the boron atom to see 
the effect of changing the substituent had, and also because in the future the fluorine atoms may be 
changed for methyl groups, using previously described methods (Section 2.1) 
The HOMO for 118 was situated on the Bodipy core and the LUMO had a slight incorporation of 
the phosphorus atom. When compared to compound 89b, with the aryl spacer between the Bodipy 
core and diphenylphosphine moiety, the HOMO and LUMO are both situated more on the Bodipy 
core. This indicates that the HOMO and LUMO orbitals are involved in the fluorescence process 
for ‘switch’ compound such as 118, but not necessarily for spacer compounds such as 89b. 
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SPACER COMPOUND   SWITCH COMPOUND  
                                                           
                  LUMO – 2.3 eV  LUMO – 2.8 eV 
                                                     
  HOMO –5.4 eV    HOMO –5.8 eV 
 
Figure 6.13 HOMO (bottom) and LUMO (top) orbital distributions for spacer compound 89b (left) and 
“switch” compound 118 (right). 
 
The HOMO-LUMO gap for the spacer ligand shows an energy difference of 3.1 eV and the ‘switch’ 
compounds shows a HOMO-LUMO gap of 3.0 eV. The HOMO of the spacer compound 89b is 
not incorporated onto the phosphorus atom until HOMO (-2). 
 
6.5 Photophysical Studies 
It was important to determine the influence that the aryl linker plays in the Bodipy compounds, and 
to establish whether the fluorescence would be quenched when the phosphorus atom was attached 
directly to the 8-position of the Bodipy core in the new ‘switch’ phosphines. Chapter 4 details the 
photophysical properties of the aryl spacer compounds, here they are compared with the ‘switch’ 
phosphines 118 and 124. 
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Table 6.1 Photophysical properties of the key compounds synthesised within this chapter. 
 λabs (nm)a λem (nm)a Φa,b 
 113 512 527 0.068 
Bod-PCy2 spacer 89a 512 526 0.44 
Bod-PPh2 spacer 89b 513 527 0.29 
Bod-PPh2 switch 118 539 552 0.005 
Bod-PPh2(O) switch 119 557 585 0.13 
Bod-PPh2AuCl switch 120 545 561 0.15 
BodPCy2 switch 124 528, 567 539 0.008 
a Measured in dry, degassed tetrahydrofuran at room temperature, dyes were excited at 485 nm; b Fluorescence quantum yields 
were measured with respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 57. 
 
Table 6.1 concludes that the addition of a phosphorus atom directly bound at the 8-position of the 
Bodipy core significantly reduces the fluorescence quantum yield compared to the analogues where 
an aryl linker separates the phosphorus group from the Bodipy core – which is known to occur 
because the phosphorus lone pair can engage in PeT.  
Compound 113 showed a decrease in quantum yield from 0.33 to 0.068 when primary phosphine 
20a was reacted with 8-thiomethyl Bodipy and resulted in a direct bond between the phosphorus 
atom and a Bodipy core. The absorption and emission spectra of compound 113 can be seen in 
Figure 6.14. 
The coordination of an oxide or metal to the phosphorus increases the fluorescence quantum yield 
– indicating the successful synthesis of an Off-On switch. The ‘switch’ phosphine complexes 118 
and 124 showed a bathochromic shift of more than 25 nm when compared to their spacer analogues 
89a and 89b and also a decrease in quantum yield. Figure 6.15 shows the absorption and emission 
spectra for compound 124. The absorption spectra shows two maxima which is not expected for 
this compound – as there is only the Bodipy core that would create a peak, this may be due to an 
impurity within the compound rather than observing two separate absorption wavelengths. This 
will be re-made and retested in the future.   
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Figure 6.14 Absorption and emission spectra for compound 113. 
 
Figure 6.15 Absorption and emission spectra for novel phosphine 124. 
 
6.6 Summary 
This chapter has described the synthesis of Bodipy compounds that have potential applications as 
fluorescence switches; the substitution of a halogen in the 8-position of the Bodipy core, for a 
phosphorus atom, resulted in significant fluorescence quenching in both cases (compounds 118 
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and 124). The formation of the phosphine oxide appeared to increase the fluorescence quantum 
yield, which may mean these compounds have potential as ROS sensors. 
The coordination of the phosphine compound 118 with a gold complex caused a significant 
increase in the fluorescence quantum yield from 0.005 to 0.15 – which has been observed 
previously with other phosphorus-gold complexes within the literature. Plenio described the 
reactions between gold complexes and phenyl acetylenes, which would enable gold-catalysed 
reactions to be monitored by fluorescence microscopy.174  
 
6.7 Experimental 
 General Procedure 
All air- and/or water-sensitive reactions were performed under a nitrogen atmosphere using 
standard Schlenk line techniques. Tetrahydrofuran was dried over sodium/benzophenone and 
deuterated chloroform was dried over phosphorus pentoxide; these solvents were distilled prior to 
use. All starting materials were purchased from Sigma Aldrich, Alfa Aesar or Fisher and were used 
as received. Column chromatography was performed on silica gel (40-63 μm, 60 Å) from Merck, 
thin-layer chromatography was carried out using Merck aluminium-based plates with silica gel and 
fluorescent indicator (254 nm). 1H, 13C{1H}, 19F{1H}, 31P{1H} and 11B{1H} NMR spectra were 
recorded on a JEOL ECS-400 (1H 399.78 MHz) or Bruker Avance III 300 (1H 300.13 Hz) 
spectrometer at room temperature (21 °C); 1H and 13C shifts were relative to tetramethylsilane, 31P 
shifts were relative to 80% H3PO4, 
11B relative to BF3.Et2O and 
19F relative to CFCl3. Infrared 
spectra were recorded on a Varian 800 FT-IR spectrometer and mass spectrometry was carried out 
by the EPSRC NMSF, Swansea. DFT calculations were carried out on Spartan 14 using the B3LYP 
functional with a 6-31G* basis set, details of the xyz coordinates and SCF energies can be found 
in the appendix. 
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 Preparation of Di-Bodipy (113) 
 
20a (0.085 g, 0.21 mmol) and 8-(thiolmethyl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (0.050 
g, 0.21 mmol) were dissolved in anhydrous THF (4 mL) and stirred at 75˚C overnight under 
nitrogen. After removal of the solvent, purification was performed by column chromatography on 
silica gel (chloroform) to yield an orange solid (0.050 g, 40%). 1H NMR (500 MHz, CDCl3) δ 7.88 
(m, 2H), 7.73  (m, 2H), 7.33 (m, 4H), 6.50 (m, 2H), 5.77 (d, 1JHP = 230.7 Hz, 1H), 2.44 (s, 6H), 
2.28 (q, 3JHH = 7.8 Hz, 4H), 1.18 (s, 6H), 0.97 (t, 
3JHH = 7.8 Hz, 6H), 0.26 (s, 6H) ppm; 13C{1H} 
NMR (126 MHz, CDCl3) δ 151.7, 148.7 (d, JCP = 27.8 Hz), 144.4 139.7, 138.9, 137.3 (d, JCP = 
12.5 Hz), 135.5 (d, JCP = 20.2 Hz), 133.4 132.8, 131.9 (d, JCP = 9.6 Hz), 130.6, 129.9 (d, JCP = 7.7 
Hz), 128.8, 118.7, 17.5, 14.8, 14.4, 12.1, 10.4 ppm; 31P NMR (202 MHz, CDCl3) δ −60.0 (dt, 1JPH 
= 230.7 Hz, 3JPH = 7.4 Hz) ppm; 11B{1H} NMR (CDCl3, 128 MHz) δ −0.92 (t, 1JBF = 27.96 Hz), 
−1.8 (s) ppm. 
 
 
 Preparation of 2,2-Dipyrrylthione (114) 
 
Pyrrole (5.0 g, 74.53 mmol) in anhydrous diethyl ether (15 mL) was added dropwise to a stirred 
solution of thiophosgene (2.86 mL, 37.27 mmol) in anhydrous diethyl ether (15 mL) at 0 C under 
nitrogen. After 30 minutes, methanol (10 mL) was added and the solution was stirred for a further 
30 minutes. The solvent was removed under reduced pressure and the residue was dissolved in 
chloroform and filtered through a short silica plug. The solvent was removed to give a dark purple 
solid which was purified by column chromatography, (toluene:chloroform, 9:1) to give the desired 
product as a dark red solid. (2.8 g, 43%).  
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1H NMR (400 MHz, CDCl3)  9.77 (s, 2H), 7.19 (m, 2H), 7.04 (m, 2H), 6.40 (m, 2H) ppm; 13C 
NMR (100 MHz, CDCl3)  193.4, 138.4, 127.8, 114.9, 112.6 ppm; HRMS (APCI+ SOLID) calcd. 
for C9H9N2SH [M+H]
+ requires m/z 177.0481, found m/z 177.0479. 
 Preparation of 2,2-Dipyrrylketone (115) 
 
 
H2O2 (10 mL, 37%) was added dropwise to KOH (3.35 g, 59.75 mmol) and 114 (2.34 g, 13.28 
mmol) in 95% aqueous MeOH (84 mL) at 0 C. The mixture was refluxed for five minutes and 
then cooled and H2O (134 mL) was added and the solution was chilled in an ice bath. The product 
was filtered and dried to give the desired compound as pale yellow needles. (1.7 g, 80%).  
1H NMR (400 MHz, CDCl3)  9.78 (s, 2H), 7.14 (m, 2H), 7.07 (m, 2H), 6.34 (m, 2H) ppm; 13C 
NMR (100 MHz, CDCl3)  172.9, 130.6, 124.0, 116.1, 111.1 ppm; HRMS (APCI+ SOLID) calcd. 
for C9H9N2OH [M+H]
+ requires m/z 161.0709, found m/z 161.0706. 
 Preparation of 8-Chloro-4,4-difluoro-4-bora-3a,4a-s-indacene (116) 
 
 
2, 2-dipyrrylketone 115 (1.0 g, 6.24 mmol) was dissolved in 1, 2-dichloroethane (50 mL). 
Phosphorus oxychloride (1.16 mL, 12.48 mmol) was added and the reaction mixture was heated to 
reflux for 3 hours and then cooled on an ice bath. Triethylamine (8.7 mL, 62.4 mmol) was added 
and the reaction was stirred at 0 ˚C for 5 minutes. Boron trifluoride etherate (8.5 mL, 68.64 mmol) 
was added dropwise while maintaining the temperature at 0˚C. The reaction was allowed to warm 
to room temperature and stirred for a further 2 hours. The resulting solution was poured into diethyl 
ether (200 mL) and washed with water, dried with magnesium sulphate and the solvent removed 
under reduced pressure. The crude product was purified using column chromatography, 
(dichloromethane:petrol, 1:1) to give the desired product as a red crystalline solid (0.72 g, 51%). 
1H NMR (400 MHz, CDCl3) δ 7.87 (s, 2H), 7.40 (d, J = 4.2 Hz, 2H), 6.56 (d, J = 4.2 Hz, 2H) ppm; 
13C NMR (100 MHz, CDCl3) δ 145.1, 141.2, 134.1, 129.4, 119.2 ppm; 11B NMR (128 MHz, 
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CDCl3) δ – 0.9 (t, 1JFB = 27.8 Hz, 1B) ppm; 19F NMR (282 MHz, CDCl3) 
δ 145.5 (q (equal intensity), 1JFB = 27.8 Hz, 2F) ppm; HRMS (APCI+ SOLID) calcd. for 
C9H6N2BClF2 [M]
+ requires m/z 226.0390, found m/z 226.0388. 
 
 Preparation of 8-Bromo-4,4-difluoro-4-bora-3a,4a-s-indacene (117) 
 
 
Compound 116 (0.50 g, 3.12 mmol) was dissolved in anhydrous DCM (30 mL). POBr3 (1.96 g, 
6.87 mmol) was added and the reaction was stirred at RT for 72 h. The mixture was cooled to 0°C 
and NEt3 (4.33 mL, 31.2 mmol) was added dropwise, followed by BF3.OEt2 (4.23 mL, 34.3 mmol) 
dropwise. The reaction mixture was warmed to room temperature and stirred for a further two 
hours. The resulting solution was poured into diethyl ether (200 mL) and washed with water (3 x 
50 mL), dried with magnesium sulphate and the solvent removed under reduced pressure. The 
crude product was purified using column chromatography, (dichloromethane:petrol, 1:1) to give 
the desired product as a red crystalline solid (0.35 g, 42%). 1H NMR (300 MHz, CDCl3) δ 7.92 (s, 
2H), 7.35 (d, J = 4.6 Hz, 2H), 6.54 (d, J = 4.6 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3)  δ 
145.2, 135.8, 133.0, 131.5, 119.3 (d, J = 8.6 Hz) ppm; 11B{1H} NMR (96 MHz, CDCl3) δ 0.1 (t, 
JBF = 28.8 Hz, 1B) ppm; 19F{1H} NMR (282 MHz, CDCl3) δ 145.2 (q (equal intensity), 1JFB = 28.8 
Hz, 2F) ppm. 
 
 
 
 
 Preparation of 8-(Diphenylphosphino)-4,4-difluoro-4-bora-3a,4a-s-indacene 
(118) 
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Diphenylphosphine (0.2 mL, 1.14 mmol) and n-butyllithium (0.44 mL, 1.14 mmol) were combined 
in THF (2 mL) at 0 ˚C under nitrogen and added dropwise to a separate flask containing 8-chloro-
4, 4-difluoro-4-bora-3a,4a-diaza-s-indacene 116 (0.25 g, 1.14 mmol) in THF (5 mL), also at 
0 ˚C. The mixture was stirred at room temperature overnight and purified by column 
chromatography (dichloromethane:petrol 1:1) to give a red solid (0.022 g, 5%).  
1H NMR (400 MHz, CDCl3) δ 7.80 (s, 2H), 7.50-7.35 (m, 10H), 6.87 (d, J = 4.4 Hz, 2H), 6.32 (d, 
J = 4.4 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 143.9, 138.4 (d, J = 16.5 Hz), 134.4 (d, 
J = 9.5 Hz), 133.9, 133.7, 131.8 (d, J = 11.7 Hz), 130.1, 129.3 (d, J = 9.0 Hz), 118.6 ppm; 31P{1H} 
NMR (162 MHz, CDCl3) δ – 7.1 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ – 0.9 (t, 1JFB = 28.6 
Hz, 1B) ppm; 19F{1H} NMR (282 MHz, CDCl3) δ 145.4 (q (equal intensity), 1JFB = 28.6 Hz, 2F) 
ppm. HRMS (APCI+ SOLID + NH4OAc) calcd. for C21H16BF2N2PH [M+H]
+ requires m/z 
376.1221, found m/z 376.1221. 
 Preparation of [AuCl(118)] (120) 
  
 
Compound 118 (0.022 g, 0.06 mmol) and [AuCl(tht)] (0.019 g, 0.06 mmol) were dissolved in 
anhydrous dichloromethane (3 mL) and stirred under nitrogen for one hour. The solvent was 
removed in vacuo and the solid was washed three times with anhydrous hexane (3 x 5mL) to 
remove the tetrahydrothiophene. The solid was then purified by column chromatography 
(dichloromethane:hexane, 2:1) to give the product as a purple solid (32 mg, 88%). 
1H NMR (400 MHz, CDCl3) δ 7.83 (m, 5H), 7.62 (m, 2H), 7.53 (m, 5H), 6.60 (d, J = 4.1 Hz, 2H), 
6.32 (d, J = 4.1 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 146.5, 135.0 (d, J = 16.5 Hz), 
134.4 (d, J = 9.5 Hz), 133.4, 133.7, 130.7 (d, J = 12.2 Hz), 130.1, 129.3 (d, J = 9.0 Hz), 120.0 ppm; 
31P{1H} NMR (162 MHz, CDCl3) δ 28.5 ppm; 1B{1H}NMR (128 MHz, CDCl3) δ – 1.1 (t, 1JFB = 
27.8 Hz, 1B) ppm; 19F{1H} NMR (282 MHz, CDCl3) δ -145.1 (q (equal intensity), 1JFB = 28.6 Hz, 
2F) ppm. 
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 Preparation of Bis-(4-Ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methanthione (121) 
 
 
 
A solution of CSCl2 (1.53 mL, 20.0 mmol) in anhydrous toluene (20 mL) was added dropwise to a 
solution of 3-ethyl-2,4-dimethylpyrrole (5.67 mL, 42.0 mmol) in anhydrous Et2O (60 mL) at 0 °C 
under nitrogen in a darkened flask. The dark purple reaction mixture was stirred at RT for one hour. 
MeOH (60 mL) was added and the solution was stirred for 30 mins. The solvent was removed and 
the dark purple residue was purified by column chromatography using silica gel (toluene: 
chloroform, 4:1) to give an orange red solid (0.89 g, 16%). 1H NMR (300 MHz, CDCl3) δ 9.09 (br 
s, 2H), 2.41 (q, J = 7.5 Hz, 4H), 2.22 (s, 6H), 2.04 (s, 6H), 1.09 (t, J = 7.5 Hz, 6H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 189.6, 129.0, 128.2, 126.7, 125.5, 17.5, 15.0, 11.7, 10.9 ppm. 
 Preparation of Bis(4-Ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methanone (122) 
 
 
 
121 (0.23 g, 0.80 mmol) was dissolved in EtOH (100 mL) and KOH (1.00 g, 17.82 mmol) was 
added and the mixture was cooled to 0 °C. A solution of 5%-hydrogen peroxide (10 mL, 22.38 
mmol) was added dropwise and the formation of a white precipitate was observed. The reaction 
mixture was refluxed for five mins. When cooled to RT, water (150 mL) was added to the solution 
and the product was extracted with chloroform (3 x 50 mL). The organic phases were washed with 
water and brine and afterwards dried over Na2SO4 and filtered. The solvent was removed in vacuo, 
and the brown residue was purified by sublimation to yield a yellow solid (174 mg, 80%). 1H NMR 
(300 MHz, CDCl3) δ 2.39 (q, 3JHH = 7.5 Hz, 4H), 2.22 (s, 6H), 2.13 (s, 6H), 1.06 (t, J = 7.5 Hz, 
6H) ppm; IR (neat) 𝜈: 3240, 2966, 2947, 1676, 1437, 1376, 1093, 1060, 965, 796 cm-1; HRMS 
(ESI+) calcd. for C17H24N2O [M+H]
+ requires m/z 273.1961, found m/z 273.1965. 
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 Preparation of 8-Chloro-4,4-difluoro-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-
3a,4a-diaza-s-indacene (123) 
 
122 (0.28 g, 0.97 mmol) was dissolved in 1,2-dichloroethane (10 mL). Phosphorus oxychloride 
(0.18 mL, 1.94 mmol) was added and the reaction mixture was stirred at reflux (86 °C) under 
nitrogen for three hours. The brown solution was cooled to 0 °C and NEt3 (1.34 mL, 9.70 mmol) 
was added and the mixture was stirred for five mins. BF3.OEt2 (1.35 mL, 10.67 mmol) was added 
dropwise, maintaining the temperature at 0 °C, the reaction mixture was warmed to RT and stirred 
under nitrogen for two hours. The solution was poured into diethyl ether (40 mL) and washed with 
water (2 x 40 mL), dried over MgSO4 and filtered. The solvent was removed in vacuo. The purple 
residue was purified by column chromatography on silica gel (DCM: petroleum ether 1:1) to yield 
an orange solid (0.19 g, 59 %).  
1H NMR (300 MHz, CDCl3) δ 2.50 (s, 6H), 2.41 (q, 3JHH = 7.7 Hz, 4H), 2.39 (s, 6H), 1.05 
(t, 3JHH = 7.7 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 152.6, 137.1, 134.1, 132.2, 128.2, 
16.1, 13.7, 12.7, 11.4 ppm; 19F{1H} NMR (376 MHz, CDCl3) δ –145.5 (q, (equal intensity), 1JFB 
= 32.6 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ 0.6 (t, 1JBF = 32.6 Hz) ppm; IR (neat) 𝜈: 
2983, 2886, 1557, 1473, 1393, 1309, 1195, 1041, 969, 807 cm-1; HRMS (APCI+) calcd. for 
C17H22BClF2N2 [M-HF+H]
+ requires m/z 319.1552, found m/z 319.1546. 
 
 Preparation of 8-(dicyclohexylphosphino)-4,4-difluoro-1,3,5,7-tetramethyl-2,6-
diethyl-4-bora-3a,4a-diaza-s-indacene (124) 
 
 
n-Butyllithium (0.08 mL, 0.21 mmol, 2.5M in hexane) was added to dicyclohexylphosphine 
(0.05 mL, 0.21mmol) in anhydrous THF (2 mL) at 0 °C. In a separate flask 123 (70 mg, 0.21 mmol) 
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was dissolved in anhydrous THF (2 mL). The lithium dicyclohexylphoshide was added dropwise 
to the solution of 123 at 0 °C. There was an instant colour change from bright pink to dark purple, 
the reaction mixture was left to stir at room temperature for thirty minutes and analysed by 31P{1H} 
NMR spectroscopy. Purification by column chromatography on silica gel (DCM:petrol, 1:1) 
afforded the desired product as a purple solid (10 mg, 10%). 
1H NMR (300 MHz, CDCl3) δ 2.49 (s, 6H), 2.38 (q, 3JHH = 7.6 Hz, 4H), 1.88-1.62 (m, 20H), 1.23 
(m, 6H), 1.04 (t, 3JHH = 7.8 Hz, 6H) ppm; 31P{1H} NMR (121 MHz, CDCl3) δ –2.9 ppm; 19F{1H} 
NMR (376 MHz, CDCl3) δ –145.6 (q, (equal intensity), 1JFB = 32.3 Hz) ppm; 11B{1H} NMR (128 
MHz, CDCl3) δ 0.5 (t, JBF = 32.8) ppm. 
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 Conclusion and Future Work 
The research generated in this thesis has shown the versatility of a primary phosphine. The main 
focus of the thesis was the synthesis of a multi-functional imaging agent which was successful and 
opens up a range of new research topics.  
The successful synthesis of novel primary phosphines – described in Chapter 2 – is a starting point 
for a library of phosphines and transition metal complexes for a range of applications – such as a 
medicinal imaging probe or an Off-On switch due to metal coordination. Further research into the 
coordination chemistry of primary phosphines would allow more in depth conclusions to be drawn 
regarding why some metals quench fluorescence of Bodipy ligands – whereas other metals do not. 
 
The development of multi-functional imaging probes is being widely researched – this is because 
one can gain more information about the fate of the pharmaceutical within the cell, including its 
mode of action, by combining several imaging techniques within one probe. The next step in this 
research would be the addition of a radionuclide, such as 18F, into the Bodipy system to allow in 
vivo imaging along with in vitro imaging. The range of phosphonium salts that were synthesised 
within this thesis showed positive cell imaging, therefore the incorporation of a second imaging 
technique such as SPECT or PET imaging, would allow us to gather further information. 
 
The introduction of a novel, chiral fluorescent catalyst was also described in this thesis. There are 
several advantages to using a fluorescent catalyst, which include the ability to detect minute traces 
of the catalyst in the final product – this is an extremely important safety aspect – especially within 
the pharmaceutical industry. The fluorescent catalyst synthesised in this research was the first delve 
into this topic, therefore future work would include testing the fluorescent catalysts in a range of 
reactions to see how their conversion and enantioselectivities compare to other catalysts. 
 
The final chapter was the development of a Bodipy “switch” which had its fluorescence turned 
“on” on the addition of a transition metal or oxidation. There are examples of these types of 
switches in the literature, however we discussed the importance of the phosphorus being attached 
to the Bodipy core and the role it played in fluorescence. Future work could include the 
coordination of other transition metals to the phosphorus to see the effect on fluorescence. Other 
work could be to look at how we could use these compounds as ROS sensors and to develop them 
further. 
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9.1 Ruthenium Complexes Absorption and Emission Spectra 
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9.2 X-Ray Data 
 
Table 1 Crystal data and structure refinement for 48. 
Identification code ljh140121_fa 
Empirical formula C27H28BN2Br 
Formula weight 471.23 
Temperature/K 150.01(10) 
Crystal system monoclinic 
Space group P21/c 
a/Å 7.8811(2) 
b/Å 21.5815(5) 
c/Å 14.0378(3) 
α/° 90 
β/° 103.154(2) 
γ/° 90 
Volume/Å3 2324.97(10) 
Z 4 
ρcalcg/cm3 1.346 
μ/mm-1 1.785 
F(000) 976.0 
Crystal size/mm3 0.22 × 0.13 × 0.04 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.514 to 55.556 
Index ranges -9 ≤ h ≤ 9, -28 ≤ k ≤ 27, -17 ≤ l ≤ 17 
Reflections collected 18566 
Independent reflections 4862 [Rint = 0.0540, Rsigma = 0.0514] 
Data/restraints/parameters 4862/261/286 
Goodness-of-fit on F2 1.024 
Final R indexes [I>=2σ (I)] R1 = 0.0454, wR2 = 0.0934 
Final R indexes [all data] R1 = 0.0692, wR2 = 0.1032 
Largest diff. peak/hole / e Å-3 0.71/-0.46 
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Table 1 Crystal data and structure refinement for 50 
 
Identification code 
 
ljh160005_off 
Empirical formula C27H30BN2P 
Formula weight 424.31 
Temperature/K 100.0(2) 
Crystal system triclinic 
Space group P-1 
a/Å 8.1644(9) 
b/Å 11.0902(13) 
c/Å 13.8384(16) 
α/° 94.936(6) 
β/° 102.715(6) 
γ/° 90.169(7) 
Volume/Å3 1217.4(2) 
Z 2 
ρcalcg/cm3 1.157 
μ/mm-1 0.120 
F(000) 452.0 
Crystal size/mm3 0.06 × 0.02 × 0.01 
Radiation Synchrotron (λ = 0.6889) 
2Θ range for data collection/° 2.936 to 48.416 
Index ranges -9 ≤ h ≤ 9, -13 ≤ k ≤ 13, -16 ≤ l ≤ 16 
Reflections collected 9867 
Independent reflections 4289 [Rint = 0.0678, Rsigma = 0.1936] 
Data/restraints/parameters 4289/0/292 
Goodness-of-fit on F2 1.034 
Final R indexes [I>=2σ (I)] R1 = 0.0807, wR2 = 0.2175 
Final R indexes [all data] R1 = 0.1042, wR2 = 0.2428 
Largest diff. peak/hole / e Å-3 0.46/-0.22 
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Table 1 Crystal data and structure refinement for 62. 
Identification code ljh140120_fa 
Empirical formula C30H34BN2O5PW 
Formula weight 728.22 
Temperature/K 150.01(10) 
Crystal system monoclinic 
Space group P21/c 
a/Å 11.97683(14) 
b/Å 17.7954(2) 
c/Å 28.5950(3) 
α/° 90 
β/° 96.6311(11) 
γ/° 90 
Volume/Å3 6053.75(13) 
Z 8 
ρcalcg/cm3 1.598 
μ/mm-1 3.910 
F(000) 2896.0 
Crystal size/mm3 0.21 × 0.11 × 0.04 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.572 to 55.494 
Index ranges -15 ≤ h ≤ 15, -21 ≤ k ≤ 22, -37 ≤ l ≤ 37 
Reflections collected 92956 
Independent reflections 13134 [Rint = 0.0636, Rsigma = 0.0450] 
Data/restraints/parameters 13134/8/773 
Goodness-of-fit on F2 1.041 
Final R indexes [I>=2σ (I)] R1 = 0.0339, wR2 = 0.0557 
Final R indexes [all data] R1 = 0.0554, wR2 = 0.0616 
Largest diff. peak/hole / e Å-3 0.55/-0.68 
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Table 1 : Crystal data and structure refinement for 77a 
Identification code ljh150128_fa 
Empirical formula C43H52BCl14N2OPRu 
Formula weight 1252.01 
Temperature/K 150.0(2) 
Crystal system triclinic 
Space group P-1 
a/Å 10.79639(19) 
b/Å 14.7361(3) 
c/Å 17.4860(3) 
α/° 98.0988(14) 
β/° 98.0661(14) 
γ/° 94.0622(14) 
Volume/Å3 2715.30(8) 
Z 2 
ρcalcg/cm3 1.531 
μ/mm-1 1.042 
F(000) 1268.0 
Crystal size/mm3 0.21 × 0.17 × 0.09 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 5.884 to 52.744 
Index ranges -13 ≤ h ≤ 13, -18 ≤ k ≤ 18, -21 ≤ l ≤ 21 
Reflections collected 83800 
Independent reflections 11092 [Rint = 0.0515, Rsigma = 0.0323] 
Data/restraints/parameters 11092/163/757 
Goodness-of-fit on F2 1.019 
Final R indexes [I>=2σ (I)] R1 = 0.0343, wR2 = 0.0756 
Final R indexes [all data] R1 = 0.0463, wR2 = 0.0814 
Largest diff. peak/hole / e Å-3 0.64/-0.49 
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Table 1.  Crystal data and structure refinement for 72. 
Identification code  ljh120090 
Chemical formula (moiety) C32H41BCl5N2PRu 
Chemical formula (total) C32H41BCl5N2PRu 
Formula weight  773.77 
Temperature  150(2) K 
Radiation, wavelength  MoK, 0.71073 Å 
Crystal system, space group  triclinic, P1 
Unit cell parameters a = 7.9866(4) Å  = 87.067(5)° 
 b = 8.3564(5) Å  = 89.842(4)° 
 c = 25.8377(15) Å  = 85.109(4)° 
Cell volume 1715.86(17) Å3 
Z 2 
Calculated density  1.498 g/cm3 
Absorption coefficient  0.918 mm1 
F(000) 792 
Crystal colour and size red, 0.40  0.30  0.02 mm3 
Reflections for cell refinement 4680 ( range 3.0 to 28.5°) 
Data collection method Xcalibur, Atlas, Gemini ultra 
 thick-slice  scans 
 range for data collection 3.0 to 25.0° 
Index ranges h 9 to 9, k 9 to 9, l 30 to 29 
Completeness to  = 25.0° 99.7 %  
Reflections collected 13069 
Independent reflections 6020 (Rint = 0.0439) 
Reflections with F2>2 5190 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.7102 and 0.9819 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0383, 11.1421 
Data / restraints / parameters 6020 / 0 / 395 
Final R indices [F2>2] R1 = 0.0600, wR2 = 0.1340 
R indices (all data) R1 = 0.0697, wR2 = 0.1402 
Goodness-of-fit on F2 1.100 
Largest and mean shift/su 0.000 and 0.000 
Largest diff. peak and hole 2.09 and 1.34 e Å3 
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Table 1 : Crystal data and structure refinement for 74. 
Identification code ljh160004 
Empirical formula C32H41BCl3I2N2PRu 
Formula weight 956.67 
Temperature/K 150.0(2) 
Crystal system monoclinic 
Space group C2/c 
a/Å 31.8575(6) 
b/Å 11.46036(19) 
c/Å 21.1225(4) 
α/° 90 
β/° 108.281(2) 
γ/° 90 
Volume/Å3 7322.6(2) 
Z 8 
ρcalcg/cm3 1.736 
μ/mm-1 2.402 
F(000) 3744.0 
Crystal size/mm3 0.23 × 0.18 × 0.04 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 5.864 to 57.512 
Index ranges -42 ≤ h ≤ 42, -14 ≤ k ≤ 14, -28 ≤ l ≤ 28 
Reflections collected 57008 
Independent reflections 8566 [Rint = 0.0397, Rsigma = 0.0287] 
Data/restraints/parameters 8566/405/393 
Goodness-of-fit on F2 1.010 
Final R indexes [I>=2σ (I)] R1 = 0.0267, wR2 = 0.0488 
Final R indexes [all data] R1 = 0.0393, wR2 = 0.0523 
Largest diff. peak/hole / e Å-3 0.80/-0.71 
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Table 1: Crystal data and structure refinement for 117. 
Identification code 117 
Empirical formula C9H6BBrF2N2 
Formula weight 270.88 
Temperature/K 150.0(2) 
Crystal system monoclinic 
Space group P21/c 
a/Å 9.9262(2) 
b/Å 13.7437(3) 
c/Å 13.8989(3) 
α/° 90 
β/° 94.0077(19) 
γ/° 90 
Volume/Å3 1891.49(7) 
Z 8 
ρcalcg/cm3 1.902 
μ/mm-1 4.338 
F(000) 1056.0 
Crystal size/mm3 0.2 × 0.13 × 0.07 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 5.876 to 57.654 
Index ranges -13 ≤ h ≤ 13, -18 ≤ k ≤ 18, -18 ≤ l ≤ 18 
Reflections collected 30425 
Independent reflections 4583 [Rint = 0.0376, Rsigma = 0.0277] 
Data/restraints/parameters 4583/0/271 
Goodness-of-fit on F2 1.045 
Final R indexes [I>=2σ (I)] R1 = 0.0281, wR2 = 0.0552 
Final R indexes [all data] R1 = 0.0423, wR2 = 0.0594 
Largest diff. peak/hole / e Å-3 0.54/-0.42 
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Table 1 Crystal data and structure refinement for 116. 
Identification code 116 
Empirical formula C18H12B2N4F4Cl2 
Formula weight 452.84 
Temperature/K 150.01(10) 
Crystal system triclinic 
Space group P-1 
a/Å 7.6468(2) 
b/Å 7.8865(2) 
c/Å 15.7750(4) 
α/° 98.274(2) 
β/° 100.467(2) 
γ/° 95.487(2) 
Volume/Å3 918.49(4) 
Z 2 
ρcalcg/cm3 1.637 
μ/mm-1 3.674 
F(000) 456.0 
Crystal size/mm3 0.23 × 0.13 × 0.1 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 5.776 to 133.476 
Index ranges -9 ≤ h ≤ 9, -9 ≤ k ≤ 9, -18 ≤ l ≤ 18 
Reflections collected 19418 
Independent reflections 3245 [Rint = 0.0295, Rsigma = 0.0173] 
Data/restraints/parameters 3245/0/271 
Goodness-of-fit on F2 1.041 
Final R indexes [I>=2σ (I)] R1 = 0.0278, wR2 = 0.0699 
Final R indexes [all data] R1 = 0.0329, wR2 = 0.0740 
Largest diff. peak/hole / e Å-3 0.24/-0.22 
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Table 1: Crystal data and structure refinement for 118. 
Identification code 118 
Empirical formula C21H16BF2N2P 
Formula weight 376.14 
Temperature/K 150.0(2) 
Crystal system triclinic 
Space group P-1 
a/Å 6.0142(3) 
b/Å 11.6841(4) 
c/Å 13.6286(6) 
α/° 100.451(3) 
β/° 101.823(4) 
γ/° 98.472(3) 
Volume/Å3 904.73(6) 
Z 2 
ρcalcg/cm3 1.381 
μ/mm-1 1.583 
F(000) 388.0 
Crystal size/mm3 0.18 × 0.13 × 0.06 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 6.79 to 133.802 
Index ranges -7 ≤ h ≤ 7, -13 ≤ k ≤ 13, -16 ≤ l ≤ 16 
Reflections collected 24557 
Independent reflections 3199 [Rint = 0.0563, Rsigma = 0.0292] 
Data/restraints/parameters 3199/0/244 
Goodness-of-fit on F2 1.041 
Final R indexes [I>=2σ (I)] R1 = 0.0363, wR2 = 0.0914 
Final R indexes [all data] R1 = 0.0477, wR2 = 0.0990 
Largest diff. peak/hole / e Å-3 0.89/-0.24 
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Table 1: Crystal data and structure refinement for 123 
Identification code 123 
Empirical formula C17H22BClF2N2 
Formula weight 338.62 
Temperature/K 150.0(2) 
Crystal system monoclinic 
Space group P21 
a/Å 8.65495(12) 
b/Å 24.3479(4) 
c/Å 12.5065(2) 
α/° 90 
β/° 107.7316(17) 
γ/° 90 
Volume/Å3 2510.29(7) 
Z 6 
ρcalcg/cm3 1.344 
μ/mm-1 2.191 
F(000) 1068.0 
Crystal size/mm3 0.29 × 0.08 × 0.04 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 7.262 to 133.92 
Index ranges -10 ≤ h ≤ 9, -28 ≤ k ≤ 28, -14 ≤ l ≤ 14 
Reflections collected 35530 
Independent reflections 8857 [Rint = 0.0505, Rsigma = 0.0404] 
Data/restraints/parameters 8857/1/640 
Goodness-of-fit on F2 1.038 
Final R indexes [I>=2σ (I)] R1 = 0.0443, wR2 = 0.1171 
Final R indexes [all data] R1 = 0.0501, wR2 = 0.1220 
Largest diff. peak/hole / e Å-3 0.34/-0.28 
Flack parameter 0.024(10) 
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9.3 DFT Calculations for Ruthenium complexes 
 
[RuCl2(C6H6)(20b)] 
 
HOMO                       LUMO 
                  
 
 
[RuCl2(p-cymene)(20b)] 
 
HOMO      LUMO 
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[RuI2(C6H6)(20b)] 
 
HOMO       LUMO 
                       
 
[RuI2(p-cymene)(20b)] 
 
HOMO       LUMO 
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9.4 DFT Calculated SCF Energies and xyz Coordinates 
 
Compound 7 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1     -574.189038       0.008755       0.095361 
            2     -574.190071       0.002673       0.028560 
            3     -574.190148       0.001438       0.004271 
            4     -574.190158       0.000454       0.004450 
            5     -574.190160       0.000146       0.000978 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :      1:52.31 
  Quantum Calculation Wall Time:      4:32.75 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry enabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 C  C1          -0.4910216    -0.0099078     0.0000000 
  2 C  C4           2.3234382    -0.0025751     0.0000000 
  3 C  C2           0.2248423    -0.0023819    -1.2060028 
  4 C  C6           0.2248423    -0.0023819     1.2060028 
  5 C  C5           1.6203405    -0.0017650     1.2057560 
  6 C  C3           1.6203405    -0.0017650    -1.2057560 
  7 H  H2          -0.3074857    -0.0038685    -2.1545745 
  8 H  H6          -0.3074857    -0.0038685     2.1545745 
  9 H  H5           2.1580372    -0.0046284     2.1504921 
 10 H  H3           2.1580372    -0.0046284    -2.1504921 
 11 H  H4           3.4100405    -0.0038702     0.0000000 
 12 P  P1          -2.3375240     0.1191064     0.0000000 
 13 H  H7          -2.5924881    -0.8205358    -1.0386115 
 14 H  H1          -2.5924881    -0.8205358     1.0386115 
 
Compound 11 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
184 
 
         Step      Energy          Max Grad.      Max Dist.  
            1    -2194.135319       0.013984       0.094978 
            2    -2194.140063       0.003594       0.101284 
            3    -2194.140618       0.002832       0.068133 
            4    -2194.140797       0.002515       0.051595 
            5    -2194.140892       0.003243       0.034545 
            6    -2194.140951       0.003630       0.027960 
            7    -2194.140989       0.003237       0.018523 
            8    -2194.141010       0.002434       0.035726 
            9    -2194.141034       0.001352       0.082614 
           10    -2194.140918       0.003357       0.069141 
           11    -2194.141070       0.001398       0.019928 
           12    -2194.141103       0.001226       0.069463 
           13    -2194.141083       0.001973       0.019469 
           14    -2194.141133       0.000924       0.034466 
           15    -2194.141151       0.001167       0.013228 
           16    -2194.141146       0.000863       0.011389 
           17    -2194.141141       0.000806       0.007439 
           18    -2194.141140       0.000730       0.021146 
           19    -2194.141139       0.000321       0.022916 
           20    -2194.141122       0.000441       0.010783 
           21    -2194.141132       0.000523       0.021721 
           22    -2194.141139       0.000572       0.017631 
           23    -2194.141147       0.000473       0.045784 
           24    -2194.141169       0.000405       0.018685 
           25    -2194.141177       0.000345       0.011530 
           26    -2194.141178       0.000174       0.007818 
           27    -2194.141182       0.000214       0.001852 
           28    -2194.141181       0.000068       0.000697 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :     16:18.98 
  Quantum Calculation Wall Time:     22:38.32 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 S  S1          -0.5160464    -2.4325983    -0.3893369 
  2 C  C1          -2.2400869    -2.2361931     0.2406812 
  3 H  H3          -2.2335358    -1.5754812     1.1140145 
  4 H  H4          -2.6478856    -3.2031188     0.5468095 
  5 C  C2           0.4101122    -2.4167552     1.2083947 
  6 H  H5           0.3096526    -3.3782811     1.7190852 
  7 H  H6           0.0014581    -1.6336966     1.8567859 
  8 S  S2          -3.3821158    -1.6138315    -1.0399532 
  9 S  S3           2.2007359    -2.1747120     0.9718362 
 10 C  C3          -2.8168888     0.1277566    -1.2145610 
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 11 H  H1          -3.2235335     0.4534951    -2.1783791 
 12 C  C4           2.2421057    -0.4124947     0.4407126 
 13 H  H2           1.8322513     0.2100378     1.2452413 
 14 H  H9           1.6037633    -0.3004402    -0.4410487 
 15 C  C6           3.6796725     0.0086210     0.1186643 
 16 H  H10          4.0876592    -0.6467994    -0.6606418 
 17 H  H13          4.3091114    -0.1265478     1.0077060 
 18 C  C7          -3.2795384     1.0629528    -0.0906917 
 19 H  H15         -2.9151204     0.6928834     0.8765467 
 20 H  H16         -4.3745633     1.0451797    -0.0349483 
 21 C  C8           3.7417224     1.4717200    -0.3474498 
 22 H  H17          3.3318083     2.1358945     0.4215174 
 23 H  H18          3.1256190     1.5984190    -1.2468712 
 24 P  P2           5.4944086     1.9846319    -0.8169797 
 25 H  H20          5.2360661     3.3798156    -0.9486618 
 26 H  H14          6.0020923     2.1186148     0.5086269 
 27 H  H21         -1.7254098     0.1181920    -1.3078108 
 28 C  C5          -2.7895402     2.5025241    -0.2980254 
 29 H  H7          -1.6933190     2.5312944    -0.3557944 
 30 H  H11         -3.1484936     2.8949906    -1.2587261 
 31 P  P1          -3.2831180     3.7616279     1.0077507 
 32 H  H12         -4.6578565     3.3952476     1.1002738 
 33 H  H8          -2.9156547     2.9858841     2.1476223 
 
Compound 13b 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -2071.226192       0.034064       0.174916 
            2    -2071.242372       0.025703       0.179473 
            3    -2071.254182       0.019905       0.167683 
            4    -2071.262385       0.013276       0.150109 
            5    -2071.267118       0.006963       0.240195 
            6    -2071.269089       0.003662       0.249205 
            7    -2071.270186       0.002116       0.244319 
            8    -2071.270945       0.001376       0.254639 
            9    -2071.271400       0.000855       0.120628 
           10    -2071.271293       0.002673       0.263177 
           11    -2071.271717       0.000364       0.166758 
           12    -2071.271681       0.000721       0.211799 
           13    -2071.271696       0.000666       0.096465 
           14    -2071.271727       0.000507       0.084564 
           15    -2071.271770       0.000164       0.121425 
           16    -2071.271786       0.000196       0.214420 
           17    -2071.271805       0.000312       0.213024 
           18    -2071.271820       0.000436       0.086736 
           19    -2071.271824       0.000187       0.055432 
           20    -2071.271825       0.000072       0.002541 
           21    -2071.271825       0.000033       0.002365 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
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  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :     28:30.66 
  Quantum Calculation Wall Time:     34:44.87 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 H  H1          -2.6276950    -0.9116923     2.2557413 
  2 C  C1          -2.4976289    -1.0303106     1.1878360 
  3 C  C5          -1.5240932    -1.8559303     0.5476725 
  4 H  H2          -4.0635614     0.3280678     0.3334127 
  5 H  H5          -0.7885047    -2.4757638     1.0440463 
  6 C  C4          -1.6818638    -1.7105769    -0.8636712 
  7 H  H4          -1.0882233    -2.2009749    -1.6244823 
  8 C  C3          -2.7523033    -0.7947933    -1.0958815 
  9 H  H3          -3.1099445    -0.4661047    -2.0630736 
 10 C  C2          -3.2570807    -0.3756499     0.1718186 
 11 Fe Fe1         -1.2649621     0.1112913     0.0020790 
 12 H  H6           0.3332212     0.8933199     2.1928750 
 13 C  C6           0.0881330     1.1291324     1.1642430 
 14 C  C7          -0.9495131     2.0070100     0.7290886 
 15 H  H8          -1.6313525     2.5529331     1.3684447 
 16 C  C8          -0.9444858     2.0159286    -0.6982898 
 17 H  H9          -1.6232088     2.5688796    -1.3349259 
 18 C  C9           0.0960330     1.1431868    -1.1386143 
 19 H  H10          0.3455327     0.9205252    -2.1690216 
 20 C  C10          0.7413150     0.5855785     0.0118072 
 21 C  C11          1.9323365    -0.3348611     0.0145897 
 22 H  H7           1.9118492    -0.9527768     0.9217995 
 23 H  H12          1.8731012    -1.0277237    -0.8342280 
 24 C  C12          3.2633445     0.4421274    -0.0486801 
 25 H  H11          3.3283689     1.1454119     0.7877864 
 26 H  H13          3.2963713     1.0349731    -0.9706998 
 27 P  P1           4.7455012    -0.7200617    -0.0843136 
 28 H  H14          5.7529136     0.2671075     0.1200474 
 29 H  H15          4.7124679    -1.0938777     1.2914157 
 
Compound 14 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1114.886255       0.103422       0.131742 
            2    -1114.930260       0.040780       0.082890 
            3    -1114.940681       0.008905       0.138901 
            4    -1114.941679       0.003971       0.121749 
            5    -1114.941919       0.002148       0.037916 
            6    -1114.941995       0.001128       0.034490 
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            7    -1114.942015       0.000356       0.011367 
            8    -1114.942016       0.000222       0.002916 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   2:01:15.97 
  Quantum Calculation Wall Time:   2:08:10.40 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 C  C1          -1.1197282    -1.8242515    -0.3076223 
  2 C  C6          -0.7989651    -0.5747595     0.2111300 
  3 C  C3          -3.3950876    -1.0918194    -0.7787366 
  4 C  C5          -1.7917644     0.4616351     0.2436847 
  5 C  C2          -2.4335434    -2.0709248    -0.7975500 
  6 C  C4          -3.1065074     0.1974381    -0.2619887 
  7 C  C10         -1.5208565     1.7577131     0.7656628 
  8 H  H2          -2.6762751    -3.0511107    -1.1999161 
  9 H  H7          -5.0781172     1.0105030    -0.6176129 
 10 H  H3          -4.3915242    -1.2937839    -1.1651538 
 11 C  C9          -2.4916799     2.7349722     0.7809671 
 12 H  H10         -0.5319134     1.9677973     1.1596006 
 13 H  H9          -2.2622168     3.7174055     1.1851992 
 14 C  C8          -3.7873283     2.4699679     0.2778696 
 15 H  H8          -4.5446742     3.2490451     0.2968888 
 16 C  C7          -4.0845938     1.2260464    -0.2308774 
 17 C  C11          0.5747394    -0.3098752     0.7537429 
 18 C  C12          3.1165968     0.1020073     1.8235633 
 19 C  C13          1.5846002     0.2678457    -0.0522199 
 20 C  C14          0.8510689    -0.6620092     2.0798932 
 21 C  C15          2.1213181    -0.4553858     2.6178939 
 22 C  C16          2.8664126     0.4677811     0.4934773 
 23 H  H6           0.0629105    -1.0992633     2.6868297 
 24 H  H5           2.3306967    -0.7344061     3.6471001 
 25 H  H12          4.1128227     0.2578165     2.2330634 
 26 C  C17          1.2842273     0.6236140    -1.5010760 
 27 H  H4           0.2966643     1.0920993    -1.5710599 
 28 H  H13          1.2051385    -0.3086161    -2.0815194 
 29 C  C22          2.3387438     1.5297076    -2.1492121 
 30 H  H15          2.2277634     2.5567709    -1.7732449 
 31 H  H16          2.1701166     1.5715234    -3.2320596 
 32 C  C21          3.7503791     1.0302510    -1.8322358 
 33 H  H14          4.5062618     1.6295872    -2.3541217 
 34 H  H17          3.8608773    -0.0031928    -2.1901632 
 35 C  C20          3.9917999     1.0870428    -0.3205786 
 36 H  H18          4.1092315     2.1400554    -0.0204226 
 37 H  H19          4.9388651     0.5965492    -0.0616741 
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 38 P  P1           0.0776925    -3.2380515    -0.2356711 
 39 H  H11         -0.3865093    -3.8954483    -1.4106835 
 40 H  H1           1.1855055    -2.6345422    -0.8907099 
 
Compound 16 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1036.296258       0.009785       0.113623 
            2    -1036.297762       0.007653       0.032495 
            3    -1036.298117       0.001902       0.028350 
            4    -1036.298150       0.000605       0.024999 
            5    -1036.298165       0.000402       0.064255 
            6    -1036.298173       0.000221       0.042445 
            7    -1036.298177       0.000218       0.001576 
            8    -1036.298178       0.000079       0.001601 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   1:13:20.38 
  Quantum Calculation Wall Time:   1:20:12.35 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry enabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 P  P1           0.0000000     0.0000000     1.2094814 
  2 C  C1           1.6704982     0.0000000     0.4046425 
  3 C  C4           4.2771492     0.0866398    -0.6541261 
  4 C  C2           1.9974724    -0.7244846    -0.7516521 
  5 C  C6           2.6757496     0.7591314     1.0273392 
  6 C  C5           3.9652988     0.8104588     0.4986603 
  7 C  C3           3.2917304    -0.6826209    -1.2746749 
  8 H  H2           1.2402226    -1.3267303    -1.2443972 
  9 H  H6           2.4448069     1.3103499     1.9361750 
 10 H  H5           4.7285340     1.4065767     0.9922815 
 11 H  H4           3.5287348    -1.2519696    -2.1700573 
 12 H  H7           5.2839322     0.1171726    -1.0625423 
 13 C  C7          -0.8352491     1.4466939     0.4046425 
 14 C  C8          -2.2136069     3.6608000    -0.6541261 
 15 C  C9          -1.9953019     1.9377014     1.0273392 
 16 C  C10         -0.3713142     2.0921042    -0.7516521 
 17 C  C11         -1.0546981     3.1920326    -1.2746749 
 18 C  C12         -2.6845273     3.0288201     0.4986603 
 19 H  H1          -2.3571997     1.4620899     1.9361750 
189 
 
 20 H  H8           0.5288709     1.7374294    -1.2443972 
 21 H  H9          -0.6801299     3.6819588    -2.1700573 
 22 H  H10         -3.5823981     3.3917422     0.9922815 
 23 H  H11         -2.7434405     4.5174332    -1.0625423 
 24 C  C13         -0.8352491    -1.4466939     0.4046425 
 25 C  C14         -2.0635423    -3.7474398    -0.6541261 
 26 C  C15         -0.6804477    -2.6968329     1.0273392 
 27 C  C16         -1.6261584    -1.3676196    -0.7516521 
 28 C  C17         -2.2370323    -2.5094117    -1.2746749 
 29 C  C18         -1.2807715    -3.8392789     0.4986603 
 30 H  H3          -0.0876071    -2.7724398     1.9361750 
 31 H  H12         -1.7690935    -0.4106991    -1.2443972 
 32 H  H13         -2.8486049    -2.4299892    -2.1700573 
 33 H  H14         -1.1461358    -4.7983188     0.9922815 
 34 H  H15         -2.5404917    -4.6346058    -1.0625423 
 
Compound 20a  
 
SCF model: 
 An unrestricted hybrid HF-DFT SCF calculation will be 
 performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1448.661177       0.045391       0.107217 
            2    -1448.686800       0.019297       0.124654 
            3    -1448.695008       0.012760       0.134780 
            4    -1448.697393       0.007965       0.084840 
            5    -1448.697764       0.006275       0.127698 
            6    -1448.698552       0.005565       0.116493 
            7    -1448.696398       0.012981       0.097583 
            8    -1448.699132       0.001929       0.092061 
            9    -1448.698897       0.004149       0.070322 
           10    -1448.699475       0.000980       0.104806 
           11    -1448.699569       0.001009       0.082493 
           12    -1448.699625       0.000496       0.097110 
           13    -1448.699666       0.001094       0.125736 
           14    -1448.699680       0.001674       0.044573 
           15    -1448.699701       0.000872       0.019639 
           16    -1448.699710       0.000229       0.016580 
           17    -1448.699712       0.000160       0.008637 
           18    -1448.699714       0.000205       0.019147 
           19    -1448.699716       0.000229       0.017860 
           20    -1448.699718       0.000190       0.033595 
           21    -1448.699722       0.000330       0.070221 
           22    -1448.699726       0.000547       0.009299 
           23    -1448.699732       0.000457       0.084571 
           24    -1448.699740       0.000483       0.046397 
           25    -1448.699741       0.000502       0.030891 
           26    -1448.699747       0.000228       0.021044 
           27    -1448.699749       0.000145       0.011857 
           28    -1448.699748       0.000067       0.002432 
 
<step 2> 
Job type: Frequency calculation. 
Method: UB3LYP 
Basis set: 6-31G(D) 
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  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   4:36:29.73 
  Quantum Calculation Wall Time:   4:48:59.34 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 C  C1           0.2126187     0.0094061     0.0082378 
  2 C  C2          -0.5021445     1.2159978    -0.0863430 
  3 C  C3          -0.4616294    -1.2196653     0.1110544 
  4 N  N1          -1.8685265    -1.2810303     0.1431118 
  5 N  N2          -1.9108701     1.2334717    -0.1016438 
  6 B  B1          -2.8799222    -0.0439593    -0.0202732 
  7 C  C4          -0.0126650     2.5873044    -0.2048176 
  8 C  C5          -1.1275127     3.3810992    -0.3076717 
  9 C  C6          -2.2905954     2.5038337    -0.2420311 
 10 C  C7           0.0717123    -2.5751438     0.2269918 
 11 C  C8          -1.0169379    -3.4037269     0.3380488 
 12 C  C9          -2.2075772    -2.5621953     0.2849796 
 13 C  C10         -3.8119576     0.0740203     1.3196941 
 14 H  H6          -3.9268131     1.1080371     1.6653923 
 15 H  H8          -3.3912265    -0.4735536     2.1734098 
 16 H  H11         -4.8311180    -0.3038995     1.1694797 
 17 C  C11         -3.6327218    -0.2087235    -1.4522540 
 18 H  H9          -4.3234333     0.6146381    -1.6679524 
 19 H  H12         -4.2402224    -1.1207047    -1.4978103 
 20 H  H13         -2.9255308    -0.2570868    -2.2917909 
 21 C  C12          1.7078391     0.0322793     0.0018644 
 22 C  C13          4.5338089     0.0682934    -0.0053885 
 23 C  C14          2.4164017    -0.0507732    -1.2039633 
 24 C  C15          2.4202559     0.1299486     1.2036748 
 25 C  C16          3.8146067     0.1460139     1.1974715 
 26 C  C17          3.8104579    -0.0368430    -1.2041853 
 27 H  H1           1.8787458    -0.1270685    -2.1459132 
 28 H  H14          1.8860587     0.1965550     2.1482822 
 29 H  H15          4.3428827     0.2251920     2.1441313 
 30 H  H16          4.3356960    -0.1069160    -2.1533751 
 31 C  C18          1.5045896    -3.0164972     0.2218694 
 32 H  H5           2.0121083    -2.7339875    -0.7052676 
 33 H  H18          1.5634797    -4.1028008     0.3180339 
 34 H  H19          2.0748383    -2.5725151     1.0429134 
 35 C  C19         -1.0521643    -4.8999455     0.4533719 
 36 H  H10         -0.1348700    -5.2519480     0.9357070 
 37 H  H21         -1.8742851    -5.1976625     1.1151569 
 38 C  C20         -1.2139101    -5.6095200    -0.9087810 
 39 H  H20         -0.3755220    -5.3791755    -1.5739663 
 40 H  H22         -2.1369467    -5.3078772    -1.4153494 
 41 H  H23         -1.2485716    -6.6937566    -0.7652200 
 42 C  C21         -3.5964729    -3.0839695     0.3830500 
 43 H  H4          -3.8337178    -3.6770805    -0.5102336 
 44 H  H24         -4.3431202    -2.3021670     0.4896073 
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 45 H  H25         -3.6734632    -3.7669061     1.2372225 
 46 C  C22         -3.6942758     2.9848528    -0.3564829 
 47 H  H7          -3.8528540     3.4080760    -1.3577328 
 48 H  H26         -3.8701810     3.7986493     0.3564868 
 49 H  H27         -4.4324509     2.2052052    -0.1923667 
 50 C  C23         -1.2120675     4.8742185    -0.4381425 
 51 H  H3          -2.0692889     5.1351824    -1.0702688 
 52 H  H28         -0.3266085     5.2458823    -0.9637664 
 53 C  C24         -1.3386794     5.6022745     0.9171880 
 54 H  H29         -2.2270941     5.2801880     1.4713689 
 55 H  H30         -1.4166577     6.6818966     0.7564301 
 56 H  H31         -0.4649881     5.4141783     1.5496169 
 57 C  C25          1.4054959     3.0737482    -0.2090294 
 58 H  H2           1.9895121     2.6339287    -1.0224377 
 59 H  H32          1.9220549     2.8234679     0.7227389 
 60 H  H33          1.4294086     4.1596447    -0.3238579 
 61 P  P1           6.3824662    -0.0571769    -0.0063582 
 62 H  H34          6.6234866     0.8730501    -1.0538763 
 63 H  H17          6.6202357     0.8839695     1.0312334 
 
Compound 20b 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1832.341060       0.084650       0.080392 
            2    -1832.387373       0.036741       0.094028 
            3    -1832.402006       0.012576       0.110190 
            4    -1832.402660       0.009174       0.110671 
            5    -1832.403838       0.007157       0.117453 
            6    -1832.403784       0.004598       0.083597 
            7    -1832.403809       0.009366       0.042199 
            8    -1832.404513       0.003013       0.053608 
            9    -1832.404599       0.001434       0.036582 
           10    -1832.404625       0.001137       0.052823 
           11    -1832.404652       0.000804       0.083886 
           12    -1832.404667       0.000373       0.061877 
           13    -1832.404670       0.000367       0.021603 
           14    -1832.404676       0.000192       0.013701 
           15    -1832.404679       0.000125       0.035046 
           16    -1832.404680       0.000098       0.027843 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   8:48:05.60 
  Quantum Calculation Wall Time:   9:05:17.09 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
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                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 C  C1           1.2293775     0.0156057    -0.0981443 
  2 C  C2           0.5331961     1.2334358    -0.0688623 
  3 C  C3           0.5632451    -1.2186987    -0.1282575 
  4 N  N1          -0.8693735     1.2565906    -0.0936634 
  5 N  N2          -0.8385076    -1.2757703    -0.1095620 
  6 B  B1          -1.8234799    -0.0211651    -0.0980285 
  7 C  C4           1.0695094    -2.5617615    -0.1465661 
  8 C  C5          -0.0410054    -3.4017836    -0.1302737 
  9 C  C6          -1.1967631    -2.5766518    -0.1011542 
 10 C  C7           1.0070397     2.5883570    -0.0441919 
 11 C  C8          -0.1229866     3.4016979    -0.0715779 
 12 C  C9          -1.2589369     2.5482696    -0.0999533 
 13 C  C12          2.4964143    -3.0330553    -0.1757029 
 14 H  H3           3.0488828    -2.7427430     0.7243305 
 15 H  H14          3.0521493    -2.6278230    -1.0268888 
 16 H  H15          2.5328455    -4.1239116    -0.2446516 
 17 C  C13         -2.6116488    -3.0580532    -0.0760103 
 18 H  H10         -3.2227680    -2.4747179     0.6170660 
 19 H  H16         -2.6494720    -4.1058101     0.2324788 
 20 H  H17         -3.0761393    -2.9806293    -1.0661984 
 21 C  C14          2.4235200     3.0880474     0.0082022 
 22 H  H5           2.4391845     4.1808867     0.0384652 
 23 H  H18          3.0116745     2.7721335    -0.8594787 
 24 H  H19          2.9556362     2.7271257     0.8942076 
 25 C  C15         -0.1769826     4.9060901    -0.0427949 
 26 H  H20         -0.9764462     5.2602300    -0.7064532 
 27 H  H21          0.7497620     5.3184215    -0.4580954 
 28 C  C16         -2.6842990     2.9960581    -0.1270915 
 29 H  H7          -3.1426463     2.9222942     0.8662081 
 30 H  H22         -3.2856350     2.3905866    -0.8094707 
 31 H  H23         -2.7458911     4.0396661    -0.4475203 
 32 C  C17         -0.4013223     5.4889820     1.3652969 
 33 H  H2          -0.4466112     6.5840416     1.3341863 
 34 H  H24          0.4099220     5.2002438     2.0429840 
 35 H  H25         -1.3387465     5.1232565     1.7986605 
 36 C  C18         -0.0501231    -4.9078721    -0.1043094 
 37 H  H8           0.7878862    -5.2941009    -0.6971408 
 38 H  H26         -0.9542638    -5.2819716    -0.5991341 
 39 C  C19          0.0290085    -5.4949270     1.3179269 
 40 H  H27          0.9469377    -5.1726333     1.8220134 
 41 H  H28          0.0196888    -6.5910793     1.2938591 
 42 H  H29         -0.8165197    -5.1605895     1.9298122 
 43 C  C20          2.7243013     0.0328026    -0.0943249 
 44 C  C21          5.5527567     0.0765970    -0.0866406 
 45 C  C22          3.4420292     0.0830200    -1.2958073 
 46 C  C23          3.4366794    -0.0004377     1.1106912 
 47 C  C24          4.8311002     0.0186915     1.1143023 
 48 C  C25          4.8363436     0.1008274    -1.2920968 
 49 H  H1           2.9042202     0.1103730    -2.2399647 
 50 H  H30          2.8951162    -0.0361559     2.0524548 
 51 H  H31          5.3569042    -0.0051342     2.0660165 
 52 H  H32          5.3663404     0.1402921    -2.2409652 
 53 P  P1           7.4004800    -0.0302508    -0.0872672 
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 54 H  H33          7.6444789     0.9606297    -1.0794275 
 55 H  H34          7.6382716     0.8598068     0.9974926 
 56 C  C10         -2.6472645    -0.0307115     1.3226073 
 57 C  C11         -3.9157867    -0.0058742     3.8766828 
 58 C  C26         -1.9867008    -0.4605910     2.4917438 
 59 C  C27         -3.9701883     0.4178804     1.4928928 
 60 C  C28         -4.5987755     0.4303263     2.7424987 
 61 C  C29         -2.5989472    -0.4509058     3.7449781 
 62 H  H4          -0.9616619    -0.8175826     2.4193142 
 63 H  H6          -4.5313530     0.7730869     0.6340878 
 64 H  H9          -5.6253248     0.7809178     2.8256352 
 65 H  H11         -2.0488738    -0.7927675     4.6191640 
 66 H  H12         -4.4014294     0.0008774     4.8494989 
 67 C  C30         -2.6614887    -0.0322918    -1.5099460 
 68 C  C31         -3.9531426    -0.0873381    -4.0513909 
 69 C  C32         -3.9787714    -0.5017962    -1.6656003 
 70 C  C33         -2.0178824     0.4017339    -2.6869844 
 71 C  C34         -2.6416676     0.3774031    -3.9342437 
 72 C  C35         -4.6189398    -0.5289916    -2.9090937 
 73 H  H13         -4.5253273    -0.8632776    -0.8000628 
 74 H  H35         -0.9975978     0.7740394    -2.6254802 
 75 H  H36         -2.1049371     0.7228935    -4.8152578 
 76 H  H37         -5.6406098    -0.8958931    -2.9812627 
 77 H  H38         -4.4476652    -0.1056462    -5.0195804 
 
Compound 50 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1522.538368       0.075780       0.121793 
            2    -1522.587541       0.040976       0.096591 
            3    -1522.604882       0.019659       0.100315 
            4    -1522.608710       0.004961       0.136597 
            5    -1522.609544       0.003772       0.138859 
            6    -1522.609852       0.004574       0.135528 
            7    -1522.610083       0.002984       0.061678 
            8    -1522.610279       0.003392       0.055371 
            9    -1522.610393       0.002128       0.070279 
           10    -1522.610427       0.003376       0.029700 
           11    -1522.610550       0.000695       0.070661 
           12    -1522.610597       0.000731       0.143277 
           13    -1522.610650       0.000756       0.046470 
           14    -1522.610660       0.000670       0.015963 
           15    -1522.610674       0.000447       0.016790 
           16    -1522.610679       0.000248       0.012518 
           17    -1522.610680       0.000163       0.006773 
           18    -1522.610681       0.000143       0.007437 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
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  Quantum Calculation CPU Time :   8:03:12.07 
  Quantum Calculation Wall Time:  10:49:58.33 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 C  C1           4.7240350     0.0281065     0.0085872 
  2 C  C4           1.8954784     0.0208104    -0.0056752 
  3 C  C2           3.9981016     0.1252022     1.2051201 
  4 C  C6           4.0112044    -0.0594284    -1.1953999 
  5 C  C5           2.6160522    -0.0619658    -1.2027892 
  6 C  C3           2.6041372     0.1137410     1.1991608 
  7 H  H2           4.5211756     0.2053021     2.1554829 
  8 H  H6           4.5439153    -0.1343438    -2.1403587 
  9 H  H5           2.0807920    -0.1377058    -2.1457154 
 10 H  H3           2.0584834     0.1787435     2.1368632 
 11 P  P1           6.5700473     0.1613709     0.0275453 
 12 H  H1           6.8263804    -0.8698946     0.9754660 
 13 H  H7           6.8237177    -0.6765156    -1.0933170 
 14 C  C7           0.4004680     0.0068396    -0.0084495 
 15 N  N2          -1.6963871     1.2369710    -0.1423970 
 16 N  N1          -1.6702579    -1.2657541     0.1430236 
 17 B  B1          -2.6258069    -0.0234182     0.0070492 
 18 C  C11         -0.2708820    -1.2204203     0.1133437 
 19 C  C12         -0.2958290     1.2198218    -0.1267161 
 20 C  C9          -3.5005438     0.1266008     1.3271912 
 21 C  C13         -3.5157557    -0.1900015    -1.3014134 
 22 C  C8           0.2155895    -2.5649279     0.2339828 
 23 C  C10         -0.9060908    -3.3874280     0.3440787 
 24 C  C14         -2.0519683    -2.5510586     0.2818391 
 25 C  C15          0.1626533     2.5736692    -0.2556097 
 26 C  C16         -2.1046392     2.5140442    -0.2782612 
 27 C  C17         -0.9761706     3.3731833    -0.3550649 
 28 C  C18          1.6386690    -3.0475265     0.2331744 
 29 H  H9           2.2212845    -2.6301545     1.0610195 
 30 H  H11          2.1640834    -2.7749367    -0.6880772 
 31 H  H12          1.6707803    -4.1369289     0.3210423 
 32 C  C19         -0.9398943    -4.8879440     0.4653284 
 33 H  H13         -1.7577481    -5.1855987     1.1336835 
 34 H  H16         -0.0227725    -5.2419687     0.9501553 
 35 C  C20         -1.1065474    -5.6102129    -0.8852559 
 36 H  H17         -2.0345558    -5.3062759    -1.3819146 
 37 H  H18         -1.1343840    -6.6977255    -0.7483187 
 38 H  H19         -0.2777318    -5.3725701    -1.5615853 
 39 C  C21         -3.4839108    -2.9699810     0.3556376 
 40 H  H20         -4.0008181    -2.4480234     1.1678255 
 41 H  H21         -3.5636932    -4.0470978     0.5188900 
 42 H  H22         -4.0128234    -2.7117758    -0.5683321 
 43 C  C22         -3.5452093     2.9061902    -0.3360523 
 44 H  H14         -3.6457451     3.9798487    -0.5095220 
 45 H  H23         -4.0566422     2.6485149     0.5979802 
 46 H  H24         -4.0635099     2.3663268    -1.1354241 
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 47 C  C23         -1.0433299     4.8724232    -0.4795180 
 48 H  H25         -1.8692680     5.1493589    -1.1469532 
 49 H  H26         -0.1356324     5.2464053    -0.9668769 
 50 C  C24         -1.2240148     5.5938577     0.8697147 
 51 H  H10         -1.2812116     6.6797942     0.7296388 
 52 H  H27         -0.3864398     5.3803196     1.5432239 
 53 H  H28         -2.1416088     5.2670426     1.3712661 
 54 C  C25          1.5761509     3.0824178    -0.2777530 
 55 H  H4           1.5875036     4.1735161    -0.3480574 
 56 H  H29          2.1463012     2.6899971    -1.1264312 
 57 H  H30          2.1287349     2.8041497     0.6254255 
 58 C  C26         -4.1807759    -0.3232186    -2.3087105 
 59 H  H8          -4.7643376    -0.4383669    -3.1947034 
 60 C  C27         -4.1552856     0.2481381     2.3426528 
 61 H  H15         -4.7295446     0.3529772     3.2359562 
 
 
 
Compound 56 
 
DFT calculations gave this output with one imaginary number present. 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1984.670941       0.088065       0.083099 
            2    -1984.720223       0.039837       0.093848 
            3    -1984.738577       0.017017       0.141107 
            4    -1984.743603       0.006297       0.109065 
            5    -1984.744183       0.002830       0.133487 
            6    -1984.744467       0.004253       0.097999 
            7    -1984.744499       0.002962       0.042669 
            8    -1984.744772       0.003502       0.040958 
            9    -1984.744908       0.001734       0.065923 
           10    -1984.744778       0.002798       0.020862 
           11    -1984.745028       0.001479       0.069408 
           12    -1984.745092       0.001319       0.141264 
           13    -1984.745228       0.001025       0.150374   
           14    -1984.744576       0.005866       0.092635 
           15    -1984.745397       0.001095       0.134468 
           16    -1984.745493       0.001028       0.137906 
           17    -1984.745593       0.000745       0.156801 
           18    -1984.745680       0.000917       0.036117 
           19    -1984.745716       0.000665       0.049603 
           20    -1984.745744       0.000303       0.040080 
           21    -1984.745748       0.000271       0.019854 
           22    -1984.745752       0.000267       0.014854 
           23    -1984.745761       0.000195       0.037945 
           24    -1984.745767       0.000185       0.025549 
           25    -1984.745770       0.000161       0.017095 
           26    -1984.745768       0.000133       0.011041 
           27    -1984.745768       0.000117       0.015232 
 
<step 2> 
Job type: Frequency calculation. 
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Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   5:28:27.80 
  Quantum Calculation Wall Time:   5:47:22.10 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 C  C1           6.2351684     0.0823468     0.0206511 
  2 C  C4           3.4079367     0.0826736    -0.0152106 
  3 C  C2           5.5192606     1.2255655    -0.3656426 
  4 C  C6           5.5112943    -1.0579220     0.3992709 
  5 C  C5           4.1165940    -1.0564093     0.3868282 
  6 C  C3           4.1250221     1.2234155    -0.3956636 
  7 H  H2           6.0550774     2.1307947    -0.6418626 
  8 H  H6           6.0367558    -1.9582204     0.7067454 
  9 H  H5           3.5698262    -1.9460405     0.6881311 
 10 H  H3           3.5874314     2.1162339    -0.7040856 
 11 P  P1           8.0849756     0.1780841     0.0537437 
 12 H  H1           8.3442001    -0.3564326    -1.2435234 
 13 H  H7           8.3201797    -1.0655955     0.7026948 
 14 C  C7           1.9127785     0.0799574    -0.0228631 
 15 C  C8           1.2357522    -0.3045273    -1.1908005 
 16 C  C9           1.2238966     0.4587881     1.1402975 
 17 C  C10          1.7169013    -0.7154119    -2.4792665 
 18 C  C11          0.5907496    -0.9719069    -3.2621559 
 19 C  C12          1.6891935     0.8993166     2.4246451 
 20 C  C13          0.5538958     1.1424183     3.1982901 
 21 C  C14         -0.5786198     0.8561961     2.3902300 
 22 C  C15         -0.5512122    -0.7266399    -2.4545382 
 23 N  N1          -0.1638158    -0.3268522    -1.2271072 
 24 N  N2          -0.1760277     0.4502465     1.1698304 
 25 B  B1          -1.1142694     0.0130580    -0.0183849 
 26 C  C16          3.1376882    -0.8618198    -2.9447053 
 27 H  H8           3.1642275    -1.1701958    -3.9935529 
 28 H  H11          3.6865823    -1.6138883    -2.3672317 
 29 H  H16          3.7026042     0.0721731    -2.8597979 
 30 C  C17          0.5523707    -1.4590932    -4.6868493 
 31 H  H17          1.4220819    -1.0763266    -5.2341078 
 32 H  H18         -0.3220881    -1.0368243    -5.1968584 
 33 C  C18          0.5151862    -2.9939964    -4.8080157 
 34 H  H12          0.4832223    -3.3054461    -5.8587125 
 35 H  H19         -0.3654113    -3.4064338    -4.3028525 
 36 H  H20          1.4002668    -3.4441468    -4.3448239 
 37 C  C19         -1.9855690    -0.8690713    -2.8468169 
 38 H  H4          -2.0724205    -1.2346665    -3.8724665 
 39 H  H21         -2.5092491     0.0893489    -2.7648666 
 40 H  H22         -2.5040051    -1.5651561    -2.1784748 
 41 C  C20         -2.0174292     0.9754483     2.7744467 
 42 H  H15         -2.5781615     0.0888148     2.4646568 
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 43 H  H23         -2.4839130     1.8343905     2.2782856 
 44 H  H24         -2.1187058     1.1019936     3.8551605 
 45 C  C21          0.4970680     1.6537592     4.6132318 
 46 H  H25          1.3859894     1.3248091     5.1645907 
 47 H  H26         -0.3546920     1.1998194     5.1352847 
 48 C  C22          0.3835265     3.1868890     4.7083669 
 49 H  H14         -0.5170766     3.5477375     4.1989723 
 50 H  H27          1.2456423     3.6728670     4.2379785 
 51 H  H28          0.3359879     3.5126807     5.7541224 
 52 C  C23          3.1040643     1.0856935     2.8948564 
 53 H  H10          3.6811649     0.1562912     2.8507011 
 54 H  H29          3.1155485     1.4374097     3.9299497 
 55 H  H30          3.6470278     1.8204068     2.2912359 
 56 C  C24         -1.9227037    -1.2916390     0.3984165 
 57 C  C25         -2.0721251     1.2172330    -0.4071031 
 58 C  C26         -2.5301378    -2.2997559     0.7190025 
 59 C  C41         -2.8081288     2.1448304    -0.6987596 
 60 C  C28         -3.2361464    -3.4846294     1.0935952 
 61 C  C29         -4.6296568    -5.8178884     1.8303385 
 62 C  C30         -3.6544980    -4.4122816     0.1189021 
 63 C  C31         -3.5295909    -3.7517362     2.4456700 
 64 C  C32         -4.2191552    -4.9066068     2.8062745 
 65 C  C33         -4.3433754    -5.5652781     0.4866682 
 66 H  H13         -3.4314032    -4.2158994    -0.9256316 
 67 H  H31         -3.2095706    -3.0438172     3.2043728 
 68 H  H32         -4.4374801    -5.0961888     3.8541781 
 69 H  H33         -4.6585682    -6.2693836    -0.2791815 
 70 H  H34         -5.1678542    -6.7180282     2.1149590 
 71 C  C34         -3.6761802     3.2292791    -1.0357564 
 72 C  C35         -5.3883019     5.3634660    -1.6942983 
 73 C  C36         -3.1631635     4.4182902    -1.5910632 
 74 C  C37         -5.0649080     3.1310216    -0.8174079 
 75 C  C38         -5.9088674     4.1895228    -1.1441892 
 76 C  C39         -4.0133010     5.4724213    -1.9161013 
 77 H  H9          -2.0938427     4.5003022    -1.7616129 
 78 H  H35         -5.4667790     2.2169549    -0.3906598 
 79 H  H36         -6.9778060     4.0977922    -0.9693119 
 80 H  H37         -3.6010092     6.3826306    -2.3439607 
 81 H  H38         -6.0498249     6.1874143    -1.9483906 
 
 
Compound 62 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -2082.657370       0.141888       0.183009 
            2    -2082.698069       0.068375       0.156671 
            3    -2082.709614       0.034956       0.162986 
            4    -2082.720080       0.006889       0.105379 
            5    -2082.717932       0.008977       0.142702 
            6    -2082.719139       0.014366       0.135617 
            7    -2082.718734       0.010187       0.126554 
            8    -2082.718919       0.013731       0.209240 
            9    -2082.719652       0.009090       0.161183 
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           10    -2082.718213       0.010233       0.187062 
           11    -2082.718798       0.020135       0.129909 
           12    -2082.718573       0.011845       0.170860 
           13    -2082.718329       0.016314       0.100095 
           14    -2082.718779       0.012269       0.092686 
           15    -2082.718086       0.017223       0.089774 
           16    -2082.719613       0.005047       0.134724 
           17    -2082.718932       0.010824       0.088930 
           18    -2082.720022       0.004589       0.189450 
           19    -2082.718913       0.009004       0.155545 
           20    -2082.719911       0.004195       0.203904 
           21    -2082.719473       0.005525       0.222392 
           22    -2082.720109       0.003457       0.144034 
           23    -2082.718263       0.007960       0.049791 
           24    -2082.720509       0.003757       0.038422 
           25    -2082.719736       0.005780       0.029030 
           26    -2082.720667       0.001183       0.011033 
           27    -2082.720650       0.001352       0.008421 
           28    -2082.720685       0.000636       0.004922 
           29    -2082.720680       0.000861       0.004700 
           30    -2082.720688       0.000616       0.006125 
           31    -2082.720688       0.000610       0.007623 
           32    -2082.720691       0.000575       0.011843 
           33    -2082.720701       0.000453       0.002606 
           34    -2082.720701       0.000373       0.002055 
           35    -2082.720695       0.000338       0.009743 
           36    -2082.720693       0.000254       0.008121 
           37    -2082.720687       0.000240       0.012695 
           38    -2082.720680       0.000272       0.008970 
           39    -2082.720677       0.000335       0.014876 
           40    -2082.720660       0.000486       0.004974 
           41    -2082.720661       0.000411       0.009644 
           42    -2082.720663       0.000407       0.013623 
           43    -2082.720662       0.000428       0.011681 
           44    -2082.720664       0.000387       0.013201 
           45    -2082.720665       0.000258       0.010208 
           46    -2082.720667       0.000138       0.013068 
           47    -2082.720668       0.000118       0.006517 
           48    -2082.720669       0.000084       0.007987 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: LACVP 
 
<step 3> 
Job type: Single point. 
Method: RB3LYP 
Basis set: LACVP 
 SCF total energy:   -2082.7206655 hartrees 
 
 
  NMR shifts (ppm) 
       Atom     Isotropic        Rel. Shift  
  --------------------------------------------------- 
     1   Mo1    8419.4055  
     2    C1      68.0052          115.90 
     3    O1    -410.6897  
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     4    C2    -152.1336          336.04 
     5    O2     101.3284  
     6    C3   -1325.9604         1509.87 
     7    O3   -1539.6879  
     8    C4     321.9722         -138.06 
     9    O4    -159.5212  
    10    C6   -1091.7013         1275.61 
    11    O6   -1325.5055  
    12    P1   15444.1783       -15155.11 
    13    H2    -291.5959          323.57 
    14    H3    -313.5921          345.57 
    15    C5   -2040.4661         2224.38 
    16    C7   -1849.3235         2033.23 
    17    C8   -1678.1996         1862.11 
    18    C9   -1785.9921         1969.90 
    19   C10   -1274.4341         1458.34 
    20   C11   -1145.9068         1329.82 
    21    H1   -1221.2870         1253.26 
    22    H6   -1410.1342         1442.11 
    23    H5    -965.3293          997.31 
    24    H4    -889.8410          921.82 
    25   C12    -671.1409          855.05 
    26   C14   -1081.1360         1265.05 
    27    N3   -1284.0716         1130.84 
    28    B1     427.6348  
    29   C13   -1300.9861         1484.90 
    30    N1   -1847.8648         1694.64 
    31   C16    -323.3806          507.29 
    32   C15   -1359.0529         1542.96 
    33   C17    -687.9162          871.83 
    34   C18    -543.0410          726.95 
    35   C19   -1410.4828         1594.39 
    36   C20    -955.3970         1139.31 
    37   C21     191.0823           -7.17 
    38    H9    -303.4020          335.38 
    39   H10    -522.7143          554.69 
    40   H14    -547.6233          579.60 
    41   C22     578.6502         -394.74 
    42   H15      18.3186           13.66 
    43   H17     106.4110          -74.43 
    44   H18     103.4239          -71.45 
    45   C23     551.0717         -367.16 
    46   H16     -11.2539           43.23 
    47   H19     -99.1373          131.12 
    48   H20       5.9843           25.99 
    49   C24     151.1677           32.74 
    50    H8   -1109.1349         1141.11 
    51   H21   -1063.1126         1095.09 
    52   H22    -783.7909          815.77 
    53   C25     489.8627         -305.95 
    54   H13      58.9417          -26.96 
    55   H23    -102.5404          134.52 
    56   C26     472.5285         -288.62 
    57   H24      24.7870            7.19 
    58   H25     113.1294          -81.15 
    59   H26    -127.5525          159.53 
    60   C27     414.2626         -230.35 
    61    H7    -378.8584          410.84 
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    62   H28    -123.9051          155.88 
    63   C28     383.5684         -199.66 
    64   H27     -44.0526           76.03 
    65   H29    -321.9638          353.94 
    66   H30    -102.9955          134.97 
    67   C29     219.8138          -35.90 
    68   H11     -30.6220           62.60 
    69   H31    -307.3803          339.36 
    70   H32     -62.5150           94.49 
    71   C30      64.3491          119.56 
    72   H12      33.4410           -1.46 
    73   H33    -190.1407          222.12 
    74   H34    -136.9543          168.93 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   7:59:49.33 
  Quantum Calculation Wall Time:   8:45:01.87 
 
 
SPARTAN '10 Properties Program:  (Linux/P4E)                      build  1.1.0  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 Mo Mo1         -5.0965766    -0.1044159     0.0717571 
  2 C  C1          -6.0480407    -0.4891471    -1.7056120 
  3 O  O1          -6.5863830    -0.7124232    -2.7236828 
  4 C  C2          -6.4004656     1.3642737     0.4756980 
  5 O  O2          -7.1631886     2.2276729     0.7128805 
  6 C  C3          -3.8528881     1.2332168    -0.8694695 
  7 O  O3          -3.1365089     1.9974546    -1.3985168 
  8 C  C4          -6.3061827    -1.4640243     1.0220855 
  9 O  O4          -6.9947914    -2.2403083     1.5692402 
 10 C  C6          -4.1139037     0.2470030     1.8395203 
 11 O  O6          -3.5460080     0.4420416     2.8483562 
 12 P  P1          -3.3587692    -1.9893680    -0.4492393 
 13 H  H2          -3.4039477    -2.6071714    -1.7425379 
 14 H  H3          -3.3988322    -3.1799264     0.3520407 
 15 C  C5          -1.5355380    -1.5462952    -0.3502858 
 16 C  C7           1.1274045    -0.6516915    -0.1717396 
 17 C  C8          -0.8258585    -1.2106314    -1.5116660 
 18 C  C9          -0.9098619    -1.4431195     0.9007511 
 19 C  C10          0.4137475    -1.0021334     0.9858073 
 20 C  C11          0.4968880    -0.7664684    -1.4206026 
 21 H  H1          -1.2970764    -1.2870260    -2.4869628 
 22 H  H6          -1.4480185    -1.6891196     1.8110168 
 23 H  H5           0.8946256    -0.9193470     1.9549423 
 24 H  H4           1.0417853    -0.5032605    -2.3211838 
 25 C  C12          2.5354830    -0.1520672    -0.0795942 
 26 C  C14          3.5906117    -1.0758329    -0.1486995 
 27 N  N3           4.9334048    -0.6401743    -0.0837853 
 28 B  B1           5.4162185     0.8742638     0.0898074 
 29 C  C13          2.7543341     1.2251671     0.0653208 
 30 N  N1           4.0708575     1.7377636     0.1405951 
 31 C  C16          3.5927811    -2.5110243    -0.2824526 
 32 C  C15          4.9337394    -2.9087592    -0.2982614 
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 33 C  C17          5.7340264    -1.7324974    -0.1712204 
 34 C  C18          1.8361531     2.3355018     0.1548857 
 35 C  C19          2.6173721     3.4873755     0.2832466 
 36 C  C20          3.9886570     3.0853042     0.2664674 
 37 C  C21          2.4209073    -3.4476995    -0.3776540 
 38 H  H9           2.7697000    -4.4781640    -0.4883774 
 39 H  H10          1.7730975    -3.2252962    -1.2326983 
 40 H  H14          1.7871141    -3.4114549     0.5157567 
 41 C  C22          7.2295145    -1.7014306    -0.1147636 
 42 H  H15          7.5921380    -1.9257730     0.8977755 
 43 H  H17          7.6351596    -0.7314356    -0.3991252 
 44 H  H18          7.6523568    -2.4601460    -0.7821312 
 45 C  C23          5.1653642     4.0002600     0.4034600 
 46 H  H16          6.0498696     3.6138225    -0.1030629 
 47 H  H19          5.4304511     4.1496814     1.4589197 
 48 H  H20          4.9332810     4.9842114    -0.0151283 
 49 C  C24          0.3326470     2.3248472     0.1238546 
 50 H  H8          -0.0972595     1.6996117     0.9139654 
 51 H  H21         -0.0698938     1.9548820    -0.8259851 
 52 H  H22         -0.0535420     3.3384983     0.2609569 
 53 C  C25          5.4735623    -4.3124367    -0.3763523 
 54 H  H13          6.4224924    -4.3152759    -0.9289963 
 55 H  H23          4.7903688    -4.9438068    -0.9584375 
 56 C  C26          5.6997957    -4.9625930     1.0085271 
 57 H  H24          6.4194356    -4.3857222     1.6008452 
 58 H  H25          6.0850949    -5.9839980     0.9056320 
 59 H  H26          4.7625262    -5.0039594     1.5746894 
 60 C  C27          2.1415042     4.9134151     0.3812456 
 61 H  H7           1.1966951     4.9549035     0.9376923 
 62 H  H28          2.8571937     5.5009642     0.9703904 
 63 C  C28          1.9439347     5.5911455    -0.9946039 
 64 H  H27          1.6159515     6.6307574    -0.8775896 
 65 H  H29          1.1901632     5.0587978    -1.5856339 
 66 H  H30          2.8773376     5.5890351    -1.5692979 
 67 C  C29          6.1784198     1.0105333     1.5267581 
 68 H  H11          7.0909948     0.4023727     1.5663318 
 69 H  H31          5.5350130     0.6877170     2.3581590 
 70 H  H32          6.4872276     2.0427737     1.7357849 
 71 C  C30          6.2987723     1.3251065    -1.2290961 
 72 H  H12          7.2775654     1.7496394    -0.9609917 
 73 H  H33          5.7743401     2.0774713    -1.8342907 
 74 H  H34          6.4911701     0.4799965    -1.9039285 
 
Compound 63 
 
SCF model: 
A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -2082.959197       0.153644       0.145815 
            2    -2082.993670       0.085776       0.157609 
            3    -2083.010900       0.041164       0.184526 
            4    -2083.021348       0.013161       0.116261 
            5    -2083.021735       0.007532       0.170643 
            6    -2083.019940       0.009314       0.148073 
            7    -2083.021525       0.009645       0.187129 
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            8    -2083.021052       0.011416       0.136711 
            9    -2083.021263       0.008014       0.171228 
           10    -2083.021593       0.007026       0.129189 
           11    -2083.020979       0.008332       0.134717 
           12    -2083.021192       0.009792       0.128342 
           13    -2083.021020       0.008973       0.097162 
           14    -2083.021087       0.009631       0.114479 
           15    -2083.022315       0.004685       0.171523 
           16    -2083.021773       0.007276       0.161521 
           17    -2083.021684       0.009428       0.115004 
           18    -2083.021630       0.009875       0.138943 
           19    -2083.021939       0.006500       0.177909 
           20    -2083.022062       0.008318       0.136064 
           21    -2083.021299       0.007917       0.173851 
           22    -2083.022532       0.007459       0.199813 
           23    -2083.021887       0.006868       0.218015 
           24    -2083.022024       0.008741       0.222237 
           25    -2083.022313       0.010041       0.197070 
           26    -2083.021657       0.013122       0.080219 
           27    -2083.023297       0.003735       0.029230 
           28    -2083.023183       0.006281       0.017837 
           29    -2083.023566       0.001991       0.122416 
           30    -2083.023053       0.004275       0.106169 
           31    -2083.023593       0.001575       0.152224 
           32    -2083.023419       0.002630       0.128197 
           33    -2083.023617       0.001646       0.007615 
           34    -2083.023618       0.001282       0.006616 
           35    -2083.023650       0.000990       0.007709 
           36    -2083.023683       0.000839       0.010010 
           37    -2083.023703       0.000815       0.007075 
           38    -2083.023710       0.000884       0.004879 
           39    -2083.023715       0.000867       0.002521 
           40    -2083.023716       0.000863       0.023344 
           41    -2083.023728       0.000837       0.016883 
           42    -2083.023729       0.000831       0.019465 
           43    -2083.023719       0.000768       0.016101 
           44    -2083.023719       0.000748       0.026082 
           45    -2083.023720       0.000685       0.025098 
           46    -2083.023722       0.000618       0.015851 
           47    -2083.023723       0.000519       0.005170 
           48    -2083.023726       0.000620       0.010442 
           49    -2083.023724       0.000626       0.016241 
           50    -2083.023724       0.000625       0.013656 
           51    -2083.023725       0.000607       0.009051 
           52    -2083.023726       0.000579       0.007672 
           53    -2083.023727       0.000526       0.010507 
           54    -2083.023731       0.000448       0.012584 
           55    -2083.023734       0.000319       0.012895 
           56    -2083.023736       0.000217       0.007767 
           57    -2083.023737       0.000126       0.003183 
           58    -2083.023739       0.000090       0.004553 
           59    -2083.023739       0.000080       0.003568 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: LACVP 
 
203 
 
<step 3> 
Job type: Single point. 
Method: RB3LYP 
Basis set: LACVP 
 SCF total energy:   -2083.0237375 hartrees 
 
 
  NMR shifts (ppm) 
       Atom     Isotropic        Rel. Shift  
  --------------------------------------------------- 
     1    W6   14043.4999  
     2    C1    -198.1844          382.09 
     3    O1   -1018.7592  
     4    C2   -1417.5045         1601.41 
     5    O2    -507.8757  
     6    C3   -2507.1960         2691.11 
     7    O3   -2698.0522  
     8    C4      90.6203           93.29 
     9    O4    -692.1275  
    10    C6   -2191.8722         2375.78 
    11    O6   -2260.1012  
    12    P1   33877.7030       -33588.64 
    13    H2    -803.7200          835.70 
    14    H3    -848.1294          880.11 
    15    C5   -4132.0126         4315.92 
    16    C7   -4099.8788         4283.79 
    17    C8   -3527.1759         3711.09 
    18    C9   -3796.0969         3980.01 
    19   C10   -2802.6318         2986.54 
    20   C11   -2552.1642         2736.07 
    21    H1   -2587.6486         2619.63 
    22    H6   -3027.6553         3059.63 
    23    H5   -2095.3864         2127.36 
    24    H4   -1914.5692         1946.55 
    25   C12   -1105.5347         1289.44 
    26   C14   -2288.4758         2472.38 
    27    N3   -2814.6390         2661.41 
    28    B1     952.8619  
    29   C13   -2770.7075         2954.62 
    30    N1   -4146.3686         3993.14 
    31   C16    -519.4867          703.40 
    32   C15   -2983.2929         3167.20 
    33   C17   -1524.3143         1708.22 
    34   C18    -941.0584         1124.97 
    35   C19   -2996.7738         3180.68 
    36   C20   -2125.3152         2309.22 
    37   C21     165.8151           18.09 
    38    H9    -675.7768          707.75 
    39   H10   -1127.8348         1159.81 
    40   H14   -1192.5567         1224.53 
    41   C22    1121.7654         -937.86 
    42   H15      80.2402          -48.26 
    43   H17     299.7507         -267.77 
    44   H18     278.5374         -246.56 
    45   C23    1047.7243         -863.82 
    46   H16      37.7049           -5.73 
    47   H19    -188.4227          220.40 
    48   H20      52.2565          -20.28 
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    49   C24      67.2709          116.64 
    50    H8   -2408.4386         2440.42 
    51   H21   -2300.0418         2332.02 
    52   H22   -1733.7469         1765.72 
    53   C25     886.1329         -702.22 
    54   H13     155.8102         -123.83 
    55   H23    -221.5373          253.52 
    56   C26     841.1156         -657.21 
    57   H24      68.9455          -36.97 
    58   H25     241.8527         -209.87 
    59   H26    -292.6684          324.65 
    60   C27     688.2962         -504.39 
    61    H7    -847.4214          879.40 
    62   H28    -267.3086          299.29 
    63   C28     623.6776         -439.77 
    64   H27    -119.3346          151.31 
    65   H29    -719.7538          751.73 
    66   H30    -211.5752          243.55 
    67   C29     316.8213         -132.91 
    68   H11     -26.8682           58.85 
    69   H31    -661.6710          693.65 
    70   H32     -97.3144          129.29 
    71   C30     -21.5431          205.45 
    72   H12     131.0857          -99.11 
    73   H33    -359.6399          391.62 
    74   H34    -263.6398          295.62 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   8:54:54.91 
  Quantum Calculation Wall Time:   9:45:52.34 
 
 
SPARTAN '10 Properties Program:  (Linux/P4E)                      build  1.1.0  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 W  W6          -4.6339777    -0.0816560     0.0667050 
  2 C  C1          -5.6186026    -0.4480173    -1.6849303 
  3 O  O1          -6.1790018    -0.6640158    -2.6950800 
  4 C  C2          -5.9254651     1.3805218     0.5120669 
  5 O  O2          -6.6843909     2.2424727     0.7748546 
  6 C  C3          -3.4067218     1.2496485    -0.8838256 
  7 O  O3          -2.6904972     2.0106004    -1.4226717 
  8 C  C4          -5.8126153    -1.4490293     1.0233269 
  9 O  O4          -6.4833040    -2.2401457     1.5761201 
 10 C  C6          -3.6183334     0.2485032     1.8080016 
 11 O  O6          -3.0280939     0.4329992     2.8086412 
 12 P  P1          -2.9225053    -1.9535721    -0.5094434 
 13 H  H2          -2.9813950    -2.5268186    -1.8212204 
 14 H  H3          -2.9794292    -3.1633987     0.2594080 
 15 C  C5          -1.0989087    -1.5208703    -0.3985961 
 16 C  C7           1.5661578    -0.6428675    -0.1984942 
 17 C  C8          -0.3804248    -1.1859825    -1.5544874 
 18 C  C9          -0.4822176    -1.4268304     0.8576234 
 19 C  C10          0.8430430    -0.9938780     0.9531095 
205 
 
 20 C  C11          0.9441362    -0.7497298    -1.4523191 
 21 H  H1          -0.8459111    -1.2550759    -2.5330078 
 22 H  H6          -1.0285726    -1.6716168     1.7630941 
 23 H  H5           1.3176725    -0.9170163     1.9257265 
 24 H  H4           1.4967116    -0.4856812    -2.3479081 
 25 C  C12          2.9755590    -0.1496887    -0.0938586 
 26 C  C14          4.0270840    -1.0782063    -0.1531985 
 27 N  N3           5.3710055    -0.6487040    -0.0734192 
 28 B  B1           5.8588483     0.8633505     0.1067235 
 29 C  C13          3.1986312     1.2264583     0.0537776 
 30 N  N1           4.5166803     1.7332814     0.1406240 
 31 C  C16          4.0242455    -2.5131292    -0.2896526 
 32 C  C15          5.3635195    -2.9168544    -0.2923606 
 33 C  C17          6.1676248    -1.7443313    -0.1544842 
 34 C  C18          2.2843485     2.3406736     0.1366977 
 35 C  C19          3.0695038     3.4889693     0.2722051 
 36 C  C20          4.4391753     3.0810058     0.2669842 
 37 C  C21          2.8489706    -3.4440413    -0.3985243 
 38 H  H9           3.1938520    -4.4759758    -0.5076756 
 39 H  H10          2.2107216    -3.2170723    -1.2596210 
 40 H  H14          2.2065961    -3.4065351     0.4886907 
 41 C  C22          7.6623114    -1.7190103    -0.0810132 
 42 H  H15          8.0124021    -1.9345264     0.9378288 
 43 H  H17          8.0751430    -0.7533287    -0.3700669 
 44 H  H18          8.0894020    -2.4860369    -0.7358875 
 45 C  C23          5.6179607     3.9912738     0.4172913 
 46 H  H16          6.5115282     3.5923242    -0.0624641 
 47 H  H19          5.8587771     4.1550912     1.4765099 
 48 H  H20          5.4013813     4.9704975    -0.0207185 
 49 C  C24          0.7810320     2.3366627     0.0946842 
 50 H  H8           0.3427193     1.7087934     0.8779900 
 51 H  H21          0.3831772     1.9745899    -0.8602340 
 52 H  H22          0.3982406     3.3511192     0.2352256 
 53 C  C25          5.8982951    -4.3225183    -0.3691251 
 54 H  H13          6.8491415    -4.3286606    -0.9185751 
 55 H  H23          5.2148084    -4.9509388    -0.9539928 
 56 C  C26          6.1173774    -4.9743161     1.0160883 
 57 H  H24          6.8367710    -4.4001652     1.6113179 
 58 H  H25          6.4997389    -5.9968776     0.9138581 
 59 H  H26          5.1779648    -5.0130477     1.5788885 
 60 C  C27          2.5992368     4.9169152     0.3687611 
 61 H  H7           1.6524782     4.9620704     0.9216726 
 62 H  H28          3.3152223     5.5011581     0.9608094 
 63 C  C28          2.4095942     5.5961483    -1.0074470 
 64 H  H27          2.0854118     6.6369875    -0.8909209 
 65 H  H29          1.6557882     5.0673332    -1.6015797 
 66 H  H30          3.3450782     5.5907290    -1.5787598 
 67 C  C29          6.6021864     0.9966744     1.5536264 
 68 H  H11          7.5124066     0.3858385     1.6049879 
 69 H  H31          5.9470682     0.6763487     2.3767670 
 70 H  H32          6.9111312     2.0281545     1.7661700 
 71 C  C30          6.7619242     1.3098610    -1.1998066 
 72 H  H12          7.7533041     1.6959071    -0.9195685 
 73 H  H33          6.2669337     2.0916418    -1.7921732 
 74 H  H34          6.9281556     0.4721461    -1.8907738 
 
Compound 72 
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SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -2695.161839       0.009544       0.117609 
            2    -2695.164844       0.004953       0.111197 
            3    -2695.165414       0.002405       0.168308 
            4    -2695.165379       0.002766       0.199388 
            5    -2695.165381       0.002761       0.205077 
            6    -2695.165494       0.001472       0.215469 
            7    -2695.165493       0.003027       0.062129 
            8    -2695.165580       0.002335       0.035588 
            9    -2695.165483       0.003560       0.046262 
           10    -2695.165680       0.001235       0.026862 
           11    -2695.165666       0.001011       0.009743 
           12    -2695.165697       0.000984       0.020359 
           13    -2695.165698       0.001014       0.013806 
           14    -2695.165710       0.000674       0.024150 
           15    -2695.165718       0.000526       0.032265 
           16    -2695.165725       0.000582       0.043861 
           17    -2695.165731       0.000746       0.046229 
           18    -2695.165746       0.001108       0.093047 
           19    -2695.165773       0.001124       0.055308 
           20    -2695.165770       0.001634       0.091000 
           21    -2695.165845       0.000702       0.061908 
           22    -2695.165836       0.001073       0.032315 
           23    -2695.165856       0.000722       0.047558 
           24    -2695.165856       0.000995       0.053988 
           25    -2695.165885       0.000848       0.134306 
           26    -2695.165933       0.000584       0.046338 
           27    -2695.165952       0.000377       0.033629 
           28    -2695.165965       0.000336       0.107460 
           29    -2695.166005       0.000522       0.098112 
           30    -2695.166052       0.000663       0.063519 
           31    -2695.166047       0.000413       0.039382 
           32    -2695.166057       0.000421       0.037409 
           33    -2695.166049       0.000360       0.065822 
           34    -2695.166036       0.000512       0.063074 
           35    -2695.166045       0.000342       0.024381 
           36    -2695.166053       0.000212       0.062140 
           37    -2695.166055       0.000323       0.027206 
           38    -2695.166061       0.000121       0.008959 
           39    -2695.166063       0.000127       0.005009 
           40    -2695.166063       0.000087       0.003633 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: LACVP 
 
<step 3> 
Job type: Single point. 
Method: RB3LYP 
Basis set: LACVP 
 SCF total energy:   -2695.1660780 hartrees 
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  NMR shifts (ppm) 
       Atom     Isotropic        Rel. Shift  
  --------------------------------------------------- 
     1    P1   12682.8298       -12393.76 
     2    C5   -2550.1743         2734.08 
     3    C7   -2218.6969         2402.61 
     4    C8   -2172.4572         2356.37 
     5    C9   -2445.4301         2629.34 
     6   C10   -1655.9949         1839.90 
     7   C11   -1467.2983         1651.21 
     8    H1   -1700.8342         1732.81 
     9    H6   -2166.1128         2198.09 
    10    H5   -1295.2051         1327.18 
    11    H4   -1172.9536         1204.93 
    12   C12    -814.4740          998.38 
    13   C14   -1254.7199         1438.63 
    14    N3   -1476.7786         1323.55 
    15    B1     321.6575  
    16   C13   -1466.6474         1650.56 
    17    N1   -1954.1849         1800.96 
    18   C16    -449.9013          633.81 
    19   C15   -1486.1974         1670.11 
    20   C17    -835.3949         1019.30 
    21   C18    -705.0623          888.97 
    22   C19   -1548.7712         1732.68 
    23   C20   -1068.5998         1252.51 
    24   C21     -32.4768          216.39 
    25    H9    -521.8602          553.84 
    26   H10    -780.5122          812.49 
    27   H14    -831.1695          863.15 
    28   C22     477.5585         -293.65 
    29   H15     -82.6972          114.68 
    30   H17     -20.7759           52.75 
    31   H18      23.1089            8.87 
    32   C23     432.3689         -248.46 
    33   H16     -63.5184           95.50 
    34   H19    -174.8137          206.79 
    35   H20     -93.4725          125.45 
    36   C24    -210.5634          394.47 
    37    H8   -1387.1100         1419.09 
    38   H21   -1397.5149         1429.49 
    39   H22   -1024.0724         1056.05 
    40   C25     357.3270         -173.42 
    41   H13     -54.7927           86.77 
    42   H23    -247.4154          279.39 
    43   C26     359.3444         -175.44 
    44   H24     -68.2679          100.25 
    45   H25      10.5343           21.44 
    46   H26    -258.5914          290.57 
    47   C27     251.6040          -67.69 
    48    H7    -525.3469          557.32 
    49   H28    -231.2347          263.21 
    50   C28     231.0932          -47.18 
    51   H27    -158.6514          190.63 
    52   H29    -478.1787          510.16 
    53   H30    -221.1128          253.09 
    54   C29     115.0003           68.91 
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    55   H11    -113.6808          145.66 
    56   H31    -414.8524          446.83 
    57   H32    -145.2487          177.23 
    58   C30     -17.9678          201.88 
    59   H12     -46.6441           78.62 
    60   H33    -233.8721          265.85 
    61   H34    -307.7051          339.68 
    62    H3   -1263.8526         1295.83 
    63    H2   -1459.2332         1491.21 
    64   Ru1   13961.7223  
    65   H36    -193.8679          225.85 
    66    C1    -424.4532          608.36 
    67    C4    -548.4599          732.37 
    68    C6    -685.5335          869.44 
    69    C2    -466.3784          650.29 
    70    C3    -608.3799          792.29 
    71   C31    -587.7517          771.66 
    72   H38    -378.2887          410.27 
    73   H39     450.1376         -418.16 
    74   H40     800.3774         -768.40 
    75   H41     132.8648         -100.89 
    76   H42     679.0347         -647.06 
    77   Cl1    9934.5672  
    78   Cl2   10752.3146  
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   8:30:28.04 
  Quantum Calculation Wall Time:   9:15:50.59 
 
 
SPARTAN '10 Properties Program:  (Linux/P4E)                      build  1.1.0  
  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 P  P1           3.2558824     1.6842855    -0.4164921 
  2 C  C5           1.4456391     1.2403769    -0.2993663 
  3 C  C7          -1.2606124     0.5061295    -0.1423553 
  4 C  C8           0.7079352     1.0260558    -1.4707116 
  5 C  C9           0.8375946     1.0808420     0.9531337 
  6 C  C10         -0.5110402     0.7220486     1.0252932 
  7 C  C11         -0.6379378     0.6594095    -1.3907025 
  8 H  H1           1.1760837     1.1315285    -2.4441908 
  9 H  H6           1.4157363     1.2016324     1.8618062 
 10 H  H5          -0.9833368     0.5970440     1.9940776 
 11 H  H4          -1.2081101     0.4900210    -2.2981428 
 12 C  C12         -2.7032252     0.1138964    -0.0652587 
 13 C  C14         -3.6851112     1.1167279    -0.1480955 
 14 N  N3          -5.0589106     0.7865808    -0.1159479 
 15 B  B1          -5.6592818    -0.6877278     0.0521075 
 16 C  C13         -3.0300125    -1.2407236     0.0746585 
 17 N  N1          -4.3840510    -1.6514368     0.1403435 
 18 C  C16         -3.5714745     2.5457442    -0.2789835 
 19 C  C15         -4.8774585     3.0473897    -0.3361147 
 20 C  C17         -5.7696608     1.9386483    -0.2320747 
 21 C  C18         -2.1977061    -2.4167704     0.1744022 
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 22 C  C19         -3.0648535    -3.5038541     0.3069820 
 23 C  C20         -4.4016124    -3.0004467     0.2804316 
 24 C  C21         -2.3294919     3.3909962    -0.3364157 
 25 H  H9          -2.5947264     4.4515742    -0.3668696 
 26 H  H10         -1.7176603     3.1791280    -1.2207947 
 27 H  H14         -1.6838884     3.2384343     0.5352332 
 28 C  C22         -7.2636558     2.0192382    -0.2331518 
 29 H  H15         -7.6626917     2.0836186     0.7874332 
 30 H  H17         -7.7223098     1.1520703    -0.7095116 
 31 H  H18         -7.5928330     2.9162450    -0.7664443 
 32 C  C23         -5.6346981    -3.8375530     0.4287954 
 33 H  H16         -6.5326078    -3.3163923     0.1039195 
 34 H  H19         -5.7817635    -4.1326367     1.4770427 
 35 H  H20         -5.5447020    -4.7607395    -0.1543653 
 36 C  C24         -0.6979063    -2.5189214     0.1508153 
 37 H  H8          -0.2254281    -2.0072558     0.9959894 
 38 H  H21         -0.2576804    -2.0870145    -0.7536675 
 39 H  H22         -0.3888160    -3.5665810     0.1924971 
 40 C  C25         -5.2960944     4.4905009    -0.4376759 
 41 H  H13         -6.2222909     4.5701291    -1.0224349 
 42 H  H23         -4.5432156     5.0575180    -0.9998174 
 43 C  C26         -5.5128999     5.1680377     0.9352744 
 44 H  H24         -6.2976427     4.6570924     1.5051274 
 45 H  H25         -5.8072801     6.2177153     0.8152948 
 46 H  H26         -4.5948332     5.1343599     1.5326337 
 47 C  C27         -2.7004989    -4.9608037     0.4233805 
 48 H  H7          -1.7661736    -5.0671711     0.9886384 
 49 H  H28         -3.4658173    -5.4849900     1.0107041 
 50 C  C28         -2.5423988    -5.6677809    -0.9429744 
 51 H  H27         -2.2967979    -6.7283136    -0.8108320 
 52 H  H29         -1.7433977    -5.2020531    -1.5306809 
 53 H  H30         -3.4665616    -5.6011468    -1.5289494 
 54 C  C29         -6.4691163    -0.7568185     1.4684665 
 55 H  H11         -7.3516851    -0.1043849     1.4693136 
 56 H  H31         -5.8320439    -0.4481803     2.3101222 
 57 H  H32         -6.8350115    -1.7667080     1.6947963 
 58 C  C30         -6.5320617    -1.0724367    -1.2904909 
 59 H  H12         -7.6177615    -1.0182401    -1.1233143 
 60 H  H33         -6.3214991    -2.0889098    -1.6474258 
 61 H  H34         -6.2953952    -0.4030090    -2.1298577 
 62 H  H3           3.3355447     2.8616320     0.3946580 
 63 H  H2           3.2882417     2.2817474    -1.7208477 
 64 Ru Ru1          5.0203015     0.1264890     0.0380469 
 65 H  H36          6.2573788     1.2985219    -2.5203275 
 66 C  C1           6.5020137     0.7767555    -1.6034555 
 67 C  C4           7.0896969    -0.6049052     0.8246020 
 68 C  C6           6.4796873    -0.6374244    -1.5643388 
 69 C  C2           6.8014846     1.5223469    -0.4077989 
 70 C  C3           7.0700685     0.8356553     0.7992916 
 71 C  C31          6.7993006    -1.3326589    -0.3431625 
 72 H  H38          6.1800614    -1.2027818    -2.4361911 
 73 H  H39          6.7867108     2.6049852    -0.4252343 
 74 H  H40          7.2192378     1.3867301     1.7179808 
 75 H  H41          6.7172138    -2.4107164    -0.3085842 
 76 H  H42          7.2364434    -1.1181890     1.7655023 
 77 Cl Cl1          3.3981711    -1.6248236    -0.5614325 
 78 Cl Cl2          4.0808632     0.2582534     2.3245692 
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Compound 76 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -3078.532687       0.020494       0.112574 
            2    -3078.543024       0.017267       0.129583 
            3    -3078.551666       0.011639       0.144750 
            4    -3078.555631       0.003249       0.102459 
            5    -3078.555005       0.007292       0.054350 
            6    -3078.556434       0.002931       0.172630 
            7    -3078.556112       0.003553       0.220106 
            8    -3078.556363       0.003619       0.165741 
            9    -3078.554849       0.008738       0.061439 
           10    -3078.556556       0.002858       0.243547 
           11    -3078.556409       0.002873       0.222284 
           12    -3078.556492       0.002990       0.114120 
           13    -3078.556404       0.002443       0.102237 
           14    -3078.556604       0.002904       0.019882 
           15    -3078.556610       0.002847       0.025999 
           16    -3078.556643       0.002869       0.121793 
           17    -3078.556689       0.001846       0.096711 
           18    -3078.556712       0.001917       0.035022 
           19    -3078.556764       0.001650       0.017697 
           20    -3078.556781       0.001383       0.032435 
           21    -3078.556809       0.000737       0.062414 
           22    -3078.556837       0.000546       0.044578 
           23    -3078.556831       0.000489       0.032690 
           24    -3078.556842       0.000678       0.021981 
           25    -3078.556846       0.000425       0.029525 
           26    -3078.556850       0.000289       0.035859 
           27    -3078.556858       0.000246       0.061727 
           28    -3078.556873       0.000365       0.157474 
           29    -3078.556842       0.001115       0.145253 
           30    -3078.556834       0.001582       0.093488 
           31    -3078.556857       0.001743       0.041037 
           32    -3078.556890       0.001433       0.057288 
           33    -3078.556914       0.001485       0.117144 
           34    -3078.556921       0.001198       0.052476 
           35    -3078.556941       0.001073       0.024328 
           36    -3078.556944       0.000911       0.027769 
           37    -3078.556946       0.000436       0.018722 
           38    -3078.556943       0.000388       0.031612 
           39    -3078.556951       0.000540       0.039453 
           40    -3078.556953       0.000602       0.027594 
           41    -3078.556964       0.000676       0.023213 
           42    -3078.556960       0.000707       0.015501 
           43    -3078.556963       0.000691       0.024802 
           44    -3078.556965       0.000636       0.019807 
           45    -3078.556970       0.000403       0.008687 
           46    -3078.556971       0.000276       0.014597 
           47    -3078.556976       0.000294       0.012511 
           48    -3078.556979       0.000149       0.008756 
           49    -3078.556984       0.000113       0.006259 
           50    -3078.556984       0.000057       0.001841 
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<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: LACVP 
 
<step 3> 
Job type: Single point. 
Method: RB3LYP 
Basis set: LACVP 
 SCF total energy:   -3078.5568266 hartrees 
 
 
  NMR shifts (ppm) 
       Atom     Isotropic        Rel. Shift  
  --------------------------------------------------- 
     1    P1   14603.3325       -14314.27 
     2    C5   -3095.3932         3279.30 
     3    C7   -2318.7099         2502.62 
     4    C8   -2779.3692         2963.28 
     5    C9   -2719.1192         2903.03 
     6   C10   -1729.1975         1913.11 
     7   C11   -1760.6113         1944.52 
     8    H1   -2208.2148         2240.19 
     9    H6   -2077.6103         2109.59 
    10    H5   -1389.8209         1421.80 
    11    H4   -1430.5615         1462.54 
    12   C12   -1547.3524         1731.26 
    13   C14   -1562.0724         1745.98 
    14    N3   -1669.5158         1516.29 
    15    B1    -278.6435  
    16   C13   -1847.9187         2031.83 
    17    N1   -2210.6357         2057.41 
    18   C16    -886.9526         1070.86 
    19   C15   -1634.0555         1817.96 
    20   C17    -953.6050         1137.51 
    21   C18   -1295.0547         1478.96 
    22   C19   -1820.2226         2004.13 
    23   C20   -1257.8636         1441.77 
    24   C21     -70.2398          254.15 
    25    H9    -557.8365          589.81 
    26   H10    -898.9458          930.92 
    27   H14    -884.8964          916.87 
    28   C22     308.6868         -124.78 
    29   H15    -230.0260          262.00 
    30   H17    -245.2763          277.25 
    31   H18    -110.3540          142.33 
    32   C23     234.8905          -50.98 
    33   H16    -375.2932          407.27 
    34   H19    -395.9141          427.89 
    35   H20    -284.1261          316.10 
    36   C24    -356.9261          540.84 
    37    H8   -1683.2183         1715.20 
    38   H21   -1760.8970         1792.87 
    39   H22   -1258.1821         1290.16 
    40   C25     306.9883         -123.08 
    41   H13    -160.7943          192.77 
    42   H23    -314.0458          346.02 
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    43   C26     290.0275         -106.12 
    44   H24    -166.1475          198.13 
    45   H25     -45.2231           77.20 
    46   H26    -303.9154          335.89 
    47   C27     115.7716           68.14 
    48    H7    -675.3803          707.36 
    49   H28    -392.4881          424.47 
    50   C28     104.7915           79.12 
    51   H27    -288.4423          320.42 
    52   H29    -650.0293          682.01 
    53   H30    -391.6636          423.64 
    54    H3   -1310.2182         1342.20 
    55    H2   -1415.1940         1447.17 
    56   Ru1   13258.3616  
    57   H36     509.0195         -477.04 
    58    C1    -312.4789          496.39 
    59    C4    -718.0876          902.00 
    60    C6    -784.5777          968.49 
    61    C2    -415.1534          599.06 
    62    C3    -446.2433          630.15 
    63   C31    -352.1510          536.06 
    64   H38     166.1655         -134.19 
    65   H39     676.8896         -644.91 
    66   H40     573.2198         -541.24 
    67   H41     254.5995         -222.62 
    68   H42     320.3520         -288.37 
    69   Cl2   11303.4746  
    70   Cl1   10074.4936  
    71   C29    -781.1595          965.07 
    72   C30    -411.9738          595.88 
    73   C32    -229.5322          413.44 
    74   C33    -351.0824          534.99 
    75   C34    -452.6135          636.52 
    76   C35    -361.4804          545.39 
    77   H11    -637.0270          669.00 
    78   H12    -288.4152          320.39 
    79   H31    -212.4015          244.38 
    80   H32    -414.9919          446.97 
    81   H33    -265.2153          297.19 
    82   C36    -691.5534          875.46 
    83   C37    -403.0748          586.98 
    84   C38    -317.5945          501.50 
    85   C39    -206.1301          390.04 
    86   C40    -353.6092          537.52 
    87   C41    -430.2699          614.18 
    88   H34    -297.4405          329.42 
    89   H35    -577.1306          609.11 
    90   H37    -373.8390          405.82 
    91   H43    -217.6125          249.59 
    92   H44    -250.9019          282.88 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   5:29:43.91 
  Quantum Calculation Wall Time:   6:04:00.29 
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  Use of molecular symmetry disabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 P  P1           4.5208376     1.7574321    -0.1308409 
  2 C  C5           2.6802429     1.4586424    -0.1157618 
  3 C  C7          -0.0581476     0.8455364    -0.0656841 
  4 C  C8           2.0212265     1.1046538    -1.3006621 
  5 C  C9           1.9729462     1.5170527     1.0918631 
  6 C  C10          0.6085353     1.2150029     1.1125469 
  7 C  C11          0.6579274     0.8035173    -1.2730558 
  8 H  H1           2.5687914     1.0272841    -2.2325579 
  9 H  H6           2.4838014     1.7610172     2.0162805 
 10 H  H5           0.0629143     1.2457547     2.0498590 
 11 H  H4           0.1513845     0.5141337    -2.1878594 
 12 C  C12         -1.5065260     0.4710410    -0.0346738 
 13 C  C14         -2.4771063     1.4592491    -0.2675158 
 14 N  N3          -3.8547628     1.1401790    -0.2418809 
 15 B  B1          -4.4705724    -0.3138845     0.0055527 
 16 C  C13         -1.8520486    -0.8613171     0.2234759 
 17 N  N1          -3.2106089    -1.2635469     0.2509834 
 18 C  C16         -2.3506208     2.8697062    -0.5178910 
 19 C  C15         -3.6511811     3.3749477    -0.6374166 
 20 C  C17         -4.5549013     2.2882013    -0.4569497 
 21 C  C18         -1.0349588    -2.0248463     0.4701178 
 22 C  C19         -1.9143220    -3.0987415     0.6405563 
 23 C  C20         -3.2436362    -2.6015269     0.4936863 
 24 C  C21         -1.0975145     3.6924518    -0.6277402 
 25 H  H9          -1.3450581     4.7342986    -0.8500534 
 26 H  H10         -0.4311265     3.3332715    -1.4190040 
 27 H  H14         -0.5145889     3.6840110     0.3002027 
 28 C  C22         -6.0453586     2.3710118    -0.4976121 
 29 H  H15         -6.4971576     1.8090868     0.3241835 
 30 H  H17         -6.4453059     1.9579840    -1.4310588 
 31 H  H18         -6.3708398     3.4112916    -0.4227943 
 32 C  C23         -4.4951085    -3.4095993     0.5878590 
 33 H  H16         -5.1791828    -3.1877134    -0.2362961 
 34 H  H19         -5.0346936    -3.2039985     1.5194669 
 35 H  H20         -4.2606380    -4.4761011     0.5600699 
 36 C  C24          0.4626070    -2.1293974     0.5383026 
 37 H  H8           0.8925204    -1.5238063     1.3428594 
 38 H  H21          0.9517869    -1.8057346    -0.3858950 
 39 H  H22          0.7642265    -3.1649131     0.7150947 
 40 C  C25         -4.0553747     4.8080500    -0.8658664 
 41 H  H13         -4.9822076     4.8443263    -1.4522400 
 42 H  H23         -3.2990518     5.3139710    -1.4790724 
 43 C  C26         -4.2552534     5.6055018     0.4439997 
 44 H  H24         -5.0342674     5.1482265     1.0647886 
 45 H  H25         -4.5478203     6.6415934     0.2349567 
 46 H  H26         -3.3305852     5.6215061     1.0320667 
 47 C  C27         -1.5493653    -4.5399563     0.8837460 
 48 H  H7          -0.6406397    -4.5936205     1.4955947 
 49 H  H28         -2.3341194    -5.0285134     1.4750469 
 50 C  C28         -1.3246183    -5.3402393    -0.4205018 
 51 H  H27         -1.0665744    -6.3836557    -0.2031995 
 52 H  H29         -0.5107056    -4.9004191    -1.0077307 
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 53 H  H30         -2.2264864    -5.3323572    -1.0434527 
 54 H  H3           4.6607751     2.7207812     0.9187225 
 55 H  H2           4.6657578     2.6138538    -1.2739143 
 56 Ru Ru1          6.1149175    -0.0353596     0.0102919 
 57 H  H36          7.8750291     2.0266165    -1.4146110 
 58 C  C1           7.9146467     1.1061275    -0.8449704 
 59 C  C4           7.9481647    -1.3236146     0.6530282 
 60 C  C6           7.8401589    -0.1404786    -1.5128961 
 61 C  C2           8.0113461     1.1546674     0.5906824 
 62 C  C3           7.9905365    -0.0517359     1.3288097 
 63 C  C31          7.8668587    -1.3616474    -0.7524258 
 64 H  H38          7.7110894    -0.1805105    -2.5857821 
 65 H  H39          8.0471014     2.1070334     1.1038373 
 66 H  H40          7.9606450    -0.0247315     2.4096908 
 67 H  H41          7.7275453    -2.3051028    -1.2631425 
 68 H  H42          7.8804368    -2.2348392     1.2313910 
 69 Cl Cl2          4.7591779    -0.6322717     1.9924249 
 70 Cl Cl1          4.5680897    -1.2474368    -1.4808209 
 71 C  C29         -5.2099225    -0.7926502    -1.3791253 
 72 C  C30         -6.3539050    -1.5679473    -3.8802738 
 73 C  C32         -4.4187824    -1.2768979    -2.4473825 
 74 C  C33         -6.5981861    -0.7045262    -1.6240446 
 75 C  C34         -7.1648001    -1.0863325    -2.8487312 
 76 C  C35         -4.9721404    -1.6588085    -3.6737587 
 77 H  H11         -3.3441549    -1.3618850    -2.3122243 
 78 H  H12         -7.2575836    -0.3283872    -0.8497161 
 79 H  H31         -8.2391591    -1.0073141    -2.9924532 
 80 H  H32         -4.3268831    -2.0281559    -4.4664435 
 81 H  H33         -6.7894197    -1.8672953    -4.8291200 
 82 C  C36         -5.3496905    -0.2675130     1.3918435 
 83 C  C37         -6.7174717    -0.1747269     3.8977798 
 84 C  C38         -6.5247143    -1.0138865     1.6273514 
 85 C  C39         -4.8843976     0.5207783     2.4705628 
 86 C  C40         -5.5486525     0.5707055     3.7000573 
 87 C  C41         -7.2016298    -0.9697604     2.8548972 
 88 H  H34         -6.9214188    -1.6485946     0.8429263 
 89 H  H35         -3.9835345     1.1138032     2.3404181 
 90 H  H37         -5.1565428     1.1900638     4.5024233 
 91 H  H43         -8.1054999    -1.5571860     2.9931124 
 92 H  H44         -7.2397512    -0.1368585     4.8492941 
 
Compound 77 
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -3235.689785       0.035424       0.072915 
            2    -3235.724364       0.022450       0.100216 
            3    -3235.744794       0.016800       0.119159 
            4    -3235.758268       0.012161       0.131955 
            5    -3235.767351       0.009548       0.147267 
            6    -3235.773844       0.008414       0.163086 
            7    -3235.778172       0.007300       0.180209 
            8    -3235.781008       0.006088       0.181664 
            9    -3235.782957       0.004921       0.186672 
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           10    -3235.784471       0.003431       0.175595 
           11    -3235.785766       0.002969       0.131227 
           12    -3235.786453       0.002080       0.089128 
           13    -3235.786774       0.001862       0.097714 
           14    -3235.787152       0.001330       0.093547 
           15    -3235.787445       0.001482       0.098708 
           16    -3235.787669       0.001697       0.104491 
           17    -3235.787868       0.001843       0.102197 
           18    -3235.788046       0.001800       0.092134 
           19    -3235.788120       0.001479       0.040849 
           20    -3235.788163       0.001101       0.029738 
           21    -3235.788197       0.000855       0.030660 
           22    -3235.788213       0.000571       0.054153 
           23    -3235.788221       0.000498       0.069308 
           24    -3235.788236       0.000578       0.159800 
           25    -3235.788265       0.001232       0.174302 
           26    -3235.788279       0.002393       0.164259 
           27    -3235.788312       0.003021       0.066180 
           28    -3235.788376       0.002951       0.060007 
           29    -3235.788420       0.002910       0.040758 
           30    -3235.788513       0.002385       0.107301 
           31    -3235.788526       0.002266       0.058698 
           32    -3235.788601       0.001958       0.036971 
           33    -3235.788652       0.001591       0.017813 
           34    -3235.788680       0.001318       0.039287 
           35    -3235.788735       0.001098       0.016998 
           36    -3235.788763       0.001050       0.027377 
           37    -3235.788774       0.000982       0.013432 
           38    -3235.788790       0.000922       0.009785 
           39    -3235.788793       0.000820       0.013315 
           40    -3235.788796       0.000753       0.013420 
           41    -3235.788807       0.000626       0.016310 
           42    -3235.788823       0.000533       0.022430 
           43    -3235.788826       0.000620       0.009378 
           44    -3235.788826       0.000542       0.008070 
           45    -3235.788829       0.000358       0.003967 
           46    -3235.788831       0.000316       0.002780 
           47    -3235.788832       0.000227       0.005307 
           48    -3235.788830       0.000111       0.004176 
           49    -3235.788832       0.000083       0.005856 
           50    -3235.788826       0.000080       0.004322 
           51    -3235.788828       0.000054       0.003027 
           52    -3235.788830       0.000064       0.001696 
           53    -3235.788827       0.000067       0.001860 
           54    -3235.788827       0.000047       0.000825 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: LACVP 
 
<step 3> 
Job type: Single point. 
Method: RB3LYP 
Basis set: LACVP 
 SCF total energy:   -3235.7886815 hartrees 
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  NMR shifts (ppm) 
       Atom     Isotropic        Rel. Shift  
  --------------------------------------------------- 
     1    P1   13794.4933       -13505.43 
     2    C5   -3155.7271         3339.64 
     3    C7   -2423.6356         2607.54 
     4    C8   -2573.6424         2757.55 
     5    C9   -3012.6332         3196.54 
     6   C10   -1951.2919         2135.20 
     7   C11   -1682.7595         1866.67 
     8    H1   -1969.1425         2001.12 
     9    H6   -2723.2304         2755.21 
    10    H5   -1580.9557         1612.93 
    11    H4   -1372.7426         1404.72 
    12   C12   -1336.6246         1520.53 
    13   C14   -1543.8094         1727.72 
    14    N3   -1726.1948         1572.97 
    15    B1    -248.3501  
    16   C13   -1829.3776         2013.29 
    17    N1   -2341.2521         2188.02 
    18   C16    -769.5133          953.42 
    19   C15   -1674.1018         1858.01 
    20   C17    -992.4422         1176.35 
    21   C18   -1142.5950         1326.50 
    22   C19   -1795.3756         1979.28 
    23   C20   -1314.3393         1498.25 
    24   C21    -137.3181          321.23 
    25    H9    -607.2298          639.21 
    26   H10    -896.6230          928.60 
    27   H14    -987.3716         1019.35 
    28   C22     322.7059         -138.80 
    29   H15    -223.2431          255.22 
    30   H17    -188.9873          220.97 
    31   H18     -82.4143          114.39 
    32   C23     220.8661          -36.96 
    33   H16    -371.2128          403.19 
    34   H19    -294.4926          326.47 
    35   H20    -390.4738          422.45 
    36   C24    -455.2093          639.12 
    37    H8   -1763.0155         1794.99 
    38   H21   -1731.9297         1763.91 
    39   H22   -1310.1498         1342.13 
    40   C25     277.8774          -93.97 
    41   H13    -143.6451          175.62 
    42   H23    -319.6397          351.62 
    43   C26     280.9396          -97.03 
    44   H24    -165.0730          197.05 
    45   H25     -50.5435           82.52 
    46   H26    -339.5412          371.52 
    47   C27      50.3204          133.59 
    48    H7    -769.8620          801.84 
    49   H28    -460.7988          492.78 
    50   C28      97.2054           86.70 
    51   H27    -299.0599          331.04 
    52   H29    -612.9988          644.98 
    53   H30    -349.1217          381.10 
    54    H2   -1716.6687         1748.65 
    55    H3   -1593.1295         1625.11 
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    56   Ru1   13821.3167  
    57    C1    -646.8396          830.75 
    58    C4    -726.0208          909.93 
    59    C6    -947.0480         1130.96 
    60    C2   -1205.5661         1389.48 
    61    C3   -1192.1782         1376.09 
    62   C31   -1445.6449         1629.55 
    63   H38    -101.7229          133.70 
    64   H39     741.0982         -709.12 
    65   H40     235.3959         -203.42 
    66   H41    -702.4593          734.44 
    67   Cl1    9211.1520  
    68   Cl2    8625.1906  
    69   C32    2505.2331        -2321.32 
    70   H35     519.1370         -487.16 
    71   H36    1683.4423        -1651.46 
    72   H37     588.9146         -556.94 
    73   C33    1129.0795         -945.17 
    74   H44   -1020.0893         1052.07 
    75   C34     427.1695         -243.26 
    76   H42     603.0200         -571.04 
    77   H45     -63.9808           95.96 
    78   H46   -1120.8652         1152.84 
    79   C35    2094.2926        -1910.38 
    80   H43    1866.8814        -1834.90 
    81   H47    1291.3321        -1259.35 
    82   H48     973.3747         -941.40 
    83   C29    -637.4275          821.34 
    84   C30    -405.0194          588.93 
    85   C36    -162.0892          346.00 
    86   C37    -288.8658          472.78 
    87   C38    -433.1602          617.07 
    88   C39    -341.4443          525.35 
    89   H11    -549.5394          581.52 
    90   H12    -273.1358          305.11 
    91   H31    -209.4921          241.47 
    92   H32    -368.6989          400.68 
    93   H33    -247.6167          279.59 
    94   C40    -760.4888          944.40 
    95   C41    -427.9040          611.81 
    96   C42    -358.6516          542.56 
    97   C43    -214.7560          398.67 
    98   C44    -365.7770          549.69 
    99   C45    -472.6930          656.60 
   100   H34    -272.2688          304.25 
   101   H49    -648.2712          680.25 
   102   H50    -436.6364          468.61 
   103   H51    -210.0613          242.04 
   104   H52    -277.5874          309.57 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :  21:49:11.57 
  Quantum Calculation Wall Time:  22:53:18.92 
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                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 P  P1           3.8466224     1.9271759    -0.6152922 
  2 C  C5           2.0220018     1.5409400    -0.4922282 
  3 C  C7          -0.6910920     0.8373434    -0.3116698 
  4 C  C8           1.2793674     1.3044465    -1.6564300 
  5 C  C9           1.4120461     1.4291729     0.7645161 
  6 C  C10          0.0611689     1.0844206     0.8480200 
  7 C  C11         -0.0711710     0.9552751    -1.5651545 
  8 H  H1           1.7481365     1.3755880    -2.6328717 
  9 H  H6           1.9958063     1.5641716     1.6671541 
 10 H  H5          -0.4106627     0.9892429     1.8204172 
 11 H  H4          -0.6428265     0.7632894    -2.4672625 
 12 C  C12         -2.1299284     0.4400583    -0.2064935 
 13 C  C14         -3.1221898     1.4279831    -0.3216037 
 14 N  N3          -4.4930982     1.0885253    -0.2498326 
 15 B  B1          -5.0762059    -0.3683307     0.0511284 
 16 C  C13         -2.4474079    -0.9066076     0.0108761 
 17 N  N1          -3.7958130    -1.3148754     0.1620181 
 18 C  C16         -3.0252512     2.8466221    -0.5369331 
 19 C  C15         -4.3366194     3.3321230    -0.6145848 
 20 C  C17         -5.2179039     2.2271747    -0.4310097 
 21 C  C18         -1.6083575    -2.0715297     0.1526923 
 22 C  C19         -2.4634905    -3.1488220     0.4070775 
 23 C  C20         -3.8015088    -2.6524889     0.4058711 
 24 C  C21         -1.7906651     3.6969788    -0.6494378 
 25 H  H9          -2.0626565     4.7554528    -0.6855868 
 26 H  H10         -1.2081209     3.4742282    -1.5510598 
 27 H  H14         -1.1158943     3.5575013     0.2012814 
 28 C  C22         -6.7092515     2.2863136    -0.4232554 
 29 H  H15         -7.1006394     2.2789044     0.6008037 
 30 H  H17         -7.1472337     1.4321585    -0.9447786 
 31 H  H18         -7.0547436     3.2025793    -0.9095016 
 32 C  C23         -5.0337926    -3.4606924     0.6409540 
 33 H  H16         -5.7479892    -2.9276390     1.2730179 
 34 H  H19         -4.7793656    -4.4055645     1.1281831 
 35 H  H20         -5.5443723    -3.6937158    -0.3010252 
 36 C  C24         -0.1118353    -2.1732176     0.0520968 
 37 H  H8           0.4030847    -1.6835231     0.8859831 
 38 H  H21          0.2815105    -1.7171097    -0.8607766 
 39 H  H22          0.1981072    -3.2211486     0.0509489 
 40 C  C25         -4.7684182     4.7618448    -0.8079714 
 41 H  H13         -5.6921464     4.7938820    -1.4008113 
 42 H  H23         -4.0182660     5.2990368    -1.4018536 
 43 C  C26         -5.0007524     5.5209025     0.5187918 
 44 H  H24         -5.7715586     5.0274949     1.1219210 
 45 H  H25         -5.3224392     6.5525304     0.3310451 
 46 H  H26         -4.0824661     5.5513950     1.1163597 
 47 C  C27         -2.0791760    -4.5902504     0.6118342 
 48 H  H7          -1.0647382    -4.6464831     1.0238597 
 49 H  H28         -2.7321312    -5.0439272     1.3696560 
 50 C  C28         -2.1486526    -5.4365038    -0.6798232 
 51 H  H27         -1.8733382    -6.4794924    -0.4821468 
 52 H  H29         -1.4663731    -5.0408735    -1.4408052 
 53 H  H30         -3.1598351    -5.4248046    -1.1029426 
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 54 H  H2           3.9232680     2.3569408    -1.9828955 
 55 H  H3           3.9467142     3.1964408     0.0437365 
 56 Ru Ru1          5.5490417     0.3899663     0.0906949 
 57 C  C1           7.4044460     1.7525761    -0.2263449 
 58 C  C4           7.3121449    -1.1627845    -0.1998372 
 59 C  C6           7.1280334     1.0024951    -1.4291532 
 60 C  C2           7.5512455     1.0119185     0.9732219 
 61 C  C3           7.5363164    -0.4289047     0.9834595 
 62 C  C31          7.0659280    -0.4122172    -1.4132473 
 63 H  H38          6.9406857     1.5348560    -2.3550941 
 64 H  H39          7.6489616     1.5366345     1.9150802 
 65 H  H40          7.6147653    -0.9368468     1.9337963 
 66 H  H41          6.7993086    -0.9454142    -2.3168642 
 67 Cl Cl1          4.5024700     0.7471527     2.3185796 
 68 Cl Cl2          3.9215829    -1.3841568    -0.4723558 
 69 C  C32          7.5065934     3.2550897    -0.2468668 
 70 H  H35          6.9219018     3.6872388    -1.0657441 
 71 H  H36          8.5499808     3.5655136    -0.3901711 
 72 H  H37          7.1553516     3.6905133     0.6934203 
 73 C  C33          7.2323078    -2.6792138    -0.2482282 
 74 H  H44          6.3601508    -2.9161393    -0.8729496 
 75 C  C34          7.0030807    -3.3362076     1.1230211 
 76 H  H42          7.8613734    -3.1946774     1.7920031 
 77 H  H45          6.8662438    -4.4148139     0.9923646 
 78 H  H46          6.1040079    -2.9388702     1.6042848 
 79 C  C35          8.5000411    -3.2452790    -0.9384942 
 80 H  H43          9.3965613    -3.0373190    -0.3417016 
 81 H  H47          8.6475193    -2.8147417    -1.9354455 
 82 H  H48          8.4095253    -4.3313681    -1.0484885 
 83 C  C29         -5.9518873    -0.8546037    -1.2485842 
 84 C  C30         -7.3176254    -1.7173830    -3.6044072 
 85 C  C36         -5.5077300    -0.5002806    -2.5440543 
 86 C  C37         -7.1036303    -1.6696173    -1.1860243 
 87 C  C38         -7.7797795    -2.0924521    -2.3395686 
 88 C  C39         -6.1714527    -0.9188451    -3.7016208 
 89 H  H11         -4.6239648     0.1237946    -2.6456444 
 90 H  H12         -7.4842071    -1.9871439    -0.2210577 
 91 H  H31         -8.6661935    -2.7143557    -2.2465425 
 92 H  H32         -5.7968018    -0.6221464    -4.6777532 
 93 H  H33         -7.8393903    -2.0423596    -4.4998035 
 94 C  C40         -5.8085594    -0.3183187     1.5189998 
 95 C  C41         -6.9508318    -0.1085043     4.1294265 
 96 C  C42         -7.1996409    -0.1706974     1.7151075 
 97 C  C43         -5.0142182    -0.3516027     2.6889488 
 98 C  C44         -5.5668283    -0.2487572     3.9696833 
 99 C  C45         -7.7655796    -0.0700308     2.9942349 
100 H  H34         -7.8603930    -0.1298117     0.8562187 
101 H  H49         -3.9379688    -0.4651981     2.5935230 
102 H  H50         -4.9192078    -0.2791530     4.8418650 
103 H  H51         -8.8417790     0.0385340     3.0998562 
104 H  H52         -7.3848883    -0.0314611     5.1220210 
 
Compound 89b  
 
SCF model: 
 A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
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Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1563.003533       0.072354       0.123425 
            2    -1563.023378       0.018333       0.146282 
            3    -1563.030515       0.006981       0.105291 
            4    -1563.032146       0.010443       0.103231 
            5    -1563.034023       0.007979       0.107680 
            6    -1563.036446       0.013371       0.130290 
            7    -1563.040070       0.015602       0.135151 
            8    -1563.043952       0.012175       0.120573 
            9    -1563.047723       0.015515       0.108392 
           10    -1563.052241       0.017529       0.096889 
           11    -1563.057651       0.017496       0.089995 
           12    -1563.064298       0.023704       0.111791 
           13    -1563.071277       0.027273       0.142456 
           14    -1563.079225       0.025425       0.133879 
           15    -1563.086933       0.026779       0.104964 
           16    -1563.095726       0.021000       0.138252 
           17    -1563.102365       0.017860       0.120165 
           18    -1563.108382       0.009090       0.143475 
           19    -1563.112073       0.012233       0.126218 
           20    -1563.115444       0.009093       0.117595 
           21    -1563.117811       0.009120       0.110646 
           22    -1563.119768       0.005136       0.112777 
           23    -1563.120967       0.002594       0.179317 
           24    -1563.121452       0.004835       0.126659 
           25    -1563.121878       0.002034       0.189614 
           26    -1563.122346       0.002647       0.199220 
           27    -1563.122921       0.002837       0.196702 
           28    -1563.123617       0.002682       0.187243 
           29    -1563.124321       0.003427       0.190160 
           30    -1563.124945       0.004316       0.179836 
           31    -1563.125506       0.004985       0.202989 
           32    -1563.125915       0.005010       0.142030 
           33    -1563.126373       0.004780       0.190261 
           34    -1563.126968       0.003829       0.174617 
           35    -1563.127742       0.001838       0.134005 
           36    -1563.128047       0.001381       0.038559 
           37    -1563.128082       0.000668       0.047559 
           38    -1563.128091       0.000348       0.021633 
           39    -1563.128099       0.000244       0.007975 
           40    -1563.128100       0.000192       0.013549 
           41    -1563.128100       0.000128       0.004744 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   4:45:59.85 
  Quantum Calculation Wall Time:   5:00:07.29 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry disabled 
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                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 B  B1           5.7241682     0.1162244    -0.1024369 
  2 C  C1           4.8945804     1.3804917     0.0534014 
  3 C  C2           4.8286862    -1.1570273    -0.5562240 
  4 C  C3           3.4408677    -1.0709841     0.0511168 
  5 C  C4           3.4189977     1.3546254     0.0935824 
  6 C  C5           2.7035643     0.1694667     0.1573287 
  7 C  C6           5.2604989    -2.5369992    -0.1749880 
  8 C  C7           3.1471445    -2.2702432     0.6514722 
  9 C  C8           4.2718960    -3.1691016     0.5106744 
 10 C  C9           7.2921421     0.0116696     0.0337726 
 11 H  H4           7.7514813    -0.5629349    -0.7826344 
 12 H  H7           7.5329602    -0.5420436     0.9546223 
 13 H  H10          7.8009973     0.9801909     0.0982539 
 14 C  C10          4.7767156    -1.0401160    -2.1188759 
 15 H  H2           5.7794618    -1.1439144    -2.5478020 
 16 H  H11          4.3744247    -0.0696750    -2.4252878 
 17 H  H12          4.1435827    -1.8310573    -2.5375146 
 18 C  C11          5.2517872     2.7178560     0.0729847 
 19 C  C12          2.9607872     2.7267135     0.1146732 
 20 C  C13          4.0689094     3.5417967     0.0995972 
 21 C  C22          1.2417815     0.1269116     0.3931645 
 22 C  C23         -1.5609169     0.0221991     0.8371445 
 23 C  C24          0.6322627     0.9427145     1.3644772 
 24 C  C25          0.4228697    -0.7532678    -0.3359161 
 25 C  C26         -0.9541967    -0.7973152    -0.1262592 
 26 C  C27         -0.7395054     0.8818379     1.5866217 
 27 H  H9           1.2491861     1.5964561     1.9727557 
 28 H  H30          0.8721312    -1.3946585    -1.0881870 
 29 H  H31         -1.5594459    -1.4780681    -0.7172470 
 30 H  H32         -1.1789317     1.5023836     2.3642898 
 31 P  P1          -3.3668409     0.0118847     1.2548190 
 32 C  C28         -4.0100017     1.4310621     0.2512350 
 33 C  C29         -5.1271947     3.6074387    -1.1357730 
 34 C  C30         -3.3814258     1.9480639    -0.8923378 
 35 C  C31         -5.1994431     2.0312217     0.6949022 
 36 C  C32         -5.7589628     3.1060043     0.0035468 
 37 C  C33         -3.9364212     3.0287923    -1.5799228 
 38 H  H34         -2.4518531     1.5078571    -1.2415875 
 39 H  H35         -5.6851841     1.6558608     1.5926862 
 40 H  H36         -6.6811848     3.5575066     0.3600137 
 41 H  H37         -3.4375164     3.4194608    -2.4633481 
 42 H  H38         -5.5565807     4.4500708    -1.6714789 
 43 C  C34         -3.9876669    -1.4712936     0.3339356 
 44 C  C35         -4.9242661    -3.8302024    -0.8845234 
 45 C  C36         -4.5059585    -1.4461194    -0.9696255 
 46 C  C37         -3.9597108    -2.6972356     1.0204872 
 47 C  C38         -4.4139425    -3.8684173     0.4146971 
 48 C  C39         -4.9722298    -2.6165776    -1.5720418 
 49 H  H33         -4.5512617    -0.5092881    -1.5166934 
 50 H  H39         -3.5841941    -2.7318714     2.0408585 
 51 H  H40         -4.3800714    -4.8074831     0.9610586 
 52 H  H41         -5.3726446    -2.5782632    -2.5820657 
 53 H  H42         -5.2887334    -4.7393736    -1.3554323 
 54 H  H43          1.9279399     3.0510210     0.1221167 
222 
 
 55 H  H44          2.2465135    -2.4892977     1.2151779 
 56 H  H45          4.3035038    -4.1812167     0.9005533 
 57 H  H47          6.2089337    -2.9719509    -0.4736543 
 58 H  H48          6.2673277     3.1007493     0.0512847 
 59 H  H50          4.0610423     4.6263555     0.1051926 
 
Compound 118 
 
DFT calculations gave this output with one imaginary number present. 
 
SCF model: 
A restricted hybrid HF-DFT SCF calculation will be performed using Pulay DIIS + Geometric Direct Minimization 
 
 
Optimization: 
         Step      Energy          Max Grad.      Max Dist.  
            1    -1485.191471       0.212036       0.122805 
            2    -1485.287424       0.112388       0.107135 
            3    -1485.339484       0.077166       0.146622 
            4    -1485.376401       0.043023       0.145001 
            5    -1485.396738       0.035130       0.138170 
            6    -1485.410731       0.015462       0.118383 
            7    -1485.415626       0.016879       0.148972 
            8    -1485.416572       0.009592       0.210141 
            9    -1485.417821       0.006758       0.069410 
           10    -1485.417703       0.007908       0.107220 
           11    -1485.418173       0.000996       0.046748 
           12    -1485.418203       0.000434       0.028455 
           13    -1485.418209       0.000241       0.002640 
           14    -1485.418210       0.000136       0.002449 
 
<step 2> 
Job type: Frequency calculation. 
Method: RB3LYP 
Basis set: 6-31G(D) 
 
  Reason for exit: Successful completion  
  Quantum Calculation CPU Time :   1:14:49.60 
  Quantum Calculation Wall Time:   1:19:45.52 
 
 
 
SPARTAN '14 Properties Program:  (Linux/P4E)                     build  14.117  
  Use of molecular symmetry enabled 
 
                     Cartesian Coordinates (Angstroms) 
       Atom            X             Y             Z      
    ---------    ------------- ------------- ------------- 
 
  1 C  C1           0.6309687     0.5665629     0.0000000 
  2 C  C2           1.3372340     0.4416037    -1.2186858 
  3 C  C6           1.3372340     0.4416037     1.2186858 
  4 N  N1           2.6776414     0.0468375     1.2272489 
  5 N  N2           2.6776414     0.0468375    -1.2272489 
  6 C  C7           0.9891461     0.7696495    -2.5608764 
  7 H  H2           0.0296741     1.1335624    -2.8945737 
  8 C  C8           3.1339685     0.1179275    -2.4839103 
  9 H  H6           4.1547677    -0.1606618    -2.7089642 
223 
 
 10 C  C9           2.1172963     0.5750902    -3.3449723 
 11 H  H7           2.2138819     0.7464405    -4.4081776 
 12 C  C10          0.9891461     0.7696495     2.5608764 
 13 H  H9           0.0296741     1.1335624     2.8945737 
 14 C  C11          2.1172963     0.5750902     3.3449723 
 15 C  C12          3.1339685     0.1179275     2.4839103 
 16 H  H11          4.1547677    -0.1606618     2.7089642 
 17 H  H14          2.2138819     0.7464405     4.4081776 
 18 P  P1          -1.1198345     1.1744859     0.0000000 
 19 C  C13         -1.9235982     0.2951631     1.4208069 
 20 C  C14         -3.3446964    -0.9042796     3.5260659 
 21 C  C15         -1.7119960    -1.0544246     1.7468103 
 22 C  C16         -2.8543395     1.0332826     2.1663874 
 23 C  C17         -3.5632980     0.4362903     3.2121676 
 24 C  C18         -2.4155625    -1.6478937     2.7923683 
 25 H  H1          -0.9834851    -1.6398937     1.1949911 
 26 H  H5          -3.0230853     2.0807711     1.9290043 
 27 H  H8          -4.2814212     1.0211869     3.7806365 
 28 H  H10         -2.2381773    -2.6919385     3.0362078 
 29 H  H12         -3.8928478    -1.3700315     4.3406741 
 30 C  C19         -1.9235982     0.2951631    -1.4208069 
 31 C  C20         -3.3446964    -0.9042796    -3.5260659 
 32 C  C21         -2.8543395     1.0332826    -2.1663874 
 33 C  C22         -1.7119960    -1.0544246    -1.7468103 
 34 C  C23         -2.4155625    -1.6478937    -2.7923683 
 35 C  C24         -3.5632980     0.4362903    -3.2121676 
 36 H  H3          -3.0230853     2.0807711    -1.9290043 
 37 H  H13         -0.9834851    -1.6398937    -1.1949911 
 38 H  H15         -2.2381773    -2.6919385    -3.0362078 
 39 H  H16         -4.2814212     1.0211869    -3.7806365 
 40 H  H17         -3.8928478    -1.3700315    -4.3406741 
 41 B  B1           3.4478865    -0.5314315     0.0000000 
 42 F  F1           4.7549731    -0.0854368     0.0000000 
 43 F  F2           3.3735633    -1.9148978     0.0000000 
 
 
